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Nanoscience is the study of phenomena at the nanoscale, where materials have different 
properties from those presented in classical physics. In the daily work of laboratories, science 
and technology are integrated giving birth to a common practice denominated 
Nanotechnoscience. This field configures a complex practice that co-creates a market with 
expected social and economic benefits, while generating new and unknown risks, both in terms 
of human health and the environment. This market is a sociotechnical network under which 
agents maximize their interests through economic calculations and where conflicts are solved 
through prices. 
The benefits of nanotechnology could be traced across economic sectors, promising new 
solutions to social problems. These aggregated promises, which are in permanent interaction 
with public policies, forge future expectations and put pressure on the process of allocation of 
national public resources, and shape the future of society in its whole. Hence, it is crucial to 
involve society in the governance of the nanotechnoscientific network from its early 
developments in order to achieve social responsibility. Experts, private companies, government 
agencies and society should be involved in an interactive process of responsible innovation, 
allowing a deliberative confrontation between different views and interpretations that would 
provide sustainable governance.  
Following Actor Network Theory, investments in the nano market could be interpreted as one 
of the most important inscriptions and translations of network interactions.  Hence, it is crucial 
to develop tools to socially and economically valuate these investments, both from the point of 
view of private investors and from the governments. While the traditional perspective on 
economic investments revolves around the notion of equilibrium and only offers actuarial 
assessment tools, the dynamic economic, social and political perspective of this thesis allows 
the integration of previously neglected social and environmental issues into a valuation 
framework that could be used by policy makers and investors.  
This thesis contributes to the theory of techno-scientific governance by unpacking the nano-
practice, its market and associated risks. It examines how the nano-practice, its industrial 
dynamics and society interact to create a market with new risks and benefits. After a 
demarcation and articulation of the concepts of sustainable nanogovernance and RRI 
responsible, this thesis evidences that the nanotechnology dynamics in Argentina is regulated 
by a de facto governance. Even though the State steers the productive sector (through funding 
and regulation) to address social inclusion, its top-down perspective to policy making excludes 
society from the different stages of the decision-making process. As a response to this finding, 
this thesis recommends the incorporation of a bottom-up public management approach that 
integrates the recognition of the centrality of the interactions between society and nature - 
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Nanoscience and nanotechnology are integrated into the daily work in the 
laboratories, leading to a practice called technoscience (Nordmann, 2012). The 
term refers to a different way of doing science, demanding exchange and 
communication between different practices (Galison, 1997; Galison, 2006) and 
seeking explanations by an eclectic use of various closed theories. In this new field, 
different disciplines and institutions converge, giving rise to a new practice. 
This practice helps to create its corresponding market, understood as a socio-
technical network where agents maximize their interests through economic 
calculations and where conflicts are resolved by fixing prices (Callon, 2012). This 
innovative market requires investments that are: (i) irreversible, due to the inability 
to recover the initial payment; (ii) uncertain, future profit flows are unsafe; and (iii) 
flexible, investors could leave the project (Dixit and Pindyck, 1994). 
On the one hand, this new market has placed nano-products in our society, which 
creates new risks for humans (Cui et al., 2005) and for the environment (Colvin, 
2003). Universities and companies that produce these nanomaterials are directly 
responsible for them. On the other hand, these organisations manage them using 
engineering methodologies regulated by the state (Medley and Walsh, 2007) and 
they also pay a premium to an insurance company that identifies, analyses, 
evaluates, and diversifies the remaining risk (Lloyd, 2007). However, this practice 
of enterprise risk management (ERM) is not socially sustainable because it does 
not contemplate social and environmental aspects, it only deals with business and 
regulators. 
In the American literature regarding technological regulation, one of the most 
influential works is Responsive Regulation, where Ayres and Braithwaite (1992) 
propose the image of a pyramid of technological regulation. It is cycle that starts 
with a flexible approach based on starting by a self-regulation (soft law), latter on 
it is accompanied by a growing state intervention. Finally, the government impose 
a strict regulation (hard law). Unlike the American program, the European Program 
Converging Technologies for the European knowledge society (CTEKS) 
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emphasizes the importance of the technological policy for the creation of a 
knowledge society guided by the precautionary principle. 
Currently the nano-market has a de facto governance built on an interaction of 
actors with conflicting interests. This context requires effective participation of 
market actors, governments and general public from the early stages of the 
innovation process to ensure a socially responsible nano-dynamic, a Sustainable 
Governance.  
This thesis proposes a sustainable governance of the nano-practice, its market and 
its associated risks. For doing this, it is important to understand how the practice is 
constituted from the relations between human and artefacts in a permanent 
transformative interaction and how it co-constitutes new risks in the society and 
creates a market. Sustainable Governance extends the traditional approach of a 
purely economic-actuarial methodology, and incorporates social and 
environmental interests in a socially responsible dynamic. A key feature is its 
ability to adapt to an uncertain process. This requires a government with 
decentralized institutions operating under rapid changing scenarios and high 
uncertainty levels (Olsson et al., 2006). While this governance must necessarily 
adapt to the dynamic, the associated political process must be thoughtful and 
deliberative to be sustainable over time. Moreover, although an exclusive 
regulation of experts appears to reflect of order and control, it clearly marginalizes 
alternative perspectives reinforcing the hegemonic vision of technology. 
This thesis aims to understand the nano-dynamic in Argentina and analyses it from 
a Sustainable governance perspective. To achieve this objective, this thesis is 
divided into four chapters. The first one begins with different views of 
nanotechnology: researchers, governments, academia, the third sector and the 
insurance sector. Then, an eclectic theoretical framework is proposed to research 
the nano-field which redefines the practice as a techno-scientific process.  
The second chapter examines how the practice is co-constituted with its market. 
The transformative power of the nano-industrial dynamics is presented, with 
emphasis on nanomedicine. Then the literature on design and creation of markets 
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is analysed in the contexts of a new market of nano-carriers. Finally, it analyses the 
rationality of investors in the sector and develop two quantitative decision models. 
The third chapter identifies nanotechnology risks. They are co-constituted both, in 
the techno-scientific practice and in the unfolding of the market dynamics. In 
particular, the risks of nanotechnology to humans and the environment are 
analysed. Finally, the point of view of industry is discussed.  
After understanding the practice, its market and its risks, chapter four presents the 
perspective of sustainable governance to achieve a socially responsible 
nanotechnology dynamics in the long term. It begins by analysing how 
expectations construct a socio-technical network, and then the concept of 
sustainable governance is introduced. The second section applies this approach to 
Argentina. It presents the governmental narratives of nanotechnology, the public 
expectations and the inscriptions set up in the country. As examples, four public-
private partnerships are presented. Finally, it analyses if the nano-dynamic in 
Argentina is socially responsible in the context of a sustainable governance. 
Chapter 1: The Nano-Techno-Scientific Practice  
What is nanoscience and what is nanotechnology? In order to address these 
questions, this chapter will examine the perspectives of different stakeholders: the 
government, the scientific community, private companies and the third sector.  
Alfred Nordmann (2006) proposes the use of the concept techno-science 
(Nordmann, 2012). Researchers pursue the goal of building nano-materials, not to 
prove their existence. When envisioning the future of the nanotechnology, it is 
important to assess how the past achievements of other technologies have been 
textually produced. The story of the past is an essential element when imagining 
the future (Thompson, 2011). This story is combined with future expectations to 
define the field (Selin, 2007). The nano-laboratory is not isolated from society. The 
relationships among stakeholders infuse meaning to the technology and claim for 
regulation.  
According to the economic theory, expectations about the future course of 
technological innovation are one of the most important features to consider by the 
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investor when choosing whether or not to adopt a new technology. These 
aggregated business decisions and their dialectical relationship with public policies 
contribute to shape future expectations and reproduce them. There is no possibility 
of sustaining over time future expectations that are not synchronized with the 
market dynamic, at least in the Western capitalist world that concerns us.  
Roco, Mirkin and Hersam (2011)  presented the US vision by describing the 
National Nanotechnology Initiative (NNI), its current situation and its expected 
development in the long term (2000-2020). It pursues the formation of an 
interdisciplinary academic community with a market orientation. This is reflected 
in the definition given by the NNI:  
Nanotechnology is the ability to understand, control, and manipulate matter at the 
level of individual atoms and molecules, as well as at the “supramolecular” level 
involving clusters of molecules (in the range of about 0.1 to 100 nm), in order to 
create materials, devices, and systems with fundamentally new properties and 
functions because of their small structure. (Roco, 2007 p.3).  
Meanwhile, the British government defines: 
Nanoscience is the study of phenomena and manipulation of materials at atomic, 
molecular and macromolecular scales, Where Significantly Differ from Those 
properties at a larger scale. 
Nanotechnologies are the design, Characterisation, production and application of 
structures, devices and systems by controlling shape and size at nanometer scale. 
(The Royal Society & The Royal Academy of Engineering, 2004 p.5) 
These definitions imply a unifying platform of science and engineering at the 
nanoscale, a technological approach to strengthen the productive sector.  
There are no theories specially adapted to the complexity of nanoscale world that 
could explain the relationship between the structure of a given material and its 
properties. The researcher deploys partial explanations taken from various theories, 
forcing them beyond their scope (Winsberg, 2006). The practice in the laboratory 
has an engineering perspective, which constructs nanomaterials by using eclectic 
frameworks (Rip, 2013). Traditional theories are extended to face the challenges 
of the world at the nanoscale. 
Nanotechnology public initiatives are excellent business opportunities for risky 
investors. Within the market logic, it is important to note the role of insurance 
companies as moderators of this dynamic, because their business is to collect 
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money in advance to cover their customers´ future contingencies. Current 
regulation of nanotechnology sector is insufficient. In response to this situation, the 
insurance industry demands greater transparency and better regulation (Lloyd, 
2007). 
After the report of different visions of the nano-world, the challenge is to 
understand how agents communicate the expected benefits to get more funding 
from governments. The narratives of past technologies are essential to imagine the 
future of nanotechnology, given that some of their traits remain. Chris Tourney 
(2006) selects the theory of myths developed by Malinowski (1954) to unpack what 
narratives has been useful to make sense of nanotechnology development.  
After analysing the narratives of the past, it is important to understand expectations 
about the future of nanotechnology. Cynthia Selin (2007) explores how different 
actors operate to define the field and what problems are legitimated. This highlights 
the ways in which different actors intend to colonize the future and try to legitimize 
their present. The fight between actors revolves around the question of what 
nanotechnology is and, crucially, what should be. Two groups emerge clearly, the 
so-called visionaries and scientists. Drexler (2013) embodies the former group, 
dominating the official discourse during the last decade of the past century (Stix, 
2001; Selin, 2007). The second group is mainly represented by the academic 
community. 
The views and narratives about nanotechnology build a new techno-scientific 
practice, which could be understood using the actor-network theory (ANT). 
According to this perspective, the relationship between agents instils meaning to 
its existence. Moreover, technologies involved are not only useful tools, but also 
defined within the boundaries of symbolic struggles (Latour and Woolgar, 1986; 
Bijker and Law, 1992). ANT approach is adequate to understand the nano-practice 
because it demands the observation of the activity in the laboratory at the micro 
level, and a theoretical concern with the organization of society, opening new 
possibilities for the study of the political role of science. In the next chapter ANT 
will be used to understand how the industrial nano-dynamics is established. 
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Chapter 2: Nano-Industrial Dynamics and the Constitution of a New Market 
This nano-techno-scientific practice is a fertile ground for the convergence of 
variety of disciplines, which impacts on its industrial dynamics (Bozeman et al., 
2007; Andersen, 2011). A specific branch of nanotechnology of particular 
importance for this thesis is nanomedicine. It is defined as the medical applications 
of nanotechnology, which involves the development of new procedures to diagnose 
and cure diseases (Paradise et al., 2008). This chapter analyses the market of nano-
carriers and its patents. The methodology proposed by Callon and Muniesa (2005) 
helps to unpack this market and offers tools for analysing their risks. 
After the analysis of the process of formation of the nano-market, this thesis 
focuses on the role of investors. Firstly, it explains the process of creating new 
businesses and identifies some lessons learned from the first generation of 
entrepreneurs. Then, a valuation model is presented, focusing on investments in 
the pharmaceutical industry. Finally, the last sections propose a mathematical 
model representing pooled investment decisions among a small nanotechnology 
company that owns the patent of a nano-carrier (possibly a spin-off) and a large 
pharmaceutical company. 
Future expectations about nanotechnology transcend industrial innovation, having 
the potential to transform other industries (Bozeman et al., 2007). A question 
immediately arises: Is Nano-industrial dynamics similar to other technologies such 
as microelectronics or biotechnology? A group of scholars argues that the nano 
market is being controlled by large multinationals with in house R&D as in the 
case of microelectronics (Larédo et al., 2009). From a different perspective, other 
authors argue that the organization of nanotechnology resembles biotechnology, 
where the spin-off university has played a prominent role (Darby and Zucker, 
2003). New nano-companies face great uncertainty (Hite and Hesterly, 2001) and 
the circulation of knowledge has been interpreted as the equivalent to the 
movement of researchers or engineers in the field (Bozeman and Mangematin, 
2004). 
Nanomedicine is defined as the set of medical applications of nanotechnology, 
including the development of new procedures to diagnose and cure diseases 
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(Etheridge et al., 2013). Reformulating a drug into nano-sized crystals generates a 
different version of the existing drug, with higher solubility. This reduces the 
required dose, diminishing adverse side effects. For instance, the insertion of a drug 
using a nano-capsule aims to target specific tumour cells (Bawarski et al., 2008; 
Davis, 2008). Another application of nanotechnology is medical diagnosis. For 
example, by using different types of labels, some nanostructures can detect the 
presence or activity of specific molecular entities within the body. (Van Kasteel, 
2009; Kamaly et al., 2013). 
In March 2009, the Food and Drug Administration (FDA) established a partnership 
with the Alliance for NanoHealth1 to expand the knowledge about how 
nanoparticles impact on biological systems, aiming to develop processes that will 
reduce possible risks. This collaboration had two main objectives (te Kulve and 
Rip, 2013). First, it has aimed at encouraging the progress of nanomedicine, 
starting with preclinical stages of development, continuing with clinical and, 
finally, supporting the marketing of new products. Second, it has improved 
understanding of the risks and benefits. 
Applying for a patent in nanomedicine is not easy, due to evaluators´ concerns with 
health risks and human safety (Bawa, 2007; Martins et al., 2013). The experience 
of the biotech industry about licensing strategies, development and financing have 
certain characteristics in common with nanomedicine: the new industrial 
applications in both sectors rely heavily on intellectual property (IP) and R&D are 
costly, complex and uncertain (Stewart, 2005). 
The markets have clear advantages that make them irreplaceable in a capitalist 
Western context: their autonomous agents innovate, they allow their coordination, 
and they facilitate contracts between parties. However, the markets have clear 
limitations: they are not designed to achieve the public good and they produce 
negative externalities on human groups (Callon, 2009). Therefore, it is necessary 
to reconsider basic questions about markets efficiency and analyse how we can 
ensure that the new nanotechnology market could be socially efficient. 
                                                 





Economic theories always are performative, and in this particular case, 
nanomaterials and technologies al play an important role in the process of market 
creation (Barry y Slater, 2002; Callon, 2010). This interaction between techno-
science and markets produces what Marilyn Strathern (2000) calls the proliferation 
of new identities, creating constantly new uncertainties about the constitution of 
the collective. This process transforms the economy, the politics and the techno-
scientific practice surrounding it (Callon, 2009). 
Nanotechnology market efficiency requires: (1) density, to attract a sufficient 
number of participants, (2) smoothness, to overcome congestion problems that can 
bring down the number of agents operating, and (3) safety and simplicity. 
Moreover, it should exclude operations based on moral reasons (Roth, 2008). 
Following Callon and Law (1997), this thesis argues that market players are 
collective hybrids in constant constitution, in which people, devices and texts 
interact. There is no difference between the person and the network of institutions 
in which she operates, or more precisely, between the person and the network of 
entities acting through it. The same idea applies to the market as a whole, its agents 
do not act isolated, they are collective hybrids. These agents interact performing 
arithmetic operations, so they are collective hybrid computing devices (Callon and 
Muniesa, 2003).  
The calculation is a feature of any market, but who does the calculation and how? 
In the literature, there are two contrasting perspectives to answer these questions. 
From a neo-classical point of view, agents´ ability to calculate is innate. 
Conversely, from the perspective of social anthropology, the calculation is an ex-
post rationalization. In this thesis, I would avoid these two extremes. On the one 
hand, people should not reduce to mere agents who calculate. On the other hand, 
calculation should not be ignored nor dissolved by ethnographic descriptions 
(Callon and Muniesa, 2003). 
In the market, the valuation process of assets arises from exchanges between agents 
making cross calculations: the calculating devices (Çalışkan and Callon, 2010). 
They include tools that actively constitutes reality and they struggle to impose 
prices one to another (Rose and Miller, 2008; Weber, 1978 [1922]; Stark, 2009). 
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The calculation is distributed among humans, formulas and artefacts (Latour, 1987; 
Lepinay and Callon, 2009). 
Nano-carriers are nanoscale elements that are introduced in the body and carry the 
drug to the place where the body needs it (Torchilin, 2012). To manufacture these 
products a patent is needed (Carbone et al., 2013). The process of transforming 
patents into transactional goods starts with a process of singling out its properties, 
so it can enter the world of the business that uses it to produce nano-carriers. Once 
the company placed the patent into its network, the production process of the nano-
carrier starts – which is then transformed into a good that would be exchanged by 
money in the market.  
There are clear asymmetries in this market. On one hand, the producer normally is 
a large multinational pharmaceutical company with a lot of calculation power. On 
the other; the consumers are able only of making simple calculations.  
After analysing the process of market creation, the focus of the thesis is 
understanding the role of investors in nanotechnology projects. In general, their 
initial goal is to register (buy or rent) a patent. Then -under its protection-, they 
begin production and sell the products. The valuation methodologies of these 
technology assets can be classified into two main groups (Mun, 2003). On the one 
hand, the traditional one, which involved costing and income calculations, and, on 
the other hand, innovative methods including real option (Schwartz, 2013). In the 
case of nanotechnology projects, valuation methods need to take into account that: 
i) they require large investments, ii) their costs are sunk, iii) their final product have 
uncertain futures prices, and iv) their investor could abandon the project (Vimpari 
and Junnila, 2014; Brealey and Myers, 2003). 
Hardly a single organization undertake a nano-medical project, usually joint 
investments are required. This thesis develops a mathematical model to analyse the 
commercial interaction between a company specializing in the development of 
nano-carriers and a pharmaceutical large company. While the former develops 
research in vitro / in vivo testing to achieve a patent; the latter has the drug and can 




Chapter 3: Risk as a Co-Created Process 
In contemporary culture, risks are present in a wide range of practices and 
experiences (van Loon, 2000). The concept of risk is a topic widely debated among 
experts, politicians, philosophers, media professionals and the public in general. In 
Western societies, the sense of risk has evolved with the development of social 
institutions, the economy and the welfare state. The rapid expansion of scientific, 
technological and medical knowledge advances have created a set of experts in the 
calculation, assessment and management of risk (Mythen, 2004). In the late 
modern period, public awareness of risk has also been influenced by the expansion 
of the media and the growth of new information and communication technologies. 
In social sciences, it is possible to identify four paradigms attempting to unpack 
risk in contemporary societies (Mythen, 2004). Firstly, inspired by the work of 
Mary Douglas (1966), there is an anthropological approach where differences in 
risk perception are explained by patterns of social solidarity, different worldviews 
and cultural values. Secondly, in the field of social psychology, psychometric 
paradigm has focused on individual cognition of risk (Slovic, 1987). Thirdly, the 
government's approach to risk has been addressed by Michael Foucault (Gordon et 
al., 1991). Fourthly, the risk society perspective led by Ulrich Beck (1992) has 
illuminated the pervasive effects of risk in everyday life. He argues that the process 
of modernization has created a unique collection of humanly produced risks (Beck, 
1999). In the last decade, the risk society has been very influential as a stimulus for 
academic, environmental and political dialogue (van Loon, 2000). The prospect of 
the risk society can discuss the constitution of risk and its effects on various social 
fields, enabling an analysis that extends the actuarial, financial or engineering risk 
protocol. 
From the hegemonic point of view, social production of wealth inevitably leads to 
social production of risks. Moreover, modern culture of risk suggests that stability 
is a failure and that taking risks is the only way to be innovative and successful 
(Sennett, 1998). In this context, many entrepreneurs are turning their attention to 
the nano-market and betting on risky new innovations as business opportunities. 
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Without proper regulation, this implies that there is an unstoppable race to promote 
innovations without increasing risk levels for society.  
This risk is co-constituted within the techno-scientific practice and in the course of 
the market dynamics. This chapter examines nanotechnology risks to humans and 
the environment. Here, the industry´s point of view is discussed. It presents both 
the traditional methodologies used in industry for valuing projects and their 
limitations. Then, the real options approach is presented as an alternative to 
overcome the flaws and weaknesses of traditional methodologies. Real options 
integrates key aspects of any innovative project: uncertainty, flexibility and 
irreversibility. Following, this chapter examines the role of the insurance sector: 
limiting, measuring and imposing prices (premium) to risks. In the last section, two 
new quantitative models are introduced. They offer tools to improve public policy 
decision making. 
The phenomenon of risk society becomes visible when dangers arose from human 
decisions exceed the possibility of any insurance company to cover it. 
Nanotechnology risks are caused by humans, through government decisions, 
industry investments and society choosing a certain lifestyle involving particular 
risks (Beck, 1992; Matten, 2004). They are global risks. In other words, they are 
neither limited by traditional national boundaries of industrial societies, nor limited 
to a certain place or to specific groups in society (Beck, 1999).  
Technological innovations are presented by the market as secure, with high 
expectations of future profits and with diffuse risks. Global regulatory policies 
consolidate the hegemony of certain economic groups. Current risk regulation are 
in the hands of technical experts, excluding the participation of other social actors. 
The former contribute to the production of a discourse that transforms potential 
risks for society into business opportunities (van Loon, 2002). 
While some studies analyse the impact of industrial activity on the governance of 
risk (Meyer et al., 2009), few dispute the impact of industrial dynamics on the 
direction of technological change (Robinson, 2009). In particular, Rafols et al 
(2011) argue that the specific features of industrial dynamics of nanomaterials have 
strong implications for their governance. At the moment, the market have a de facto 
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governance built by conflicting actors (Rip, 2010). This is not controllable from a 
top-down approach; on the contrary, Rafols et al (2011) propose a bottom-up 
management to account for the distributed interactions in the system (Rip, 2010). 
From the methodological point of view, the investment projects involving research 
and development challenge financial valuation. These projects encompass multiple 
sources of uncertainty and learning processes of different actors. Furthermore, the 
total cost of the investment is uncertain. Each stage of the investment is subject to 
exogenous and endogenous sources of uncertainty or catastrophe, putting the 
completion of the project at risk. Dixit and Pindyck (1994) argue that most 
investment decisions in innovative projects have three key features that demands 
the use of the methodology of real options instead of traditional approaches. 
Firstly, these investments are mostly irreversible (fully or partially). Secondly, 
there is uncertainty about the future return on the investment. Future prices of 
assets are unpredictable and profit flows are uncertain. Thirdly, investors have the 
option of waiting for better information about future prices (Pindyck, 1991; 
Trigeorgis, 1996; Brennan and Schwartz, 1985; Trigeorgis, 1993; Insley and 
Wirjanto, 2010; McDonald and Siegel, 1986). 
For an effective nanotechnology policy management, this thesis proposes the 
inclusion of two quantitative tools in the decision making process. Based on the 
financial structure of the project, this section introduces a tool able to address the 
uncertainty of future benefit and to assess the appropriateness of investing in the 
project. If the government chooses to fund the project, the second financial tool 
would help to identify the most socially efficient way of giving incentives.  
Although there is a vast literature on the precautionary principle used in the 
European community (Monaghan et al., 2012), it is difficult to operationalize it as 
a quantitative tool available for policymakers (de Sadeleer, 2012). In this thesis, 
the first proposed financial tool presents a model that quantifies the social value of 
caution. This tool overcomes the standard methodology of cost-benefit that 
proposes to carry out every project with positive expected net benefits. However, 
if uncertainty and irreversibility of the project is contemplated, this threshold is 
greater than zero (Farrow, 2004). The literature recognizes two main categories of 
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government incentives: push (paid before a project starts) and pull (paid if a project 
is successful) (Nemet, 2009). Nanotechnology projects usually rely on government 
funding (Hsu and Schwartz, 2008). The second financial tool introduced in this 
thesis identifies the most effective government response to a particular project in 
different scenarios. In general, the more efficient incentive are hybrid contracts that 
gives an initial sum to projects (Push) but also reward the project that is socially 
responsible and achieved a solution to a public problem (Pull). 
This chapter argued that enterprise risk management and government regulation 
are not enough to contemplate social and environmental risks. Technicians perform 
risk management without considering impacts on society.  
Chapter 4: Process for Establishing a Sustainable Nano-Governance 
As analysed in Chapter 1, public perception of nanotechnology moves between two 
extremes: those who argue that nanotechnology is the salvation for humanity and 
those who assimilate it to apocalyptic nightmares (Mekel, 2006). While some 
groups produce narratives where the imagined future is a promise of small 
programmable machines capable of curing diseases or clean the planet from 
pollution, others assert a vision where the panic against the possibility that these 
machines achieve autonomy is paramount (Highfield, 2003). As discussed in the 
first chapter, various disciplines and institutions interact to create expectations, 
often conflicting, about future profits. In recent years, nanotechnology future 
expectations have added economic value to investment projects, attracting new 
public and private investors. The nano-industrial dynamics has developed from a 
mere discourse in the early millennium to an economic reality today.  
Firstly, this chapter examines how nanotechnology actors coordinate expectations 
by innovating and shaping a complex and controversial dynamics. Researchers, 
businesses, governments and NGOs interact in a network of relationships from 
positions often conflicting with each other. Secondly, the State role is interpreted 
as a distributed computation agency. This section critically analyses North 
American and European regulation. It concludes that the European precautionary 
principle is compatible with sustainable governance. Next, it is argued that the 
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market for nanomedicine is a dynamic non-equilibrium system contrasting with the 
orthodox approach hegemonic market equilibrium.  
Next, this chapter unpacks the Argentine case using the sustainable governance 
approach. In the early stages of the nanotechnology field in this country, public 
funding aimed at fostering technology and productive innovation. However, in 
response to the negative reaction of different social groups, the national 
government started to considerate social impact as a key aspect to fund projects. 
This chapter describes four recent experiences of collective hybrids. They have 
acted as agents of change (public-private partnerships with clear objectives to 
innovate in the nanotechnology context) with specific plans aiming to address 
social problems in Argentina. 
Economic theory, since the 1970s, asserts that expectations about the future course 
of innovation is crucial for business decisions about technology (Rosenberg, 1976). 
These private expectations compete for allocation of national public resources, 
defining the future of society as a whole (van Lente and Rip, 1998; van Lente, 
1993). Nanotechnological promises are functionally important to the new market 
(Konrad, 2006). In the early stages of this market, such promises provided a 
framework that launched the nano-dynamics. However, after a while, the later 
needed to address specific demands and had to offer measures of success (van 
Lente, 1993). A dual dynamic is then established, where specific promises give 
legitimacy and credibility to the general one, and the last one gives sustainability 
to the first one (Parandian et al., 2012). 
The Western hegemonic thinking understands the relationship between nature and 
society from the perspective of equilibrium (Worster, 1977; Worster, 1993). This 
idea is culturally rooted in political, academic and lay discourses. In the context of 
a crisis, policymakers usually seek to regain the equilibrium of the economic 
system. A clear example of this is the reaction of First World governments to the 
latest international financial crisis, where they promoted policies to return the 
system to its equilibrium. This perspective clearly has reinforced the power of the 
dominant group and has silenced voices of dissent, denying the complex dynamics 
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of the co-constitution of the dynamic previously described in this thesis (Scoones 
et al., 2007). 
Within this complex dynamics of expectations, the State is a fundamental actor. 
Modernity has conceptualized the State as an element of modern social order, 
seeing the state as an actor (Passoth and Rowland, 2010). However, other 
perspectives have interpreted the state as a distributed network of agents, not 
necessarily coordinated (Carroll, 2006; Latour, 2000; Passoth and Rowland, 2010). 
In this view, no government entity is per se an actor, state action only acts in 
relation to socio-technical networks in a continuous process of transformation 
(Carroll, 2006).  
This network also involves private actors, leading to a mixed system of governance 
with negotiations made at different levels. At the regional and international levels, 
this negotiation is particularly complex because the industry representatives meet 
agents of various governments, which often pursue conflicting interests. Moreover, 
the economic structures are subject to historical change and this is reflected in 
changes in their modes of governance. Kornelia Konrad (2010) proposed the 
concept of governance of and by expectations to capture the different ways of how 
expectations are coordinated and shape the technological dynamics.  
This conceptualization provides a comprehensive approach that focuses on the 
different modes of production and coordination of expectations in markets where 
different actors interact respecting rules but following their own interests. It is 
crucial to analyse the social construction of nature in the scientific and policy 
discourse (Forsyth, 2003), being fundamental to break the separation between 
nature and society (Latour, 2004) and accept the complexity of the network 
(Scoones, 1999).  
Traditional definition of sustainability emphasizes a necessary balance between 
present and future human needs (Brundtland, 1987). However, in the case of Nano-
medicine this static approach is insufficient due to its complex and uncertain 
dynamics. The valuation of human needs is a process of permanent constitution, 
with agents interacting with divergent prospects. 
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How States should respond to network disturbances/shocks and how it would be 
possible to achieve sustainable governance of innovative technology? If the shock 
is short lived and internal, the response to the problem requires stability and 
encourages the restoration of the lost equilibrium. If the source is external, on the 
contrary, the policymaker needs resilience. If the disturbance is long lasting and 
internal, durability is required. If the shock is long lasting and external, the network 
must to react with strength (Scoones et al., 2007).  
While the concept of responsible innovation has been analysed in the literature for 
almost a decade, it only appeared in the European official discourse in May 20112. 
The European model of responsible innovation is based on the principle of 
inclusion and requires the participation of all stakeholders throughout the 
innovation process. Owen, Macnaghten and Stilgoe (2012) highlight three main 
features of the European official policy discourse on the subject. First, they 
highlight the concept of science for society, which means research and innovation 
should be promoted in order to solve concrete problems of society in the context 
of a deliberative democracy. These authors identify the notion of contribution to 
the future development and the explicit link between innovation and responsibility 
(Owen et al., 2012) as significant. 
In particular, the European commission outlines six principles for responsible 
innovation. Firstly, it asserts the need of the commitment with the responsible 
innovation process from researchers, entrepreneurs, policy makers and civil society 
in the process. Secondly, it also demands a commitment to gender equality. 
Thirdly, it remarks the importance of creative learning. In other words, Europe 
should not only increase the number of researchers, but also have to educate future 
stakeholders to be able to fully engage in a responsible manner with all sorts of 
innovation processes. Fourthly, it states an ethical principle. Fifthly, it proposes 
that innovative processes must be transparent and accessible to the general 
population. Finally, it proposes that innovations should be designed for and with 
society (Stilgoe et al., 2013). 
                                                 
2 Opening Conference of the workshop held at the Directorate-General Research (Brussels) in May 2011 by 
Octavi Quintana, quoted by Owen, Macnaghten and Stilgoe (2012). 
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In this view, a responsible innovation process has to be anticipatory, reflexive, 
deliberative and responsive. It has to be anticipatory because it requires an analysis 
of all impacts that might arise during its development, whether at economic, social, 
and environmental levels. It has to be reflexive because it must reflect on the goals, 
motivations and impacts on every project, allowing discussion about what is known 
and what not. It should be deliberative because it needs dialogue, compromises and 
debates, in order to incorporate the perspectives of all stakeholders. It has to be 
responsive because it must be inclusive and open to a learning process (Owen et 
al., 2013).  
In a newspaper article (La Nación 2004), the Argentina's economic minister stated: 
Nosotros acabamos de lanzar un programa para el desarrollo de las 
nanotecnologías. Tomando contacto con centros de excelencia, identifiqué a quien 
dirigió las tesis de cuatro argentinos que trabajan en nanotecnología en la que es 
probablemente la empresa más importante del mundo en la materia, Lucent. 
(Caligaris, 2004 p.1) 
the minister was aware of the importance of coordination with companies, but the 
agreement only with Lucent was questioned by various actors (Andrini and 
Figueroa, 2008). This monopoly contract was immediately rejected by the political 
opposition and researchers. In 2005, the national state created the Argentina 
Nanotechnology Foundation (FAN), aiming to develop human and technical 
resources for the industrial sector. From 2004, the government has set future 
expectations to encourage research and give monetary incentives to move the 
industry. Researchers has also claimed for funding to pursue their own agendas.  
In 2006, after a conflict between political parties, the government published Plan 
estratégico nacional de ciencia, tecnología e innovación Bicentenario (2006 - 
2010) where it explained the governmental strategic view about nanotechnology in 
Argentina (SCTIP, 2006). Here, the government recognised that its efforts have 
been insufficient to create a market and called for proposals aiming to solve 
productive and social problems. In 2007 the government organized the first 
congress called Nanomercosur 2007. Science, Business and the Environment. 
Although the name of the event suggests wide range of participants, the analysis of 




In 2010, The Argentina Nanotechnology Foundation published a document called 
Who's Who in Nanotechnology in Argentina. Here, the Secretary of Planning and 
Policy of the Ministry of Science, Technology and Productive Innovation, Ruth 
Ladenheim, presented the government guidelines on nanotechnology policy. The 
key aim of the policy is to promote the production of nano-technological improved 
goods rather than nano-products. In the Ministry´s own words: 
La tendencia es a que no haya nanoproductos, sino los productos clásicos con 
importantes mejoras por la intervención de la Nanotecnología (FAN, 2010 p.13). 
In April 2012, the Minister of Science, Technology and Innovation, Dr. Lino 
Barañao, explained Argentine techno-scientific policy during a conference at the 
Institute of Experimental Biology and Medicine (Barañao, 2012). He translated the 
presidential social inclusion discourse into the techno-scientific field. He remarked 
that investment in science and technology is being made by the government and 
companies, and it should be oriented to solve social demands. To achieve this, the 
government strongly relies on partnerships, collective hybrids that act as agents of 
change. One example is POTENCIAR project, which was a collective project that 
articulated government, academia, business and international actors. It brought 
together doctors, chemists, physicists, biologists, and engineers (among others), 
constituting a small sociotechnical network whose aim was to develop and 
commercialize biomedical implants developed with advanced nanotechnology. 
The socio-technical network is built around a material: ultrananocrystalline 
diamond (UNCD). A second examples is another innovative project born out of a 
government initiative to promote nanotechnology applied to the production 
processes of clothing. This project has sought to develop clothing that repels 
mosquitoes to prevent the contagion of dengue in Argentina. 
After presenting nanotechnology in Argentina and its process of constitution, this 
chapter analyses it from the Responsible Research and Innovation (RRI) 
perspective. With regard to the first principle, the ministers in charge of the 
innovation policy have specified that public funding must have productive and 
social goals. However, only experts, private companies and relevant government 




Secondly, in relation to the commitment to gender equality, the new 
interdisciplinary nanotechnology domain follows a hybrid gender dynamic, 
intimately linked with the features of the disciplinary fields that converge in its 
production. Physics, engineering and chemistry have been mainly masculine in 
Argentina (and in the world); whereas in biology or medicine there has been a 
steady increase of the participation of women in recent years. In this sense, 
nanotechonology presents new opportunities and challenges to achieve gender 
equity (Meng and Shapira, 2011). In this foundational stage in Argentina, it is 
important to achieve greater gender diversity in laboratories, companies and 
government agencies, in order to achieve sustainable governance. Although the 
government should be a key player in promoting gender equity, the FAN directory 
is made up by seven men and only two women.  
Thirdly, with regard to the promotion of creative learning as part and parcel of RRI, 
the Argentina government has increased the number of researchers associated with 
nano-technological projects. However, it still falls short with regard to the 
promotion of learning spaces and opportunities for social actors to be able to fully 
engage and participate in the decision making process associated with the public 
funding of nano-technological innovation and research.  
Fourthly, with regard to the RRI principle that demands great social relevance and 
acceptability of the innovation process, Argentina follows international regulations 
that protect workers who are exposed to nanotechnology risks. However, this 
policy does not address local issues or pay attention to local stakeholders.  
Fifthly, RRI requires transparency and accessibility. The Argentine government, 
through the FAN, deploys various initiatives in this regard. For example, the 
Nanotechnology for Industry and Society initiative holds regular meetings open to 
the public. Another example is the government´s efforts to coordinate actions with 
different regulatory agencies under the Nano-sustainable program. This fosters 
interactions between government agencies, researchers and industry.  
Finally, with regard to the overarching concern of RRI with promoting a nano-
technological field for and with society, the Argentine government has deployed 
various initiatives to disseminate innovation and promote interactions without 
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promoting open public debates. The last attempt to promote public dialogue has 
been the launch in October 2014 of a public consultation process around 
nanotechnology on the Internet. However, up to now, the official website does not 
show comments, suggestions or requests from the public. This lack of strategies to 
engage different publics has been harshly criticised by various actors (such as 
NGOs).  
Conclusion  
This thesis has argued that Argentina does not have a sustainable nano-governance. 
Although in this country nanotechnology has been linked to social inclusion and 
impact on levels of employment, it has a clear top-down governmental approach 
that has excluded society from the policymaking decision process. A RRI 
responsible nano-governance should involve an anticipatory, reflexive, 
deliberative and receptive dynamic.  
Anticipation requires analysing in detail all the impacts that might arise at 
economic, social and environmental levels. Government funding should be 
accompanied by multi-faceted impact analyses. For example, in the case of 
clothing –such as the new mosquito nano-repellent mentioned above-, it is crucial 
that governmental agencies examine in advance how this innovation would modify 
the economics relations in the sector as well as its environmental impact. 
Reflexivity demands reflection on the motivations and promotes honest 
discussions about what is known and what is not. As it is explained above, although 
Argentine governmental motivations seem clear, there is no place for wider debate. 
Moreover, governmental risk analysis is only based on international standards. In 
this sense, although this could be efficient for certain Western post-industrial 
countries, it could be harmful for Argentine society. More research focuses on the 
Argentine nanotechnology context is needed in order to foster a responsible 
approach to public policies. 
Deliberation demands the inclusion of stakeholders´ perspectives through 
dialogue. The Argentine top-down approach only takes into account the 
government´s vision of nanotechnology. This thesis has argued that it is important 
to give more participation to the Congress and to universities. Public interactions 
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of conflicting views about nanotechnology will help to find a new and socially 
more efficient path for its sustainable governance. 
Receptivity fosters an open inclusive learning process. In this sense, this thesis has 
shown the relevance of developing updated databases with information on all sorts 
of nanotechnology projects (whether successful or not). This will allow researchers 
to unpack them and propose best practices for the future.  
This thesis has made several contributions to unpack the process of nano-
governance in Argentina. The first chapter proposed the use of Nano-technoscience 
as a fruitful concept to capture the convergence of the scientific and technical 
aspects of research, is an engineering way of doing science. The interaction of 
scientists, their artefacts and materials in the laboratory define the nano-practice.  
The second chapter analysed the construction process of the nano-market, 
particularly, patenting and production of nano-carriers. To do this, it stressed the 
importance of analysing transactions between collective hybrid agents (human and 
artefacts) interacting in a constant process of co-creation. Their ability to calculate 
reflect its economic power in the market (ability to impose prices). In particular, it 
presented the market for nano-carriers as an algorithmic configuration.  
The third chapter conceptualized the nano risk as co-constituted, both during the 
techno-scientific practice and within the associated market. Firstly, it examined the 
industry´s perspective, where uncertainty is taken as part and parcel of the decision-
making process. Secondly, it argued that the methodology of real options, which 
integrates uncertainty, flexibility and irreversibility, is socially efficient for the 
valuation nano-medicine projects. Moreover, this chapter argues that the enterprise 
risk management procedures –although complying with governmental regulations- 
cannot be considered responsible due to their disregard of social and environmental 
aspects. 
This thesis has argued that Argentina has a de facto governance of nano-technology 
built on conflicting interests. The State sets the context of political discussion and 
controls the nano-dynamic with a top-down regulation. To be sustainable and 
socially responsible, reflection, discussion and confrontation between different 
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interpretations are needed. This requires that the State changes its governance 
practices and has to widen its scientific vision into a socially inclusive one.  
From the presented analysis, it is possible to delineate different lines of inquiry for 
future research in Argentina. First, it would be important to analyse, using 
qualitative and quantitative methodologies, how private companies deal with the 
Argentine nano-market and to establish if they could be considering RRI 
responsible. Secondly, it would be relevant to examine local nanotechnology risks 
and the role of insurance companies in their management. Thirdly, it would be 
crucial to carry out comparative analyses of national public policies in order to 
identify possible alternative solutions to shape Argentine´s public policy agenda 





Nanoscience is the study of phenomena and manipulation of materials at atomic, 
molecular and macromolecular scales, where significantly differ from those 
properties at a larger scale. 
Nanotechnologies are the design, characterisation, production and application of 
structures, devices and systems by controlling shape and size at nanometer scale. 
(The Royal Society & The Royal Academy of Engineering, 2004 p.5) 
In the daily work of laboratories, nanoscience and nanotechnology are integrated 
giving birth to a common practice denominated Nanotechnoscience. This term 
accounts for a way of doing research, different to the traditional way used in 
chemistry and physics, which demands exchange and communication between 
different scientific and technological practices (Galison, 1997) and looks for 
explanations using several theories. Under this new field several disciplines, public 
and private institutions converge giving birth to a new practice. It is a process that 
co-constitutes itself with its corresponding market, understanding the latter as a 
sociotechnical network under which agents maximize their interests through 
economic calculations and where conflicts are solved through prices (Callon, 1999; 
Guesnerie, 2006).  
This complex field configures a market that promises benefits on a number of areas 
(Paradise et al., 2008), while generating new and unknown risks both in terms of 
the environment and human health (Kimbrell, 2006; Faunce, 2014; Arnall, 2003). 
Nanotechnology is currently still on its embryonic phase, yet, judging by the 
international public and private movement generated by it, we are facing a whole 
new way of analysing and studying matter, a new chapter on human development 
altogether, which is to have a high impact on social and productive structure.   
The benefits of nanotechnology could be traced across industries, promising new 
solutions to social problems while growing industrial productivity. These 
aggregated promises, which are in permanent interaction with public policies, 
sustain future expectations, pressuring the process of allocation of national public 
resources, and defining the future of society in its whole (van Lente and Rip, 1998; 
van Lente, 1993). In order to mobilize resources towards their projects, 
nanotechnologists present narratives anticipating States’ agendas and formulates 
strategic promises knowing that they will contribute to shape its priorities and 
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concerns (Rip et al., 2010). These uncertain promises play a key role in the 
production of innovative markets such as the nanotechnology market because they 
assign future economic value to current investments. 
One of the most important global social problems is the provision of sufficient food 
to a growing world population.  Some nanotechnological applications may offer 
some solutions (Lyons et al., 2011; Prasad et al., 2014; Agrawal and Rathore, 
2014). Over the last few years, nanotechnology has contributed to the productivity 
growth of both agriculture (Prasad et al., 2014; Parisi et al., 2014) and animal 
husbandry (Garg, 2014). Some examples of products that are already on the market 
include nanoparticles which are used to transport active principles, the use of 
nanofibers as environmental biosensors, and nano-compounds for the exploitation 
of agricultural residues (Parisi et al., 2014). 
Another economic sector impacted by nanotechnology is the textile industry, 
which has developed fibres that solve diverse social needs (Kakad et al., 2015). An 
example is the inclusion of carbon nanofibres3 on clothes to effectively increase 
fibres resistance to traction, thus granting it with greater durability (Karwa et al., 
2012). Another key application is the production of cloth that has functionalities; 
for example, cloth that repels stains (Popescu and Popescu, 2013), water (Anitha 
et al., 2013), insects (Van Langenhove and Paul, 2014), or detects a patient’s health 
condition (Rai et al., 2014), or localizes its user by GPS (Syduzzaman et al., 2015). 
The global industrial framework requires high levels of electrical consumption for 
its functioning, therefore there is a need for new and more efficient ways of 
producing and consuming power, which must also contemplate environmental 
impacts (Menegaki, 2014). In this respect, through the inclusion of 
nanotechnology, it has been possible to produce plastic solar cells that have greater 
electrical efficiency (Oh et al., 2012; Kim et al., 2012), less contaminant fuel such 
as hydrogen obtained through the process of nano-catalysis on water  (Li et al., 
2011), and long lasting batteries capable of absorbing great quantities of lithium 
ions without damaging electrodes. These innovations have contributed to the 
                                                 
3 Nanofibres may be defined as fibres with a diameter lesser than 1 mm or 1.000 nm, and are characterized by having a high 
superficial area to volume and a small pore size in the form of fabric. 
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decrease of environmental pollution, which is one of the expected benefits of 
nanotechnology for our society (Liu et al., 2014). 
Another area of great importance for an inclusive global society is that of the 
provision of clean water for human consumption. Currently, only 2.5% of the 
planet’s water is potable so it is urgent to find new methods of water treatment. 
The alternatives that nanotechnology proposes are diverse. Firstly, the use of nano-
membranes and nano-clay for water filtration (and its desalination) increases 
efficacy over other methods4. Secondly, processing waste waters with activated 
nano-particles allows for its re-use. Thirdly, the use of nano-sensors can help 
monitor the quality of water by detecting bacteria, heavy metals, and toxins 
(Bhattacharya et al., 2013; Qu et al., 2012). Water treatment on the basis of 
nanotechnology includes the use of nano-membranes and filters based on carbon 
nanotubes (Liu et al., 2013),  nano porous ceramic (Mittelman et al., 2015), and 
magnetic nano particles (Si et al., 2012). Lastly, the use of nanomaterials such as 
silver and titanium dioxide with antimicrobials characteristics can supply an 
alternative to chlorine treatment (Liga et al., 2011). 
Another global challenge that may be overcome with the help of nanotechnology 
is the urban pollution levels. The air pollution can be monitored using 
nanotechnology (Penza and EuNetAir, 2014). Different nano-filters may be 
applied on automobiles and other vehicles with exhaust gases to filter its 
contaminants before they enter the atmosphere. In this way, the technology of 
nano-catalyzers used on the vehicle’s catalytic converters removes contaminants 
and increases the driving quality. At the same time, nano-sensors that can detect 
very low concentrations of toxic gases on the atmosphere have already been 
developed (Penza and EuNetAir, 2014). 
Nanomedicine is one of the fastest growing sub-disciplines of nanotechnology and 
has been the object of high expectations with regard to its impact on human health. 
It is an interdisciplinary sector that gathers fields such as biology, materials science 
and engineering, and information technology. The challenge for researchers is to 
                                                 
4 Nanotubes made from carbon  have proven to be very effective on water filtration, reducing significantly the costs from 
desalination (Brame et al., 2011). In addition, magnetic nano-particles can decompose organic contaminants and remove 
salts and heavy metals allowing for the recycling of waste waters (Waijarean et al., 2014; Neyaz et al., 2014). 
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understand the explicative mechanisms of a certain disease and to intervene on a 
nanoscale. The constitutive basic blocks of life are nano-structures. Hence 
articulating nanomaterials with biological structures at this level open up new 
opportunities. For example, a biosensor typically used on the field of medicine has 
a biological detection component, a physical transductor to generate a measurable 
signal, and an informatics component to process the generated data (Yao et al., 
2014). 
Nanotechnology impacts on diverse branches of medicine: early and precise 
diagnosis, image diagnosis, highly specific drug handling, and regenerative 
medicine. Currently, the industry counts with nano-gadgets used as biosensors for 
monitoring, implants, drug transporters for cancer therapy, or surgical tools. In 
particular, the nano-pharmaceutical field supplies with an efficient drug 
management, as nanoparticles identify specific objectives and release precise dozes 
of drug into them, minimizing secondary effects (Grossman and McNeil, 2012; 
Schroeder et al., 2012; Bertrand et al., 2014). 
On the year 2010, there were 35 million people suffering from some degree of 
Alzheimer (Pouryamout et al., 2012). A search for the cure is currently being 
undertaken on an international level, in particular, a new drug denominated RNS-
60 from the company Revalesio is being tested on humans, the effectively prevents 
and may cure Alzheimer. It is a nanostructure composed of a functional platform 
of Sodium Chlorine, Hydrogen, and Oxygen5. What makes this drug innovative is 
that it includes the action mechanism with no side effects (Modi et al., 2013).  
Another globally extended and growing disease is diabetes, which is the main non-
traumatic risk factor of amputation of the lower limbs. Currently several methods 
to avoid amputation are available. One of the most effective consists of the 
infiltration of a saline solution through several injections directly on the wound, 
which has the inconvenient of being a very painful treatment. On the year 2007 the 
Centro de Ingeniería Genética y Biotecnología de la Habana (Cuba) registered the 
WO2007087759A2 patent that proposes the use of nano-spheres as a epidermal 
                                                 
5 For its production, a 10% saline solution (sodium chlorine) is subject to a patented process under which cavitations are 
generated, this help the oxygen nano-bubbles adhere to the sodium chlorine creating a stable structure similar to a platform. 
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growth factor of parenteral application, which has the advantage of producing a 
faster cicatrisation of the wound6  (Vicedo, 2015). 
Products containing nanomaterials have also reached the cosmetic and solar 
protector sectors (Nohynek and Dufour, 2013). Sunscreen with titanium dioxide or 
zinc oxide are used to prevent burns. Creams made of mono-crystalline particles 
are being replaced by nano-crystalline structures making the creams transparent 
instead of white. Nano-silver and nano-gold particles are also used for its 
antibacterial characteristics (Balasubramanian, 2014). 
Another field where nanotechnology is being applied is the aerospace industry, 
where nanotechnology finds application in minimizing the size, weight, and 
electrical consumption of relevant gadgets (Pedai and Astrov, 2014). Nano-crystals 
are paving the way for the production of plastics that are resilient to extreme 
situations (Leung et al., 2013), reinforcing the original atomic structure, granting 
both lower weight and greater resistance to the materials (Zhou et al., 2013). 
Another area of impact is that of NRAM memory development industry, namely, 
the development of high density, non-volatile, and aleatory access memories based 
on carbon nano-tubes. 
After mention some of the diverse applications of nanotechnology, it is legitimate 
to ask oneself about the nature of its industrial organizational dynamics. As a first 
step to answer this, one could ask whether nanotechnology is similar to previous 
technologies, such as microelectronics, and biotechnology. Since the 1970s, the 
top-down approach allowed the microelectronic industry, constituted by big 
corporations with strong vertical integration and R+D departments, to reduce the 
size and increase the circuit density of the semiconductor. Subsequently, during the 
1980s, the biotechnological industry was formed on the basis of new small 
companies (Invernizzi, 2011). While nanotechnology is somewhat similar to 
earlier technologies, its practice constitutes an industrial dynamics of its own. The 
first marketed nano products were just nano aggregates of pre-existing products, 
mainly produced by big corporations with massive markets. Nevertheless, thanks 
                                                 
6 Centro de Ingeniería Genética y Biotecnología, La Habana, Cuba. “Patente de invención WO2007087759, 2007”. 




to the State’s financing of  academic institutions, during 1990s university spinoffs 
started to emerge and develop nano products, many times patenting their products 
(Robinson, 2009).  
This dynamics of nanotechnology requires a global institutionalization of patents 
and standards. Patents are intangible assets that allow persons (either 
organizations, States or humans) to protect their interests by creating barriers of 
entry to avoid market competition (Somaya, 2012). Patents have emerged from a 
multidisciplinary nanotechnoscientific practice articulated with the market adding 
economic value to its owner (Chen et al., 2013). At the same time, in order to 
develop a nanotechnological market, it is fundamental to count with industrial 
standards to produce good quality goods and to protect workers´ physical health. 
A global regulation is required that allows us to speak a common language, 
allowing similar production everywhere. Although the technology advances at a 
very fast pace, bureaucratic structures struggle to keep up with its impact on the 
knowledge economy. To fill this gap, it is necessary to create efficient standards  
(Kica and Bowman, 2012; Murashov and Howard, 2011). 
The establishment of patents and standards is necessary, but it is not sufficient to 
activate a nano market. Studies show that one of the main problems for companies 
that decide to initiate nanotechnology companies (start-ups) is the lack of enough 
funding for hiring highly qualified professionals, acquiring expensive equipment, 
and buying (or licensing) patents during the first stages of the production process 
(Fu, 2014). Getting an investor willing to not receive profit for years is a serious 
problem, even in the presence of state funding for the development of 
nanotechnology. Only certain informed and solvent investors interested on the 
technological business (angels) invest their own capital and involve themselves in 
the company for it to be successful (Prowse, 1998). 
Governments are investing on R+D projects, yet investors require more 
information to take part into projects as some of them are not familiar with the 
complexities and expected future growth of the technology. There is a need for 
economic valuation methodologies of nanotechnological projects showing 
potential investors future benefits (Beaudry and Allaoui, 2012). Moreover, this 
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patent and goods market requires large long-term risky investments which have 
distinctive features. They are irreversible due to the impossibility of recovering  
initial payments; uncertain -as the future benefits are unknown-; and flexible –due 
to the fact that investors could join after the beginning of the project or could leave 
it before it ends (Dixit and Pindyck, 1994; Smit and Trigeorgis, 2012). 
Although the market is relatively new, the first companies created in the 1990s 
have gained valuable experience. The literature on the matter identifies some 
lessons from the first generation of entrepreneurs. Firstly, they have shown the 
importance of focusing on the necessities of the market instead of concentrating on 
the technological platform. Secondly, it is not convenient to start hunting for funds 
in the exchange stock market before obtaining sale profits. While the importance 
of patents is recognized, intellectual property has a low value if it is not paired with 
the production and selling of concrete products. The first generation of 
entrepreneurs destined large sums of capital to create of patents but low sums to 
develop products. Thirdly, it is also fundamental to anticipate delays associated 
with the approval of regulators, and not underestimate regulative obstacles. Lastly, 
the effective marketing of nanotechnology based products requires to raise as much 
capital as possible when the capital market is open. This is explained by the long 
term and high capital requirements inherent to the marketing of nanotechnology. 
Successful companies should be capable of subsisting during diverse phases of 
economic cycles, in particular during economic recessions. (Maebius and Jamison, 
2009). 
From the point of view of the State, nanotechnological development should serve 
to purposes such as the reduction of pollution, the solution of social problems, and 
the decrease of electrical consumption. Nevertheless, governments must face the 
risks that these innovations may involve to both humans (Cui et al., 2005; Lam et 
al., 2004), and the environment (Colvin, 2003). Risks are co-produced by a 
complex socio-technic network through articulations and performances. Risks 
cannot be regulated in isolation.  
While universities and nanomaterial companies have a direct responsibility over 
the existence of risks produced by their activities, these organizations internally 
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identify risks in their fabrication processes and manage them through engineering 
methodologies regulated by the State (Medley y Walsh, 2007). Afterwards, in order 
to cover for the unidentified dangers, companies pay a premium to an insurer that 
identifies, analyses, evaluates, and diversifies the remaining risk (Lloyd, 2007). 
However, this practice of engineering and actuarial risk management is not socially 
sustainable, as it does not contemplate human and environmental aspects. 
The new nanotechnological dynamics leads to new risks for human beings and for 
the environment which are only partially managed by these organizations. In this 
context, State policies gain centrality as tools for protecting society and promoting 
sustainable markets. The American literature on technological regulation proposes 
a regulation pyramid to illustrate a flexible approach that has companies’ self-
regulation (soft law) at its base; as we go up the State’s intervention increases 
leading up to the top of the pyramid, where regulation is strict (hard law) (Ayres 
and Braithwaite, 1992). Unlike the American program, the European one 
Converging Technologies for the European knowledge society (CTEKS) stresses 
the State technological policy as a tool for the creation of a knowledge society, 
guided by the precautionary principle (Klinke et al., 2006). 
In order to develop efficient public policies, it is essential to have investment 
valuation tools and financing instruments. An efficient economic-financial 
analysis which also evaluates social impact is needed to provide decision 
instruments for policy makers. Traditional tools for project valuation have serious 
limitations to reflect the complexity of the economic and social aspects this new 
market involve. They do not include regulatory aspects, policies, market behaviour, 
manpower cost uncertainty, among other complexities of innovative nano-
technological projects (Paxson, 2003; Pennings and Lint, 1997). 
Nowadays, a de facto governance is operating in the nano products market, built 
on everyday choices and decisions made by dissimilar actors with conflicting 
interests (Rip, 2010). Hence, it is necessary a different approach, a sustainable one, 
in order to constitute a socially innovative nanodynamic that is socially responsible 
in the long-run. Therefore, it is necessary that technoscientists interact from the 
very start of the innovative process with market agents, the State, and the general 
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public. In this scenario, the State has the possibility to regulate through incremental 
regulation the existing de facto governance, making space for a dialogue between 
parts. Dealing with the incredible potential of the nanotechnological network and 
the uncertain associated risks demands the State intervention through policies 
protecting society and promoting a sustainable market aligned with society’s 
requirements.  
Nano-technological innovation opens up a debate on public policies that intervene 
on research funding, price fixation, and the socially optimal degree of patent use, 
taking into account the uncertain costs, future income, and effects on human health 
and the environment. What is necessary is the use of valuation models that 
contemplate this complex process. For the State, it is essential to have a long-run 
sustainability (Dhingra et al., 2010; Eason et al., 2011). To achieve this, it is 
important to propose diverse instruments of public-private funding and the creation 
of incentives for the private sector (Roco et al., 2011). Due to the impact of 
investments on economic growth and the magnitude of the new challenges, it is 
necessary to develop responsible public-private financing tools that contribute to 
technological innovations. Responsible public policies encompass an improvement 
on the population´s living conditions, as far as they are anticipatory, reflexive, 
deliberative, and receptive (Owen et al., 2012).  
This thesis assumes an individually reflexive and socially deliberative approach, 
which would contribute to the creation of an innovative nano dynamics where 
controversies are made explicit. It argues that a sociotechnical network needs to be 
sustainable, innovative, responsible, and inclusive (Rip, 2014). Its focuses on the 
analysis of the nano dynamics on the Argentinean context. Currently the nano-
technologic sector in Argentina is configured by a network of scientific and 
technological institutions, funding bodies, bilateral institutions, and technology 
based companies, wherein the State promotes the development of the internal 
market by promoting new associations that articulate what is public and what is 
private to stimulate the productive framework with a socially inclusive impact 
(Foladori et al., 2012; Vila Seoane, 2011). 
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With respect to the Argentinean agro-industry, the Instituto Nacional de 
Tecnología Agropecuaria (INTA) is the most active organisation within the nano-
sociotechnic network.  Variety of products are currently being developed and 
researched. For example, the application of self-cleaning patterns characteristic of 
biological surfaces to the agro sector is being studied7. In addition to this, in the 
environmental monitor area, it is being developed equipment designed to detect 
agro-chemical molecules combining micro-fluidic, plasmon resonance on nano-
structures metal substrata and molecular recognition elements8.  
Regional economies are important for a socially inclusive growth of Argentina 
(Bekerman and Dalmasso, 2014; Casparri et al., 2014; Miguez, 2014). One of them 
-linked to the ovine production- has grown considerably reaching a production of 
14.859.486 heads on a national level in March of 2015 (Mueller, 2013). However, 
one disease - the ovine Brucelosis - is threatening the industry by producing 
economic loss to both the producers and the State (Robles 1998). The application 
of a nano-vaccine developed and patented by INTA prevents this disease, having a 
positive local impact on ovine production9 (OIE, 2012; SENASA, 2014; INTA, 
2013; INTA, 2015; Manazza et al., 2006). 
The State funded and promoted various projects related to the principal areas of 
scientific innovation, through the Sectorial Argentinean Fund10 (FONARSEC). 
The government aims to steer innovation in such a way that it contributes to the 
solution of social problems. For instance, it has funded the development of 
functional textiles. Among the different functions that may be added to textile, 
researchers have been focusing on the development of insect repellence targeting 
disease vectors, such as dengue (Tallone, 2015). An example of a nano-
technological private company (which receives governmental support) is Unitec 
Blue in 2012. The investment demanded more than U$$1000 million for the 
creation of a factory of chips commonly used on micro and nanotechnology. The 
                                                 
7 http://inta.gob.ar/noticias/inta-con-otro-premio-bajo-el-brazo-1/ 
8 A Start-up called Nanotedeccion is currently on incubation state on the CITES centre, located in the city of Rafaela, Santa 
Fe. http://www.fan.org.ar/proyectos-presemilla/dr-nicolas-tognalli  
9 The development consists of a lipidic molecule inserted on a nano-vehicle, which transports the synthetic molecule that 
directs an antigen to certain cells of the immune system. This optimizes the prophylactic action of the vaccine, allowing it 
to adhere to the receptor of the dendritic cell of the immune system, the molecule is thus directed to a certain cell that 
activates the immune system. 
10 The FONARSEC is a tool of the Ministry of Science, Technology, and Productive Innovation that supports projects to 
develop critical capacities on high impact areas and with transference to the productive sector. 7 areas were defined in this 
sense, Nanotechnology being one of them. 
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company produces chips to be used for the traceability of drugs, cattle-herding, 
auto-parts, identity documents, mobile communication systems, credit cards, and 
LED monitors (Enriquez, 2015).    
In an attempt to address some of the key challenges of the nanosociotechnical 
network, this thesis contributes to the theory of technological governance. It argues 
that the network has been constituted by its practice, risks, and interactions between 
the market, the State, and users; and it needs a sustainable and responsible 
governance that is co-constituted with this nanotechnological innovative dynamics. 
In addition, the proposed approach will be used to examine the case of 
nanotechnology in Argentina. 
To achieve this contribution, this thesis has six specific objectives. Firstly, to 
understand how the practice is constituted on the basis of relations between agents, 
both human and artefacts in a permanent transformative interaction inside the 
laboratory. Secondly, to comprehend how this practice spills over the construction 
process of a sociotechnical network giving birth to a market. Thirdly, to understand 
how the network co-constitutes risks for the human being and the environment. 
Fourthly, to elaborate a project valuation model where joint investments take place. 
Moreover, this model also must contemplate the necessary cooperation between 
the market actors, the market uncertainty, and regulation and incentives from the 
State. Hybrid agents (human-matter) interact in a controversial manner, 
contributing to the formation of the nanotechnological sociotechnical network. It 
is a complex, uncertain, and conflictive process, where relations, human needs and 
limitations are articulated in a process of permanent constitution. It is crucial to 
align this process with the requirements of society as a whole for a sustainable and 
responsible nano-governance that analyses and reflects on these processes and 
proposes alternatives. Fifthly, this thesis aims to understand the role of the 
regulatory framework in the constitution of the nanotechnoscientific market, 
focusing on the role of the State; it argues that is necessary to forge a sustainable 
nano-governance, extending the traditional economic-actuarial equilibrium to an 
integration of social and environmental interests. This thesis has an individually 
reflexive and socially deliberative approach, which allows to claim for an 
innovative socially responsible nano dynamics. Finally, the last specific objective 
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of this thesis is to assess if the governance of the nanotechnoscientific dynamics in 
Argentina could be considered sustainable and Responsible Research and 
Innovation (RRI) responsible. To do so, the inscriptions, translations, and black 
boxes of the constitutive process of the sociotechnical network in Argentina are 
analysed. Furthermore, it offers some guidelines on how this network could move 
towards a sustainable nanogovernance.  
To achieve its goals, this thesis is divided into four chapters. The first one examines 
the constitution process of the nanotechnoscientific practice. The second one 
studies how this practice spill over beyond the lab, constituting a new market. At 
the same time, this nanotechnological industrial dynamics co-constitute risks for 
the society and nature, this is analysed in chapter three. Lastly, the fourth chapter 
proposes an approach of sustainable nanogovernance and RRI responsible, which 
it will be used to analyse the nano problematic in Argentina. Next, the content of 
these four chapters is detailed. 
The first chapter starts examining diverse agents’ views on nanotechnology. The 
US government, for example, states that nanotechnology is a unifying platform 
between science and engineering. In other words, it is a technological approach to 
science, supported by strong public financing, aiming to establish American 
companies as global leaders (Roco et al., 2011). From a scientific perspective, 
nanotechnology works in a context where nature starts to behave in a quantic 
manner, being necessary a re-statement of the micro theory (Nordmann, 2010). For 
the market, the emergence of nanotechnology is a business opportunity and it 
promotes soft government regulation. In addition to this, insurers have economic 
incentives to ask for more regulation (Swiss Re, 2005; Lloyd, 2007). After 
introducing these different visions, the chapter problematizes the constitution 
process and unfolds its eclectic theoretical framework.  
This nanotechnoscientific laboratory practice has a pragmatic approach situated 
between the classic and quantic theories (Roukes, 2001). Laboratory researchers 
search for a partial explanation through the eclectic use of several theories, 
articulating speeches about past technologies and future expectations. Past 
speeches allow to construct a nanotechnological myth, helping to imagine the 
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future of nanotechnology (Tourney, 2006). Moreover, expectations about the 
future from different actors also define the field, each of them is aiming to conquer 
the future and legitimating its present interests (Selin, 2007). Finally, as a way to 
integrate what was presented before, this chapter introduces actor-network theory 
(ANT) proposed by Bruno Latour (2005). This methodology is used to describe 
and explain the sociotechnical network as a constitutive process. It articulates 
laboratory observations at a micro level with concerns over the organization of 
society. This methodology will be used in the second chapter to account for how 
the industrial dynamics is constituted. 
The nanotechnoscientific practice described has the potential to make several 
disciplines converge, which is key to understand the constitution of its 
transforming industrial dynamics. To understand this process, the second chapter 
starts by studying the literature on market design and constitution. Markets have 
advantages, its agents stimulate innovation, its structure allows for the coordination 
of expectations and its organization facilitates contracts between the parts that 
would not surge in a context of central planning. Nevertheless, they are not 
designed to achieve common good, so they could produce negative impacts on 
humans (Callon, 2009). Therefore, it is necessary to answer basic questions about 
markets and analyse how we can guarantee that their operations are socially 
responsible. This chapter examines nano technological markets, leaving aside 
abstract debates, by recognizing the growing role of experimentation in their 
inception, the fundamental role of technology, and the performative role that 
economic theory plays (Barry and Slater, 2002; Callon, 2010). After discussing the 
theory of market constitution, the chapter argues that the nano industrial dynamics 
has a transformative power over the economy in general. The evolution of the 
sector is analysed starting from early products, which were an aggregate of nano 
technology into traditional ones, to current developments such as nanocarriers 
(nano-dispositive that transport drugs to specific places of the human body). 
Following Callon and Muniesa (2005), the production and marketing of these 
products is thoroughly analysed using ANT. After understanding the constitution 
process of the market, this part analysis the role of investors in it by scrutinizing 
the role of new companies and revising some of the lessons learnt from the first 
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generation of nano entrepreneurs. From an economic perspective, a model of 
quantitative investment valuation for the pharmaceutical industry is examined. 
Lastly, this section presents a mathematical model that represents joint investment 
decisions between a small nano company that owns the patent of a nanocarrier 
(usually spin-off) and a big pharmaceutical that has both the drug to be transported 
and the access to the market.  
This nanotechnological dynamics co-constitutes risks which are analysed on the 
third chapter of this thesis. Firstly, several approaches to the problematic of risk 
are presented (Adam and van Loon, 2000; Mythen, 2004), with a particular 
emphasis on the risk society approach (Beck, 1992). For the hegemonic Western 
thought, the production of wealth is associated with inevitable social risks. On the 
contrary, this thesis conceptualizes nano risk as co-constituted both during the 
technoscientific practice as well as in the dynamic of the associated market. 
Additionally, risks for the environment and the human being are analysed. 
Consequently, it is also argued that the nano industrial dynamics have implications 
for its governance.  
From the point of view of the industry, uncertainty is taken as a constitutive part 
of the company’s decision process. Hence, the traditional methodologies used for 
the valuation of investment projects are analysed, emphasising that they do not 
account for the complex dynamics of nanotechnology. To surpass this limitations, 
this work proposes the valuation methodology known as real options, which lets 
consider the uncertainty, flexibility, and irreversibility that exist in innovative nano 
projects (Trigeorgis, 1993; Kumaraswamy, 1996; Schwartz, 2013). Subsequently, 
the role of insurance companies - bounding, measuring, and pricing risks - and the 
risk evaluation process are examined, focusing on how experts calculate price 
without contemplating the impacts on society and without a clear understanding of 
the properties at nanoscale. It is important to create new standards to account for 
toxicity and for the effects of nano size. Next, this chapter focuses on the role of 
public policies. In so doing, it presents two mathematical models. The first model 
allows for the quantitative evaluation of whether it is optimal to start a given project 
in accordance to the precautionary principle. The second quantifies the social 
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benefits of two different kind of State incentives (known as pull and push). This 
tools helps governments’ decision making process, quantifying costs and benefits. 
This nanotechnoscientific practice that interacts with its market, building a 
sociotechnical network of controversial relations that co-constituting new risks, 
requires an adequate approach of sustainable governance. Chapter four starts with 
an examination on how expectations enlarge and strengthen the sociotechnical 
network through private and governmental actions. Without forgetting that State is 
an actor and recognizing that it is constituted through a historical process as a 
distributed agency, the State is modelled in this thesis as collective hybrid of 
calculus (Passoth and Rowland, 2010). Moreover, State institutions are decisive 
for the generation of aggregated macro effects fuelled by the actions of agents. In 
this context, the challenge is to understand causal mechanisms that promote an 
adequate governance. Then and there, the conflictive constitution of the nano 
sociotechnical network in the European context is analysed from the European 
perspective known as Responsible Research and Innovation (RRI) (Owen et al., 
2012). The starting point is a technical, economic, and political knowledge that 
requires reflection and confrontation between diverse points of view and 
interpretations to achieve a dynamic sustainability. It is an approach characterised 
as individually reflexive, socially deliberative, anticipatory, and receptive of the 
best practices.  
Following, the nanotechnology in Argentina is examined through the 
operationalization and application of the key concepts of the RRI. To explore if the 
Argentinean nanotechnoscientific dynamics is sustainable and RRI responsible, 
firstly, the discourse of the governmental agencies is studied. Next, it analyses the 
proposed regulatory mechanisms and the degree of citizen participation in the 
process, describing narratives, expectations, and inscriptions that are in a process 
of constitution. Then, five examples of public-private associations are presented. 
Although the public policy is oriented towards the promotion of socially inclusive 
innovative production, this approach is a top-down, so it excludes society from the 
decision making process. Finally, strategies for the current nano dynamic in 




1 La práctica nanotecnocientífica 
Summary 
What is nanoscience and what is nanotechnology? In order to address these 
questions, this chapter will examine the perspectives of different stakeholders: the 
government, the scientific community, private companies and the third sector.  
Alfred Nordmann (2006) proposes the use of the concept techno-science 
(Nordmann, 2012). Researchers pursue the goal of building nano-materials, not to 
prove their existence. When envisioning the future of the nanotechnology, it is 
important to assess how the past achievements of other technologies have been 
textually produced. The story of the past is an essential element when imagining 
the future (Thompson, 2011). This story is combined with future expectations to 
define the field (Selin, 2007). The nano-laboratory is not isolated from society. The 
relationships among stakeholders infuse meaning to the technology and claim for 
regulation.  
According to the economic theory, expectations about the future course of 
technological innovation are one of the most important features to consider by the 
investor when choosing whether or not to adopt a new technology. These 
aggregated business decisions and their dialectical relationship with public policies 
contribute to shape future expectations and reproduce them. There is no possibility 
of sustaining over time future expectations that are not synchronized with the 
market dynamic, at least in the Western capitalist world that concerns us.  
Roco, Mirkin and Hersam (2011)  presented the US vision by describing the 
National Nanotechnology Initiative (NNI), its current situation and its expected 
development in the long term (2000-2020). It pursues the formation of an 
interdisciplinary academic community with a market orientation. This is reflected 
in the definition given by the NNI:  
Nanotechnology is the ability to understand, control, and manipulate matter at the 
level of individual atoms and molecules, as well as at the “supramolecular” level 
involving clusters of molecules (in the range of about 0.1 to 100 nm), in order to 
create materials, devices, and systems with fundamentally new properties and 
functions because of their small structure. (Roco, 2007 p.3).  
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Meanwhile, the British government defines: 
Nanoscience is the study of phenomena and manipulation of materials at atomic, 
molecular and macromolecular scales, Where Significantly Differ from Those 
properties at a larger scale. 
Nanotechnologies are the design, Characterisation, production and application of 
structures, devices and systems by controlling shape and size at nanometer scale. 
(The Royal Society & The Royal Academy of Engineering, 2004 p.5) 
These definitions imply a unifying platform of science and engineering at the 
nanoscale, a technological approach to strengthen the productive sector.  
There are no theories specially adapted to the complexity of nanoscale world that 
could explain the relationship between the structure of a given material and its 
properties. The researcher deploys partial explanations taken from various theories, 
forcing them beyond their scope (Winsberg, 2006). The practice in the laboratory 
has an engineering perspective, which constructs nanomaterials by using eclectic 
frameworks (Rip, 2013). Traditional theories are extended to face the challenges 
of the world at the nanoscale. 
Nanotechnology public initiatives are excellent business opportunities for risky 
investors. Within the market logic, it is important to note the role of insurance 
companies as moderators of this dynamic, because their business is to collect 
money in advance to cover their customers´ future contingencies. Current 
regulation of nanotechnology sector is insufficient. In response to this situation, the 
insurance industry demands greater transparency and better regulation (Lloyd, 
2007). 
After the report of different visions of the nano-world, the challenge is to 
understand how agents communicate the expected benefits to get more funding 
from governments. The narratives of past technologies are essential to imagine the 
future of nanotechnology, given that some of their traits remain. Chris Tourney 
(2006) selects the theory of myths developed by Malinowski (1954) to unpack what 
narratives has been useful to make sense of nanotechnology development.  
After analysing the narratives of the past, it is important to understand expectations 
about the future of nanotechnology. Cynthia Selin (2007) explores how different 
actors operate to define the field and what problems are legitimated. This highlights 
the ways in which different actors intend to colonize the future and try to legitimize 
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their present. The fight between actors revolves around the question of what 
nanotechnology is and, crucially, what should be. Two groups emerge clearly, the 
so-called visionaries and scientists. Drexler (2004; , 2013) embodies the former 
group, dominating the official discourse during the last decade of the past century 
(Stix, 2001; Selin, 2007). The second group is mainly represented by the academic 
community. 
The views and narratives about nanotechnology build a new techno-scientific 
practice, which could be understood using the actor-network theory (ANT). 
According to this perspective, the relationship between agents instils meaning to 
its existence. Moreover, technologies involved are not only useful tools, but also 
defined within the boundaries of symbolic struggles (Latour and Woolgar, 1986; 
Bijker and Law, 1992). ANT approach is adequate to understand the nano-practice 
because it demands the observation of the activity in the laboratory at the micro 
level, and a theoretical concern with the organization of society, opening new 
possibilities for the study of the political role of science. In the next chapter ANT 
will be used to understand how the industrial nano-dynamics is established. 
Introducción 
¿Qué es nanociencia y qué es nanotecnología? Para empezar a caminar posibles 
respuestas, en este capítulo se transcribirán, analizarán y contrastarán diferentes 
visiones: la gubernamental, la científica, la de la empresa privada y la del tercer 
sector.  
En cuanto a lo disciplinar, es Alfred Nordmann (2006) quien describe ciertas 
características de la investigación nano y propone el uso del concepto 
Nanotecnociencia, donde el término tecnociencia significa un modo de 
investigación diferente al científico tradicional (Nordmann, 2012). Peter Galison 
(2006) señala que los investigadores nano persiguen el objetivo de construir, no de 
demostrar existencia11. Es importante remarcar que, como los investigadores 
provienen de diferentes formaciones básicas, habitualmente difieren en qué teorías 
utilizan, pero todos coinciden en qué instrumentos y qué programas de ordenadores 
                                                 
11 Se trata de una forma ingenieril de hacer ciencia, extendiendo marcos teóricos existentes hacia uno ecléctico. 
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utilizan. Estos artefactos se transforman en los referentes comunes en la comunidad 
y adquieren una importancia extrema. 
A la hora de imaginar el futuro de una nueva tecnología, siempre es importante 
evaluar la forma en que se describen los logros pasados de otras tecnologías. En el 
contexto particular de la aparición de la nanotecnología, Chris Tourney (2006) 
postula que el relato del pasado es fundamental a la hora de imaginar el futuro de 
la nanotecnología. Esto se conjuga con las expectativas futuras para definir el 
campo (Selin, 2007). Claramente, se ponen de manifiesto las maneras en que los 
distintos actores pretenden utilizar la historia y las expectativas para colonizar el 
futuro y legitimar sus intereses presentes.  
Desde un punto de vista de la teoría económica, las expectativas sobre el curso 
futuro de la innovación tecnológica son uno de los factores más relevantes a tener 
en cuenta por el empresario a la hora de elegir si adopta una nueva tecnología. Esas 
decisiones empresarias agregadas y su relación dialéctica con las políticas públicas 
sostienen estas expectativas futuras y las reproducen. Sin dudas, no hay posibilidad 
de sostener en el tiempo expectativas futuras que no estén sincronizadas con la 
empresa, al menos en el mundo occidental capitalista que nos concierne. 
Notoriamente, el análisis de la dinámica de las expectativas es un elemento clave 
en la comprensión científica y en el cambio tecnológico.  
Ahora bien, para un entendimiento acabado de la práctica nanotecnocientífica, es 
necesaria la caracterización social que la acompaña. La relación entre los actores 
involucrados le infunde significado, legisla su existencia y la materializa. Las 
tecnologías no son sólo herramientas que se utilizan o aplicaciones de la ciencia, 
sino que más bien se definen a través de argumentos y contraargumentos que, en 
algún momento futuro, se estabilizan en un plano social y se materializan sus 
estructuras (Latour and Woolgar, 1986; Bijker and Law, 1992). Y, más importante 
aún, se deberían estar estudiando los efectos sociales, cualquiera que sea su forma 
material, si queremos dar respuesta a las preguntas macro sobre la estructura, poder 
y organización12. En este sentido, lo tecnocientífico es siempre social y se vincula 
                                                 
12 El análisis sociológico necesita incorporar a la materia como un actor, para entender en forma acabada la 
reproducción (Law, 1992). La reputación de un investigador o instituto, su inclusión en los planes de estudio, 
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a las cuestiones de legitimidad y de construcción de credibilidad en las 
comunidades (Shaw, 2012).  
Para analizar la práctica nanotecnocientífica, este capítulo primeramente analiza 
diferentes visiones sobre el concepto: Desde los propios investigadores, de los 
gobiernos, la academia, del tercer sector y desde el sector asegurador. Luego, se 
propone un marco teórico ecléctico para dar soporte a la investigación en el campo 
nano. Ahora bien, esta práctica se construye, también, con relatos. La sección 
tercera continúa planteando relatos del pasado que permiten construir el mito 
nanotecnológico y analiza cuales son las expectativas de futuro. Finalmente, en la 
última parte, se plantea el enfoque de la teoría de actor-red (ANT) sobre la práctica 
tecnocientífica y se la caracteriza como una dinámica divergente de búsqueda.  
1.1 Diferentes visiones nano 
Para comenzar a responder posibles respuestas a la pregunta con la que iniciamos 
esta subsección ¿qué es nanociencia y qué es nanotecnología?, se transcribirán, 
analizarán y contrastarán las definiciones que expresaron, en los últimos años, 
actores claves del campo: La National Nanotechnology Initiative de EEUU (Roco, 
2004; Roco et al., 2011), la oficina de patentes de EEUU (Lee et al., 2006), la FDA 
de EEUU (Kimbrell, 2006), el Gobierno Británico (The Royal Society & The 
Royal Academy of Engineering, 2004; Bensaude-Vincent, 2012), la organización 
ecologista Greenpeace (Huw Arnall, 2003), la visión que tienen los científicos 
(Tahan, 2007) y el sector privado empresarial y asegurador (Swiss Re, 2005; Lloyd, 
2007; Marchant, 2014). 
1.1.1 Visión gubernamental 
Roco, Mirkin y Hersam (2011) presentan la visión de EEUU en un trabajo donde 
se describe la génesis de la Iniciativa Nacional de Nanotecnología (NNI)13, su 
situación actual y su probable evolución en el largo plazo (2000-2020). Desde el 
                                                 
en las citas científicas o técnicas, artículos, o el éxito con la recaudación de fondos, podrían servir para apoyar 
una idea. 
13 La NNI es un compromiso a largo plazo de investigación y desarrollo (I + D) en EEUU, que se inició en el 
año 2001 (actualmente, coordina 25 agencias independientes). El total de inversión en I + D en los años fiscales 
2001-2005 fue de más de 4.000 millones de dólares. 
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comienzo, se persiguió la formación de una comunidad académica 
interdisciplinaria en nanotecnología con una fuerte llegada al mercado.  
Para que el largo plazo sea sostenible, es esencial la planificación y el 
establecimiento de prioridades en la gestión pública. En ese sentido, propone un 
fuerte financiamiento público y privado para el futuro, y nos ofrece la promesa de 
aumentar la eficiencia en las industrias tradicionales y llevar radicalmente nuevas 
aplicaciones a través de las tecnologías emergentes. En este documento, Roco 
referencia la definición de la NNI que establece que la Nanotecnología  
… is the ability to understand, control, and manipulate matter at the level of 
individual atoms and molecules, as well as at the “supramolecular” level involving 
clusters of molecules (in the range of about 0.1 to 100 nm), in order to create 
materials, devices, and systems with fundamentally new properties and functions 
because of their small structure. (Roco, 2007 p. 3).  
Esta definición implica una plataforma unificadora entre la ciencia y la ingeniería 
a nanoescala. En resumen, el enfoque es tecnológico y con un fuerte financiamiento 
para que la empresa norteamericana en el futuro pueda establecerse como líder y 
ser un motor fundamental en la nueva economía. 
Cientos de nano-productos ya están ampliamente disponibles14 y son 
especialmente frecuentes en los productos de cuidado personal. La FDA tiene 
autoridad reguladora sobre muchos de estos productos, sin embargo, hasta el 
momento, no ha adoptado medidas que contemplen las diferentes propiedades y 
riesgos asociados a los nanomateriales. G.A. Kimbrell (2006) evalúa la postura 
actual de la FDA con respecto a la reglamentación de los productos de consumo 
masivo que incluyan nanomateriales. El autor alienta a la FDA a modificar sus 
reglamentos para hacer frente a los nuevos riesgos humanos y ambientales, que los 
productos que contienen nanomateriales pudieran producir.  
                                                 
14 Complementando la visión norteamericana, Lee et al. (2006) realizan un análisis del estado actual de las 
patentes nanotecnológicas: si bien las actuales son, básicamente, materiales pasivos, se espera un futuro 
promisorio. Asimismo, la Agencia Federal de Alimentos (FDA) ha expresado su opinión sobre la aparición de 
productos nanotecnológicos en el mercado de consumo masivo, pero sin regular todavía. 
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1.1.2 Visión desde la academia y desde el tercer sector 
Desde el ambiente académico, algunos científicos e ingenieros prefieren plantear 
que, en la actualidad, la nanotecnología se limita, solamente, a la fabricación de 
nanomateriales; cualquier otro futuro posible es por ahora, meramente, una 
posibilidad15. Sólo tal vez la nanotecnología del futuro incluirá la manipulación 
átomo por átomo, o molécula por molécula, y la posibilidad de construir 
dispositivos activos (Tahan, 2007). A pesar de esta visión restrictiva, es notable la 
cantidad de investigadores que trabajan en el nuevo campo, piden financiamiento 
a los políticos bajo las promesas nanotecnológicas y publican en las numerosas 
revistas científicas16.  
Para muchos científicos que trabajan en el área de materiales, la nanotecnología es 
una evolución natural de la tecnología, pero que al llegar a nivel nano, muchas 
propiedades cambian de forma radical. Por ejemplo, partiendo de la 
microelectrónica, si realizamos circuitos cada vez más pequeños, se llega a un 
límite crítico donde los materiales se comportan de manera muy diferente: un hilo 
de 1 mm de espesor es conductor y sigue la ley de Ohm, pero cuando se reduce a 
un nanómetro, la ley de Ohm no es válida. En esos espesores, la naturaleza se 
empieza a comportar de manera cuántica, siendo necesario un replanteo de toda 
nuestra teoría, y dando lugar a la teoría ecléctica(Nordmann, 2010).  
Las aplicaciones biomédicas son vastas y dan lugar a lo que se denomina 
nanomedicina. Los científicos la consideran una disciplina nueva, pues se relaciona 
con el acceso a la célula, donde las dimensiones son nanométricas (Bawa and 
Johnson, 2009). Si podemos acceder al interior y manipular el contenido con algún 
dispositivo inteligente, estamos frente a lo que llamaríamos bionanotecnología. 
Según este punto de vista, la nanociencia, en la medicina, es tal en tanto exista la 
posibilidad de acceder al interior celular y operar en él. 
                                                 
15 Además, existe un proyecto que detalla todos los productos nanotecnológicos que se encuentran en el 
mercado hoy. Claramente, son mayoritariamente nanomateriales pasivos en objetos de consumo (Project on 
Emerging Nanotechnologies, 2008) 
16 Leydesdorff y Zhou (2007) describen la evolución de la Nanotecnología como una disciplina, analizando 
las publicaciones en las revistas científicas. Utilizando el Índice de citas del 2003, 2004 y 2005, los autores 





Por último, se trae a la discusión la voz de las organizaciones no gubernamentales. 
En particular, Greenpeace plantea que el nuevo campo multi-disciplinario 
propuesto por la nanotecnología y el creciente flujo de dinero público, abre la 
posibilidad de una nueva carrera armamentista entre los gobiernos (Faunce, 2014; 
Arnall, 2003). El tercer sector advierte sobre el uso de la nanotecnología, como una 
etiqueta para una variedad de disciplinas científicas con el fin de obtener dinero de 
los presupuestos gubernamentales (Arnall, 2003). 
1.1.3 Visión desde el sector asegurador 
Ahora se prestará atención a un último actor, clave desde el punto de vista del 
mercado: las aseguradoras de riesgo. Estas empresas persiguen un fin de lucro en 
un sistema de mercado pero, a diferencia de otras empresas que buscan invertir en 
negocios riesgosos (tal vez nanotecnológicos), su negocio es cobrar primas en 
forma anticipada para cubrir a sus clientes por futuras contingencias. El valor de 
esas primas debería representar la probabilidad de la contingencia multiplicada por 
la intensidad. Claramente, el surgimiento de la nanotecnología es una oportunidad 
de grandes negocios, pero el cálculo de esas primas es incierto en un contexto de 
novedad y escasa regulación; esta incertidumbre sobre los beneficios o pérdidas 
futuras preocupa al sector, pues solamente sufrirá las pérdidas y no sus beneficios. 
Esta problemática interesó a las aseguradoras líderes a nivel mundial y han 
realizado informes en los que expresan su posición (Swiss Re, 2005; Lloyd, 2007). 
La reactividad química de un material está relacionada con su superficie en 
comparación con su volumen, por lo que las nanopartículas de una sustancia 
determinada pueden ser mucho más reactivas que en grandes volúmenes, para un 
mismo peso dado de la sustancia. Los informes de las aseguradoras enfatizan que 
estos productos ya están en el mercado y se utilizan en productos de consumo. La 
toxicidad es desconocida y se pueden dispersar fácilmente. Por esta razón, la 
industria de seguros se propone vigilar esta situación, para evitar la quiebra de la 
aseguradora17 (Lloyd, 2007).  
                                                 
17 Según las investigaciones al día de hoy, no está claro si las nanopartículas pueden causar efectos crónicos 
de salud, llevando a la industria a contraer deudas millonarias a futuro por efectos ocasionados hoy. 
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La industria reconoce los grandes beneficios potenciales, sin embargo, alerta que 
no debe permitirse comercializar estos productos antes de evaluar adecuadamente 
los riesgos asociados. Esto lo hace velando por su propia salud financiera, evitando 
que no se produzcan quebrantos secuenciales por una agregación sistémica de la 
pérdida por negocios nanotecnológicos. Asimismo, se alerta sobre el mecanismo 
utilizado por algunos países de dejar que los productos salgan al mercado masivo 
y esperar y ver los riesgos, siendo una forma muy peligrosa de determinar los 
riesgos asociados. En resumen, la opinión de este último actor, las aseguradoras, 
es la de mantener el ritmo rápido del desarrollo del campo, promover la formación 
de redes de académicos que trabajen en este ámbito y enfatizar que en la actualidad 
existe un vacío de regulación. La falta de reglamentación nunca es útil para los 
aseguradores responsables y, en este sentido, la industria de seguros debe ejercer 
presión por medio de lobbies para exigir una mayor transparencia y eficacia. Esto 
permitiría proteger la solvencia de largo plazo de la industria (Lloyd, 2007). 
Luego de revisar las diferentes visiones sobre la práctica nanotecnocientífica, la 
siguiente sección problematiza el proceso de formación disciplinar dentro de un 
marco teórico ecléctico. 
1.2 Un marco teórico ecléctico 
Es Alfred Nordmann (2006) quien recuerda que, a fines de 1940, el físico Werner 
Heisenberg (1971) introdujo el concepto de teorías cerradas. En particular, se 
refirió a cuatro: la mecánica newtoniana, la teoría de la relatividad, la mecánica 
estadística de Gibbs (Kirkwood, 1946), y la mecánica cuántica no relativista. Estas 
teorías son consideradas cerradas debido a que su desarrollo histórico ha llegado a 
su fin, constituyendo cada una un dominio herméticamente cerrado y siendo 
siempre válidas.18 Heisenberg, asimismo, enuncia que sus dominios son acotados 
y no incluyen ninguna proposición cierta sobre el mundo empírico porque son una 
idealización del éste. Evaluar en qué medida los fenómenos experimentales pueden 
                                                 
18 Alisa Bokulich (2006) examina en detalle las similitudes y diferencias entre la noción de Teoría cerrada de 
Werner Heisenberg y el concepto de paradigma de Thomas Kuhn. Si bien Heisenberg y Kuhn comparten una 
concepción holista de las teorías y la noción de inconmensurabilidad, sus opiniones divergen, 
fundamentalmente, en lo que respecta a la cuestión del realismo científico. 
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ser explicados por la teoría es una cuestión de calibración, afinación, de ajuste 
mutuo entre fenómeno y teoría. 
Por otro lado, los investigadores en nanotecnociencia no tienen como objetivo 
acomodar la teoría a la realidad para explicar esta última. En este sentido, se toman 
los fenómenos nano como un mundo complejo situado entre la teoría clásica y la 
cuántica (Roukes, 2001). Asimismo, no existen teorías especialmente adaptadas 
para tener en cuenta la particular complejidad del mundo a nanoescala, ni que 
expliquen la relación entre la estructura de un determinado material y sus 
propiedades. En lugar de utilizar teorías cerradas, el investigador busca una 
explicación parcial mediante un uso ecléctico de varias teorías, forzándolas, más 
allá de su ámbito de aplicación.  
Nuevamente, Alfred Nordmann (2004) ofrece un claro ejemplo donde, para medir 
la corriente a través de un complejo orgánico-inorgánico, el investigador elige, 
indistintamente, entre reconstruir la medida en forma cuántico-química o de forma 
clásica. De esta manera, los investigadores utilizan teorías e instrumentos que no 
fueron hechos para trabajar en esta escala19. El investigador se enfrenta a un 
cosmos donde las propiedades clásicas, como el color y la conductividad, surgen 
al aumentar el tamaño desde los niveles cuánticos; y donde fenómenos, como la 
conductividad cuántica, emergen al reducir la escala hasta llegar al régimen 
cuántico (Roukes, 2001).  
Para operacionalizar este marco ecléctico dentro del laboratorio es necesario 
construir modelos de simulación que integren varias teorías, de forma de predecir 
el comportamiento de un sistema a escala nano. Eric Winsberg (2006) ilustra este 
comportamiento emergente describiendo el uso de modelos computacionales en 
los estudios en esta escala. Estos algoritmos descriptivos de una dinámica se 
separan de la explicación causal tradicional y ofrecen un posible mecanismo de 
explicación ad hoc mediante el uso de un software específico20 (Gruner, 2013).  
                                                 
19 Esto implica también que el núcleo mismo de las teorías se fuerza para dar cuenta de una estructura causal 
detrás de los fenómenos observados. 
20 Un ejemplo claro de lo anterior es el artículo “Conductance of a Molecular Junction”, publicado en la revista 
Science en 1997 (Reed et al., 1997).  
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En tanto la nanotecnociencia considera el mundo como complejo, caracterizado 
por las leyes de la química y por actividad biológica, aspira a construir materiales 
vivos en lugar de dispositivos pasivos. Un buen ejemplo de ello es el término 
superficie selectiva que atribuye a la agencia algo que sigue siendo pasivo: las 
células pueden adherirse a una determinada superficie en forma diferencial, pero 
la selección la realiza el ingeniero que elige la superficie a fin de lograr alguna 
funcionalidad. Lo mismo cabe decir de conceptos tales como materiales 
inteligentes, movimiento autónomo, etc. Todos estos términos tienen un 
significado concreto y, al mismo tiempo, se refieren a algo visionario (Nordmann, 
2006). 
1.2.1 El poder de las imágenes  
Si, como se dijo recientemente, el ámbito de investigación fuerza eclécticamente 
teorías ajenas para construir explicaciones, ¿cómo puede el investigador estar o no 
satisfecho con su entendimiento de un determinado fenómeno? Para Heisenberg y 
cualquier filósofo de la ciencia que tenga orientación hacia la física teórica, esta 
cuestión se reduce al poder predictivo de la ciencia cuantitativa: los valores 
numéricos que predice la teoría se comparan con los valores obtenidos en la 
medición y se verifica que se encuentren razonablemente cercanos. Esto no es 
posible en las investigaciones a escala nano, pues en forma explícita se manipula 
al realizar la medida (en general se bombardea la materia y se lee a partir de la 
respuesta del material).  
Esta imposibilidad lleva a postular el criterio de semejanza (likeness). Se evalúa 
visualmente la semejanza entre la imagen de una simulación del modelo y otra 
imagen que representa la medición. Esta situación nos aleja del paradigma 
cuantitativo y nos propone un mecanismo cualitativo de evaluación. Lo que 
compara el investigador son dos representaciones, la simulación del modelo y la 
lectura del laboratorio21.  
                                                 
21 Desde ya, que esta metodología tiene muchos problemas, siendo el principal, la subjetividad del investigador 
al comparar imágenes provenientes de dos monitores. Uno ofrece una interpretación visual de los datos que 
fueron obtenidos a través de una serie de mediciones, mientras que el otro, presenta una simulación dinámica 
del proceso que podría haber sido la observación realizada con un software de simulación visual. En base a 
esas dos imágenes, se extraen conclusiones sobre los procesos de causalidad probable. 
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Como los investigadores provienen de diferentes formaciones básicas, 
habitualmente difieren en qué teorías utilizan, pero todos coinciden en qué 
instrumentos y qué programas de ordenadores utilizan. Estos artefactos se 
transforman en los referentes comunes en la comunidad y adquieren una 
importancia extrema22. Estas imágenes del nanocosmo son cada día más populares. 
Al pasar de comparaciones cuantitativas de valores numéricos a la construcción del 
concepto de semejanza cualitativa por imágenes, se sustituye una realidad por otra 
desde lo simbólico. En este sentido, el poder de las imágenes23 ha convertido a la 
nanotecnociencia en lo que es (Nordmann, 2006).  
Este vuelco a lo cualitativo, a la hora de contrastar el modelo con la realidad, ha 
molestado a filósofos de la física como Otavio Bueno (2004) y Pieter Vermaas 
(2006), pues se deja al relativismo de un ojo humano el comparar dos figuras. De 
esta forma, el poder de las imágenes plantea algunos de los problemas más graves 
para las nanociencias y las nanotecnologías; las imágenes en los medios producen 
su propia realidad que, muchas veces, contradice la intención del científico que la 
produjo24. En este sentido, los científicos invocan, en forma casi automática, a 
imágenes de transporte de electrones sin sentir la necesidad de demostrar su 
existencia: piensan los electrones pasando a través de una molécula como si fuera 
un objeto material.  
Rom Harré (2003) contrasta los instrumentos científicos que sirven como prueba 
para evaluar causalidad, con los dispositivos (incluyendo simulaciones) que 
producen fenómenos. Utilizando instrumentos se obtienen medidas que pueden 
remontarse en la cadena causal a algún estado físico, propiedades o proceso; no 
ocurre lo mismo cuando se utiliza una imagen de una simulación para compararla 
con la imagen que produce un dispositivo de lectura. En resumen, la práctica de 
                                                 
22 A este respecto, es especialmente interesante el trabajo realizado por Jochen Hennig (2006) sobre la historia 
del microscopio scanning probe, como así también el de Ann Johnson (2006), que estudia el papel que ocupan 
los ingenieros de software en este proceso. 
23 Historiadores del arte y teóricos como William Mitchell (2005) o Hans Belting (1994), en particular, han 
puesto de relieve la diferencia entre los signos convencionales, que sólo persiguen la representación de otra 
cosa, y las fotografías o imágenes que encarnan visiones y deseos. 
24 Nordmann (2006) recuerda como ejemplo, la famosa imagen a escala nano producida por Don Eigler y 
Erhard Schweizer (1990). Por primera vez en la historia, los seres humanos manipularon los átomos a voluntad 
y dieron una imagen al mundo que fue leída como la prueba de concepto de las increíbles posibilidades de la 
nueva tecnología. Esto no era, precisamente, lo que Eigler y Schweizer quisieron decir; su imagen es 
testimonio de la dificultad y de los límites tecnológicos para el control de átomos individuales (Eigler, 1999). 
Pero el poder de la imagen difundida en los medios superó cualquiera de sus testimonios en contrario. 
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laboratorio nano tiene una perspectiva ingenieril del conocimiento, se construyen 
materiales utilizando un marco ecléctico específico (Rip, 2013).  
1.2.2 Hacia una disciplina 
En la subsección anterior se presentó a la Nanotecnociencia en términos de 
cuestiones disciplinares (un complejo campo parcialmente explicado, mediante la 
extensión de teorías cerradas), metodológicas (la comparación por semejanza de 
imágenes, no de números) y ontológica (indiferencia). 
A partir de la mecánica cuántica, hidrodinámica, etc., aparecen las teorías que 
sirven de guía a nanoescala. Si bien éstas son las ciencias básicas, como planteamos 
anteriormente, no pueden postularse como cuerpo teórico de la nanociencia. El 
dominio de interés para las nanociencias y las nanotecnologías comprende a todo 
aquello que se encuentra en la zona fronteriza entre el mundo cuántico y la física 
clásica. Se extienden marginalmente teorías25 para enfrentar los desafíos que 
presenta el mundo a escala nano.  
Resumiendo, no hay ningún marco teórico para lograr, en el mundo real, controlar 
los fenómenos de escala nano en nuestro beneficio. Sólo se puede extender el 
marco existente hacia uno ecléctico para explicar un comportamiento dentro del 
laboratorio. Pero ese trabajo, muy posiblemente, no será lo bastante robusto como 
para servir de base para la producción masiva de componentes nanotecnológicos. 
Todo parece posible, pues nuestro conocimiento actual no lo invalida. Es evidente 
que el mero hecho de que algo no esté en contradicción con las leyes conocidas, no 
es suficiente para establecer que es posible técnicamente lograr que funcione a 
nivel masivo y fuera del laboratorio (Nordmann, 2006). Es en el proceso de salir 
del laboratorio, donde los relatos del pasado y las expectativas de futuro impactan 
en el proceso de constitución. La siguiente sección analiza esta problemática. 
                                                 
25 Esta forma de trabajo “marginal” también se ve reflejada en la forma que se evalúan los riesgos toxicológicos 
asociados a las nanotecnologías (nanotoxicología). Además, se extienden procedimientos de evaluación de 
riesgos químicos a la escala nano, debido a la falta de metodologías propias. El investigador realiza 
modificaciones ad hoc a los métodos para que se adecuen al nuevo ámbito, pero no hay certeza de estar 
evaluando los riesgos en forma correcta, poniendo en peligro vidas humanas y al medio ambiente. 
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1.3 Relatos y expectativas del futuro 
A la hora de imaginar el futuro de una nueva tecnología siempre es importante 
evaluar la forma en que se describen los logros que en el pasado otras tecnologías 
han construido. En el contexto particular de la aparición de la nanotecnología, 
Chris Tourney (2006) postula que el relato del pasado es fundamental a la hora de 
imaginar el futuro de la nanotecnología, teniendo en cuenta que algunos rasgos de 
ese pasado continuarían en un futuro posible. Este autor selecciona la teoría de los 
mitos26 de Malinowski (1954) para detectar cuáles podrían ser los relatos o 
historias útiles a la hora de construir el relato de la nanotecnología. Para Tourney, 
la nanotecnología podría generar las condiciones necesarias para el relato del mito, 
de la misma forma que lo ha hecho la recombinación de ADN.  
Los puntos a considerar del desarrollo de Malinowski que Tourney sostiene como 
necesarios para su hipótesis son, por un lado, que el relato del mito surge en 
circunstancias tensas, particularmente, cuando un grupo debe justificarse sobre 
otro, cuando su experiencia de la historia se modifica o cuando aparecen eventos 
que molestan. El resultado del relato del mito es justificar, legitimar o racionalizar 
las circunstancias que rodean a la gente. De esta forma, podría ser un ejercicio 
como para llegar a un arreglo de las tensiones actuales. Muchas de las relaciones 
que involucra la nanotecnología asemejarían las condiciones que genera el relato 
del mito en la teoría de Malinowski, en la medida que coexisten varios relatos 
narrados27. 
Tourney (2006) organiza a las diferentes posturas en relación a la nanotecnología 
en cuatro categorías. La primera es la postura en extremo nanofílica, cercana a la 
ciencia ficción, de la cual Eric Drexler es uno de sus principales exponentes. La 
segunda, es optimista en cuanto a los beneficios, pero menos fantasiosa. Fue en 
este sentido que la administración Clinton favoreció varios proyectos, pensando en 
los beneficios para la salud y en la mejora de los estándares de la población. A la 
tercera postura la denomina como de escepticismo mesurado. Se oponen y 
                                                 
26 La teoría de Malinowski plantea la existencia de una relación entre las condiciones sociales del presente y 
los relatos de las historias del pasado. En este sentido, sostiene que una de las razones por la que la gente relata 
mitos, es debido a la necesidad de justificar ciertas condiciones del presente. 
27 En el mismo sentido que los Trobriander narran su mito. 
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ridiculizan a la postura en extremo nanofílica, haciendo hincapié en las 
consecuencias que podría ocasionar tanto en la ciencia como en la sociedad. La 
cuarta y última postura es la extrema hipérbole nanofóbica. Su postura es tan 
exagerada como la nanofílica. Esta visión realiza una analogía de la nanotecnología 
con la historia de Frankenstein, en la cual toda predicción se presume como 
peligrosa y arrogante. Asimismo, hay quienes preanuncian el fin de la humanidad 
(Joy, 2000).  
Como dijimos anteriormente, Tourney (2006) selecciona un caso tecnológico 
semejante: la recombinación de ADN de 1970 (donde se cumplirían las 
condiciones de Malinowski)28. La posición de Tourney (2006) es que la historia de 
la recombinación de ADN va a ser relevante para la nanotecnología cuando estén 
presentes las siguientes tres condiciones. La primera, cuando la hipérbole tecnófila 
inspire su reacción opuesta denominada hipérbole tecnofóbica. Es válido 
argumentar que esta situación podría estar pasando actualmente en relación a la 
nanotecnología.  
La segunda alude a las condiciones de Malinowski: la nanotecnología pareciera 
afectar a diferentes personas en diferentes modos y podría incrementar la diferencia 
de poder o riqueza. Algunos grupos podrían controlar la investigación y el 
desarrollo, mientras que otros se sentirían más poderosos. Asimismo, generaría un 
cambio histórico profundo y los ciudadanos podrían no entender la situación en la 
que se encuentran. De este modo, las tres condiciones del relato del mito de 
Malinowski podrían desplegarse. Finalmente, la tercera condición mencionada por 
Tourney (2006) plantea el desinterés por la salud pública29.  
De esta forma, la lección más importante es que esa hipérbole y las condiciones de 
Malinowki han intensificado los valores, las esperanzas y los miedos que podrían 
                                                 
28 Este caso demostraría diferentes condiciones que permitirían anticipar algunos efectos en las reacciones 
públicas en relación a la nueva tecnología. Además, consideramos que la selección de este caso fortalece el 
concepto de proceso dinámico de construcción del campo nanotecnológico a partir de la interacción de los 
diferentes actores involucrados. Inicialmente, la recombinación de ADN trajo aparejada una considerable 
hipérbole tecnofílica. Sus consecuencias serían nuevos beneficios de magnitudes desconocidas: productos 
farmacéuticos más efectivos, comprensión de las causas del cáncer, abundantes cosechas de alimentos, hasta 
nuevas soluciones para los problemas de energía (Grobstein, 1977) 
29 Si bien este tercer elemento todavía no estaría establecido en el caso de la nanotecnología, el autor sugiere 
la necesidad de anticiparse a la reacción pública, indagando acerca de los riesgos que los científicos e 




ser anticipados en la reacción pública hacia la nanotecnología en un futuro cercano. 
Si no se enfatiza en la salud y seguridad pública, la reacción seguramente será de 
miedo y rechazo hacia la nanotecnología. Luego, las historias que la gente relate 
de la nanotecnología cobrarían la forma del relato del mito al estilo de 
Malinowski30 (Tourney 2006).  
Luego de analizar las narrativas del pasado, nos concentraremos en las expectativas 
sobre el futuro. Cynthia Selin (2007) explora cómo las expectativas 
nanotecnológicas de los diferentes actores involucrados operan para definir el 
campo, como así también qué problemas son los legítimos, poniendo de manifiesto 
las maneras en que los distintos actores pretenden utilizarlas para colonizar el 
futuro y legitimar sus intereses presentes. La pelea entre los actores gira alrededor 
de la pregunta acerca de qué es nanotecnología y, fundamentalmente, qué debe ser. 
El punto de partida de la autora es simplificar este multientramado de actores 
agrupándolos en dos: los llamados visionarios y los científicos.  
En este nuevo desarrollo del campo disciplinar, convergen diversas disciplinas, 
diferentes instituciones, como así también financiamientos, políticas económicas y 
sociales, culturales y los medios masivos de comunicación. Asimismo, es 
importante mencionar que estas expectativas sobre la nanotecnología siguen una 
dinámica que busca evidenciar beneficios futuros que permitan construir un nuevo 
orden mundial. Los más apasionados hasta mencionan un mundo donde esta 
tecnología nos libraría de los problemas de salud y limpiaría nuestro mundo de 
todo tipo de polución presente. Selin se refiere a un concepto de expectativa como 
similar a motivación y a intención (Selin, 2007 p.198). 
Desde un punto de vista de la teoría económica, el profesor de la universidad de 
Stanford Nathan Rosenberg (1976) asegura que las expectativas sobre el curso 
futuro de la innovación tecnológica es uno de los factores más relevantes a tener 
                                                 
30 Asimismo, las representaciones narrativas compiten con otras para lograr la credibilidad y la autenticidad 
histórica. Es decir, se relatan diferentes historias del pasado, y según cuál sea el futuro posible, se seleccionan 
las principales lecciones que deben ser pensadas. Entonces, para construir el relato de la nanotecnología, los 
científicos e ingenieros que trabajan en estas investigaciones pueden contribuir con historias de mucho valor, 
que seguramente, disputarán con las historias de otros. Es válido pensar que esos otros relatos, también 
poderosos, pueden provenir de ciudadanos participantes que quizás tengan otros valores y otras lecciones.  
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en cuenta por el empresario a la hora de elegir si adopta una nueva tecnología31. 
Desde el punto de vista sociológico, es muy interesante el aporte que se realiza a 
la problemática en el número especial de la revista Technology Analysis and 
Strategic Management donde los editores invitaron a un grupo de sociólogos a 
discutir sobre el rol de las expectativas en el delineamiento del cambio 
tecnocientífico (Borup et al., 2006). Para ellos, las expectativas y las visiones 
futuras son importantes para la sociedad en su conjunto, más allá de las opiniones 
de los científicos e ingenieros directamente involucrados en la tecnociencia en 
cuestión32.  
El futuro imaginado de la nanotecnología es una promesa de pequeñas máquinas 
programables capaces de curar todos los males y de limpiar el medio ambiente de 
la polución, que nosotros mismos hemos causado. Es un futuro creado para seducir, 
ofreciendo soluciones mágicas a problemas que nuestra sociedad no quiere 
enfrentar por el camino más arduo (i.e. cambio de dieta y ejercicio físico para 
mejorar nuestra salud y un serio programa de reducción de emisión de gases de 
efecto invernadero a la atmósfera).  
Ese futuro conlleva miedos, irracionalmente exagerados. Michel Crichton (2002) 
sitúa su novela Prey en un laboratorio nanotecnológico en el desierto de Nevada. 
Debido a un experimento fuera de control, una nube de nano-robots se ha escapado. 
Esta nube es autónoma, se autoreproduce y aprende. Se presenta como un ser vivo 
que se expande sin límite. Esta predicción futurista se ha dado en llamar grey goo 
(Highfield, 2003). Si bien el lenguaje pseudocientífico está siempre presente en el 
discurso, la comunidad científica contrapone teorías y experiencias, postulando la 
bajísima probabilidad de que esto ocurra. No es necesario imaginar enemigos 
irreales para encontrar seres que se autoreproducen y que amenazan a diario la 
sobrevivencia: virus, bacterias y, el más dañino, los seres humanos (Tahan, 2007).  
                                                 
31 Esas decisiones empresarias agregadas y su relación dialéctica con las políticas públicas sostienen estas 
expectativas futuras y las reproducen. Sin dudas, no hay posibilidad de sostener en el tiempo expectativas 
futuras que no estén sincronizadas con la empresa, al menos, en el mundo occidental capitalista que nos 
concierne. 
32 Dichas expectativas desempeñan un papel central en la asignación de recursos públicos nacionales, 
definiendo el futuro de la sociedad en su conjunto (van Lente and Rip, 1998; van Lente, 1993). Por estas y 
otras razones, el análisis de la dinámica de las expectativas es un elemento clave en la comprensión científica 
y en el cambio tecnológico. 
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El libro de K. Eric Drexler Engines of Creation: The Coming Era of 
Nanotechnology visiblemente describe increíbles beneficios futuros en conjunto 
con escalofriantes riesgos previamente impensados (Drexler, 1986). El autor 
plantea que la nanotecnología tiene un control exhaustivo de la materia a nivel 
molecular y sostiene como algo cierto en el futuro cercano la posibilidad de diseñar 
moléculas a voluntad33 (Drexler, 1992). En un reciente trabajo K. Eric Drexler 
(2004) remarca que la revolucionaria visión de Feynman hizo de la nanotecnología 
una moda y puso en marcha una carrera a nivel global por dominarla. Sin embargo, 
la comunidad científica, luego de valerse de esta visión futurista para lograr 
financiamiento y temiendo que la preocupación pública con respecto a sus peligros 
pudiera interferir con dichos fondos, ha tratado de reducir las expectativas de corto 
plazo generadas por la nanotecnología, para excluir lo problemático de la visión de 
Feynman.  
Drexler (2004; , 2013) ofrece definiciones para dar su opinión sobre cuatro 
conceptos que habitualmente se confunden: nanoreplicador, nanobot, ensamblador 
y fabricación molecular. Tal como se utiliza aquí, un ensamblador es un 
mecanismo para orientar reacciones químicas. Un nanobot genérico, entonces, 
puede ser un ensamblador o algún otro tipo de mecanismo robótico a nanoescala. 
La fabricación molecular es un proceso de construcción átomo por átomo. Por 
último, un nanoreplicador es una compleja y especializada especie de nanomáquina 
que permite la autoreplicación de los nanobots. En la visión de Drexler, estos 
mecanismos descritos previamente son la solución a la contaminación, a la escasez 
de recursos alimentarios y a la desigualdad económica. De acuerdo con muchos 
autores, Drexler personifica la corriente que llamaríamos visionaria 
nanotecnológica (Stix, 2001; Selin, 2007). Sin dudas, ha sido una figura clave para 
este nuevo paradigma tecnológico y ha dominado el discurso oficial durante todos 
los años 90.   
                                                 
33 Además, prevé máquinas moleculares programadas por nanocomputadoras para llevar a cabo tareas 
específicas. Así también se imagina la manipulación de átomos individuales para obtener formas determinadas. 
Estos dispositivos no serían simples máquinas, incluirían una componente orgánica. Dependiendo de la misión 
programada al diseñarla, el organismo podría romper enlaces a nivel molecular para construir nuevas formas.  
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Actualmente, los resultados concretos en nanotecnología son modestos y se 
reducen a la producción de nanopartículas34. Sin embargo, existen posibles riesgos 
a evaluar, que no deben ser minimizados, asumiendo que nuestro conocimiento 
sobre materiales en estudio hasta el nivel micro se aplica a la escala nanométrica. 
En consecuencia, el aumento de la superficie de contacto entre los materiales y el 
medio ambiente o los seres humanos aumenta su poder reactivo. Por un lado, 
permite que las nanopartículas de plata sean, a igual peso, más efectivas que sus 
hermanas mayores en tareas de esterilización. Análogamente, ese mayor poder 
reactivo puede tener mayor nivel de toxicidad para el ser humano (Cui et al., 2005; 
Lam et al., 2004; Shvedova et al., 2003) o para el medio ambiente (Colvin, 2003).  
Las promesas de beneficios futuros de la nanotecnología tardan en llegar y muchos 
empiezan a sospechar que, tal vez, tarden demasiado o nunca lleguen. Esta 
situación, claramente, se ha transformado en los últimos años, en un problema para 
el financiamiento de la actividad.  
1.4 La práctica tecno-científica  
De acuerdo a la teoría del actor-red (ANT), la relación entre los actores 
involucrados en una práctica científica (o tecnocientífica) es la que le infunde 
significado, legisla su existencia y la materializa. Asimismo, las tecnologías 
involucradas en la práctica no son sólo herramientas que se utilizan o aplicaciones 
de la ciencia, sino que más bien se definen a través de argumentos y 
contraargumentos que, en algún momento futuro, se estabilizan en un plano social 
y se materializan (Latour and Woolgar, 1986; Bijker and Law, 1992).  
Si bien el materialismo relacional de este enfoque es distintivo35, tiene puntos en 
común con otras perspectivas sociológicas. El hecho de vincular el materialismo y 
                                                 
34 Si bien estos nanomateriales son la prehistoria de lo esperado por los visionarios, igualmente han producido 
un impacto increíble a lo largo del último decenio. El Instituto Inglés de Física editó una nueva revista llamada 
Nanotechnology en 1991. Ese mismo año, por su parte, los departamentos de desarrollo corporativos 
comenzaron los anuncios de desarrollos nanotecnológicos. Por ejemplo, el vicepresidente de IBM, J.A. 
Armstrong, ese año presentó su plan de inversiones nanotecnológicas, comparando la futura revolución con la 
“micro” de los 70 (Williams and Alivisatos, 2000).  
35 Cuando se busca describir las tecnologías y las consecuencias de su aparición, es necesario considerar una 
multitud de factores derivados de la heterogeneidad de los actores. En este campo, interactúan no sólo los 
científicos con sus artefactos, sino también los gobiernos (y sus leyes), las universidades y los centros de 
investigación, el mercado empresario, los medios de comunicación públicos. Asimismo, no sólo interactúan 
actores humanos sino también elementos materiales y discursos escritos (inscripciones) imponen su naturaleza, 
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las relaciones sociales se ha realizado tanto en el marxismo, como en muchas 
perspectivas feministas (Law, 1992) aunque en estas perspectivas, la relación entre 
estos dos elementos no se plantea de la misma forma continua como lo hace ANT. 
El enfoque es, pues, una teoría de la agencia, una teoría del conocimiento y una 
teoría de las máquinas. Y, más importante aún, se debería estar estudiando los 
efectos sociales, cualquiera que sea su forma material, si queremos dar respuesta a 
las preguntas macro sobre la estructura, poder y organización. El análisis 
sociológico necesita incorporar a la materia como un actor, para entender en forma 
acabada la reproducción (Law, 1992). 
Según Bruno Latour,  
…we study science in action and not ready made science or technology; to do so, 
we either arrive before the facts and machines are blackboxed or we follow the 
controversies that reopen them.(Latour, 1987 p.258).  
La imagen sugiere tomar una proposición técnica e imaginarla entre comillas y en 
la boca de un orador. Luego, poner a todos ellos en una situación específica, en 
algún lugar del tiempo y del espacio, rodeado por máquinas y colegas. Se observa 
la controversia que se desarrolla fijando la atención en qué elementos nuevos 
aparecen con el objeto de convencer o seducir a sus colegas. Luego, se ve cómo la 
gente que ha sido captada deja de discutir, la imagen propuesta empieza a 
desaparecer, dando lugar a un cuadro donde sólo aparece la nueva frase técnica 
inscrita en un libro texto similar al inicial. 
Siguiendo a Latour, se puede hablar de un hecho solamente cuando se estabilizó 
colectivamente a partir de controversias y los nuevos documentos técnicos al 
respecto no sólo dejan de criticar la idea, sino que empiezan a confirmarla. En la 
medida que las controversias aumentan la literatura, se convierte en técnica. Esta 
controversia se realiza con una retórica que incluye amigos para soportar el 
argumento propio, referencias a textos antiguos y la búsqueda de ser citado a 
futuro36 (Mifsud, 2014). 
                                                 
y se resisten. Por consiguiente, la red de actores está constituida por diversos elementos: discursos, materiales 
y humanos (Latour, 2012). 
36 Ahora bien, cabe preguntarse cómo se logra que una determinada idea sea aceptada. Latour dirá que se puede 
responder a través de “traducción”. Denomina traducción a un proceso mediante el cual los actores se definen 
y constituyen el uno por el otro, o bien, a la forma en que los actores atraen a otros agentes a posiciones 
favorables para los primeros (Callon, 1999). Por ejemplo, una vez que otros tienen una particular 
representación del futuro, se ha producido la traducción (Latour, 1987). 
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Bruno Latour (1987) analiza la construcción argumentativa como un proceso 
destinado a establecer legitimidad. Se refiere a los procesos de traducción original, 
como a la interpretación dada con la esperanza de atraer el interés de los demás. El 
éxito de una traducción implica inscribir a otras personas para sus intereses. Latour 
esbozó varias estrategias para traducir los intereses (Latour, 1987 p.108-9), y 
denominó aliados no sólo a los recursos que únicamente incluyen cifras y 
ecuaciones, sino también a otras asociaciones que representen a autoridades tanto 
de orden científico, social o político. La reputación de un investigador o instituto, 
su inclusión en los planes de estudio, en las citas científicas o técnicas, artículos, o 
el éxito con la recaudación de fondos, podrían servir para apoyar una idea. En este 
sentido, lo tecnocientífico es siempre social y se vincula a las cuestiones de 
legitimidad y de construcción de credibilidad en las comunidades.  
1.4.1 La ciencia en la sociedad 
En esta subsección, se contrasta la teoría propuesta por Bruno Latour con la de 
Bloor, defensor de una explicación social del conocimiento científico, y uno de los 
más importantes exponentes de la Sociology of scientific knowledge (SSK). Si bien 
Latour comparte la importancia de lo social, se separa de la explicación puramente 
social del conocimiento científico de SSK, para sostener una visión ontológica del 
trabajo realizado por la actividad científica y le interesa el rol social de la ciencia, 
siendo su objeto de estudio la ciencia en la sociedad. 
Eve Seguin (2000) argumenta que, a pesar del ataque masivo a la teoría de Latour 
hecho por David Bloor (1999), el debate no se basa en un desacuerdo, sino en una 
incomprensión fundamental por parte de Bloor con respecto a cuál es el campo en 
cuestión. De hecho, la dificultad en aceptar el trabajo de Latour tiene que ver con 
el hecho de ser abordado desde el punto de vista de SSK. Bloor (1999) sugiere que 
los dos enfoques están destinados a explicar el mismo fenómeno de diferentes 
maneras. Para Bloor, Latour trata de desarrollar una alternativa a SSK para el 
estudio de la ciencia como conocimiento.  
La ciencia difiere profundamente de otras cosmologías. La diferencia entre la 
ciencia y otras formas de conocimiento se encuentra en la actividad del laboratorio. 
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Esto significa que la ciencia no debe ser considerada como una colección de 
creencias. Se trata de un conjunto de procedimientos que se activan en una realidad, 
mostrando, claramente, que ya no estamos en el estudio de la ciencia como 
conocimiento37. Latour teoriza sobre la función social ejercida por la ciencia, 
queriendo explicar la sociedad, compuesta por cosas, hechos y artefactos, sin 
necesidad de utilizar explicaciones sociales38.  
Callon y Latour son taxativos al decir: 
We have never been interested in giving a social explanation of anything, but we 
want to explain society, of which the things, facts and artifacts, are major 
components.(Callon and Latour, 1992 p.348) 
Latour, en su libro Politics of Nature: How to Bring the Sciences into Democracy39 
aporta un nuevo enfoque a las discusiones ontológicas sobre la naturaleza (Latour, 
2004). Se propone un cambio radical en las actuales concepciones de la ecología 
política. Si separamos lo humano de lo no humano, los intereses sociales de la 
naturaleza y la política de la ecología, ponemos en peligro los cimientos de la 
democracia. La naturaleza no está para ser conquistada, pero tampoco para ser 
protegida como un objeto pasivo. Por el contrario, nuestras concepciones de hechos 
naturales y realidad deben ser reexaminadas para dar cabida a una política 
ecológica más amplia. Latour comparte con la tecnocracia un fuerte interés en dar 
cuenta de la centralidad de la ciencia en la sociedad contemporánea, y afirma que 
él “…simplemente busca que la filosofía de la ciencia no haga solamente la mitad 
del trabajo de la filosofía política en las sombras” (2004).  
                                                 
37 Si bien se reconoce el logro de SSK de secularizar el conocimiento científico, Latour plantea que el análisis 
de la ciencia en términos de creencias tiene un valor limitado, ya que ignora el carácter distintivo de la “ciencia 
como práctica”. Los seguidores de SSK no abordan esta cuestión porque su objetivo es eliminar la brecha que 
la epistemología establece entre la ciencia y las creencias 'irracionales'. 
38 Por otro lado, SSK busca arrojar luz sobre los intereses sociales que condicionan la formación del 
conocimiento científico, su objeto puede ser llamado "la sociedad en la ciencia”. Sin embargo, ambos enfoques 
tienen algo muy importante en común, comparten un micro-enfoque marcado por una preferencia de conocer 
detalladamente “estudios de caso”; si bien SSK se inscribe en la tradición que examina las condiciones de 
posibilidad de la tarea científica (e.g. Marxismo, feminismo), donde la única función que la ciencia puede 
ejercer es la de reproducir los intereses sociales dominantes y el orden existente. Sin embargo, introduce como 
novedad un análisis cuidadoso de los micro-mecanismos que explican el contenido de los conocimientos 
científicos (Seguin, 2000). 
39 El libro mencionado teoriza sobre el papel de la ciencia en forma de un tratado de filosofía política, 
argumentando que nuestra vida pública está compartimentada en dos: la política y la ciencia. La primera se 
ocupa de los valores y la sociedad; la segunda se refiere a hechos y a la naturaleza (y es oficialmente apolítica). 
Este autor presenta a esta organización como defectuosa y postula que la ciencia es un régimen absolutista por 
el cual el “orden natural” es construido por científicos a puertas cerradas. Para Latour, esta lucha exige una 
transformación republicana y el estudio de la ciencia es una forma de entender la sociedad en su conjunto.  
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Resumiendo, el enfoque de Latour es original por cuanto combina una observación 
de la práctica científica a nivel micro, con una preocupación teórica sobre la 
organización de la sociedad, abriendo nuevas posibilidades para el estudio de la 
función política de la ciencia40. Es por eso que esta perspectiva será extendida en 
el capítulo segundo para dar cuenta de cómo se constituye la dinámica industrial a 
partir de esta práctica. 
1.4.2 Régimen de búsqueda 
El progreso científico de los últimos años ha sido impulsado por tres áreas: ciencias 
de la vida, de la información y de los materiales. Debido al gran impacto de estas 
nuevas disciplinas, es importante preguntarse si son sustancialmente diferentes de 
las consolidadas con respecto a su práctica científica y a su emergente dinámica 
industrial. El análisis en detalle permite anticipar consecuencias para la 
formulación de políticas y en tal sentido, para la sociedad. Andrea Bonaccorsi 
(2008) desarrolla la noción de régimen de búsqueda como una caracterización de 
la dinámica de la ciencia. Se proponen tres dimensiones: la tasa de crecimiento, el 
grado de diversidad interna y la naturaleza de la complementariedad. En su trabajo 
sostiene que las nuevas ciencias siguen un patrón diferente de las ciencias 
establecidas.  
Las nuevas ciencias amplían la búsqueda de la explicación causal a fenómenos 
nuevos y más complejos. Analizan sistemas mucho más complejos41 que los 
sistemas físicos o químicos, por lo que requieren descripciones más largas y 
generan teorías de validez local (no grandes teorías unificadas). Si bien sigue 
siendo la aspiración reduccionista la que impulsa la búsqueda de explicaciones 
causales en la ciencia de materiales, su complejidad es creciente, lo cual produce 
                                                 
40 En particular, para el análisis del funcionamiento del discurso científico y el impacto de su práctica en la 
esfera pública (Seguin, 1996; , 2001). 
41 Si bien complejidad es un concepto controversial, este trabajo asume complejidad cuando existe un gran 
número de variables y formas de retroalimentación (Kline, 1995), cuando se presenta con un gran número de 
niveles jerárquicos interdependientes (Simon, 1981) o cuando las condiciones iniciales modifican la propia 
dinámica del proceso (Ruelle, 1993). 
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algunas explicaciones unificadas, al mismo tiempo que produce una cantidad 
creciente de subteorías especializadas (Heimeriks and Leydesdorff, 2012).42  
Para explicar la dinámica de estos sistemas complejos, se necesita información 
sobre los elementos constitutivos, pero también conocer la arquitectura sobre la 
cual aquéllos se articulan (Kline, 1995). Los materiales a escala nano son sistemas 
complejos que presentan una jerarquía de dimensiones espaciales con fuertes 
interacciones entre los distintos niveles. El estudio de los sistemas complejos no 
reduce el número de teorías. En el nivel local, coexisten subteorías que compiten 
por explicar el comportamiento de los nanomateriales, siendo todas plenamente 
coherentes con una teoría general sobre los elementos constitutivos. Los 
nanotecnocientíficos comparten una teoría fundamental común a nivel de 
elementos constitutivos, pero difieren en las explicaciones causales de aplicación 
local a cada jerarquía (espacial o temporal) del sistema complejo.  
Si bien esta complejidad imposibilita obtener nuevas estructuras directamente 
desde propiedades macroscópicas, se puede descomponer y agregar información 
de la arquitectura. De esta forma, los materiales pueden ser diseñados; se observa 
y se manipula el material al mismo tiempo. La nanotecnociencia se inscribe entre 
la ciencia y la tecnología (ingeniería). Bonaccorsi presenta a la ciencia de 
materiales como una nueva ciencia con metodología reduccionista, cuya dinámica 
rompe los límites entre lo natural y lo artificial.  
Como se ha indicado al comienzo de la sección, Andrea Bonaccorsi (2008) propone 
tres dimensiones para analizar las propiedades dinámicas de la nanotecnociencia: 
la tasa de crecimiento, el grado de diversidad, el tipo de complementariedad. La 
evidencia preliminar presentada por el autor, utilizando métrica de publicaciones 
científicas43, habla de una disciplina que crece rápidamente, en diferentes 
direcciones y hace uso de nuevas formas de complementariedad. Los estudios 
específicos confirman que el patrón de crecimiento en la primera década ha sido 
                                                 
42 Esta dinámica afecta las nuevas prácticas científicas y su política asociada. Si bien se presenta 
contraintuitiva, es útil remitirse a la literatura sobre el problema de los límites al conocimiento científico y la 
imposibilidad de explicación (Casti and Karlqvist, 1996) (Barrow, 1999)  
43 Según el autor, el único objeto de observación es el resultado producido por los científicos en la literatura. 
Se centra en algunas propiedades estadísticas de las palabras nuevas: la tasa de crecimiento después de la 
primera entrada, el efecto de la composición (relación entre las palabras nuevas y viejas en las disciplinas) y 
el índice de concentración. 
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exponencial con una tasa constante de crecimiento del orden del 14% de magnitud 
(Darby and Zucker, 2003). Este autor sostiene que la nanotecnociencia es un 
régimen de búsqueda divergente, un modelo dinámico donde las conclusiones de 
un proyecto dan origen a nuevas hipótesis que se constituyen, luego, en nuevos 
programas de investigación. Asimismo, propone una visión interesante sobre el 
tipo de complementariedad que se observa en nanotecnociencia. Gran parte de los 
inventores (patentes) son también autores de artículos científicos, y una gran parte 
de los fundadores de nuevas empresas son también inventores o autores. El autor 
encuentra evidencia de un sistema de conocimientos altamente interconectado en 
el que los logros científicos se traducen en resultados patentables y formación 
rápida de empresas donde los científicos tienen un papel preponderante. Durante 
los últimos 15 años, la nanotecnología ha crecido por encima del crecimiento de la 
ciencia y de la tecnología en general (con cifras sorprendentes para los artículos: 
14% contra un promedio de 2%) y es una disciplina divergente (utilizando como 
indicador la tasa anual de aparición de nuevas palabras clave). 
Si bien la nanotecnología tiene antecedentes disciplinarios en la física y en la 
química, su práctica es diferente y claramente es necesario analizarla en la 
dinámica industrial de la ciencia. En primer lugar, los nuevos campos de 
investigación dentro de la nanotecnociencia crecen en forma exponencial con el 
tiempo. En 10 años (1993-2003), cerca de 100.000 científicos de todo el mundo se 
incorporaron y miles de nuevas instituciones entraron en el campo. De hecho, gran 
parte de esta dinámica se explica por un explosivo proceso de entrada de nuevas 
palabras claves en las publicaciones (Bonaccorsi and Vargas, 2010).  
En segundo lugar, la nanotecnociencia sigue una dinámica divergente44 de 
búsqueda donde nuevas hipótesis se generan a partir de los paradigmas 
establecidos. En particular, se observa un patrón de comportamiento donde, dadas 
ciertas premisas comunes, las conclusiones originan nuevas hipótesis (y nuevos 
programas de investigación) (Bonaccorsi, 2008).  
                                                 
44 En oposición a un “régimen búsqueda convergente”, aquel modelo dinámico en el que de ciertas premisas 
comunes; cada conclusión es una premisa para otras conclusiones (Bonaccorsi, 2008). 
68 
 
En tercer lugar, surgen nuevas formas de complementariedad. Andrea Bonaccorsi 
(2008) plantea tres formas: Cognitiva, técnica e institucional. En la 
nanotecnociencia la complementariedad cognitiva está regida por la necesidad 
epistémica de diferentes realidades observadas en el laboratorio y el límite difuso 
entre lo natural y lo artificial. Las complementariedades técnica e institucional 
están dadas por la necesidad de articular diferentes laboratorios con diversas 
posibilidades técnicas y de presupuesto (Bonaccorsi, 2008). 
Conclusión del capítulo 
Se ha propuesto el uso del concepto Nanotecnociencia, mediante el cual se da 
cuenta de un modo de investigación en el cual confluyen lo científico y lo técnico, 
siendo una forma ingenieril de hacer ciencia. Los investigadores no tienen como 
objetivo encontrar una teoría nano sobre la realidad para explicar esta última. En 
el laboratorio se trabaja dentro de un contexto complejo situado entre la teoría física 
clásica y la cuántica, donde se buscan explicaciones parciales mediante un uso 
ecléctico de varias teorías, forzándolas, más allá de su ámbito de aplicación 
tradicional. En otras palabras, el núcleo mismo de las teorías se fuerza para dar 
cuenta de una estructura causal detrás de los fenómenos observados a escala nano. 
Los investigadores, los materiales y los artefactos dan lugar a la constitución de 
una práctica nanotecnocientífica. Los actores humanos provienen de diferentes 
formaciones básicas, por lo que, habitualmente, difieren en qué teorías utilizan para 
trabajar, pero todos coinciden en qué instrumentos de medición y qué programas 
de computadoras utilizan. Estos artefactos se transforman en los referentes 
comunes en la comunidad y adquieren gran importancia en la dinámica de la propia 
práctica. 
Además, y debido a la necesidad de los grupos científicos de conseguir fondos 
gubernamentales, la narrativa del pasado (de tecnologías similares) y las 
expectativas de futuro juegan un rol crucial a la hora de entender las interacciones 
nano. Esta interacción entre agentes humanos, una teoría ecléctica, materiales y 
artefactos se constituye como práctica. Para dar cuenta de lo expuesto, se ha 
utilizado la teoría del Actor-Red para describir las relaciones entre los nodos y se 
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2 La dinámica industrial nano y la constitución de un 
nuevo mercado 
Summary 
This nano-techno-scientific practice is a fertile ground for the convergence of 
variety of disciplines, which impacts on its industrial dynamics (Bozeman et al., 
2007; Andersen, 2011). A specific branch of nanotechnology of particular 
importance for this thesis is nanomedicine. It is defined as the medical applications 
of nanotechnology, which involves the development of new procedures to diagnose 
and cure diseases (Paradise et al., 2008). This chapter analyses the market of nano-
carriers and its patents. The methodology proposed by Callon and Muniesa (2005) 
helps to unpack this market and offers tools for analysing their risks. 
After the analysis of the process of formation of the nano-market, this thesis 
focuses on the role of investors. Firstly, it explains the process of creating new 
businesses and identifies some lessons learned from the first generation of 
entrepreneurs. Then, a valuation model is presented, focusing on investments in 
the pharmaceutical industry. Finally, the last sections proposes a mathematical 
model representing pooled investment decisions among a small nanotechnology 
company that owns the patent of a nano-carrier (possibly a spin-off) and a large 
pharmaceutical company. 
Future expectations about nanotechnology transcend industrial innovation, having 
the potential to transform other industries (Bozeman et al., 2007). A question 
immediately arises: Is Nano-industrial dynamics similar to other technologies such 
as microelectronics or biotechnology? A group of scholars argues that the nano 
market is being controlled by large multinationals with in house R&D as in the 
case of microelectronics (Larédo et al., 2009). From a different perspective, other 
authors argue that the organization of nanotechnology resembles biotechnology, 
where the spin-off university has played a prominent role (Darby and Zucker, 
2003). New nano-companies face great uncertainty (Hite and Hesterly, 2001) and 
the circulation of knowledge has been interpreted as the equivalent to the 
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movement of researchers or engineers in the field (Bozeman and Mangematin, 
2004). 
Nanomedicine is defined as the set of medical applications of nanotechnology, 
including the development of new procedures to diagnose and cure diseases 
(Etheridge et al., 2013). Reformulating a drug into nano-sized crystals generates a 
different version of the existing drug, with higher solubility. This reduces the 
required dose, diminishing adverse side effects. For instance, the insertion of a drug 
using a nano-capsule aims to target specific tumour cells (Bawarski et al., 2008; 
Davis, 2008). Another application of nanotechnology is medical diagnosis. For 
example, by using different types of labels, some nanostructures can detect the 
presence or activity of specific molecular entities within the body. (Van Kasteel, 
2009; Kamaly et al., 2013). 
In March 2009, the Food and Drug Administration (FDA) established a partnership 
with the Alliance for NanoHealth45 to expand the knowledge about how 
nanoparticles impact on biological systems, aiming to develop processes that will 
reduce possible risks. This collaboration had two main objectives (te Kulve and 
Rip, 2013). First, it has aimed at encouraging the progress of nanomedicine, 
starting with preclinical stages of development, continuing with clinical and, 
finally, supporting the marketing of new products. Second, it has improved 
understanding of the risks and benefits. 
Applying for a patent in nanomedicine is not easy, due to evaluators´ concerns with 
health risks and human safety (Bawa, 2007; Martins et al., 2013). The experience 
of the biotech industry about licensing strategies, development and financing have 
certain characteristics in common with nanomedicine: the new industrial 
applications in both sectors rely heavily on intellectual property (IP) and R&D are 
costly, complex and uncertain (Stewart, 2005). 
The markets have clear advantages that make them irreplaceable in a capitalist 
Western context: their autonomous agents innovate, they allow their coordination, 
                                                 





and they facilitate contracts between parties. However, the markets have clear 
limitations: they are not designed to achieve the public good and they produce 
negative externalities on human groups (Callon, 2009). Therefore, it is necessary 
to reconsider basic questions about markets efficiency and analyse how we can 
ensure that the new nanotechnology market could be socially efficient. 
Economic theories always are performative, and in this particular case, 
nanomaterials and technologies al play an important role in the process of market 
creation (Barry y Slater, 2002; Callon, 2010). This interaction between techno-
science and markets produces what Marilyn Strathern (2000) calls the proliferation 
of new identities, creating constantly new uncertainties about the constitution of 
the collective. This process transforms the economy, the politics and the techno-
scientific practice surrounding it (Callon, 2009). 
Nanotechnology market efficiency requires: (1) density, to attract a sufficient 
number of participants, (2) smoothness, to overcome congestion problems that can 
bring down the number of agents operating, and (3) safety and simplicity. 
Moreover, it should exclude operations based on moral reasons (Roth, 2008). 
Following Callon and Law (1997), this thesis argues that market players are 
collective hybrids in constant constitution, in which people, devices and texts 
interact. There is no difference between the person and the network of institutions 
in which she operates, or more precisely, between the person and the network of 
entities acting through it. The same idea applies to the market as a whole, its agents 
do not act isolated, they are collective hybrids. These agents interact performing 
arithmetic operations, so they are collective hybrid computing devices (Callon and 
Muniesa, 2003).  
The calculation is a feature of any market, but who does the calculation and how? 
In the literature, there are two contrasting perspectives to answer these questions. 
From a neo-classical point of view, agents´ ability to calculate is innate. 
Conversely, from the perspective of social anthropology, the calculation is an ex-
post rationalization. In this thesis, I would avoid these two extremes. On the one 
hand, people should not reduce to mere agents who calculate. On the other hand, 
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calculation should not be ignored nor dissolved by ethnographic descriptions 
(Callon and Muniesa, 2003). 
In the market, the valuation process of assets arises from exchanges between agents 
making cross calculations: the calculating devices (Çalışkan and Callon, 2010). 
They include tools that actively constitutes reality and they struggle to impose 
prices one to another (Rose and Miller, 2008; Weber, 1978 [1922]; Stark, 2009). 
The calculation is distributed among humans, formulas and artefacts (Latour, 1987; 
Lepinay and Callon, 2009). 
Nano-carriers are nanoscale elements that are introduced in the body and carry the 
drug to the place where the body needs it (Torchilin, 2012). To manufacture these 
products a patent is needed (Carbone et al., 2013). The process of transforming 
patents into transactional goods starts with a process of singling out its properties, 
so it can enter the world of the business that uses it to produce nano-carriers. Once 
the company placed the patent into its network, the production process of the nano-
carrier starts – which is then transformed into a good that would be exchanged by 
money in the market.  
There are clear asymmetries in this market. On one hand, the producer normally is 
a large multinational pharmaceutical company with a lot of calculation power. On 
the other; the consumers are able only of making simple calculations.  
After analysing the process of market creation, the focus of the thesis is 
understanding the role of investors in nanotechnology projects. In general, their 
initial goal is to register (buy or rent) a patent. Then -under its protection-, they 
begin production and sell the products. The valuation methodologies of these 
technology assets can be classified into two main groups (Mun, 2003). On the one 
hand, the traditional one, which involved costing and income calculations, and, on 
the other hand, innovative methods including real option (Schwartz, 2013). In the 
case of nanotechnology projects, valuation methods need to take into account that: 
i) they require large investments, ii) their costs are sunk, iii) their final product have 
uncertain futures prices, and iv) their investor could abandon the project (Vimpari 
and Junnila, 2014; Brealey and Myers, 2003). 
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Hardly a single organization undertake a nano-medical project, usually joint 
investments are required. This thesis develops a mathematical model to analyse the 
commercial interaction between a company specializing in the development of 
nano-carriers and a pharmaceutical large company. While the former develops 
research in vitro / in vivo testing to achieve a patent; the latter has the drug and can 
produce it. This interaction is modelled using game theory and real options.  
 
Introducción 
La práctica nanotecnocientífica tiene el potencial de hacer converger varias 
disciplinas, lo cual se manifiesta en su dinámica industrial transformadora del 
entramado productivo (Bozeman et al., 2007; Andersen, 2011). Si bien comparte 
el carácter innovador de otras industrias del sector, tiene particularidades que la 
definen y la constituyen. En particular, comparando con la dinámica de la 
microelectrónica o con la de la biotecnología, existen al menos tres diferencias 
importantes. La primera refiere a la diferente forma de interacción entre las grandes 
empresas industriales y los nuevos emprendedores (start-ups). La segunda se 
refiere al grado de concentración geográfica y la tercera es su organización 
industrial (Larédo et al., 2009).  
Una rama específica de la nanotecnología, de particular importancia para este 
trabajo, es la nanomedicina. La misma se define como las aplicaciones médicas de 
la primera, incluyendo el desarrollo de nuevos procedimiento para diagnosticar y 
curar enfermedades46 (Paradise et al., 2008). Para entender la formación del 
mercado de comercialización de nanotransportadores y de sus patentes, se aplica 
la metodología propuesta por Callon y Muniesa (2005), comprendiendo este 
mercado para luego analizar sus riesgos y sus métodos de valuación de inversiones.  
Este capítulo está dividido en cuatro secciones. En la primera se presenta el poder 
transformador de la dinámica industrial nano, con énfasis en la nanomedicina. 
                                                 
46 La nanomedicina comercial se encuentra en desarrollo aunque ya se han producido algunos productos 
realmente innovadores. Asimismo, tiene importantes desafíos por delante relativos a aspectos legales, 
ambientales, de seguridad, de ética y, en particular, los relacionados a la reglamentación de las patentes. 
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Luego analiza críticamente la literatura sobre diseño de mercados, el rol de los 
experimentos y el rol performativo de las teorías, agentes y práctica 
nanotecnológica en el proceso de constitución. En la sección tercera, se presenta el 
mercado de nanotrasportadores como un proceso de co-constitución dentro de la 
dinámica propuesta. La última sección se pregunta por las decisiones de inversión 
y la valuación de los proyectos en el sector de nanomedicina y se propone una 
formalización matemática de la cuantificación de las decisiones. 
2.1 El poder transformador de la dinámica nano 
Luego de analizar la práctica tecnocientífica en el capítulo anterior, este trabajo se 
vuelca ahora a comprender las relaciones entre dicha práctica, las instituciones y 
los agentes económicos. Como se ha planteado en el capítulo anterior, la práctica 
nanotecnocientífica hace converger varias disciplinas47. Es más, las expectativas 
de la nanotecnología transcienden la innovación industrial, teniendo el potencial 
de transformar otras industrias48 (Bozeman et al., 2007). 
Una cuestión que surge en forma inmediata es preguntarse si la dinámica industrial 
nano será similar a otras tecnologías, tales como la microelectrónica y la 
biotecnología. Por un lado, en la industria microelectrónica surgida en los años 70 
del pasado siglo, las actividades innovadoras estaban centradas en las empresas 
tradicionales con fuerte integración vertical. Claramente este enfoque top-down (en 
consonancia con la Ley de Moore) permitió a la microelectrónica reducir tamaño 
y aumentar la densidad de los circuitos en el semiconductor. Por el contrario, 
durante los primeros años de la industria biotecnológica (años 80 del pasado siglo), 
la creación de nuevas empresas desempeñó un papel catalizador en el proceso de 
constitución del nuevo mercado, vinculando los descubrimientos de los 
laboratorios con las empresas tradicionales (Invernizzi, 2011).  
Teniendo en cuenta la experiencia de las tecnologías anteriores, la literatura plantea 
dos posiciones diferentes con respecto a la evolución de la nanotecnociencia. Un 
                                                 
47 Los partidarios de la transformación masiva hablan de la convergencia de las NBIC (Nanotecnología, 
Biotecnología, Tecnología de información y comunicación) o de BANG (Bit, Atom, Neuronal y Gene) (Wetter, 
2006). 
48 No quedando claro si será mediante la creación de un nuevo mercado o como una nueva tecnología 
disponible dentro de los existentes (Larédo et al., 2009). 
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grupo de académicos argumenta que el mercado nano está siendo controlado por 
grandes multinacionales, respaldadas por empresas específicas de I + D (Larédo et 
al., 2009). Si bien las pequeñas empresas desempeñan un papel importante en la 
comercialización, esta línea de pensamiento sostiene que los países con más 
multinacionales tienen más probabilidades de convertir descubrimientos de 
laboratorio en aplicaciones comerciales (Shapira et al., 2010). Desde una 
perspectiva diferente, otros autores argumentan que la organización de la 
nanotecnología se asemeja a la de la biotecnología, donde los spin-off 
universitarios han jugado un papel destacado. Darby y Zucker (2003) prevén un 
modelo de desarrollo similar a la biotecnología49, con la presencia de científicos de 
renombre, vínculos estrechos entre las universidades y la industria, una 
organización eficaz de transferencia de tecnología, la creación de empresas basadas 
en la investigación y el capital riesgo para financiar las fases iniciales de 
desarrollo50. La nanotecnociencia plantea una dinámica diferente a las anteriores 
tecnologías. Lo primero que se comercializó fueron agregados de tecnología nano 
en productos existentes, lo cual ha otorgado fundamental importancia a las 
inversiones realizadas por grandes empresas líderes mundiales en sus respectivos 
mercados masivos, de acuerdo al primer grupo de autores mencionados51.  
La nanotecnología se encuentra en estadio inicial de su ciclo de vida y todavía falta 
acumulación de conocimiento para fomentar innovaciones. Esto no descarta el 
papel de la creación de nuevas empresas, pero requiere de un reposicionamiento en 
relación con la comprensión de la dinámica de un campo emergente52 (Darby and 
Zucker, 2003; Zucker and Darby, 2005). Hite y Hesterly (2001) señalan que 
durante las primeras etapas de una nueva industria, las nuevas empresas enfrentan 
                                                 
49 Es más, incluso en la biotecnología ha habido relativamente poco desplazamiento de los operadores 
tradicionales, impulsando la idea de que la "destrucción creativa" se llevó a cabo dentro de las grandes 
empresas existentes (especialmente, las empresas farmacéuticas). 
50 Donde sí hay acuerdo en la literatura es sobre la lentitud de la comercialización de la nanotecnología, a pesar 
del crecimiento exponencial de las publicaciones científicas. Por ahora no se encuentran explicaciones a este 
fenómeno (Andersen, 2011). 
51 Un segundo horizonte, que recién empieza a desarrollarse ahora, plantea la integración de los conocimientos 
("convergencia NBIC") y se basará en la creación de empresas que iniciarán nuevos nichos de mercado (Larédo 
et al., 2009), de forma similar al argumento del segundo grupo de autores.  
52 En general, el grado de madurez de una nueva tecnología define tanto las condiciones cognitivas como la 
dinámica industrial de creación de conocimiento. En la práctica científica, la exploración de hipótesis se lleva 
a cabo en un ambiente turbulento, donde la introducción de nuevas soluciones técnicas amplifica la 
incertidumbre en lugar de reducirla. En el mercado, la llegada de una tecnología radicalmente nueva genera 
nuevos proyectos (Bozeman et al., 2007), tanto en las industrias existentes o estimulando la creación de nuevas. 
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una gran incertidumbre y la circulación del conocimiento equivale a la circulación 
de los investigadores o ingenieros53 (Bozeman and Mangematin, 2004).  
Esta dinámica industrial innovadora descrita se ve claramente en el caso de las 
aplicaciones médicas, donde un pequeño spin-off de universitarios patenta un 
nanotransportador que debe complementarse con la gran farmacéutica para lograr 
llegar al mercado con una determinada droga. La siguiente subsección introduce a 
las aplicaciones médicas de la nanotecnología. 
2.1.1 Nanomedicina 
En el presente trabajo se define Nanomedicina como el conjunto de las aplicaciones 
médicas de la nanotecnología, lo cual incluye el desarrollo de nuevos 
procedimientos para diagnosticar y curar enfermedades (Etheridge et al., 2013). En 
particular, se están produciendo comercialmente nuevas drogas, dispositivos de 
diagnóstico e implantes utilizando nanotecnología, los cuales serán brevemente 
descritos a continuación. 
La reformulación de la droga en forma de cristales de tamaño nanométrico genera 
versiones de fármacos existentes que tienen mayor solubilidad. Esto reduce el 
volumen necesario de dosis, disminuyendo los efectos secundarios adversos. Por 
otro lado, la inserción de las drogas dentro de una nanocápsula puede permitir la 
administración de fármacos específicamente a las células tumorales54 (Bawarski et 
al., 2008; Davis, 2008).  
Otro campo de acción es el de diagnóstico médico. Mediante el uso de diversos 
tipos de etiquetas, ciertas nanoestructuras pueden detectar la presencia o actividad 
de entidades moleculares específicas en el cuerpo55. Asimismo, se han desarrollado 
                                                 
53 Zucker, Darby y Armstrong (2001) proponen que la ciencia y la tecnología, en sentido amplio, son 
acumulativas. Hacen hincapié en la proximidad geográfica, en la creación de empresas de alta tecnología y en 
la circulación de conocimiento tácito a través de los recursos humanos, similar a la historia reciente de la 
biotecnología (Zucker et al., 2007). 
54 Un ejemplo es el medicamento Abraxane que se utiliza para enfrentar la metástasis del cáncer de mama (de 
la empresa Abraxis, Los Ángeles, California). El mismo es una reformulación como nanopartículas del 
paclitaxel, realizado mediante la técnica de polímeros conjugados. La formulación nano evita la reacción de 
hipersensibilidad asociada con el disolvente “Cremophor EL” utilizado con el paclitaxel tradicional54 
(Bawarski et al., 2008).  
55 Un ejemplo son los “puntos cuánticos”, nanocristales semiconductores fluorescentes que identifican las 
células cancerosas en el cuerpo al unirse a las células tumorales y emitir diferentes colores dependiendo del 
estado de enlace (Chan, 2006). 
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varios tipos de dispositivos de diagnóstico de mano que pueden verificar la 
existencia de una determinada proteína56 (Van Kasteel, 2009; Kamaly et al., 2013).  
El uso de nanomateriales en dispositivos médicos implantables posee una 
oportunidad de mercado en los EEUU, debido a que en el mercado se espera un 
aumento del 9% anual durante los próximos años sobre los 27 mil millones de 
dólares anuales que mueve este mercado (Durmus and Webster, 2012). Cada vez 
es mayor el alcance que debe darse a la satisfacción de las necesidades de 
dispositivos implantables, básicamente por la perfección con la cual se deben 
realizar los mismos para evitar que éstos sean rechazados ante la colocación, y que 
los mismos puedan llegar a causar alguna enfermedad (Harris and Graffagnini, 
2007). Existen diferentes empresas que se dedican a la fabricación o 
perfeccionamiento de dispositivos implantables a través del uso de nanomateriales. 
La empresa AcryMed utiliza nanopartículas de plata para prevenir las infecciones 
al realizar los implantes y no alterar sus funciones. Por su parte, Nanotecnologías 
Altair trabaja con el Consejo Nacional de Investigación de Canadá para realizar 
revestimientos ortopédicos con dióxido de titanio, lo que otorga dureza y 
resistencia en los implantes. Nanotech Catheter Solutions desarrolla catéteres y 
stents con nanotubos de carbono. Nanicopeia es una empresa que desarrolla la 
incorporación de nanomateriales para mejorar los dispositivos médicos, así como 
la creación de recubrimientos avanzados y formulación de nuevas drogas (Harris 
and Graffagnini, 2007; Santos, 2012). 
Claramente, los incentivos que impulsan a las empresas a utilizar nanotecnología 
en la medicina se relacionan con el aporte que genera a la producción de nuevas y 
mejores drogas, debido a la reducción del consumo de energía al producirlos, al 
abaratamiento de los insumos que se requieren en la producción, al uso de nuevos 
materiales que suplantan a materiales que contaminan el medio ambiente y a la 
posibilidad de establecer nuevas patentes. Si bien los incentivos son muchos, 
                                                 
56 Un ejemplo es el método de detección de proteínas de alta sensibilidad denominado Nano-ELISA. El mismo 
es la realización por medio de nanoparticulas del procedimiento enzyme-linked immunosorbent assays 
(ELISAs). Nanopartículas de oro se modifican con un detector de anticuerpos monoclonal y con Horseradish 
peroxidase (para aumentar la intesidad de la señal), de forma de generar señales ópticas que reflejan la cantidad 
de la proteína en cuestión. Este método es tan simple como ELISA y de mayor sensibilidad, por lo que puede 




también existen problemas con el uso de esta tecnología desde el punto de vista 
empresarial. Los desincentivos de las empresas en el uso de nanotecnología vienen 
dados por el tiempo que se tarda en comercializar los productos desarrollados, los 
riesgos que pueden acarrear el patentamiento de los productos, la contaminación 
ambiental con algún nanomaterial, así como la percepción pública de estos riesgos 
del uso de nanotecnología, la cual puede acarrear una oposición frente al uso de 
esta (Bhattacharya, 2007).  
Se vislumbran claros problemas con el uso de nanotecnología tales como los 
riesgos ambientales y el posible monopolio por uso de patentes exclusivas 
(Bhattacharya, 2007). En Marzo del año 2009, la Food and Drug Administration 
(FDA) realizó una asociación con la Alliance for NanoHealth57 para ampliar el 
conocimiento de cómo las nanopartículas impactan en los sistemas biológicos, de 
forma de desarrollar procesos que reduzcan los posibles riesgos asociados. Las 
partes dejaron claro que esta colaboración tiene dos objetivos principales58. En 
primer lugar, incentivar el avance de la nanomedicina, comenzando con las fases 
preclínicas de desarrollo, continuando con las clínicas y, por último, apoyar su 
comercialización. En segundo lugar, comprometerse a trabajar para mejorar la 
comprensión de los riesgos y beneficios del desarrollo de productos nano-
ingeniería médica en la medida en que esta información puede ayudar a la 
regulación y evaluación de productos nanomédicos. En particular, las partes 
reunidas en Octubre del año 2008 establecieron siete prioridades que desagregan 
los dos grandes objetivos mencionados. La primera, determinar la capacidad de 
distribución de los portadores de nanopartículas. Luego, se mencionó la 
importancia de entender las dosis administradas por las mismas. La tercera y cuarta 
prioridad marcan la necesidad de desarrollar modelos matemáticos (y 
computacionales) que permitan predecir los diferentes riesgos y beneficios de su 
uso. La quinta enfatiza la necesidad de establecer normas para los protocolos de 
los materiales. La sexta se relaciona con el transporte masivo en el cuerpo humano. 
Finalmente, la última, se propone el desarrollo de un conjunto de herramientas 
                                                 
57 FDA publicó un comunicado de prensa en la sección de noticias de FDA.gov en Marzo 2009 anunciándolo. 
El mismo puede consultarse en http://www.fda.gov/bbs/topics/NEWS/2009/NEW01971.html 
58 El "Memorandum of Understanding" entre las partes está publicado por el registro Federal de EEUU el día 
13 de Marzo de 2009 (72 FR 10927). 
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analíticas para la fabricación de nanopartículas con fines médicos (Maebius and 
Jamison, 2008). 
Luego de esta descripción general de la nanomedicina, la siguiente subsección 
detalla el rol fundamental que tienen las patentes en la formación y evolución del 
mercado. 
2.1.2 Patentes 
La nanomedicina comercial se encuentra en la etapa de desarrollo aunque ya se han 
producido algunos productos realmente innovadores. Sin embargo, la industria 
tiene muchos desafíos por delante en los aspectos legales, ambientales, de 
seguridad, de ética y, en particular, los relacionados a la reglamentación de las 
patentes. Solicitar una patente en nanomedicina no es algo fácil, debido a la 
preocupación de los evaluadores sobre si se puede considerar que la nanotecnología 
no produce riesgos en la salud y la seguridad de las personas. La experiencia de la 
industria biotecnológica acerca estrategias de licenciamiento, desarrollo y 
financiamiento a la nanomedicina. Tienen las siguientes características en común: 
las nuevas aplicaciones industriales en ambos sectores dependen fuertemente de la 
propiedad intelectual (IP) que surge de los laboratorios (tanto universitarios o 
corporativos). Por otro lado, la investigación y desarrollo es costoso, complejo e 
incierto. Por último, la empresa que desarrolla la tecnología puede no ser la misma 
que lleva el producto final al mercado (Stewart, 2005). 
Uno de los problemas para el futuro desarrollo de la industria es la aprobación de 
las patentes59. Se se deben cumplir ciertos requisitos, a saber: debe poder ser 
considerado una invención nueva con respecto a todo lo que fue patentado en el 
pasado; debe tener utilidad; y debe estar bien descrito a manera de demostrar su 
posesión, entre otras características60 (Bawa, 2007; Martins et al., 2013).  
                                                 
59 Tener un derecho de propiedad intelectual implica tener un activo intangible pero como la ley que los regula 
se ha modificado según las necesidades del mercado, es necesario tener en cuenta que no todas las innovaciones 
son susceptibles de ser patentables. 
60 Por otro lado, el cumplimiento de los requisitos no es garantía del otorgamiento de la patente, debido a que 
este es un proceso largo, caro y tedioso por el hecho de tener que pasar por el proceso de examen (revisión de 
la patente), de persecución (intercambio de documentos entre los que examinan y los abogados de quienes 
piden la patente), y de aviso de derecho de emisión (el cual se da si la patente cumple con los requisitos) 
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El pedido de patentes se realiza en base a un incierto flujo de beneficios futuros, 
que los inversores consideran que les generaría ganancias a posteriori (por lo que 
realizan la inversión en investigación y desarrollo). Claramente, entonces, los 
pedidos de patentes son un indicador de actividad y es relevante, económicamente, 
su cuantificación. Para medirlas se toman en cuenta distintos parámetros: el 
alcance, la aplicabilidad en otros campos, entre otros. Sin embargo, los expertos 
consideran que el sistema de patentamiento hoy en día produce una limitación por 
las batallas legales a las que deben enfrentarse para el otorgamiento de la misma 
(Murray et al., 2012). Esto genera ciertos temores ante la posibilidad de que el 
otorgamiento de las patentes retarde en cierto sentido el avance en la industria 
tecnológica. Ahora bien, por otro lado, un exceso de patentes en el mercado 
obligará al gobierno en cuestión a actuar para evitar comportamientos 
monopólicos, defendiendo una competencia leal para fomentar una mayor 
cooperación (Bouchard, 2012). 
2.1.3 De la universidad al mercado: el caso de Nanosphere Inc. 
Nanosphere Inc. es la empresa que se considera como pionera en nanotecnología; 
una de las primeras empresas de nanotecnología en llegar a hacer una oferta 
pública. La empresa fue fundada en el año 2000 por los doctores Robert Letsinger 
y Chad Mirkin de la Universidad Northwestern. Ellos han logrado un prototipo de 
proteína sensible de diagnóstico molecular del ADN que permite detectar 
proteínas. Durante los primeros años de vida, la empresa logró convertir su 
tecnología en propiedad intelectual protegida (IP). Su tecnología está basada en el 
diagnóstico in vitro (IVD), ahora conocido como Sistema Verigene (Beal et al., 
2013), en torno al cual se construye una cantidad de sistemas médicos de 
diagnósticos. El objetivo corporativo es cambiar el mercado de IVD con el 
desarrollo de sus dos proyectos denominados Verigene I y II, y ser la única empresa 
capaz de beneficiarse con los desarrollos de esta parte de la medicina (Shalleck, 
2009). 
Nanosphere ha construido sus ingresos en base al sistema de pruebas IVD; sin 
embargo, este sistema le ha ocasionado grandes pérdidas a causa del bajo volumen 
de ventas que se proyectan para los próximos años. IVD representa el 30% de todo 
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el mercado de diagnóstico médico, el cual incluye el diagnóstico médico de 
imágenes en vivo61. Según Alan B. Shalleck (2009), existe una serie de supuestos 
en los que se proyecta el negocio de la compañía. Primeramente, Verigene se 
considera la primera plataforma nanotecnológica habilitada para generar pruebas 
moleculares y ser capaz de probar proteínas. Luego, proporciona menores costos y 
tiempos de respuestas más rápidos con una plataforma más fácil de usar. Además, 
posee una sensibilidad al menos 100 veces mayor para las pruebas de proteínas en 
los ensayos, y ofrece altos recuentos en la multiplexación de capacidades y ofertas 
para el futuro en la línea de desarrollo de pruebas moleculares. 
Muchos de los expertos encuentran a la tecnología de Nanosphere como excelente; 
su sistema Verigene fue aprobado por la FDA en 2007 y los usuarios se encuentran 
satisfechos con el rendimiento de éste. Sin embargo, se dificulta el desarrollo del 
sistema en otras áreas y esto hace más difícil de lo esperado el despegue del 
producto, provocando que la generación de ingresos sea menor a la esperada, 
aunque crece (al igual que las pérdidas). Es así que se propuso introducir, en el 
2009, dos productos innovadores con ingresos proyectados para el 2010 en 3 ó 4 
millones de dólares. A pesar de ello, si las pérdidas continúan, la empresa se 
enfrenta a una decisión estratégica importante: ¿podrá la empresa sostener un 
crecimiento con la recaudación que tendrá?, o bien ¿deberá obtener capital antes 
de lanzarse nuevamente al mercado? (Shalleck, 2009). 
Los problemas estratégicos para el inversor en la empresa incluyen el intento de 
tratar de determinar si la empresa nunca obtendrá beneficios de gestión para las 
proyecciones que se hacen con respecto a la rentabilidad de sus productos. 
Asimismo, se debe tratar de determinar si el precio pagado inicialmente, en 
propiedad intelectual, se justifica (Shalleck, 2009). 
                                                 
61 Por otra parte, aparece como competencia el diagnóstico molecular (MD), el cual proporciona un diagnóstico 
temprano e información básica para la medicina preventiva. No obstante, estas pruebas requieren técnicos 
altamente calificados y un complicado procedimiento de preparación que es muy costoso y largo de desarrollar. 
De esta manera, surge una medicina preventiva orientada a los sistemas IVD por causa de cuestiones de 
procedimiento y costos de las pruebas de MD. Las pruebas de IVD requieren dos exigencias: a) especificidad 
de las medidas de precisión del sistema y b) sensibilidad en los sistemas de diagnóstico. 
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2.2 Diseño y constitución de mercados  
Esta dinámica nano, descrita en la sección anterior, constituye un nuevo mercado 
mediante la interacción entre práctica tecnocientífica, gobierno, agentes 
económicos y usuarios. En esta sección se presenta la literatura sobre diseño y 
constitución de mercados en general y se detalla aquella que se utilizará en la 
siguiente sección para analizar el mercado específico de nanotransportadores.  
Los mercados tienen indudables ventajas62 que los hacen insustituibles en un 
contexto occidental capitalista: sus agentes autónomos innovan, permiten la 
coordinación de agentes y facilita contratos entre partes que no surgirían en un 
contexto planificado centralmente. Ahora bien, los mercados tienen claros límites: 
no están diseñados para lograr el bien público y producen externalidades negativas 
sobre grupos humanos que no son tenidos en cuenta (Callon, 2009). Por tanto, es 
necesario volver a considerar las cuestiones básicas sobre los mercados y analizar 
cómo podemos garantizar que funcionen correctamente.  
Para ello, es primordial prestar especial atención al rol de los experimentos 
realizados en el mundo real, los cuales despiertan una controversia que abre un 
debate superador del enfoque meramente económico, incluyendo aspectos 
políticos, regulatorios y sociales. Lo anterior permite asegurar entonces que el 
diseño es un proceso de mutua interacción, el proyecto necesita ser validado por la 
experimentación y ésta actúa sobre el primero (Roth, 2008). Estos mercados 
cuentan con agentes económicos que interactúan en ellos para lograr la constitución 
del mismo con características experimentales. Este trabajo interpreta a estos 
agentes como híbridos colectivos de cálculo y a los mercados como acuerdos socio-
técnicos.  
La propuesta del presente trabajo es focalizar en mercados reales, dejando de lado 
los abstractos, reconociendo el creciente papel de los experimentos en la 
concepción de los mercados, destacando el rol fundamental que las tecnologías 
                                                 
62 Ciertos defensores a ultranza del mercado sostienen que éste permite la iniciativa privada, regula la escasez 
de recursos y logra, mediante innovaciones, satisfacer las necesidades de la sociedad en el largo plazo. Si bien 
estas ventajas del mercado están en discusión, el planteo tradicional no aborda la cuestión fundamental: si los 
mercados se presentan como solución, ¿qué tipos de mercados se deben diseñar y cuál es su organización 
socio-técnica? (Callon, 2009).  
84 
 
tienen en la constitución de los mercados económicos y el papel evidentemente 
performativo de las teorías económicas (Barry and Slater, 2002; Callon, 2010). 
Esta interacción entre la tecnociencia y los mercados produce lo que Marilyn 
Strathern (2000) denomina la proliferación de nuevas identidades, creando, 
constantemente, nuevas incertidumbres acerca de la constitución de lo colectivo63. 
Un primer punto de partida es discutir el mismo diseño de los mercados. 
2.2.1 El diseño de mercados 
Los economistas han adquirido una experiencia considerable en el diseño de 
mercados concretos en los últimos años (Roth, 2008). Estas experiencias de diseño 
enseñan que las operaciones y las instituciones son más importantes que lo que 
anteriormente se suponía, por lo que se ha ido reemplazando la tarea tradicional 
del análisis estilizado de los mercados por el desafío de diseñar los mismos64. Esto 
exige un análisis detallado que involucra diversos actores: empresarios, políticos, 
reguladores, abogados matemáticos, etc. Wilson (1992) presenta un amplio 
panorama de la literatura sobre diseño de subastas65, donde se destacan los trabajos 
teóricos de Myerson (1981) y Bulow y Roberts (1989). Asimismo, es importante 
la literatura orientada empíricamente al estudio de la evolución de los mercados de 
trabajo (Roth, 1984) y la vinculada con los mercados de energía eléctrica, los cuales 
son un buen ejemplo de la importancia del diseño en un contexto donde lo 
económico se encuentra inexorablemente vinculado con lo político y lo regulatorio 
(Wilson, 2002; Cramton and Ockenfels, 2012). 
Para el diseño de un nuevo mercado se puede aprender mucho de la historia de los 
mercados relacionados. En la década de 1990, la teoría de juegos comenzó a tomar 
un papel muy importante en el diseño de mercado, dando lugar a una nueva 
                                                 
63 Estas nuevas identidades se constituyen en su interacción con otras y con objetos materiales, requiriendo 
nuevos procedimientos, nuevas instituciones y, fundamentalmente para resolver la cuestión del tratamiento 
democrático y participativo de la tecnociencia, se necesita entender la relación entre mercado y democracia 
(Callon et al., 2001). 
64 A nivel técnico, muchos de estos nuevos mercados presentan el problema de tratar con productos 
complementarios, no sustitutos. Además, el diseño frecuentemente requiere rapidez; en algunos casos 
transcurre tan sólo un año entre que se requiere y se implementa (Roth, 2002). Un ejemplo claro de esta 
urgencia fue la subasta de las bandas 3G de telefonía móvil que se realizó en Reino Unido. Al realizarla luego 
de EEUU, el gobierno británico necesitaba urgente las reglas del nuevos mercado para realizar la subasta 
(Binmore and Klemperer, 2002).  




disciplina que Alvin Roth (2002) propuso denominar design economics66. Los 
encargados de diseñar un nuevo mercado no pueden trabajar sólo con los modelos 
conceptuales simplificados propios de discusiones teóricas sobre mercado, el 
diseño exige un enfoque ingenieril que complemente la teoría de juegos con 
experimentos y la resolución de modelos computacionales (Roth, 2002).  
2.2.2 El rol de los experimentos económicos  
Jean-Baptiste Say (1841) fue uno de los primeros autores en afirmar que la 
economía es una ciencia experimental y debería dedicarse a la observación y a la 
recolección de los hechos a fin de señalar las regularidades causales. Sin embargo, 
dejó claramente a la economía fuera del laboratorio, reservado para las ciencias 
naturales. La economía recién entra en los laboratorios a principios de la década de 
los sesenta del pasado siglo (Smith, 1962). Desde su creación, la economía 
experimental ha tenido que justificar su validez fuera del laboratorio (Guala, 2002). 
Es importante notar que, al definir las condiciones para la validez externa de un 
experimento económico, Vernon Smith (1989) establece que el laboratorio 
experimental debe ser real, contar con personas reales, bienes reales y dinero real 
(Deck and Smith, 2013). 
Una segunda característica de la economía experimental es su capacidad 
manipuladora, se interviene sobre la materia de diversas formas. Por ejemplo, si el 
objeto es un coche a testear, la manipulación puede ser desde hacer un focus group 
con usuarios que abren y cierren puertas, hasta implicar la destrucción del objeto. 
Esto lleva a un tercer aspecto importante de la economía experimental: su objeto. 
Según Vernon Smith, los experimentos son un medio para contrastar teorías 
económicas; su objeto son las teorías, no el comportamiento humano (Muniesa and 
Callon, 2007). El entorno experimental pretende imitar las teorías económicas, no 
la actividad económica concreta (Smith, 1994). El contexto es, por consiguiente, 
un sistema micro-económico controlado y estable donde los agentes económicos 
(caracterizados con funciones de utilidad) interactúan. El conocimiento así 
producido es legítimo en la medida en que permite contrastar hipótesis derivadas 
                                                 
66 Si bien la teoría de juegos económica proporciona un contexto desde el cual abordar el diseño, es 
fundamental un análisis detallado alejado de los modelos económicos estilizados. 
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de las teorías económicas en cuestión. La generalización de los resultados 
experimentales se complica debido al localismo de los experimentos en cuestión67, 
pero no es un impedimento (Burlando and Guala, 2005).  
En resumen, los experimentos económicos tienen un impacto performativo sobre 
los mercados; los investigadores describen un objeto producido por ellos mismos68. 
Cada vez más, los experimentos económicos son un elemento fundamental en el 
proceso de construcción de mercados. Y, sobre todo, en el caso de los experimentos 
a escala real la controversia abre la posibilidad de ampliar el debate superando el 
enfoque meramente económico e incluir aspectos políticos, regulatorios y sociales. 
2.2.2.1 La co-constitución del mercado 
El diseño de mercados es un proceso de mutua interacción; el proyecto necesita ser 
validado por la experimentación y ésta actúa sobre el primero (Roth, 2008). Ahora 
bien, estos experimentos pueden ser in vitro (desarrollados dentro de un 
laboratorio) o in vivo (experimentos en el mercado real) coexistiendo en un proceso 
de permanente intercambio (Muniesa and Callon, 2007). Para esto, deben existir 
redes que organicen y faciliten las relaciones entre ellos de manera de permitir el 
avance de los conocimientos teóricos sobre los mercados, por un lado, y los 
dispositivos materiales e institucionales, por el otro. Estos experimentos se han ido 
estableciendo progresivamente en los mercados y han permitido su mejoramiento 
permanente. En particular, en los nuevos mercados, donde todo tiene que ser 
inventado, ni los economistas, ni los agentes económicos habituales pueden 
diseñarlos sin ayuda. Tienen que cooperar y aceptar que otros actores están 
involucrados y que, en contextos de incertidumbre, el proceso de diseño debe 
consistir, necesariamente, en un largo proceso de ensayo y error (Callon, 2009).  
                                                 
67 Muchas veces el objetivo de un experimento es convertir una teoría compleja en un conjunto explícito de 
reglas y comportamientos. Este vuelco hacia lo explícito ya estaba presente en los primeros experimentos de 
(Chamberlin, 1948). Los experimentos pueden llevarse a cabo en las aulas, dentro de sistemas informáticos o 
en un mercado real (Muniesa and Callon, 2007). 
68 Si bien esto es claro cuando se trabaja dentro de un laboratorio, resulta más evidente en experimentos que 
utilizan un mercado real como su campo de testeo; al realizar el experimento en mundo real ya están 
construyendo el nuevo mercado. Por ejemplo, cuando se permite utilizar una medicina en un área controlada 
determinada del país se está testeando y creando a la vez (Muniesa and Callon, 2007). En los mercados 
financieros muchas veces se experimenta con nuevos productos (por ejemplo, derivados exóticos) (MacKenzie 
and Millo, 2003). Es más, muchas veces las economías nacionales pueden convertirse en un experimento para 
probar una doctrina económica (Ghannadian and Goswami, 2004). 
87 
 
La eficiencia de un experimento de mercado radica en organizar la discusión de los 
asuntos de interés que emergen de su propio funcionamiento, contemplando los 
desbordes (externalidades). Se deben establecer procedimientos para facilitar la 
evaluación de soluciones teóricas o prácticas a esos problemas. Este enfoque otorga 
centralidad a los experimentos y abre los debates; se presenta como un par 
problemático indivisible: lo económico y lo político (que muchas veces intenta ser 
excluido)69 (Callon, 2009).  
Los mercados, en fase experimental, resaltan este proceso de reconfiguración 
conjunta. Este enfoque permite una problematización multidimensional, 
constituyendo una red de problemas. Es más, la configuración del mercado puede 
dar prioridad a un enfoque sobre otro y esto no es casual sino que es parte del 
diseño. Se puede encontrar, entonces, que la dimensión política quede reducida a 
su mínima expresión.  
En el experimento aquéllos que diseñan e implementan los nuevos mercados deben 
contestar preguntas emergentes, tratando de no encerrarse en organizaciones 
existentes y permitiéndose innovar en busca de la solución. Incorporando esta 
problematización en el proceso de diseño se construye una economía política 
compleja. Asimismo, en este proceso, las ONG se convierten en socios legítimos e 
inevitables. Este mercado en proceso de diseño evoluciona transformando la 
economía, la política y la ciencia que lo rodea, por lo que experimentar nuevos 
mercados tiene un carácter performativo de la realidad y es una acción política. Los 
procedimientos que se diseñan en el mercado son dialógicos. Se debe permitir que 
todos los actores concernidos por el diseño y el funcionamiento de un mercado 
puedan expresarse y, luego, analizar las cuestiones y comparar las soluciones 
propuestas70 (Callon, 2009). 
                                                 
69 En los mercados emergen cuestiones donde la incertidumbre es tal que no se sabe cuál es el enfoque 
adecuado para resolverlos. No es claro si el abordaje debe ser político, económico o tecno-científico. Callon 
sostiene que ni la economía ni la política ni la ciencia pueden ser consideradas como realidades acabadas y 
estancas. Callon centra su posición entre el constructivismo social (que considera que lo como el político, 
económico y científico es simplemente el resultado de un enfrentamiento entre grupos que luchan por imponer 
sus propios puntos de vista) y el esencialismo (hay una o más definiciones de la política, la economía y la 
ciencia, que proporcionan criterios objetivos que permiten decir, a priori, si un comportamiento, forma de 
pensar o dispositivo es político, económico y científico).  
70 Si la teoría de juegos va a ser un instrumento fundamental para el diseño, deberá contener no sólo el 
herramental formal para el desarrollo de conceptos a partir de modelos sencillos, sino también incluir las 
complicaciones de los mercados concretos. Alvin Roth (2002) señala dos tipos de complicaciones. 
Primeramente, las complicaciones en el entorno estratégico, en los resultados posibles y en las estrategias 
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El diseño debe anticiparse a cómo las personas se comportarán en el ambiente 
delineado. Asimismo, es importante asegurar la sustentabilidad del proyecto en el 
largo plazo, pero verificando su posibilidad de corto plazo. Tradicionalmente, el 
énfasis formal al analizar sistemas estuvo puesto en los equilibrios en infinito; es 
indispensable verificar la viabilidad del corto plazo para alcanzar ese equilibrio 
futuro. Los métodos computacionales cumplen un rol fundamental al permitir el 
análisis de juegos complejos, imposibles de resolver analíticamente. Los 
experimentos de laboratorio, por su parte, informan sobre cómo se comportará la 
gente cuando se enfrenta a estos ambientes que estamos diseñando y cómo 
adquieren experiencia.  
Los experimentos71 son un ejemplo claro de la característica performativa de la 
economía. Un experimento es un crisol en el que las teorías, discursos, textos, 
prácticas, intereses y materiales interactúan y se co-constituyen.  
2.2.3 Mercados eficientes 
Roth sostiene que el funcionamiento eficiente de los mercados requiere (1) 
densidad72 (para atraer a un número suficiente de participantes), (2) superar los 
problemas de congestión que puede traer la cantidad de agentes operando (realizar 
transacciones con suficiente rapidez que permitan a los agentes tomar decisiones), 
y (3) que sea seguro y simple. Asimismo, debe contemplarse que algunas 
operaciones están moralmente excluidas, lo cual es una limitación a tener en cuenta 
al diseñar el mercado. Por último, el autor destaca el rol que tienen los 
experimentos en el diagnóstico y la comprensión de las deficiencias del mercado, 
                                                 
disponibles para los jugadores. En segundo lugar, las complicaciones en el comportamiento de los agentes 
económicos reales que no se comportan como meros maximizadores de beneficio.  
71 Muniesa y Callon (2007) presentan una distinción entre tres configuraciones esquemáticas de 
experimentación que se diferencian por su grado de apertura: el laboratorio, la plataforma, y el experimento in 
vivo. 
72 Tradicionalmente, se reconoce la importancia de la densidad de los mercados, pero no siempre se 
contemplaron los temas de la congestión, la seguridad y la sencillez. Una forma de evitar la congestión de los 
mercados es emplear una cámara de compensación centralizada para coordinar el mercado donde un algoritmo 
aprobado realice las asignaciones. Ahora bien, Roth (1984) demuestra que la evolución de los mercados puede 
hacer imposible que el algoritmo funcione eficientemente frente a transformaciones. La congestión es un 
problema, especialmente, en mercados en los que las transacciones son heterogéneas y las ofertas no se pueden 
hacer a todo el mercado. Aunque las operaciones se realicen rápidamente, al tener que dirigir la oferta hacia 
agentes particulares, se corre el riesgo de que otras oportunidades desaparezcan.  
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en contrastar el éxito de un diseño y en la comunicación de resultados a los 
responsables políticos (Roth, 2008).  
2.3 El mercado de nanotransportadores como un proceso de co-
constitución 
La tradición occidental ha establecido una clara distinción entre el individuo y lo 
colectivo73, generando una relación dialéctica que ha dominado la producción en 
ciencias sociales (Callon and Law, 1997). En el caso particular de la ciencia 
económica, la noción de racionalidad limitada de Herbert Simon (1982) ha 
obligado al homo economicus a reconocer un contexto de objetos que lo 
condiciona. Las sociedades humanas son heterogéneas y se constituyen en 
conjunto con tecnología, textos, bienes y capital, capturando la complejidad que 
conlleva una asociación colectiva de entidades heterogéneas donde los objetos y 
procedimientos no son simples recursos o restricciones, sino que pueden intervenir 
activamente para impulsar la acción en direcciones inesperadas (Callon and Law, 
1997). 
Dentro de esta sociedad heterogénea, los mercados tienen indudables ventajas que 
los hacen insustituibles en un contexto occidental capitalista. Sus agentes 
autónomos innovan y se coordinan facilitando la concreción de contratos entre 
partes. Sin embargo, tienen claros límites: no están diseñados para lograr el bien 
público y producen externalidades negativas sobre grupos humanos que no son 
tenidos en cuenta. Por tanto, es necesario volver a considerar las cuestiones básicas 
sobre los mercados y cómo podemos garantizar que funcionen correctamente 
(Callon, 2012). 
El presente trabajo analiza un mercado en particular que se encuentra en proceso 
de constitución como tal: el de la nanomedicina, definido como las aplicaciones 
médicas de la nanotecnología, lo cual incluye el desarrollo de nuevos 
procedimientos para diagnosticar y curar enfermedades (Paradise et al., 2008). 
Para ello, se estructura en tres secciones. Primeramente, se define el concepto de 
                                                 




híbrido colectivo, el cual interactúa para constituir un mercado y se postula que la 
capacidad de cálculo es fundamental para entender las relaciones de poder. En la 
segunda sección se aplica lo expuesto al mercado en desarrollo de la nanomedicina, 
analizando cómo interactúan los agentes para objetivar, singularizar y hacer 
calculable (poner precio) a dos productos en particular: los nanotransportadores (de 
droga en el cuerpo humano) y sus patentes. Por último, se analiza cómo las 
diferencias en capacidad de cálculo establecen asimetrías en el mercado. 
2.3.1  Interacción entre entidades colectivas  
En un contexto de interacción entre entidades colectivas heterogéneas, el mero 
concepto de mercado es problemático. Muchas veces es presentado como un 
espacio abstracto en el que la demanda agregada y la oferta se cruzan entre sí y, a 
través de ajustes sucesivos, terminan por definir el precio (Cournot, 1838). Esta 
concepción presenta dificultades lógicas y teóricas, sobre todo, cuando se trata de 
explicar los mecanismos de agregación. Para superar la oposición entre los 
mercados abstractos y los concretos, se debe tomar como punto de partida la propia 
transacción, no la macro-estructura hipotética. La propuesta es, entonces, 
focalizarse en mercados reales, reconociendo el creciente papel de las interacciones 
a nivel micro. 
Se presenta, de este modo, al mercado como un conjunto de localidades donde el 
debate entre los grupos emergentes define las diversas maneras de organizarlos, 
dependiendo de cuestiones relacionadas con los tipos de productos e 
interpretaciones del derecho de propiedad. Las transacciones se describen mediante 
un doble proceso de entrelazamiento de actores y su posterior separación (Callon, 
1998). Esto no significa que no hay proceso de estructuración de los mercados sino 
más bien, que el proceso en sí es lo que se debate (Barry and Slater, 2002). En otras 
palabras, el mercado se presenta como una red de muchas y complejas relaciones, 
donde el doble movimiento de entrelazamiento y separación explica cómo se 
forman los negocios bilaterales.  
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Esta red, que se constituye como mercado, puede ser entendida como un acuerdo 
socio-técnico (STA), con tres características destacables74. Primeramente, 
permiten organizar la concepción, producción, circulación y transferencia de 
bienes. En segundo lugar, se presentan como un conjunto de componentes 
heterogéneos: normas, instrumentos técnicos75, narrativas, conocimientos, así 
como las competencias y habilidades incorporados en los seres vivos. Y, por 
último, son un espacio de confrontación y luchas de poder que producen múltiples 
y contradictorias valoraciones de los bienes (Çalışkan and Callon, 2010).  
Ahora bien, si utilizamos esta noción de acuerdo socio-técnico, dejamos implícita 
una división entre humanos que organizan, y las cosas que se dejan pasivamente 
utilizar. Para introducir en forma explícita la capacidad de actuar de ciertas cosas, 
Deleuze y Guattari (1998) propusieron la noción de agencement76. En otras 
palabras, agencements refiere a acuerdos socio-técnicos considerados desde su 
capacidad de actuar, acorde a su diversidad de fuerzas (Çalışkan and Callon, 2010). 
Éstos se componen de seres humanos y dispositivos materiales, técnicos y 
textuales, dependiendo de las configuraciones particulares77.  
Siguiendo a Callon y Law (1997), esta tesis propone capturar la idea presentada 
utilizando el concepto de colectivo híbrido en constitución78. En ese proceso 
interactúan personas, dispositivos y textos, no habiendo diferencia entre la persona 
y la red de entidades en las que actúa. O más precisamente, entre la persona y la 
red de entidades que actúan a través de ella, constituyéndose como el producto de 
un proceso de composición conjunta. Lo mismo ocurren el mercado, sus agentes 
                                                 
74 Claramente, esta definición general permite distinguir a los mercados de otros tipos de organización. 
Contrariamente a lo presentado, el constructivismo social se centra en los mecanismos "sociales" y analiza los 
mercados como una organización social más, perdiendo de vista la especificidad propia de la dinámica del 
mercado. Asimismo, reduce sus dimensiones materiales y técnicas a nociones generalizadas abstractas como 
"recursos" o "capital". Las relaciones sociales son el único elemento explicativo (Bloor, 1991). 
75 El especial énfasis en materialidades y tecnicismos para entender los mercados no es una idea nueva se 
encuentra ya presente en los escritos de Weber (1978 [1922]). (Weber, 1978 [1922]) 
76 Agencement es una palabra francesa cuyo significado está muy cerca de "acuerdo", transmitiendo la idea de 
una combinación de elementos heterogéneos que se han ajustado entre sí. 
77 Asimismo, estos agencements pueden ser deliberativos (McCarthy and Kelty, 2010), pueden tener capacidad 
de cálculo o no, pueden ser colectivos o individuales (Callon and Law, 2005). Es, asimismo importante 
destacar que estas entidades mencionadas no son naturales, sino efectos relacionales. Por lo tanto su forma, su 
contenido y sus propiedades son producto de ese proceso relacional, y su identidad surge en el curso de la 
interacción. Son procesos de transformación, de compromiso mutuo y de negociación (Callon and Law, 1997). 
78 Por ejemplo, Bruno Latour (1999) nos presenta un ejemplo de lo anterior: “Pasteur”. Claramente el ser 
humano Pasteur ha logrado realizar lo que figura a su nombre porque una red de elementos a su alrededor le 
dio la posibilidad de realizar su práctica científica diaria. 
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no actúan, solamente, gracias a su capacidad mental individual, son también 
híbridos colectivos79.  
Estos agentes interactúan en el mercado realizando operaciones de cálculo, por lo 
que se propone, entonces, conceptualizarlos como dispositivos híbridos colectivos 
de cálculo (Callon and Muniesa, 2003). Ahora, si bien, notoriamente, el cálculo es 
una característica del mercado, la pregunta es: ¿quién realmente calcula y cómo? 
En la literatura, se encuentran dos respuestas antagónicas. Mientras que, para la 
teoría económica neo-clásica, los agentes calculan ya que está en su naturaleza 
hacerlo, desde una perspectiva de antropología social, el cálculo es una 
racionalización ex post de las decisiones que, realmente, se toman en base a otras 
lógicas. Estas dos visiones son extremos que se deberían evitar para entender el 
mercado. Por un lado, no debe tomarse la visión formal económica de los 
mercados, que reduce a los agentes económicos a sus preferencias y aptitudes de 
cálculo pero tampoco hay que deshacerse de la idea de cálculo y disolverla 
mediante descripciones etnográficas (Callon and Muniesa, 2003). 
El proceso de valoración de los bienes surge de los intercambios mercantiles 
mediante la realización de cálculos cruzados80. Los agentes involucrados en estas 
operaciones son los dispositivos de cálculo (Çalışkan and Callon, 2010). Éstos 
cuentan con herramientas disponibles que no sólo permiten alcanzar ciertos fines, 
sino que contribuyen, activamente, en la constitución de su realidad (Rose and 
Miller, 2008). Estas valoraciones y cálculos se manifiestan, públicamente, como 
precios, luego de una lucha entre agentes que tratan de imponerse uno al otro 
(Weber, 1978 [1922]; Stark, 2009). Los agentes calculan estos precios sobre la base 
de sus valoraciones81, elaborando fórmulas de cálculo (Lepinay and Callon, 2009). 
Es importante notar que varios estudios han demostrado que los actores vinculan 
directamente la cuestión de la equidad de los precios a sus fórmulas de cálculo, 
                                                 
79 A modo de ejemplo, imaginemos una alta ejecutiva de una gran empresa que es la presidenta durante un 
proceso de crecimiento exponencial de la corporación y cuenta con una experiencia notable en el mercado. Es 
fácil imaginar, entonces, que es una estratega ejemplar, activa y energética. Ahora bien, ¿qué pasaría si 
elimináramos sus teléfonos, su fax y los informes que tiene sobre su escritorio? Seguramente, dejaría de ser la 
estratega empresarial conocida. 
80 Los encuentros pueden ser múltiples y se pueden producir cálculos superpuestos. 
81 Incluyendo otros precios, aunque se trate de una operación bilateral (Guyer, 2004). 
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reclamando que la construcción de las fórmulas sea justa (Guyer, 2009; Muniesa, 
2003). 
Ahora bien, para especificar la noción de cálculo presentada, se propone partir de 
la idea de centro de cálculo desarrollado por Bruno Latour (1987), y conceptualizar 
los agentes económicos como híbridos colectivos de cálculo. Agencias equipadas 
con instrumentos, donde el cálculo no se realiza sólo en las mentes humanas, sino 
que se distribuye entre los seres humanos y artefactos. Se postula una definición 
general de cálculo como un proceso de tres pasos82: En primer lugar, las entidades 
en cuestión deben ser separadas y colocadas en un espacio determinado. Luego se 
asocian entre sí, se manipulan y transforman materialmente. Finalmente, se extrae 
un resultado que se convierte en una entidad separable que puede circular en el 
mercado (Callon and Muniesa, 2003).  
Los mercados con su propia dinámica generan externalidades que impactan en la 
sociedad, impulsando espacios políticos de discusión e interacción. Si bien el 
enfoque tecnocrático económico tradicional propone dar cuenta de estas 
externalidades incluyéndolas en los modelos como variables, estos desbordes 
exceden lo técnico e impulsan una discusión claramente política. Se presenta, 
entonces, una confrontación entre el enfoque tecnocrático abstracto que intenta 
cuantificar externalidades sociales por un lado83, versus un enfoque político que 
propone un espacio de discusión por el otro.  
                                                 
82 El concepto de configuración algorítmica del mercado ayuda a entender cómo es posible tener 
representaciones abstractas del mercado, que se pueden utilizar para actuar en mercados concretos. Ellos hacen 
explícito lo que llamamos las configuraciones algorítmicas del mercado, las cuales son acuerdos socio-
técnicos, dispositivos de cálculo en el sentido que Callon y Muniesa (2003) le dan al término. En primer lugar, 
delimitan el grupo de agencias de cálculo haciéndolas identificables y numerables. Seguidamente, explicitan 
el proceso de conexión y, por último, establecen las reglas que gobiernan el orden en que las conexiones deben 
ser realizadas. Estas configuraciones algorítmicas de los encuentros no son estructuras existentes en las que 
las agencias de cálculo sólo circulan y se desarrollan. Los agentes participan en diversos grados en el diseño 
de los mercados en los que operan.  
83 Polanyi, que tanto contribuyó a la comprensión de los mercados, también sostiene una definición abstracta 




El mercado no puede ser entendido como una categoría unificada84. No existen las 
macroestructuras que sostienen las transacciones; lo que existen son relaciones en 
constante co-constitución en un nivel micro85 (Callon, 2009).  
Los mercados son una combinación de reglas definidas por los poderes públicos y 
agentes privados. Algunos se estructuran de tal forma que favorecen la creación de 
asimetrías, mientras que otros están más abiertos al debate sobre su funcionamiento 
y a su posible reorganización. Es más, el análisis de los diversos dispositivos de 
cálculo con los que cuentan los STA permiten entender las relaciones de 
dominación que definen los diferentes mercados. Son las diferencias en el poder 
de cálculo las que posibilitan que las agencias más poderosas sean capaces de 
imponer sus valoraciones y presionar por una mayor parte de la distribución de 
riqueza (Bourdieu, 2005). 
Una forma de concebir las relaciones de dominación que atraviesan los mercados 
es inscribirlas en relaciones de cálculo (Hirschman, 1977). Es cada vez más difícil 
de ocultar las luchas de poder detrás de las transacciones comerciales86. Ahora 
bien, este escenario de asimetrías y relaciones de poder nos lleva a preguntarnos: 
¿cómo es posible realizar un cambio? Callon y Muniesa proponen que una de las 
primeras tareas de un estudio es identificar las fuerzas que participan en estas redes 
y entender cómo se interrelacionan. En este sentido, es fundamental el rol 
performativo de los experimentos en el proceso de aprendizaje para lograr 
mercados democráticos. Esto moviliza una verdadera ingeniería económica sobre 
la base de ensayo y error, abriendo la posibilidad de concebir nuevas formas de 
organización y teorización (MacKenzie, 2009; Callon, 2009). 
                                                 
84 Como lo ha sido hasta la primera mitad del siglo XX. 
85 Su organización depende de las actividades profesionales y de las tecnologías involucradas, de forma que 
las metáforas de amplia difusión en la literatura de “infraestructura subyacente” o la de embeddedness 
(Granovetter, 1985) dejan de ser útiles. 
86 Algunos mercados se estructuran de tal forma que favorecen la creación de asimetrías, mientras que otros 
están más abiertos al debate sobre su funcionamiento y a su posible reorganización. No sólo el mundo privado 
interviene en su creación; los mercados son una extraña combinación de reglas definidas por los poderes 
públicos y agentes privados. En particular, el análisis de los diversos dispositivos de cálculo que actúan en los 
mercados permite entender las relaciones de dominación y sus asimetrías.  
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2.3.2 La constitución del mercado  
Como fue mencionado anteriormente en el presente trabajo, el concepto tradicional 
de mercado remite a la existencia de un espacio abstracto en el que la demanda y 
la oferta se encuentran y, por sucesivos ajustes, terminan por definir el precio. El 
problema de este enfoque aparece cuando los mercados son incompletos, en 
formación o con pocos agentes negociando; en estos casos es claramente necesario 
rastrear las interacciones para poder entender el proceso de formación de precio. 
Este es el caso de la nanomedicina. Para entender la formación del mercado de 
comercialización de nanotransportadores (Parveen et al., 2012) y de sus patentes 
(Martins et al., 2013), este trabajo aplica la metodología propuesta por Callon y 
Muniesa (2005).  
Esta metodología de analizar transacciones concretas entre agentes del mercado se 
conoce en economía como microfundación. La noción refiere a entender el efecto 
macro de un conjunto de transacciones limitadas entre un número limitado de 
agentes, un número limitado de productos y en un marco regulatorio en cambio. 
En particular, esta sección rastrea las relaciones que, partiendo de la práctica 
científica (registro de patentes), transfiere a las empresas (uso de patentes y 
producción de nanoportadores) y permite que la nanomedicina llegue a los usuarios 
(facilitado por sus médicos). Este rastreo explicita el proceso de constitución del 
mercado como una configuración algorítmica donde híbridos colectivos 
interactúan.  
2.3.2.1 Objetivación y singularización  
En una transacción de mercado, un bien se vende por un precio que, como 
consecuencia, conlleva un cambio de manos del producto, dejando al vendedor y 
al comprador satisfechos con la transacción. El bien se separa del mundo del 
vendedor y se adjunta a la del comprador (Muniesa and Callon, 2007). En el caso 
bajo estudio se encuentran dos bienes objetivables. El primero que surge es la 
patente. Si bien es intangible, claramente es material y un bien transable. El 
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segundo es el nanotransportador como producto masivo, cuya materialidad es 
obvia87.  
Es importante destacar que ambos son valiosos, solamente, si sus propiedades 
representan un valor para los potenciales compradores. Esta evaluación puede ser 
expresada como un precio que el comprador está dispuesto a pagar para apropiarse 
de la cosa, es decir, apegarse a él, para incorporarlo a su mundo. Una vez que él o 
ella han adquirido este bien, el comprador se convierte en el propietario. La 
transformación es doble: no sólo es el bien poseído por el dueño, sino que también 
se convierte en parte del mundo del propietario.  
El proceso de singularización de la patente consiste en una definición progresiva 
de sus propiedades, de tal manera que pueda entrar en el mundo de la empresa que 
la utilizará para producir el nanotransportador. A lo largo de este proceso de 
calificación, el objeto patente X se transforma, progresivamente, en un bien a ser 
vendido. Cuando una empresa compra una patente (u obtiene permiso de uso por 
tiempo determinado), ésta entra a formar parte de las relaciones socio-técnicas que 
constituyen el mundo corporativo.  
Una vez que la empresa colocó en su red la patente, puede iniciar el proceso de 
producción del nanotransportador para luego iniciar el proceso de 
individualización del mismo, que consiste en una definición progresiva de las 
propiedades del producto, en una interacción con los profesionales de la medicina 
y los usuarios finales. El producto entra en el mundo del usuario por medio del 
profesional médico que recomienda su uso en el cliente, por lo que el largo proceso 
de calificación del producto, se realiza en íntima relación con el médico. La 
objetivación y la singularización de la patente se producen al mismo tiempo, siendo 
las propiedades objetivadas aquéllas que permiten a la patente unirse al mundo de 
la empresa compradora.  
A la hora de pensar las propiedades de las patentes es necesario construirlas en 
contexto. Es más, la compra es el resultado de un encuentro entre sujeto y objeto; 
                                                 
87 Es importante aclarar que el alquiler o permiso poseen materialidad, de la misma forma que la venta total 
de la patente a un tercero. En el caso de los nanotrasportadores, la materialidad es obvia debido a que son 
objetos físicos separables. En otras palabras, son materiales en la nanoescala (1-100 nm de diámetro) que 
pueden llevar múltiples medicamentos a un tejido destino del organismo humano (Parhi et al., 2012).  
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un proceso de relación que califica los productos y que termina en la 
singularización de sus propiedades. Esta co-producción de las propiedades requiere 
la participación de un gran número de profesionales del mercado (marketing, 
productoras, anunciantes, diseñadores, comerciantes, vendedores, etc.)88. El 
científico, como híbrido colectivo, y en relación con sus ayudantes y colegas, 
construye el objeto. Claramente, la lectura de revistas científicas, la interacción con 
el exterior (por ejemplo, con médicos) y las políticas públicas de financiamiento 
co-elaboran las propiedades del intangible. Es más, una parte importante de su 
materialidad es contar con una buena documentación de los procedimientos 
involucrados para que el comprador asigne un valor económico lo más alto posible 
a la patente (Hall and Harhoff, 2012). Asimismo, el grupo de investigación debe 
saber que ciertas propiedades, perjudiciales para la salud, impedirán que el trabajo 
termine con una patente aprobada. Ahora bien, el comprador de la patente adquiere 
con ella el derecho (no la obligación) de producir nanotransportadores. Para definir 
las características del producto, es fundamental entender las necesidades médicas 
concretas (seguramente, intuidas por el científico que logró la patente), ya que es 
fundamental una relación estrecha. Antes de la producción masiva, se requiere una 
serie de fases de testeo clínicos para lograr la aprobación del producto por parte de 
los entes reguladores. Cumplir con el regulador y lograr un producto deseable por 
parte de los médicos (y los usuarios) no es suficiente para entender el valor 
económico del producto.  
Como hemos detallado anteriormente, el proceso de singularización consiste en 
una serie de operaciones que resultan en la posibilidad de realizar un cálculo sobre 
la mercancía en cuestión. Es más, estudiar la competencia de mercado consiste en 
establecer un espacio de cálculo en el que se puede conectar y comparar el producto 
en cuestión con una lista finita de otros productos. Comparabilidad y la posibilidad 
de sustitución se encuentran en el corazón de los métodos de fijación de precios. 
Cuanto más complejo sea un producto, su comercialización planteará mayores 
problemas en términos de singularización. El producto oscila entre un alto nivel de 
                                                 
88 Este proceso de adaptación también implica una exploración extensa y sistemática de las redes de 
vinculación que constituye el comprador (potencial) del mundo. Uno de los principales requisitos, que los 
diseñadores y los vendedores tienen que cumplir, es el estudio de las necesidades de los compradores con el 
fin de ser capaces de proponer nuevas.  
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singularización (sustitución débil) y un alto nivel de estandarización (sustitución 
fuerte).  
La patente en cuestión se convierte en singular y calculable después de una 
operación de extracción, traducción y cambio de formato. Es necesario vincularla 
con otras patentes para lograr una correcta clasificación, como así también hacerla 
comparable con otras para que pueda calcularse su valor en el mercado. En el 
vocabulario de los profesionales de marketing, esto tiene un nombre: el 
posicionamiento. Durante la vida útil de la patente, seguramente, tendrán lugar una 
larga serie de reposicionamientos.  
Una vez que se cuenta con la patente, lograr construir el objeto nanotransportador, 
requiere muchas conexiones en la red sociotécnica en cuestión. Durante la etapa de 
I+D, intervienen científicos que han descubierto la tecnología y aquéllos que 
realizarán las pruebas clínicas. Asimismo, cuando el producto llega al mercado, 
compite con otros productos similares y, al cruzarse con la demanda, definen 
precio.  
El nanotransportador sufre un proceso similar al de la patente para hacerse 
calculable. Se trata de un proceso de clasificación, agrupación y clasificación que 
hace que los productos de dos compañías sean comparables pero diferentes. 
Asimismo, este proceso de vinculación de agentes, implica, entre otras cosas, el 
establecimiento de controles de calidad que permitan medir y objetivar ciertas 
propiedades, de forma que un producto pueda ser reconocido por los usuarios como 
mejor, y ellos le asignen un mayor valor económico.  
En conclusión, tanto la patente como el nanotransportador son objetivados y 
singularizados para poder ser calculables. Al lograr estabilizar las propiedades de 
los mismos, se puede describir una fórmula que permita calcular sus precios89. 
                                                 
89 Una vez objetivado, el bien deja el mundo de la empresa que lo oferta y penetra el mundo del comprador, 
que se ha configurado para recibirlo con la ayuda del médico. El nanotransportador, visiblemente, pasa ser 
parte del organismo del usuario y opera en su cuerpo para lograr el efecto requerido. Ahora bien, ahí no termina 
la relación comercial, el vendedor debe recordar su responsabilidad por daños del producto.  
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2.3.3 Asimetrías en el mercado  
La existencia de una multiplicidad de formas prácticas de confrontación entre la 
oferta y la demanda para definir un mercado se denomina configuración del mismo. 
Esta tiene una gran relevancia a la hora de definir precios y relaciones comerciales, 
a la vez que identifica a los agentes autorizados para participar en una transacción. 
Dentro del contexto que plantea la regulación estatal, interactúan la oferta y la 
demanda. En particular, existen normas regulatorias que el Estado impone, que 
restringen la producción de nanoportadores (como producto medicinal) y normas 
que obligan al usuario a contar con un médico que avale el uso del producto en su 
cuerpo. Estas restricciones al mercado, necesarias para la actividad médica, 
claramente, son parte fundamental del proceso de formación de precios90 (Vashist 
et al., 2012; te Kulve and Rip, 2013).  
Con nuevas tecnologías de información, el poder y la diversidad de las tecnologías 
de encuentro se amplifican en el mercado (Chaboud et al., 2014) y las 
configuraciones se convierten en objetos por derecho propio en los que puede ser 
llevado a cabo la investigación y la experimentación91. Esta configuración 
algorítmica, donde se desarrollan los encuentros entre gobierno, usuarios, 
empresas, científicos y médicos, no son estructuras que ya existen. Son los agentes 
participantes los que lo diseñan y para analizarlos, Callon y Muniesa (2005) 
proponen preguntarse dos cuestiones que refieren a la relación entre un mercado 
concreto de nanomedicina y el abstracto que surge de un modelo económico-
financiero. La primera refiere a la relación entre la elección de determinadas formas 
de organización de mercado y su impacto en el mercado agregado. La segunda 
refiere a las condiciones de validez de los modelos abstractos que proporcionan 
una descripción sintética y permiten calcular precios.  
                                                 
90 Estos procedimientos de formación de precios en un contexto regulado se constituyen como una 
configuración algorítmica. Visiblemente, son dispositivos de cálculo, pues identifican las agencias de cálculo, 
organizan sus encuentros y establecen las reglas.  
91 Un ejemplo es la red creada por NanoKTN para promover y aumentar las relaciones en el mercado de la 
nanomedicina. Si bien se realizan encuentros donde exponen líderes de la industria y académicos de renombre, 
el mayor flujo de intercambio es virtual a través medios tecnológicos, que exploran formas de avanzar en la 
comercialización de los productos. 
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Las agencias de cálculo92 son híbridos colectivos equipados con los instrumentos 
de cómputo. El modelo matemático que permite valuar patentes médicas (Guo et 
al., 2013) en base a ciertos parámetros es una herramienta, así como la 
computadora, donde el modelo se ejecuta. Asimismo, es necesario que 
profesionales puedan calibrar los parámetros e interpretar los resultados del 
modelo93.  
Callon y Muniesa (2005) proponen un análisis de estas asimetrías en base a dos 
criterios. Las agencias de cálculo se caracterizan por su poder de cálculo y por su 
grado de autonomía. Una agencia de cálculo será tanto más fuerte cuando sea capaz 
de: a) establecer una lista larga de entidades diversas, b) permitir relaciones 
complejas entre las mismas, y c) formalizar los procedimientos y los algoritmos de 
forma de multiplicar las jerarquías y las clasificaciones posibles entre estas 
entidades. Es fácil entender que el poder de cálculo, así definido, se distribuye en 
forma desigual entre los organismos de cálculo. Se consideran dos explicaciones 
para esta desigualdad: el grado de complejidad y riqueza de los dispositivos de las 
agencias de cálculo, y la red de interconexiones entre ellos.  
El mercado, en el caso de las patentes (Sandner and Block, 2011), implica, por lo 
menos, dos agencias de cálculo: la empresa que compra la patente para utilizar en 
la producción de nanotrasportadores y el científico (o grupo) que realiza la patente. 
En primer lugar, la empresa compradora realiza una valuación de la patente, 
involucrando referencias de terceros, prestigio del científico y todo tipo de 
información pública disponible por parte del gobierno (Chari et al., 2012). El 
marketing que realicen los científicos de su patente mediante revistas científicas, 
eventos94, etc., constituye un sistema de conocimiento distribuido que participa, 
activamente, en el proceso de valuación y singularización de la patente en cuestión. 
                                                 
92 Las capacidades de las agencias de cálculo están vinculadas a su equipamiento distribuido. Esta 
caracterización permite tener en cuenta las asimetrías de poder de cálculo, un tema clave en el análisis de las 
guerras comerciales (Callon and Muniesa, 2005). 
93 La estimación se realiza en base a información histórica disponible y en base a preguntas a expertos. 
Claramente, es un agente distribuido de cálculo el que se presenta a valuar una patente. Mediante la 
introducción de estas nuevas entidades (modelos, estimación de parámetros, computadoras), se han ampliado 
las capacidades de los actores humanos.  
94 Los investigadores de los laboratorios saben que sus innovaciones necesitan ser comunicadas, por lo que 
existe una clara maquinaria de marketing para crear mercado (Berman, 2011). 
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Por otro lado, la empresa compradora, seguramente, requerirá la realización de 
pruebas con la patente y la discusión de los resultados.  
Independientemente de qué tan fuerte es la agencia de cálculo del científico que 
registra la patente, sigue siendo débil en comparación con la potencia de cálculo 
con la que cuenta una empresa farmacéutica95 que evalúa su uso. Frente a un 
científico de un laboratorio, generalmente, del otro lado hay una multitud de 
profesionales armados con computadoras, estudiando sus patentes y calculando 
con poderosos algoritmos cuál es el flujo futuro esperado de la patente. Sin 
embargo, esta relación de poder no es inmutable96.  
Ahora bien, en la medida que el científico tiene más prestigio, más patentes y 
mayor soporte de la institución que lo cobija, su poder de cálculo aumenta 
(D'Angelo and Benassi, 2015). Adquiere herramientas que le permiten cambiar el 
equilibrio de poder, siendo más activos en términos de cualificación y 
singularización. Este cambio de la geopolítica de las competencias de cálculo es, 
probablemente, más visible en el contexto de bienes intangibles como las patentes, 
que en otros contextos industriales de producción de bienes tangibles masivos. Tan 
pronto como una patente se establece como hegemónica en un mercado, su éxito 
impulsa a otros a invertir en posibles competencias cuyo impacto puede ser 
devastador para los intereses establecidos.  
En el caso del nanotransportador como producto de consumo médico, es 
fundamental el rol que juega el médico que tiene que aconsejar el uso del 
nanoportador, para lo cual realiza evaluaciones que implican referencias y 
evaluación de productos de varias marcas. El médico constituye un sistema de 
conocimiento distribuido que participa, activamente, en el proceso de calificación 
y la singularización del nanoportador. Es más, los médicos requerirán pruebas de 
la efectividad de la tecnología y discutirán los resultados con la empresa 
proveedora (Vizirianakis, 2014).  
                                                 
95 Como muestran diversos estudios, las grandes farmacéuticas tienen altas rentabilidades y utilizan un poder 
de mercado casi oligopólico (Spitz and Wickham, 2012; Suarez-Villa, 2014) 
96 En estos últimos años varios billonarios filántropos han traído financiación sin precedentes para hacer el 
tratamiento para la malaria, el SIDA y la tuberculosis a disposición de los pobres. A la vez los beneficios de 
las grandes farmacéuticas se van reduciendo. Esto obliga a ir pensando en una nueva dinámica tal vez en unos 
años (Pollock, 2011). 
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Pero, independientemente, de qué tan fuerte es la agencia de cálculo de los usuarios 
(y sus médicos), sigue siendo débil en comparación con la potencia de cálculo de 
la empresa proveedora (especialmente, si es una gran farmacéutica), ya que utiliza 
una serie de profesionales para analizar el mundo de la demanda e integrar mejor 
el producto. En otras palabras, la diferencia entre la capacidad de cálculo del 
médico y la del vendedor es, esencialmente, la consecuencia de la asimetría de los 
equipos distribuidos de cálculo con los que cuentan cada uno de ellos. En aquellos 
países con transparencia de la información y con asociaciones médicas fuertes y 
responsables, permite cambiar el equilibrio de poderes, habilitando que la demanda 
sea más activa en términos de cualificación y singularización.  
Si pensamos que el productor es una gran multinacional farmacéutica, ésta cuenta 
con unidades de negocio descentralizados, que se comportan como agencias de 
cálculo distribuido. Pero se agregan, a la hora de contribuir, a la rentabilidad de la 
empresa. El consumidor rara vez tiene la posibilidad de movilizar y controlar un 
gran número de organismos autónomos de cálculo. El estudio de estas conexiones, 
su naturaleza y su forma, nos permite plantear la cuestión de la autonomía relativa 
de las agencias: una conexión puede conducir a una dependencia pura si un 
organismo está en condiciones de tener acceso sin restricciones al poder de cálculo 
a otro organismo.  
2.4 Decisiones de inversión y la valuación de proyectos 
Luego del análisis de la sección anterior que permite entender el proceso de 
constitución del mercado, esta sección pone foco en el rol de los inversores en el 
mismo. La primera parte explica el proceso de creación de nuevas empresas y 
recorre algunas lecciones aprendidas de la primera generación de empresarios 
nano. A continuación, se analiza la valuación económica-financiera de activos 
intangibles separables e identificables, en particular, activos basados en la 
tecnología, tales como patentes, procesos y conocimientos técnicos. Luego se 
presenta un modelo de valuación de inversiones en la industria farmacéutica. Por 
último se presenta un modelo matemático que representa las decisiones de 
inversión conjuntas entre una pequeña empresa nanotecnológica que posee la 
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patente de un nanotransportador (posiblemente un spin-off) y una gran 
farmacéutica que tiene la droga a transportar y con llegada al mercado masivo.  
2.4.1 Creación de nuevas empresas  
Cuando un grupo de emprendedores se plantea un proyecto de inversión en el área 
de nanotecnología va a necesitar un manejo financiero eficiente que le permita 
obtener fondos externos97. En particular, los fundadores de una empresa de 
nanomedicina deben llevar a cabo varias tareas para lograr un negocio exitoso. 
Primeramente, seleccionar las estrategias del producto y armar un plan de negocios. 
Para continuar, se debe negociar un acuerdo de licencia con la Universidad (o 
gobierno), logrando términos comercialmente razonables para asegurar el éxito del 
lanzamiento. Armar un consejo de administración del negocio y otro Consultivo 
Científico, negociando los salarios y/o participación en las ganancias de cada uno. 
Solicitar capital a los inversores de riesgo y negociar su participación en las 
ganancias (Stewart, 2005). 
La mayoría de los acuerdos implican exclusividad para la empresa98. A modo de 
ejemplo, en el año fiscal 2003 en EEUU, el 94% de los acuerdos otorgó 
exclusividad, pero limitando el uso de la licencia a un tipo particular de producto. 
Asimismo, es muy común que la empresa entregue acciones a la universidad. En 
el año fiscal 2003 en EEUU las universidades recibieron acciones en el 67% de los 
acuerdos y el porcentaje de participación oscila entre 1% y el l0% (Bastani et al., 
2004). Por encima de las acciones muchos acuerdos requieren que la empresa 
entregue efectivo a la universidad en diferentes instancias del negocio. 
Primeramente es usual que se requiera dinero para cubrir el gasto de patentamiento 
del descubrimiento, también es práctica habitual exigir pagos durante el desarrollo 
                                                 
97 La mayoría de los inversores prefieren una sociedad anónima, la cual está gravada al impuesto a las 
ganancias pero a nivel empresa (no de accionistas). Los inversores “Ángel”, sin embargo, son una excepción 
pues generalmente requieren la formación de una sociedad de responsabilidad limitada al inicio del proyecto 
hasta que se haga la primera ronda de pedido de capital.  
98 La estrategia “Out-licensing” plantea que, a partir de una tecnología propia, el desarrollo esté financiado por 
una gran corporación y se licencia a la misma para que lo comercialice. Otra estrategia, “costos y ganancias 
compartidas”, requiere que las invenciones sean propias, los costos del desarrollo se realicen en forma 
compartida y el beneficio también sea compartido. La última estrategia, “integración total”, postula que 
partiendo de invenciones propias, la empresa autofinancie el desarrollo y su comercialización (Stewart, 2005).  
104 
 
cada vez que se termina una etapa y, por último, una vez iniciada la venta, se 
requiere un pago de royalty99 (3% a 6% sobre ventas netas) (Bastani et al., 2004).  
Otro tema relacionado a esta problemática es el rol del grupo científico 
universitario que inventó la tecnología, en el proyecto. El trabajo de grupo en la 
nueva empresa puede ser a tiempo completo, parcial, o meramente consultivo. Por 
otro lado, si es uno de los fundadores de la empresa, tendrá acciones de la misma. 
Por último el científico también participa en las regalías en efectivo que realiza la 
empresa a la universidad (Stewart, 2005).  
En el año 2009 la revista del sector Nanotechnology Law & Business realizó un 
listado de algunas lecciones que la primera generación de empresarios que 
trabajaron en el campo nano dejaron para los nuevos. Se remarca la necesidad de 
hacer foco en las necesidades del mercado en lugar de la creación de una plataforma 
tecnológica. Muchas empresas se centraron en el desarrollo de plataformas 
tecnológicas que se podrían utilizar para una variedad diferente de productos y casi 
todas estas han fracasado porque debían enfrentarse a diferentes tipos de mercado 
al mismo tiempo (Maebius and Jamison, 2009). 
Otras de las lecciones aprendidas es que no se debe empezar la venta al público si 
no se dispone de una estimación de los ingresos futuros que generarán los 
productos. Los primeros empresarios no anticiparon correctamente la demora en 
comercializar los productos, debido a la necesidad de esperar la calificación del 
producto. Se debe tener en cuenta las complicadas cuestiones regulatorias, pues 
esto impone barreras relacionadas con la comercialización. 
A nivel financiero del proyecto100, es importante recaudar la mayor cantidad de 
capital posible cuando se sale al mercado pues la comercialización ha requerido 
                                                 
99 Una fuente posible de financiamiento para la empresa es encontrar un socio corporativo de gran tamaño con 
el cual realizar una alianza estratégica. Estos socios pueden invertir solo o en conjunto con inversionistas de 
riesgo. La estrategia de producto debe ser determinada en conjunto con el plan financiero y las estrategias de 
comercialización. La estrategia óptima del producto dependerá de los fondos necesarios para desarrollar el 
período de investigación, el capital propio de la nueva empresa para el desarrollo y para vender el nuevo 
producto. 
100 La producción masiva de nanomateriales conlleva una gran incertidumbre técnica; existen incógnitas sobre 
algunos comportamientos que ocurren a nanoescala, porque es muy importante contar con parámetros en el 
plan de negocios que contemplen la misma. Por otro lado, es importante no subestimar las capacidades 
tecnológicas de los materiales tradicionales. Se debe contemplar que existe una continua innovación de las 




más tiempo y más capital del inicialmente anticipado por los empresarios. A esto 
se suma la última crisis financiera que ha dejado descapitalizados a muchos 
emprendedores. Ahora bien, es importante el correcto uso de esos capitales 
evitando construir capacidad instalada de producción antes de investigar a fondo 
la demanda a satisfacer. Por otro lado, la propiedad intelectual posee poco valor si 
el producto no está realizado. Muchas empresas han realizado inversiones en 
cartera con patentes ya otorgadas, las mismas a pesar de tener cierto valor no 
generan altos rendimientos hasta que el producto real sea comercializado. Por lo 
tanto el capital invertido en propiedad intelectual puede ser más valioso si se dirige 
principalmente al desarrollo de los productos (Maebius and Jamison, 2009).  
La última lección compendiada por los autores mencionados enfatiza que la 
definición del precio puede ser tanto o más importante que la performance del 
producto final. No siempre es posible imponer un precio alto sin impactar la 
demanda, solamente se puede si se tiene poder monopólico (Maebius and Jamison, 
2009).  
2.4.2 Valuación de activos tecnológicos.  
En la literatura académica, así como en las prácticas corporativas, un activo 
intangible tecnológico se define como un recurso que no tiene una forma de 
realización física, y cuya explotación industrial y económica otorga un beneficio 
futuro a su propietario (Lev, 2001). La presente sección se centra en analizar la 
valuación de activos intangibles separables e identificables (Guatri, 1989), activos 
basados en la tecnología, tales como patentes, procesos y conocimientos técnicos. 
Estos activos basados en la tecnología pueden generar ingresos (y, por lo tanto, 
valor) a la compañía que los posee. 
Los proyectos tecnológicos tienen como objetivo el registro de una patente, para 
luego, bajo su protección, comenzar la producción y comercialización de productos 
protegidos por la misma101. Las metodologías de valuación de activos tecnológicos 
                                                 
101 Ahora bien, aquella es un derecho, no una obligación de hacer uso exclusivo de una invención a un precio 
predeterminado, por un período predeterminado de tiempo. Por consiguiente, la valuación de dichos proyectos 
tecnológicos, los cuales incluyen derechos de propiedad intelectual, es un desafío para los profesionales. Si 
bien, tradicionalmente, los enfoques se han basado en flujos de caja descontados, en los últimos años se ha 
puesto especial interés en la metodología de opciones reales (Sereno, 2006; Cohen, 2011).  
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se pueden clasificar en dos grupos principales (Mun, 2003). Por un lado los 
métodos tradicionales, tales como el de costo, de mercado y por ingreso y, por el 
otro, los métodos innovadores, entre los cuales se destaca el método de opciones 
reales. Estas metodologías se difunden, no sólo en la literatura académica, sino, 
también, en la práctica empresarial (Mullen, 1999). Las metodologías 
tradicionales, habitualmente utilizadas, son la metodología de costos, la valuación 
de mercado y la valuación por ingresos. A continuación, se describirán, 
brevemente, cada una de ellas. 
El método de costos102 evalúa el valor de los activos de la tecnología mediante la 
medición de los gastos necesarios para producir103. El método de valuación por 
costos incluye los costos hundidos de I+D para producir una patente, pero no tiene 
en cuenta la cantidad de beneficios económicos relacionados con la explotación de 
la misma. Asimismo, asume que los gastos siempre crean valor; esto es 
particularmente problemático para valuar inversiones de alto riesgo como la 
presente. Este método se utiliza, generalmente, cuando la aplicación está en una 
etapa temprana de desarrollo y se carece de información del posible mercado y, por 
ende, no se pueden estimar los futuros ingresos.  
Otra de las metodologías tradicionales es la basada en el mercado, la cual estima 
que el precio de una tecnología es comparable con otra similar que esté, 
actualmente, en el mercado (Pratt et al., 1998). Se mide el valor presente de los 
beneficios futuros, utilizando los precios de mercado disponibles hoy de bienes 
similares. Este método de evaluación104 se basa en el principio económico de la 
competencia y asume equilibrio de mercado (Chiesa and Chiaroni, 2005). En 
general, si ya existe un mercado comparativo donde los activos se negocian 
activamente y, si la información sobre los costos de transacción ya está disponible, 
puede convertirse en un método práctico. En este sentido, si bien es eficaz para la 
                                                 
102 Chiesa y Chiaroni (2005) presentan diferentes definiciones posibles de costo. En primer lugar, se puede 
pensar el costo de evitar, el cual cuantifica el ahorro que el propietario de la tecnología (por ejemplo, patente) 
logra debido a contar con la propiedad de la misma. En segundo lugar, el costo histórico, donde los valores del 
desarrollo se cuantifican y se actualizan, utilizando un índice de inflación. En tercer lugar, el costo corriente, 
es decir, el costo tomado a precios actuales para desarrollar la tecnología en cuestión. 
103 Se basa en el principio económico de la sustitución; un inversor prudente no pagaría más por un activo 
tecnológico de lo que costaría crear o adquirir un bien similar. La estructura de costos utilizada puede variar. 
104 Para utilizar con éxito este método, se requiere que el mercado tenga una gran cantidad de transacciones de 
un bien similar y que la información sea pública. No contempla la posibilidad de transacciones únicas que 
surgen de una negociación puntual. 
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evaluación de propiedades inmuebles, no es eficaz para evaluar los casos de activos 
intangibles de propiedad intelectual o cuando el mercado es incompleto 
(transacciones poco frecuentes o secretas). 
El último método tradicional que se menciona en este trabajo es de valuación por 
ingresos, el cual considera que el valor de un activo es el valor presente del flujo 
futuro de los beneficios financieros que se obtienen de su explotación, por lo que 
el valor de un activo es la suma de los valores actuales de los flujos de efectivo 
futuros. Esta metodología no tiene en cuenta los costes de desarrollo de la 
tecnología y determina el valor de la tecnología de acuerdo a sus posibilidades de 
creación de beneficios futuros esperados105 (Boer, 2000). Este método, mientras 
que es conveniente para las patentes, marcas registradas, derechos de autor y otras 
propiedades intelectuales que pueden crear un beneficio futuro, tiene la desventaja 
de no poder reflejar con precisión el valor de la tecnología que no genere un 
beneficio directo. 
Estas metodologías tradicionales tienen serias limitaciones para poder valuar 
correctamente inversiones innovadoras. La principal desventaja del enfoque 
basado en los precios de mercado es que no siempre existen tecnologías similares 
en el mercado. En segundo lugar, el enfoque por ingresos se basa en el valor 
presente de los beneficios futuros hipotéticos que la tecnología en cuestión puede 
proveer. Sin embargo, no contempla decisiones estratégicas. En tercer lugar, los 
métodos basados en el descuento de flujos de fondos ciertos futuros desconocen la 
naturaleza incierta e irreversible de los proyectos tecnológicos106. Por último, la 
regla del valor presente no puede incorporar los riesgos y los diferentes escenarios 
estratégicos implícitos en las decisiones de un proyecto tecnológico ya que es un 
enfoque estático, y la decisión de inversión sólo se puede tomar ahora o nunca. Si 
bien existen modificaciones que intentan dar cuenta del riesgo, por ejemplo, 
descontando a una tasa mayor, es difícil de justificar a qué nivel de la tasa de 
descuento se incorporan todos los riesgos futuros (Brealey et al., 2009). 
                                                 
105 Entre ellos, el método de flujo de caja descontado es el más utilizado. Se construye un flujo de fondos 
futuros neto de costos reversibles y, luego, se lleva al valor presente mediante una tasa de descuento apropiada.  
106 Estos proyectos contienen diversas formas de incertidumbre. Primeramente, sobre el éxito técnico de la 
etapa de I+D. En segundo lugar, acerca de la protección jurídica que la patente en cuestión pueda dar al inversor 
durante un período y, por último, sobre el éxito comercial, una vez que entre en el mercado competitivo 
(Audretsch and Link, 2012). 
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2.4.2.1 Opciones reales 
En particular, los proyectos tecnológicos conllevan innovaciones, cuya 
introducción puede implicar grandes inversiones, generalmente, como costos 
hundidos. Asimismo, existe una gran incertidumbre sobre los beneficios futuros 
que evolucionan estocásticamente, siguiendo al mercado. Otra idea importante de 
los proyectos tecnológicos es que durante el mismo existen decisiones estratégicas 
de invertir en la siguiente etapa o no; a las cuales el inversor responde en función 
de la realización de eventos favorables o no, durante el proceso del proyecto 
(Schwartz, 2013).  
Además, otro tema importante es el momento en que se realiza la inversión. En la 
mayoría de los casos, la inversión puede ser pospuesta a la espera de nueva 
información. Por ejemplo, contar con una patente tecnológica crea una oportunidad 
de inversión irreversible que puede o no, realizarse. En otras palabras, es una 
opción de compra americana (derecho, pero no la obligación de gastar el dinero 
ahora o en el futuro, a cambio de un activo) (Brealey and Myers, 2003). Dado que 
su valor futuro es incierto, hay un costo de oportunidad de invertir en la actualidad, 
lo cual se describe como una opción de esperar (Vimpari and Junnila, 2014).  
2.4.3 Valuación de inversiones conjuntas en el mercado de 
nanomedicina 
Las inversiones conjuntas en nanomedicina requieren la cooperación necesaria 
entre dos empresas (una especialista en nano y una farmacéutica con llegada al 
mercado global), prever la incertidumbre del mercado debido a la tecnología y a la 
política de regulación y analizar los incentivos gubernamentales. Esta sección 
presenta un modelo formal que permite analizar la interacción comercial entre una 
empresa especializada en desarrollo de patentes nano y una farmacéutica con 
llegada al mercado global de medicamentos. La primera empresa desarrolla la 
investigación base y realiza los testeos in vitro/in vivo para lograr el patentamiento 
de un determinado nanotransportador; la segunda tiene la droga a transportar y la 
capacidad de producir en forma global. Esta interacción se modeliza utilizando 
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teoría de juegos y la valuación del proyecto conjunto se realiza mediante opciones 
reales.  
2.4.3.1 El modelo 
La economía consta de dos compañías, una es una pequeña empresa especializada 
en desarrollos de nanomedicina pero sin acceso al mercado de consumo de 
medicamentos. La segunda es una empresa farmacéutica con experiencia en el 
mercado de medicamentos. Para poder lanzar un nuevo nanotransportador que 
permita suministrar una droga específicamente en un lugar del organismo humano, 
se necesitan mutuamente. Se plantea una línea de tiempo de tres momentos: Uno 
inicial (t=0) donde la empresa nano desarrolla el nanotransportador, en t=1 la 
empresa farmacéutica realiza su inversión y, finalmente, en t=2 el proyecto llega a 
su fin y se recibe el ingreso logrado. 
Al momento inicial las empresas discuten el proyecto conjunto y acuerdan invertir 
(KN, KF) respectivamente. Específicamente, al momento inicial, la empresa nano 
(N) invierte KN en desarrollar la nanomolécula y testearla. Para el momento t=1 
cuenta con una patente, por lo que la empresa farmacéutica invierte KF para 
comenzar la producción. Esto les permite esperar un ingreso medio Y al finalizar 
el proyecto. Asimismo acuerdan que el resultado final se divida entre las empresas, 
la empresa Nano recibe Y y la farmacéutica el resto (1-)Y. 
Debido a la incertidumbre del Mercado (por ejemplo la posibilidad de que otro par 
de empresas logren un producto que compita) el ingreso final del proyecto en 𝑡 =
2 puede ser mayor del esperado (u.Y) o debajo (d.Y). Para tomar en cuenta esto, se 
asume que el ingreso final sigue un movimiento browniano, los agentes tienen 
aversión al riesgo cero y el proyecto tiene una probabilidad de éxito p (Hull, 2006; 
Luenberger, 1998).  
Para asegurar que la valuación inicial es consistente con los supuestos (y realizando 
una aproximación de primer orden), los valores de u y d son los siguientes: 
 
𝑢 = 1 + 𝜎√
1 − 𝑝
𝑝
  ;   𝑑 = 1 − 𝜎√
𝑝
1 − 𝑝













Línea de tiempo y pago a la empresa nano 
La estructura básica del problema se resume en anterior. En el momento inicial, la 
empresa nano calcula el valor presente del proyecto (utilizando un factor de 
descuento β) y decide si invertir o no. Si decide investigar y obtener la patente 
aprobada, la tecnología está lista para la etapa de producción en t=1. También en 
el momento inicial la farmacéutica evalúa el proyecto y decide si invertirá 𝐾𝐹 en 
𝑡 = 1 (acordando pagar a la empresa nano una fracción α del resultado del proyecto 
en el momento 2). Asimismo, el proyecto está sujeto a incertidumbre, representada 
por la probabilidad p (escenario favorable) y una volatilidad 𝜎, lo cual determina 
dos escenarios en t=2. 
 
2.4.3.2 Condiciones para que se realice la inversión conjunta 
Como se ha mencionado anteriormente, cada uno de los agentes evalúa la inversión 
conjunta desde su propio punto de vista. La empresa nano recibirá una fracción α 
del resultado, por lo que se descuenta este valor dos períodos y se lo compara con 
la inversión inicial requerida al momento inicial. La farmacéutica, por su parte, 
descuenta su participación final un periodo para comparar con la inversión que se 
le pide.  
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Ahora bien, para participar en el proyecto conjunto ambas empresas deben recibir 
al final un valor que supere (o iguale) la inversión actualizada. Por lo que las dos 
condiciones que deben cumplirse para que el proyecto conjunto se realice son: 
Nano β2[p u Yα + (1 − p) d Y α] ≥ KN 
(2.2) 
Farmacéutica β[p u Y(1 − α) + (1 − p) d Y (1 − α)] ≥ KF 
(2.3) 
De estas ecuaciones surge en forma inmediata que  impacta en las ganancias de 
ambas empresas. Si  =1, la empresa nano recibe la ganancia máxima, mientras 
que la farmacéutica pierde todo el capital invertido. Por el contrario, si  =0, la 







Valor presente de la ganancia como función de 
El gráfico muestra que, mientras el proyecto conjunto sea rentable, la empresa nano 
participará si la participación es mayor que un determinado valor (𝛼 ≥ 𝛼𝑑) y el 
productor lo hará si ∝≤∝𝑢 ; por lo que la inversión será exitosa si 𝛼 ∈ ⟦𝛼𝑑, 𝛼𝑢⟧. 
Asumiendo que la farmacéutica tiene mayor poder de negociación, podría imponer 
un =d y maximizar su rentabilidad. Ahora bien, si presiona en exceso forzando 
un 𝛼 < 𝛼𝑑, la inversión no tendrá lugar (la empresa nano se retira al no satisfacer 
su restricción).  
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Conclusión del capítulo 
En este capítulo se ha examinado cómo la práctica, en su proceso de constitución 
interdisciplinar y ecléctico, da lugar a un nuevo mercado nano que se encuentra en 
pleno proceso de formación y diseño. En lugar de utilizar como punto de partida la 
idea abstracta de mercado se ha propuesto describir y analizar las transacciones 
concretas.  
En particular, se ha descrito el proceso de objetivación, como bien transable, de los 
nanotrasportadores (y sus respectivas patentes). El presente trabajo argumenta que 
el mercado nano se presenta como una red de relaciones complejas donde hay un 
doble movimiento de agrupamiento (construcción de objetos transables) y 
separación (la venta a usuarios). Se ha conceptualizado a los agentes del mercado 
como colectivos híbridos de cálculo, lo cual permite fundamentar, desde lo micro, 
las asimetrías de poder a la hora de fijar precios. Esto es decisivo para entender en 
las relaciones de poder entre pequeñas empresas nano innovadoras y las 
farmacéuticas. Asimismo, se analizó la dinámica industrial de la nanotecnología y, 
en particular, a la de la nanomedicina. Se describió la problemática legal de las 
patentes y la necesidad de una política gubernamental que contemple la necesidad 
de innovación mediante la emisión de patentes, pero que también cuide la 
competencia, no permitiendo monopolios en el sector.  
Se remarca la importancia de entender las transacciones entre agentes (humanos y 
artefactos) híbridos colectivos de cálculo que interactúan en un proceso de 
constante co-constitución y como la capacidad de cálculo de cada uno de ellos se 
refleja en poder económico de mercado. Asimismo, se ha conceptualizado el 
mercado de nanotransportadores como una configuración algorítmica y se analiza 
cómo las diferencias en capacidad de cálculo establecen asimetrías en el mercado.  
Se concluye que la naturaleza distribuida de las agencias de cálculo (humanos y 
artefactos) muestra más explícitamente la importancia de la agencia no-humana 
para comprender el proceso de constitución del mercado de nanotransportadores y, 
en particular, cómo las grandes empresas farmacéuticas concentran poder en base 
a su capacidad de calcular y de fijar precios. A continuación, se ha analizado el 
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punto de vista del inversor, sus decisiones y la valuación de proyectos innovadores 
en el sector.  
Ahora bien, estos mercados vinculados con la nanomedicina, con su propia 
dinámica, generan externalidades que impactan en la sociedad, impulsando 
espacios políticos de discusión e interacción. Si bien el enfoque tecnocrático 
económico tradicional propone dar cuenta de estas externalidades incluyéndolas en 
los modelos como variables, estos desbordes exceden lo técnico e impulsan una 
discusión claramente política de los riesgos nanotecnológicos. Se presenta, 
entonces, una confrontación entre el enfoque tecnocrático abstracto que intenta 
cuantificar externalidades sociales por un lado, versus un enfoque político que 
propone un espacio de discusión por el otro. El siguiente capítulo analizará los 





3 Risk as a Co-Constituted Process 
Introduction 
In contemporary culture, risks are present in a wide range of practices and 
experiences (van Loon, 2000). The concept of risk is a topic widely debated among 
experts, politicians, philosophers, media professionals and the public in general. 
The rapid expansion of scientific, technological and medical knowledge advances 
has created a set of experts in the calculation, assessment and management of risk, 
additionally, public awareness of risk has also been influenced by the expansion of 
the media and the growth of new information and communication technologies. 
(Mythen, 2004). In social sciences, it is possible to identify four paradigms 
attempting to unpack risk in contemporary societies (Mythen, 2004). Firstly, 
inspired by the work of Mary Douglas (1966), there is an anthropological approach 
where differences in risk perception are explained by patterns of social solidarity, 
different worldviews and cultural values. Secondly, in the field of social 
psychology, psychometric paradigm has focused on individual cognition of risk 
(Slovic, 1987). Thirdly, the government's approach to risk has been addressed by 
Michael Foucault (Gordon et al., 1991).  
Fourthly, the risk society perspective led by Ulrich Beck (1992) has illuminated the 
pervasive effects of risk in everyday life. He argues that the process of 
modernization has created a unique collection of humanly produced risks (Beck, 
1999). This perspective has been very influential as a stimulus for academic, 
environmental and political dialogue (van Loon, 2000). The prospect of the risk 
society can discuss the constitution of risk and its effects on various social fields, 
enabling an analysis that extends the actuarial, financial or engineering risk 
protocol. From the hegemonic thought point of view, social production of wealth 
leads inevitably to risks, naturalizing it as part of social evolution. Modern culture 
proposes that been cautious is synonymous of failure, successful people have to 
take new risks to be innovative (Sennett, 1998). Consequently, many entrepreneurs 
were coming to the risky nano market aiming for future benefits. Clearly, in order 
to protect society from this new risk and from this risky investors, it is crucial the 
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intervention of the States. Besides, in a global financial system this race is beyond 
the control of each Nation-States, hence, it is necessary a multilateral agreement.107 
To analyses how this nanotechnological dynamics co-constitutes new risks, this 
chapter is divided in five sections. Firstly, several approaches to the problematic of 
risk are presented (Adam and van Loon, 2000; Mythen, 2004), with a particular 
emphasis on the society of risk approach (Beck, 1992). It conceptualizes nano risk 
as co-constituted both during the technoscientific practice as well as in the dynamic 
of the associated market. Secondly, it is also argued that the nano industrial 
dynamics have implications for its governance. From the point of view of the 
industry, uncertainty is taken as a constitutive part of the company’s decision 
process. In this chapter the traditional methodologies used for the valuation of 
investment projects are analysed, emphasising that they do not account for the 
complex dynamics of nanotechnology. To surpass this limitations, this work 
proposes the valuation methodology known as real options, which lets consider the 
uncertainty, flexibility, and irreversibility that exist in innovative nano projects 
(Trigeorgis, 1993; Kumaraswamy, 1996; Schwartz, 2013).  
Thirdly, the role of insurance companies - bounding, measuring, and pricing risks 
- and the risk evaluation process are examined, focusing on how experts calculate 
price without contemplating the impacts on society and without a clear 
understanding of the properties at nanoscale. It is important to create new standards 
to account for toxicity and for the effects of nano size. Fourthly, in the light of what 
was said on the previous sections, it is fundamental to take into account the voices 
of the different actors (non technoscientists) with respect to the use of 
nanotechnology in general and its medical applications on particular. Finally, last 
section it focuses on the role of public policies. In so doing, it presents two 
mathematical models. The first model allows for the quantitative evaluation of 
whether it is optimal to start a given project in accordance to the precautionary 
principle. The second quantifies the social benefits of two different kind of State 
incentives. This tools helps governments’ decision making process, quantifying 
costs and benefits. 
                                                 




3.1 Co-constitution of the Risk Society  
Risk society becomes visible when its threats are not covered by any type of 
insurance (Beck, 1992). While danger always existed, risks that arise from human´s 
decisions may exceed the insurability of the industry. In his book, Beck compares 
the current risk society with earlier stages of history (Sennett, 1998). 
Firstly, these risks are generated by humans: through government decisions, 
through the industry, through society as a whole, or through the choice of a lifestyle 
that carries certain risks. Secondly, these risk are global: they are not limited by 
traditional boundaries of industrial societies, nor are they limited to a certain place, 
nor to certain groups and confronts political institutions (Beck, 1999). Thirdly, 
these new risks present a challenge to the actuarial approach. In many cases, the 
probability of a catastrophic event tends to zero, but its potential loss tends to 
infinity, which collapses the traditional normative of financial institutions. Finally, 
the political institutions of modern societies can’t cope with these new types of 
emerging risks, because the responsibility is diluted108. 
Taken individually, each risk has a rational concrete cause, so it can be predicted, 
explained and managed. However, the society of risk presents itself as a 
cumulative, complex phenomenon that does not admit the individual management 
of each risk. This leaves us with three possible paths of action: denial , apathy or 
transformation (van Loon, 2002). The first two are inscribed in our modern western 
culture, on the contrary, transformation requires a new way of being that becomes 
a force for social change. Ulrich Beck (1992; , 2000) and Anthony Giddens (1991; , 
2003) call for social and political reform towards greater reflexivity to analyse the 
complex phenomenon of risk and society co-constitution. 
Policymakers gives the control of technological risks to the technicians, setting 
aside all participative practice, and building a discourse that narratively transforms 
                                                 
108 The described situation is known as organized irresponsibility (Beck, 1995 p 2). The risks of our society 
have a logic of inadequate distribution where the poorest are more exposed to risks, while the richest are able 
to avoid the dangers. A clear example is the recent European crisis of 2008, where those who suffer the 





potential risks into business opportunities109 (van Loon, 2002). In a certain way, 
this technocracy unwillingly produces a reaction of citizens groups that propose a 
globalization from the bottom, and that claims for an open and public debate (Beck, 
2000 p.37). This risk society offers us a game where the winner takes all the wealth, 
probably without risk, and leaves the emerging risks to the rest of society. 
3.1.1 A Reflexive and Democratic Process110 
 
The political awareness may be radically altered by the experience of a catastrophe; 
this gives us the opportunity to think about the transformation of the status quo. 
Ulrich Beck (2006) presents catastrophes as moments of involuntary 
enlightenment, that inspires survivors and forces them to reorder their priorities 
and beliefs. The challenge is to re-signify such catastrophic experiences to mobilize 
change, creating a sense of crisis to avoid further collapses. 
Clearly, the Fukuyima disaster leads us to rethink all the risks involved in 
innovative technologies. Although, what comes first is a collective panic against 
any use of technology and an overestimation of the precautionary principle, after a 
while it is important to make a thoughtful process that allows to propose and 
articulate protocols and regulations on the use of technology. Instead of the urgent 
reactions to crises that usually politician have, Seyla Benhabib (1986) raises the 
importance of analysing present contradictions, as they signal the path to a political 
practice that includes public participation. Political awareness can be radically 
altered by the experience of the catastrophe itself. 
From an interpretative perspective of reality, the crisis is a way to signify 
disappointments and failures, and reorient actions toward the future (Benhabib, 
                                                 
109 A clear example of this is the market for green bonds. It is intended to simplify the complex phenomenon 
of global climate change through a financial instrument that gives incentives to the third world to emit less 
carbon to the atmosphere in exchange for money. It tries to solve a global problem that involves all of us as 
humans, using a financial market that magically regulates incentives of economic agents. This policy prevents 
urgent reflection and reconsideration and, as a result, ultimately, contributes to the proliferation of new risks. 
110 The ideas of this section were born from Sarah Ambler’s presentation (Aston University) on January 16th, 
2009 in the event Future Ethics Workshop, A World Without Us? Imagining the end of the human. The author 






1986). The narrative of the crisis doesn’t describe a given reality, on the contrary, 
it describes moments of reflection, assessment and decision on the social 
conditions, and it should communicate the possibility of transformation, creating a 
space of opportunity and hope. 
The transforming function of a crisis has its greatest expression in certain traditions 
of traditional Marxist thought, where the revolution is set as the system that shows 
the contradictions of capitalism through a personal crisis. However, the reaction to 
the dominant ideology has many points in common with the populist policies that 
have proven so effective in the consolidation of conservative systems. For this 
reason, it is essential to contemplate demands, sentiments, and dissatisfactions 
generated by society111  (Benhabib, 1986). 
When evaluating these hypotheses, issues of equality must be considered. These 
ethical considerations urge policymakers to incorporate social welfare in their 
decisions and to achieve a smooth distribution of risk over time and space. León 
Olivé (2004) contrasts the expert risk assessment with the public perception of it. 
The technical model of risk assessment must be reconciled with democratic values, 
as the only way to identify and manage risks (Fiorino, 1990). In other words, if 
western democracy is understood as a partnership project based on common values, 
it is incompatible with a technocratic approach to risk management (Olive, 2004). 
Technological innovations are presented as a secure, with high expectations of 
future profits and with diffuse risks (and far away on the time axis). It does not 
seem evident the possibility of human suffering and global injustice that these new 
financial relations crystallize. Moreover, experts have imposed a premature 
normativism in recent decades globally, implementing improvised policies that 
consolidate differences, while failing to achieve the objectives they claim. These 
global policies consolidate the hegemony of certain power groups112. The public 
                                                 
5 On the other side, and in relation to global risks, in recent years, they have become important in the study of 
risks, ethical and democratic considerations. Kristin Shrader-Frechette (1991) and Leon Olive (2004) argue 
that the specialist should reflect to discover the social impact of your practice and courses of action consistent. 
It is essential to consider popular opinion when managing risks. Moreover, if a scientific method of calculation 
indicates that some hypotheses may be valid, it must be put into question the impacts that will arise from their 
acceptance.  
112 Against this reality, Benhabib (2002) proposes a deliberative democratic model that internalizes cultural 
controversy in institutions and other social organizations. While certain global rules are necessary, certain 
types of legal pluralism and citizen participation can occur in different regions. The author argues that 
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sphere is presented as the intertwining of various forms of association that interact, 
leading to an anonymous public conversation. This issue is taken up in the next 
chapter when it is proposed to account for this complexity with a sustainable and 
democratic governance. 
In summary, this work proposes that, instead of having a technocrat regulation 
designed by politicians, it is imperative to have an agreement of values that defines 
a new global ethics regarding the use of technologies. The society needs new rules 
for global economic and financial relations that does not harm certain social 
groups. This initiative implies; globalization of the political power, enforcing 
international cooperation and improving the international law. It is important that 
intergovernmental organizations, non-governmental organizations, democratic 
States, businesses and civil society have to be involved in the process. The active 
participation of citizens becomes a central point, since they vote for politicians, 
they are the consumers and they act through nongovernmental organizations. This 
new symbiosis between politics, business and civil society will allow a new 
governance that contributes to build a fair, sustainable and participatory society, 
achieving a symbiotic relationship between the rulers, civil society and business.  
3.1.2 De facto Nanogovernance  
The dynamics of the nanotechnoscientific practice and its market constitutes new 
risks. Given this, State´s policies are crucial to protect society and to promote a 
sustainable market. For example, in the US, the government started a program 
called Converging Technologies for Improving Human Performance (CTIHP), 
commonly referred as Nano-Bio-Info-Cogno (NBIC) (Roco, 2007). The 
nanoworld is modified to benefit governments, markets, societies, nations and 
human beings, which must adapt to the changing world. In the American literature 
on technological regulation, one of the most influential work is Responsive 
Regulation (Ayres and Braithwaite, 1992). The authors have a flexible approach 
and propose a pyramid of regulation which has self-regulation its base (soft law). 
                                                 
democratic equality and deliberative practices are necessary for new global institutional designs. Although 




When climbing a greater state intervention appears to reach the top, where it is 
strictly regulated (hard law)  (Bowman and Hodge, 2006). 
Unlike the American program, the European program Converging Technologies 
for the European Knowledge society (CTEKS) emphasises the creation of a 
knowledge society, guided by the precautionary principle113 (Echeverría, 2005; 
Klinke et al., 2006). An interesting case to analyse is that of the UK, where the 
institutions emerged from the Report of the Royal Society & The Royal Academy 
of Engineering (2004) and its subsequent developments (Rogers-Hayden and 
Pidgeon, 2008) are a clear example of hybrid regulation (Dorbeck-Jung, 2007).  
A new perspective regarding these issues is known as sustainable governance114. 
This concept extends the perspective of economic equilibrium, incorporating social 
and environmental concerns and it will be discussed in detail in the next chapter 
(Kemp et al., 2005). This form of risk management requires collaboration between 
technoscientists, market players, governments and general public in the process of  
innovation and in its diffusion (Renn and Roco, 2006). 
The question now is to understand these alternatives in the specific context of 
nanotechnology, a technique of general purposes that impact other industries; so it 
is necessary to analyse the categories of innovation proposed by Abernathy and 
Utterback (1978) and to differentiate between the product and the process, 
considering the presence or absence of nanoparticles in the final products (Laredo, 
2009). Consequently, it is essential to distinguish between embedded nano (where 
there are no political implications and they propose a functional approach to 
regulation), from enabled nano (where previous asbestos experience force to 
consider the full life cycle) (Abernathy and Clark, 1985). Moreover, regarding the 
processes, it proposes the implementation of workers’ safety standards and a 
protocol for safe intermediate goods circulation115. 
                                                 
113 Some authors propose a European prudential regulation, extending the scope beyond the purely economic 
(Dupuy, 2007; Dupuy and Greenbaum, 2004). 
114 In Europe, a group of social researchers from the Institute for Environmental Decisions have applied to 
understand the case of nanotechnology in Switzerland (Wiek et al., 2007). 
115 It also intends to explore the lessons of sociology of innovation and, in particular, to rethink the role of 
public authorities in shaping selection mechanisms (Delemarle et al., 2009), considering its global nature and 
its need for the learning processes. 
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While some studies analyse the impact of industrial activity in its governance 
(Meyer et al., 2009), only few authors dispute the impact of industrial dynamics in 
the direction of technological change (Robinson, 2009). In particular, Rafols et al 
(2011) argues that the specific features of industrial dynamics of nanomaterials 
have strong implications for their governance, because they are involved in shaping 
technology. The key issue in relation to industrial dynamics is that nanomaterials 
are not generally consumer goods; they are intermediate goods that are being used 
by other industries. Moreover, in many cases they allow innovation in traditional 
mass-production manufacturing processes, so its regulation is a complex challenge. 
Rafols et al (2011) notes the importance of three issues in the literature on 
nanotechnology. Firstly, nanotechnology is not a single concept, on the contrary it 
is a set of juxtaposed different technologies, summarizing the term is of no help for 
its efficient regulation (Rip, 2010; Doubleday, 2007; RCEP, 2008; Rip and Van 
Amerom, 2009). Secondly, there is uncertainty regarding the toxicity of 
nanomaterials, so these authors recommend the use of the precautionary principle 
(RCEP, 2008; Hansen et al., 2008). Thirdly, the discussion of the risks and benefits 
should focus on the innovation control process.  In other words, the proposal is to 
replace the traditional risk management approach with an efficient governance of 
innovations116 (Felt and Wynne, 2007). 
Today the market has a de facto governance117, that it is created by diverse actors 
with conflicting interests (Rip, 2010). In this market, the development of 
nanomaterials depends on interactions between multiple agents, and it is not 
controllable from a top-down regulation; on the contrary, Rafols et al (2011) 
proposes a bottom-up approach, accounting for interactions in the distributed 
system (Rip, 2010). They also argue that attempts to regulate must be interventions 
in the de facto governance to be effective. 
Even though benefits of nanotechnology would be effective in gene therapies, 
creating new surgical instruments and more accurate diagnoses. The lack of a 
                                                 
116 A governance of innovation seeks to influence technology decisions towards socially agreed targets. 
117 The proposal stresses that there is a governance even in the absence of explicit regulation because existing 
social networks facilitate or limit future technological developments. 
122 
 
complete knowledge precludes proper risk measurement118. Potential 
nanotechnology risks include the possibility of using it for terrorist purposes and 
some negative externalities on human health.  
3.1.3 Risk Co-constitution Process: From the Laboratory to the Market 
One of the first areas investigated by toxicologists is the damage caused by the 
inhalation of nanoparticles. In the report of the Royal Society & The Royal 
Academy of Engineering of the United Kingdom (2004), the authors argue that the 
greatest danger will come from the nanoparticles embedded in objects of mass 
consumption, due to the possibility of detaching and being inhaled119. These 
particles can cause damage and produce breathing difficulties in the long run. 
Moreover, nanotubes are highly resistant, so antibodies may die trying to dissolve 
them, increasing the tissue deposited in the lungs. Muller et al (2005) conducted a 
study which concluded that carbon nanotubes cause inflammation in the lung 
similar to the previous asbestos problem. Therefore, if these nanoparticles can 
cause similar response to asbestos inhalation in the short term, it is possible that 
they induce the same effects in the long term. 
A recent study introduced copper nanoparticles in mice and it concluded that the 
animals under study developed serious kidney and liver injury (Chen et al., 
2006)120. These nanoparticles are being used in a number of products that come 
into direct contact with the skin (clothing, cosmetics and sunscreen) and once 
absorbed through the skin (and come in contact with blood vessels), it has the same 
risk of intake (Monteiro-Riviere and Inman, 2006). 
The British government mentioned the unavailability of data on the potential 
negative impacts on the environment (The Royal Society & The Royal Academy 
of Engineering, 2004). Some nanoparticles, such as copper or silver, have proven 
to be harmful to aquatic life. They could be quickly absorbed by plants and soil or 
                                                 
118 Within the workshop Mapping out Nano Risks, held in Brussels on 1 and 2 March 2004, Goran Hermerén 
(2004) raised the discussion about the importance of an ethical approach to assessing the development of these 
new technologies and their consequences.  
119 There are strong similarities between inhalation of asbestos fibers in the past and possible inhalation of 
carbon nanotubes that appear today in various consumer goods. 
120 It is noteworthy that using copper microparticles the same effect was found, showing how different 
toxicological nano scale level. 
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be transported over long distances through the air or be suspended in the water. 
These studies warn us against the possible risks involved. In the UK it is allowed 
the use of nanoparticles in the environmental, but the Government encourages the 
industry to adopt a responsible approach. In the US, the Environmental Protection 
Agency (EPA ) recently published a White Book that set out its research needs (US 
Environmental Protection Agency, 2007). 
The constitution process of the nanotechnology industrial dynamics raises specific 
and general issues. On the one hand, the specific ones arise in each research process 
in its transition from the laboratory to industry. On the other hand, the general 
issues are those related with how these research projects are inserted on the 
scientific community and the society, and how they are forwarded, controlled, and 
governed. 
For example, particles of the same chemical composition have different properties 
according to their size. However, regulations on toxicity do not take this into 
account, it only accounts for its organic composition. This means that a substance 
can pass toxicity controls but, due to its nano size, be effectively toxic121. To take 
these effects into the discussion, Schummer (2007) suggests to define new 
standards and to do more research on the harmful effects associated with the size 
of the particles. Moreover, according to Schumer (2007), the central question 
revolves around the fact that nanotechnologies can cause damage to humans 
without being able to identify who was responsible. This requires a regulatory 
framework that specifies the responsibility of the manufacturers (Schummer, 
2007)122.  
Moreover, military applications also raise questions, since it is now possible to 
create a new range of biological and chemical weapons.  But beyond this collective 
concern, many military nanotechnology projects of this kind are secret and 
therefore fall outside the scope of society. This situation imposes a barrier to the 
                                                 
121 Furthermore, the fact that the properties change depending on the size makes the effect that certain 
applications are unpredictable for science that, at present, only takes into account the chemical composition. 
This goes hand by hand with the rapid dissemination of research-based manufacturing nano on an industrial 
scale because it is in this area where massively produce new materials with these new unpredictable properties. 
122 Indeed, the tools manufactured at the nanoscale have the ability to produce effects on humans without the 




development of a democratic governance. Additionally, several ethical issues arise 
in the field of biomedicine. On the one hand, the publicity (sometimes similar to 
science fiction movies) regarding the possibility of curing terminal diseases with 
gene therapies gives false illusions to patients. However, there is currently no 
scientific proof about its efficiency, so this propaganda can be detrimental to the 
evolution of these patients. On the other hand, professionals and medical 
institutions authority have been challenged by the possibility of self-healing nano-
devices. In addition, there is a risk of diverting resources now applied to therapies 
needed by patients to the improvement of the human race (Schummer, 2007).  
A further ethical issue is the progress of nanotechnology in developing countries, 
contributing to narrowing the gap between rich and poor. In this sense, there are 
many property rights barriers preventing open access to scientific information. It 
is a problem of regulation, since the rules of patenting are lax and unclear; implying 
that access to scientific progress is increasingly restricted for those outside the 
industrialised world.  
Hermerén (2004) proposes a problem analysis model that states that, before taking 
a decision, all relevant information available on the issue should be detailed, as 
well as the current regulatory starting points. As for the relevant information, it 
should account for the state of the art at the time of the various feasible alternatives 
and their consequences, and preferences of the different groups involved or 
affected by each course of action available. For his part, a regulatory point of 
departure should establish explicit and consistently ethical and cultural 
characteristics of the population involved, as well as their goals and values. For 
analysis, Hermerén used as a regulatory framework the principles of human dignity 
and integrity, autonomy, the duty not to harm and justice. 
According to the author, this model applies regardless the ethical approach 
(consequentialist or deontological)123. He also identifies the existence relevant 
problems that are relevant from any starting ethical point: the risk-benefit 
                                                 
123 The author identifies in its contribution two traditions. On the one hand, the consequentialist theory that 
establishes a correspondence between the moral value of a share and the value of the consequences of that 
action. Therefore, to decide on a certain action is necessary to assess their potential results. On the other hand, 
is the ethical tradition which states that the moral value of an action depends on whether such action is 
compatible with certain duties and rights based on religion, social contracts or natural rights. 
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evaluation, information and consent, privacy and integrity, costs and research 
priorities, fairness and justice and public confidence and transparency. As the risk-
benefit evaluations regards, Hermerén, identifies some difficulties: determining 
which actor is the most suitable to measure risks and benefits, which are its costs, 
how probable are they, and who is benefitted and who handicapped. Taking into 
account that evaluations are subjective and depend on who performs it, a correct 
risk and benefit evaluation would require a continuous flow of dialogue between 
the parts. 
3.2 The Dynamics of the Price Risk  
While corporate strategy is essential to assess the financial suitability of an 
investment, traditional methods do not take it into account. However, traditional 
methodologies are widely used by practitioners and they play a central role in 
corporate finance. They usually have three stages: 1) estimation of future cash 
flows generated by the project; 2) find an appropriate discount rate for each cash 
flow ; 3) estimate the initial cost of investment (Brealey and Myers, 2003)124. 
From the methodological point of view, investment projects involving research and 
development represent a challenge for its financial valuation since they include 
multiple sources of uncertainty. It is necessary to have a valuation model that take 
into account the learning process involved125, the uncertainty of the total cost and 
the uncertain time needed to develop the product (Pindyck, 1993). It is a learning 
by investing approach to innovations. 
Moreover, each stage of development is subject to exogenous adverse factors, such 
as technical, economic or political catastrophes. In other words, the expected future 
benefit is actual only after successfully completing the R+D process. These 
possibility of success, clearly, relates to the uncertainty of the project during its 
development, as both, commodity prices and the expected final price of 
                                                 
124 These methods are easy to apply, but have the disadvantage of not reflecting the complexity of social and 
economic phenomena involved in many investment projects.  
125 Initially, they were used analytical models used to value these projects come from financial derivatives, 
with the Black and Scholes formula paradigmatic example (Hull, 2009). However, regardless of the enormous 
importance of these analytical formulas for valuing real opportunities, lack of flexibility in the description of 




nanoproduct, fluctuate with the market. Moreover, each stage of product 
development has a significant probability of failure, which is associated with 
techno-scientific problems. Summing up, uncertainty prevents investors from 
knowing the duration and the possibility of success with certainty. 
This section introduces the concept of real options and analyse the impact of 
uncertainty in the definition of the optimal investment. At that point, this section 
identifies irreversibility as a key issue in many investments (especially in 
technological innovations). Finally, the basic model of Dixit and Pindyck for 
investment valuation under uncertainty are presented. 
3.2.1 Real Options 
Traditional valuation techniques are easy to use and allows, in simple and certainty 
contexts, make efficient investment decisions. However, if the investment decision 
is strategic or takes place in an uncertain environment, or their costs are 
irreversible, these techniques are not appropriated, due to their limitations. In 
particular, one of the traditional techniques utilised by practitioners is the net 
present value methodology126 (NPV). This valuation methodology ignores the 
flexibility of the investment and undervalue the investment (Brealey et al., 2009). 
Another method is the criterion of the internal rate of return127 (IRR), asking for 
choosing the project with higher IRR. The problem is that could exist multiple 
IRRs for the same project, so election process is confusing (Brealey et al., 2009). 
While the aforementioned limitations do not invalidate the use of traditional 
methodologies for analysing simple projects, it is necessary to note that in complex 
and uncertain situations, they become invalid.  
Overcoming the limitations of traditional methodologies, Real options allow an 
assessment of the investment options in all markets, either with complete or 
incomplete information. This method recognizes market flexibility and learning 
dynamics. Many studies suggest the integration of real options with the NPV. Has 
                                                 
126 This tool is also known as the rate of return of discounted cash flow (DCF). It is obtained as the discount 
rate that makes the NPV equal to zero. The criterion of this tool is to accept an investment project when the 




been Trigeorgis (1993) which has quantified this approach, saying that the NPV of 
investment in assets equals the sum of its traditional NPV and its real options. 
Moreover, often the adoption of real options in R&D projects encourages long term 
investment (Kumaraswamy, 1996; Brealey et al., 2009).  
In his original work, Black and Scholes (1973) provided a framework for the 
valuation of a common case in finance, European options. After a few years, Myers 
(1977) proposed to analyse investments in real economy assets, using the concept 
of financial option. A real option is defined as the right (with no obligation) to 
conduct any business decision (usually an option to make an equity investment in 
a project) (Brealey and Myers, 2003). 
Dixit and Pindyck (1994) argued that the investment decisions have three essential 
features that requires real options for its valuation. Firstly, investments are mostly 
irreversible (total or partial), and its capital costs are sunk. Secondly, there is 
uncertainty about the future return on investment; future prices of assets are 
unpredictable, so future benefit flows are uncertain. Thirdly, investors have the 
option of waiting for better information about future prices.  
The literature on these issues is vast, but several items listed as essential reference 
in this field. The seminal work of McDonald and Siegel (1986), Pindyck (1991), 
Trigeorgis (1996) presents the basics of this method, using dynamic programming 
techniques. On the other hand, in the classical theory of real options, Brennan and 
Schwartz (1985) and Trigeorgis (1993) referred to the valuation of the investment 
opportunity as an integrated set of real options128 (Insley and Wirjanto, 2010).  
3.2.2 Optimal Investment in Uncertain Contexts 
This subsection focuses on understanding the impact of uncertainty in the optimal 
investment decision. Faced with a new business project in uncertain contexts, 
investors need to establish the optimal level of investment that balance current 
                                                 
128 In other words, the flexibility of an investment is what generates the value of real options, increasing the 
valuation of a project. Usually , this added value can be conceptualized as asset net present value, which is 
defined as the sum of net present value and the actual value of the associated option (Brealey and Myers, 2003; 




costs and future returns. To analyses this problem this thesis proposes the dynamic 
programming perspective (Abel and Eberly, 1994). There are two main channels 
through uncertainty impacts on the dynamics of investment and capital 
accumulation. The first reflects the nonlinearity of the operational benefits over the 
variables that characterize the uncertainty, the Hartman (1972) Abel (1983) and 
Knight (1991) effect, known in the literature as HAC. The second reflects frictions 
in capital adjustment, summarized in different forms of capital adjustment costs 
(Bulan et al., 2009). 
Following the literature mentioned, the problem of maximizing the performance of 
a project is formalized by controlling investment. To analyse this, an economy is 
postulated where there is a risk-neutral business that must decide the level of 
investment I optimum, so as to maximize the current expected value of future 
profitability π (minus its cost), subject to a given capital dynamic (K) and changes 
in an exogenous stochastic variable Z. Using the concepts of dynamic 
programming we can express the problem as follows (Dixit and Pindyck, 1994): 
 
 𝐹(𝐾(𝑡), 𝑍(𝑡)) = max
𝐼𝑡
( 𝜋(𝐾(𝑡), 𝑍(𝑡))
− 𝐶(𝐾(𝑡), 𝐼(𝑡)) + 𝑒−𝜌𝑑𝑡 𝐸𝑡(𝐹(𝐾(𝑡 + 𝑑𝑡), 𝑍(𝑡 + 𝑑𝑡))) ) 
(3.1) 
s.a. 
𝑑𝑍(𝑡) = 𝑓(𝑍, 𝜇, 𝜎) 
𝑑𝐾(𝑡) = 𝑔(𝐾, 𝐼, 𝛿) 
where ρ is the discount rate and δ the depreciation rate of capital (Wu, 2009).  
The cost function presented depends on the level of capital and investment  
𝐶(𝐾(𝑡), 𝐼(𝑡)) . It includes both, costs of direct purchase of capital goods and costs 
associated with capital adjustment. These costs are a convenient way to model the 
friction, delaying the response to updated information about profitability  
(Caballero, 1991). Moreover, convexity of the cost function requires that the 







While there is agreement in the literature regarding this equation, literature is 
divided about this cost function shape. While one group of authors (HAC), assumes 
that the first derivative respect to capital is zero. Another group, belonging to the 
macroeconomic studies on growth, assumes that the cost function is linearly 
homogeneous respect to investment and capital, for example Lucas y Prescott 
(1971) and Abel (2003). 
If the cost function 𝐶(𝐾(𝑡), 𝐼(𝑡)) is convex and profit 𝜋(𝐾(𝑡), 𝑍(𝑡)) is linear, the 
proposed objective function is concave . This ensures the existence and uniqueness 
of the solution to the problem. For the profit function 𝜋(𝐾(𝑡), 𝑍(𝑡)) to be lineal it 
is necessary to assume perfect competition in both factors and homogeneous 
technology and lineal, being formally expressed by (Wu , 2009): 
 
 𝜋(𝐾(𝑡), 𝑍(𝑡)) = max
𝐿(𝑡)
[𝑝(𝑡) ∗ 𝐾𝛽(𝑡) ∗ 𝐿1−𝛽(𝑡) − 𝑤(𝑡) ∗ 𝐿(𝑡)]
= ℎ(𝑍(𝑡)) 𝐾(𝑡) 
(3.2) 
It is important to note that the function ℎ(𝑍(𝑡)) is convex, since that, for a given 
capital stock, once resolved the uncertainty, the company can adjust after for 
compensate labour (Varian, 1992). This problem of substitution effect between 
capital and labour was highlighted by Hartman (1976). The convexity of operating 
income compared to the uncertainty, ensures a positive relationship between 
uncertainty and the expected investment, due to Jensen's inequality (Abel, 1983). 
This result is generalized by Caballero (1991) and are summarized in the literature 
as the Hartman-Abel-Caballero effect. 
Conversely, if the cost function 𝐶(𝐾(𝑡), 𝐼(𝑡)) is linear, π (K (t), Z (t)) has to be 
concave respect to K to ensure the existence of one only solution. It was set into a 
model by Pindyck (1988), and it was assumed each unit of capital can produce one 
unit per period time; together with the requirement of an inverse price-quantity 
relationship, ensures the concavity of the operating profit. To assess these effects 
in next subsections, all model parameters remain constant except the volatility 




3.2.2.1 Impact of uncertainty in the short term 
Most studies have focused on the effects of uncertainty in the level of investment 




and Helliwell, 2012). To avoid analysing an instant effect, several authors, 





However, either formulations assume that the Z(t) process is constant, which is not 
true since a variation in volatility stochastic process changes the distribution of 
Z(t). To compensate for this effect, empirical studies use the following relationship 




In other words, this expression analyses how a change of volatility impact on the 
responsiveness of investment to changes in 𝑍(𝑡). 
While in contexts of certainty a critical value exists, which separates the investment 
decision, under uncertainty, on the contrary, there is a range where the optimum 
means wait. In particular, it is important to note that the volatility of 𝑍(𝑡) increases 
the range of inaction where it is optimal to continue analysing the project rather 
than invest with uncertain consequences. To recognize the impact of uncertainty 
turns investors more cautious. Moreover, Bloom et al (2007) showed that under 
irreversible investments, increased uncertainty reduces responsiveness of the 
investment to changes in demand. 
 
3.2.2.2 Impact of uncertainty in the long run 
Despite the importance of setting short-term capital, the stock capital is what 
ultimately causes the production and creates value in the company. Therefore, it is 
important to analyse the effects of long-term uncertainty on capital. Abel (1984) 
presented the first work129 where explicitly the effects of uncertainty on the 
                                                 
129 The author uses a process of mean reversion to model Z (t). 
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expected long-term capital (assuming convex costs of adjustment) are studied. The 






For its part, (Abel and Eberly, 1999)130 separating the capital stock from 
irreversible investments (𝐾𝐼(𝑠)), the one who is related to reversible projects 








This subsection clearly showed the effects of uncertainty on the short and long term 
investments. It is now necessary to analyse how it affects the valuation of these 
investments (Abel and Eberly, 2012). 
3.2.3 The Valuation of Irreversible Investments 
 
Past century literature on investment projects valuation had highlighted two of its 
most important features. Firstly, these projects required irreversible investments, 
with sunk cost. Secondly, investors expected new information about prices, costs 
and other market conditions before committing resources131. Moreover, the 
irreversible nature of the investment is deeply exposed to different risks. In 
particular, with respect to the flow of future profits, interest rates involved in the 
calculation and the final cost of the investment (Pindyck, 1991).  
Irreversibility arises because the capital involved in the project cannot be used 
productively in other investment. For example, a petrochemical plant is specific 
for use in the relevant industry, and can only be used to produce petrochemical 
items. If demand for products in this sector falls, the market value of the plant 
decreases. Clearly, investment in the plant should be seen as a sunk cost at least 
                                                 
130 The authors modelled Z(t) as a random walk. 
131 Ben Bernanke (1983) has developed a model where companies have an incentive to delay irreversible 
investments, so they can wait for further information. However, the author assumes that this information 
reduces future uncertainty, while this paper focuses on the situations in which new information is coming, but 
the future is always uncertain. 
132 
 
partially (reversible can be taken as the value of the land, for example). Another 
source of partial irreversibility is infrastructure investment, for example, office 
furnishing, computers or automobiles. These items have a low resale price instantly 
after the purchase. 
The concept of irreversibility restates the theoretical foundation of standard 
neoclassical investment models, while invalidates the net present value rule. 
Investment makes it particularly sensitive to uncertainty over future product prices 
and operational costs132 (Mason and Weeds, 2010). 
From a mathematical modelling point of view, an irreversible investment 
opportunity is similar to a financial call option. The latter gives the holder the right 
(not the obligation) to buy an asset at the strike price during a specified future time. 
In the real economy a company with an investment opportunity has the option of 
spending money (similar to the financial strike price) now or in the future, in return 
for an asset (for example a project) of any value. As is the case of the financial 
derivatives market, the choice of the company to invest is valuable in part by the 
future value of the asset that the company gets through investment remains 
uncertain. If the asset increases in value, the profitability of the investment rises. 
On the contrary, if it falls in value, the company does not invest, and it only loses 
what they paid for the investment opportunity initially. Often these investment 
opportunities are not purchased, but arise from the management of the company 
(technological knowledge, reputation, market share)133.  
A company that put money in an irreversible project, decides to exercise its option 
to invest. It causes a loss that should be included as part of the cost of the 
investment. Recent studies have shown that this opportunity cost can be large, and 
suggest that traditional valuation methodologies ignore it134. In addition, this 
opportunity cost is very sensitive to future uncertainty. Changes in economic 
conditions affect the perceived risk of future cash flows and have an important 
impact on investment spending and may be greater than a change in interest rates. 
                                                 
132 From the perspective of macroeconomic policy, this means that if the aim is to encourage investment, 
reduce institutional uncertainty may be much more important than the direct tax incentives. 
133 The importance of real growth options as a source of value for the company is detailed in Myers (1977) 
and Kester (1984). 






If the future value of the project is uncertain and requires an initial sunk cost, an 
opportunity cost of investing is created, opening a gap between the current value 
of the project and the direct cost of the investment. This creates an opportunity cost 
of closing the project (value could increase in the future). A clear example of this 
is the valuation of mining projects in which there are sunk costs (Brennan and 
Schwartz, 1985). The mine is subject to landslides and floods when it is not in use, 
so a temporary closure requires incurring in sunk costs to avoid damages and to 
reopen, also a considerable expenditure could demand. Sunk costs of opening and 
closing a mine can explain the observed hysteresis. In other words, when 
entrepreneurs face low prices, they decide to continue to put unprofitable deposits 
knowing that operation will open again in the future. Dixit (1989) formalized it: if 
there are opportunity costs to enter to investment, it increases the critical price at it 
is optimal. Moreover, companies that had entered into an industry when the price 
was very high, tend to stay there for a long time, even if prices drop below variable 
cost (Park, 2012). 
3.2.3.1 Sequence of investments 
Many investment projects require several stages before a product is ready for the 
market. For example, investment in a pharmaceutical drug begins with research in 
the laboratory, aiming to obtain a new compound to be tested. Numerous tests are 
performed until the final approval of the government agency responsible for 
regulating drugs. Only after that approval, the production plant is prepared and, 
when final product be ready, it will sell to users. The whole project may last up to 
ten years. 
These sequential projects could also result in abandonment in the halfway, if the 
value of the final product decreases or increases the expected investment. 
Therefore, these investments can be seen as compound options; each stage 
completed gives the company an option to complete the next step. Majd and 
Pindyck (1987) propose a model in which a company invests continuously to 
complete the project. The authors propose that investment can be stopped and 
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restarted at no cost, imposing a maximum rate at which money can be incorporated 
into the project. High volatility increases the opportunity cost of waiting and also 
reduces the expected rate of growth of the project value for investment, so the 
expected return is reduced to complete. However, sequential investment often 
occurs in discrete steps, so to find the optimal investment rule, investor must 
perform retrospective induction to make an optimal decision (Hachicha et al., 
2011). 
Learning 
As discussed so far in this thesis, futures prices are always uncertain. However, in 
some sequential investments, early stages provide information relevant for later 
ones. For example, investments in research and development determine the 
efficacy and side effects of the drug and therefore its value.  
In particular, Roberts and Weitzman (1981) developed a model that considers 
sequential investment while learning, information in each stage reduces future 
uncertainty. The fundamental assumption of the model is that prices and costs do 
not evolve stochastically; you learn while you invest. The expenditure made in the 
early stages can gather information, adding value, increasing the information. 
Although net present value of a project is negative, it may be wise to invest in the 
early stages to lower uncertainty and achieve, in the future, a profitable project. 
Using this methodology, Weitzman, Newey, and Rabin (1981) evaluated whether 
to build pilot plant for the production of synthetic fuel plants, concluding that 




So far, we have examined the decisions to invest in new projects that require a 
certain amount of investment to carry forward. However, much of the economic 
literature studies the incremental investment. That is, companies invest just to 
equalize the marginal cost of capital to the present value of expected revenues 
(Merton, 2012). 
                                                 
135 There is debate about the role of government in these matters, particularly if subsidies for pilot plants are 
justified. These issues are discussed in Joskow and Pindyck (1979). 
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This problem was studied initially by Manne (1961). He showed that, in the context 
of economies of scale, uncertainty about demand growth implies an increase of the 
optimal size of investments, incrementing the present value of the expected costs. 
Many times, the choice of the size of the production plant, carries a choice on which 
technology to use.  
In his work, Pindyck (1988) determines, at the same time , the optimal level of 
capital and choice regarding the technological flexibility (Baker and Adu-Bonnah, 
2008). In particular, he developed a model that takes into account the possibility of 
incremental investment in a context of irreversible projects. In his model, the 
company had a stochastic demand, and he showed that, in the context of high 
demand uncertainty, it is optimal to have smaller capital. However, although a 
priori, this is not intuitive, the market value of the company rises136. 
As mentioned in the previous section, Hartman (1972) notes that in the case of a 
competitive company which combines capital and labour with a linear 
homogeneous production function, the uncertainty increases investment demand. 
Moreover, Abel (1983) extended the result of Hartman to a dynamic model in 
which the price follows a geometric Brownian motion with convex adjustment 
costs of capital. The author agreed with Hartman to demonstrate that the 
uncertainty increases the rate of investment in the company. Finally, following this 
line of argument, Caballero (1989) presented the asymmetric adjustment costs to 
allow irreversibility and showed that higher price uncertainty increases the rate of 
investment. However, it assumes constant returns and perfect competition, making 
the performance of the marginal product of capital, regardless of the current stock.  
The papers presented in this section, especially Pindyck (1988) clearly argued that 
the level of uncertainty is the most important investment determinant. It assigns an 
undeniable relevance for the design of public policies. Particularly, Ingersoll and 
Ross (1992) have examined irreversible investment decisions on projects where 
the interest rate evolves stochastically, but future cash flows are uncertain. With 
uncertainty about future cash flows, it creates an opportunity cost of investing.  
                                                 
136 The idea that uncertainty about future demand may increase the value of a marginal unit of capital is not 




Unlike the traditional method of present value, investment should be made only 
when the interest rate is below a critical rate, which is lower than the IRR. 
Moreover, the difference between these rates increases as the volatility of interest 
rates increases. Cox, Ingersoll and Ross (2012) suggested that the level of interest 
rates is less important and its volatility determines aggregate investment. It implies 
that to stimulate investment, stability and credibility may be more important than 
tax or interest rates incentives (Pindyck, 1991). 
3.2.4 A Basic Model of Investment Valuation under Uncertainty 
This subsection presents an elemental model for the valuation of investments under 
uncertainty. Firstly, an example where the use of the net present value (NPV) 
methodology can lead to a sub optimal investment decision is given. Then, an 
investment model in certain context is presented and compared with the basic 
methodology for the valuation of investment in uncertain contexts attributed to 
Dixit and Pindyck. 
3.2.4.1 Example: the value of wait 
The next example shows that sometimes the traditional NPV criterion can lead to 
mistaken decisions. The starting point is a project that contemplates two future 
scenarios, each one with a 50% probability. The first one produces a net benefit of 
$8 per period forever, the second one $24 in the same conditions. A discount rate 







∗ 0.5 = $320 







∗ 0.5 − $200 = $120 > 0 
Because NPV is positive, the decision rule indicates that the investment should be 
made at the initial moment because it is profitable. What would had happened if 
the investor waits till the second period to decide the investment? Clearly on the 
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one hand the first payment is lost, on the other hand we are certain about what the 
future payments are about. Clearly there are two possible outcomes at time 2: 
 




− $200 = −$40 < 0 




− $200 = $280 > $120 
This exercise shows clearly that waiting is valuable, investors could avoid 
unprofitable investment. This aggregate value for waiting is denominated by the 
literature as the value of the option (in obvious reference to the financial options) 
(Brealey et al., 2009; Brealey et al., 2009).  
3.2.4.2 Valuation under certainty 
This subsection presents a model of valuation under certainty, the value of the 
completed project is known for sure. The investment decision allows to terminate 
the project if necessary and to maximise firm’s value. Let us consider an 
investment in a project where termination cost is 𝐶 is a constant, the investment 
rate is I (with a maximum value, 𝐼𝑀𝐴𝑋) and the duration of the project is. After the 
project is completed, the firm receive an asset valued 𝑉. Knowing the duration of 
the project,  T =
C
𝐼𝑀𝐴𝑋
, the opportunity to invest 𝐹(𝐶) is given by (He and Pindyck, 
1992): 
 
𝐹(𝐶) = 𝑚𝑎𝑥 [𝑉 𝑒
−𝑟
𝐶
𝐼𝑀𝐴𝑋 − ∫ 𝐼𝑀𝐴𝑋 𝑒





Where 𝑟 is the free-risk rate. 
Solving the integral and reordering, F is: 









 ; 0} 
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The optimal investment rule is: to continue the project if 𝐹(𝐶) > 0 (𝐶 < 𝐶*). To 
calculate optimal cost 𝐶*, we must find the value of 𝐶 that makes the first 
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  (3.4) 
The value of 𝐶∗ represents the maximum value that can be rationally accepted as 
the total true cost of an investment; if it is higher, the project should not be 
continued. 
3.2.4.3 The Dixit-Pindycks´ methodology 
McDonald y Siegel (1986) wrote a model that analysed in which moment it is 
optimal to invest, receiving at exchange a project whose value is 𝑉 (which evolves 
in accordance with a geometric Brownian motion). The investment opportunity is 
equivalent to what is known in financial engineering as perpetual buy option. The 
decision to invest is equivalent to decide when to exercise this option. Pindyck 
(1991) presented a simple models for irreversible investment using dynamic 
programming. 
The value of an investment project could be modelled as a geometric Brownian 
motion and mathematically be represented by: 
 𝑑𝑉(𝑡) = 𝛼𝑉(𝑡)𝑑𝑡 + 𝜎𝑉(𝑡)𝑑𝑧 (3.5) 
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In this case, the investment decision consists in choosing the optimal moment to 
invest 𝐼 (and start the project). Assuming a discount rate 𝜌, the Bellman equation137 
for this problem is: 
 𝐹(𝑉(𝑡)) = max ( 𝑉(𝑡) − 𝐼 ,   𝑒−𝜌𝑑𝑡 𝐸 (𝐹(𝑉(𝑡 + 𝑑𝑡))) ) (3.6) 
The proposed methodology transforms it into a stopping problem. In fact, there 
exists a critical value 𝑉∗ that separates the region where it is optimal to wait 
(𝑉 < 𝑉∗) from the zone where stopping is the best choice. 
If 𝑉 < 𝑉∗  ⇒     𝐹𝐸(𝑉(𝑡)) =   𝑒
−𝜌𝑑𝑡 𝐸 ( 𝐹𝐸(𝑉(𝑡 + 𝑑𝑡))) 
If 𝑉 > 𝑉∗  ⇒   𝐹𝐷(𝑉(𝑡)) =  𝑉(𝑡) − 𝐼  
If 𝑉 = 𝑉∗   ⇒   𝐹𝐸(𝑉
∗) =  𝐹𝐷(𝑉




(V∗) =  
dFD
dV
(V∗)  (Continuity of F derivative) 
Also, it requires that FD and FE compliances with monotonicity condition. 
 
                                                 




3.1. The value of the waiting option of 𝑉 
 
In the region where it is optimum to wait: 
 𝐹𝐸(𝑉(𝑡)) =   𝑒
−𝜌𝑑𝑡 𝐸 ( 𝐹𝐸(𝑉(𝑡 + 𝑑𝑡))) 
Multiplying both members by   𝑒𝜌𝑑𝑡 : 
   𝑒𝜌𝑑𝑡 𝐹𝐸(𝑉(𝑡)) = 𝐸 ( 𝐹𝐸(𝑉(𝑡 + 𝑑𝑡))) 
Subtracting 𝐹𝐸(𝑉(𝑡)): 
(𝑒𝜌𝑑𝑡 − 1)𝐹𝐸(𝑉(𝑡)) = 𝐸 ( 𝐹𝐸(𝑉(𝑡 + 𝑑𝑡)) −  𝐹𝐸(𝑉(𝑡))) 




𝐸 ( 𝐹𝐸(𝑉(𝑡 + 𝑑𝑡)) −  𝐹𝐸(𝑉(𝑡)))
Δ𝑡
 





On the other hand, as we know that V follows a geometric Brownian motion, we 
can write  𝑑𝐹𝐸(𝑉) using the Ito lemma: 






2𝑉2) d𝑡 +  𝐹′𝐸(𝑉)𝜎𝑉 𝑑𝑧 
The expectation is: 






















𝜎2𝑉2 𝐹′′𝐸(𝑉) +  𝛼𝑉𝐹
′
𝐸(𝑉) − 𝜌𝐹𝐸(𝑉) = 0 
(3.7) 
s.t.    𝐹𝐸(0) = 0, 𝐹𝐸(𝑉
∗) = 𝑉∗ − 𝐼 , 𝐹′𝐸(𝑉
∗) = 1 
The proposed solution takes the form 𝐹𝐸(𝑉) = 𝐶 𝑉




𝜎2𝛽(𝛽 − 1) + 𝛼𝛽 − 𝜌 = 0 
With two roots 𝛽1 > 1  and 𝛽2 < 0. 
𝐹𝐸(𝑉) = 𝐶1 𝑉
𝛽1 + 𝐶2 𝑉
𝛽2 
The restriction 𝐹𝐸(0) = 0 means that the term with the negative exponential must 
vanish, so 𝐶2 = 0. 



















The critical value 𝑉∗ separates the region where is optimum to wait (𝑉 < 𝑉∗) from 
the region where it is convenient to abandon the project. 
3.2.5 Schwartz´s Model for the Pharmaceutical Industry 
 Inside the universe of technological projects, this work focuses on those that 
involve mobilizing a great quantity of resources in research and development 
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activities, and are, therefore, highly strategical. The real options methodology is 
the most adequate because it allows for the explicit modelling of the strategical 
activity and the involved uncertainty. This methodology extends the traditional 
static vision through a dynamic multi-period process. At the same time, it 
incorporates the idea that businesses actively manage their investment 
opportunities, adapting their investment strategies as the uncertainty resolves itself 
as time goes by. 
In the context of the pharmaceutical industry Schwartz (2004) model is an example. 
The author developed a numerical model for the valuation of R+D projects 
protected by patents. The innovation in the pharmaceutical industry proposes a 
debate over the public policies referred to the financing of their research costs, over 
the determination of price levels, and on the social optimum regarding the use of 
patents. In particular, the developing of drugs is a lengthy process (10 years or 
more), and it is fundamental to take into account the uncertainty in its costs and the 
future income. Even more, once the project is approved, there is uncertainty over 
sales and the cash flow that those may generate. 
This section overviews some aspects of the valuation of pharmaceutical projects 
proposed by Schwartz (2004); it uses a discrete simulation focus to determine the 
value of the R+D project, using the real options methodology. An uncertain context 
is assumed where key variables of the valuation, such as the cost to finish each 
stage of the project, the future flows of cash, and the possibility of an adverse effect 
(technical, economical, legal, or political) intervenes in the possibility of not 
finishing the project, are stochastic. The strategic decision of abandoning the 
project when the costs are greater than expected or when the estimated flow of cash 
is less than expected. 
Formally, it is proposed to valuate to valuate R+D projects through a simulation 
based on a discrete real option focus that contemplates the uncertainty in costs, the 
flow of cash, and the possibility of catastrophic events that may endanger the 
possibility of finalizing the project. It is also allowed to abandon the project when 
the actual costs are greater than the expected costs, or when the estimated cash 
flows are lower than expected (Schwartz, 2004).  
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Considering that the investment is realized through time, it is assumed that there 
exists a maximum investment rate (𝐼𝑚) and that as the funds enter the project, the 
remaining cost to complete it (𝐶) is reduced. This cost is considered a random 
variable. On other order of things, it is frequent that a project may fail and not be 
able to reach completion, because of this a Poisson probability of project failure is 
assumed; if the project fails, its value is zero. At a strategical level, the investor 
counts with the possibility of abandonment, which he will use when the cost result 
greater than expected, or the flow of cash lower than expected. At last, when the 
project is finalized, the proprietor starts receiving the benefits of the investment, 
represented by a rate of net cash flow 𝐵 (modelled as a stochastic process). 
With respect to the investment costs uncertainty, the author postulates that the 
remaining costs follow a dynamic described by a diffusion process of the form: 
 𝑑𝐶 = −𝐼𝑑𝑡 + 𝜎(𝐼𝐶)1/2𝑑𝑧 
(3.10) 
 The first term of the process refers to the control of the diffusion process; as the 
investment advances, the estimated remaining cost to finish the process decreases. 
The second term corresponds to what Pyndick denominates technical uncertainty, 
and is related to the physical difficulty associated with the completion of the 
project, where 𝑑𝑧 is the increment of a Brownian motion. 
On the other hand, the dynamic of the future flow of net benefits is modelled from 
a geometric Brownian motion given by: 
 𝑑𝐵 = 𝛼𝐵𝑑𝑡 + 𝜎𝐵𝑑𝑤, 
(3.11) 
Where 𝑑𝑤 is the increment of a Gaussian Weiner process, correlated with the 
market portfolio and which can also be correlated with the expected cost. The 
correlation between the costs and the cash flows signify simply that costs that were 
greater than expected reduce the expected future cash flows (is because of this that 
the correlation may be assumed to be negative). Something to take into account is 
that this flows are only perceived once the investment is completed, so flows may 
change as the uncertainty related to the project is decreased during the investment. 
Altogether, in order to observe the effects of valuation before a neutral risk, the 
author suggest the following risk adjusted flow expression: 
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𝑑𝐵 = (𝛼 − 𝑒)𝐵𝑑𝑡 + 𝜎𝐵𝑑𝑤 = 𝛼∗𝐵𝑑𝑡 + 𝜎𝐵𝑑𝑤 
Where 𝑒 is the risk premium associated with the process. 
Lastly, when the project investments have been completed, the value of the project 
will depend on the future cash flows to be generated. Let 𝑉(𝐵, 𝑡) be the value of 
the project at time 𝑡, with cash flows 𝐵 and assuming that the patent of the project 
expires at the moment 𝑇. There is a residual value of the project as well, 
represented by the cash flow generated after the patent has expired: 𝑀 𝑥 𝐵. 




∗𝐵 𝑉𝐵 + 𝑉𝑡 − 𝑟𝑉 + 𝐵 = 0 
(3.12) 
Subject to 𝑉(𝐵, 𝑇) = 𝑀. 𝐵 
Before the investment is completed, the value of the project R+D, 𝐹(𝐵, 𝐶, 𝑡), 
depends on the projected cash flow rate (which is only effective if the project is 
completed), the remaining cost, and time. Altogether, this value must satisfy the 






𝜎2 𝐼 𝐶 𝐹𝐶𝐶 + 𝜑𝜎 𝜌 𝐵 √𝐼 𝐶 𝐹𝐵𝐶 +  𝛼
∗𝐵 𝐹𝐵 − 𝐼 𝐹𝐶 + 𝐹𝑡 − (𝑟 − 𝜆)𝑇 − 𝐼 = 0 
(3.13) 
Subject to 𝐹(𝐶, 0, 𝑡𝑒) = 𝑉(𝐶, 𝑡𝑒) 
The difficulty inherent to the frontier condition is that the investment realization 
date (𝑡𝑒) is a random variable. The value of the R+D project at the time of 
completion depends not only on the cash flows at that time, but also on the duration 
of the investment (because the duration of the cash flows finish with the expiration 
of the patent). 
The basic model exposed can be extended to satisfy the characteristics present in 
the pharmaceutical market, where the project is realized in two stages. The first 
stage comprises the search for a chemical compound that generates the wished 
effect, and a second stage that must insure that that the compound found is effective 
and safe to use on humans. 
145 
 
The development process of drugs is a sequential process; because of this it is 
imperative to detail at which time the investor may leave the project. This decision 
will depend on different factors, such as: potential beneficial therapeutic benefits, 
the expected frequency and severity of adverse reactions, marketing and logistics, 
production costs, and the estimation of future income. In this way, once the 
compound is a strong candidate, it must be presented before the FDA; thirty days 
after this presentation, clinical trials must begin on humans. These trials are 
produced during three different stages: the first stage of the trials is done on a small 
group of (generally) healthy people, and it’s done basically to obtain the degree of 
toxicity and dosage security on humans. On stage II, the drug is administered on a 
bigger group of people which are considered to need the drug for a posterior 
recovery. On stage III the drug is administrated massively so as to find the 
definitive efficacy graduation, and possible adverse reactions. Once the clinical 
phase is completed and it is considered that the drug will be approved, it is 
presented before the FDA for approval, so the FDA’s revision may be regarded as 
a fourth stage of the project’s cycle138.  
3.3 Delimiting, Measure and Price Risk  
As was mentioned on the first chapter, the insurers are private actors that, even 
when looking its economical benefice, pressure governments for greater 
regulation. Clearly a meagre regulation endangers the solidity of this companies. 
To face the problematic of bounding, measure, and price risk, the first part of this 
section will analyse the problematic of nano risk measure. The second focuses on 
the specific role of insurers. Lastly, a concrete example where the industry 
evaluates nano-materials risk is detailed. 
                                                 
138 The simulation focus of the model proposed by (Schwartz, 2004) can be adapted to different investment 




3.3.1 Nano Risk Measurement 
 The possibility of establishing clear rules and a quantifiable punishment for the 
non-observance of this institutions is limited by the weakness existent in risk 
evaluation. This is the starting argument from Françoise Roure (2004), who 
sustained, in the Brussels’s nanotechnological workshop, the already mentioned 
hypothesis that financial risk evaluation models supply with the institutional 
framework necessary to face its main problems139. 
A first approach in this line is being carried by the European Union whose 
parliament approved in 2004 a resolution on corporative governance and financial 
services, a ruling that supports the initiative of the European Commission in 
establishing the collective responsibilities in the short term and promotes the 
advancement towards the outline of individual responsibilities140. 
Regarding the organizations with good reputation, they should articulate the 
variety of nanotechnological methods and principles, with its potential benefits and 
risks. In relation to the research, it should be widely financed and develop models 
of communication and information for the incorporation of public debate. The 
government should increase the financing to know the consequences of nano-
structures on health, and the environment, revise the current regulatory framework, 
and develop communication strategies to keep the public informed. In addition, it 
should develop training programs to alleviate the scarcity of human resources and, 
together with the private sector, it should anticipate risks and mitigate them. 
Finally, the educative system should advance on work, training, and trans-
disciplinary experience models, on the development of critic thought, and the 
relation between social sciences and technology. 
Of what was previously said, some results follow. On one hand, scientific 
knowledge and technical advance are governance’s instruments, where what 
matters is not the goal but the means, the innovation. Different countries have 
heterogeneous agendas which, in time, have consequences on the international 
                                                 
139 In effect, Roure (2004) expresses that both investors and insurers have the right and the duty to evaluate 
and announce the financial risks involved on its contractual relations. 
140 Roure argue that this focus should be extended to all technologic convergence projects to establish a bridge 
between the institutional models that separate the United States from the European Union. 
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theatre, where the technoscience is developed. Despite acting under the same 
scientific paradigm, nations have a tendency to create very different innovations. 
In any case, Echeverría (2005) affirms, the most important thing is to develop a 
rational governance that links mediums and available resources with ends and that 
articulates itself in the international theatre. What the author proposes is that, 
instead of putting its diverse agendas in competition, countries must achieve an 
international division of objectives. 
Now well, in light of what was said on the previous chapter where it is clearly set 
that the industrial nano dynamics is constituted with asymmetries that clearly set 
conflictive power relations, the universalist view (or by country) presented on the 
previous paragraph is only the first step for an efficient governance. In order to 
surpass this vision of governance associated to countries and not to affected 
collectives, the fourth chapter of this thesis adds complexity to the problem in 
proposing that a complex nano dynamic needs a sustainable governance that will 
coexists with permanent conflict because of power struggles. 
The ability of governments to act must regulate the technologies to minimize the 
conflict between the actors of the sociotechnical network. It is important to create 
new toxicity standards that take into account the effects of size over environmental 
and health risks. In addition, it is necessary to change the moral and legal scheme 
that supposes that only humans execute autonomous actions, in view that new 
nano-devices actions with autonomy from its inventor or user. At the same time, it 
is required to regulate the activities of it over humans so as to prohibit the usage of 
individuals to prove experiments. Lastly, because of equality issues, it is required 
to make patenting laws more flexible so that developing nations may access to the 
benefits of nanotechnology (Schummer, 2007).    
3.3.2 The Role of Insurance Companies 
Another aspect to take into account at the time of analysing nanotechnology is 
financial risk on the part of the investors in nanotechnology. Annabelle Hett (2004) 
warned on the difficulties for the development of an insurance market for the 
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companies that invest on nanotechnology, given that this ventures have a high 
degree of uncertainty141.  
Before this requisites, nanotechnology presents a challenge for the insurers in the 
measure that there exists a great level of uncertainty referring to the adverse effects 
of nanotechnology on the environment and over the possibility of emergent future 
social protests. An adequate and precise evaluation of the risks involved has not 
yet been made, nor is clear the regulatory framework to tackle said risk should they 
materialize. All of this contributes to the difficulty to celebrate contracts to insure 
the great mass of capital already compromised in this sector. 
According to Hett, both the development of a common language, and a constant 
dialogue between the parties are key elements that would drive us to a clearer 
panorama. The former would contribute to the performing of a standardized 
evaluation of risks in the spirit of the comparison of scientific knowledge between 
dissimilar countries and industries, and also to a universal nomenclature to 
determine the performance requirements that the insurers impose on the insured. 
The dialogue that should involve regulators, businessmen, scientists, insurers, and 
the population in itself is, today, insufficient compared to the progress currently 
being made on the field. The addition of the general population to the dialogue 
would impose itself as necessary to know how it and assimilates and values the 
new projects. Furthermore, plural dialogue has a fundamental role in risk detection, 
as it avoids that the interested parties minimize them before the public opinion. 
3.3.3 Expert´s Evaluation  
On their work, Robichaud et al. (2005) performed an assessment of the relative 
risks associated with the production process of a sample of five manufactures nano-
materials, chosen by its current or potential production, and commercialization on 
a massive scale. To perform this analysis, the methodology of choice was based on 
the scheme of each material’s production process (synthesis), identifying inputs, 
                                                 
141 It is necessary to take into account that insurance companies carry out their business on the basis of risk 
assessment, identification, and diversification. In this sense, risk diversification mechanisms are limited when 
it is not possible to evaluate the probabilities and risks associated with a given venture, when the insurers are 
affected by the same contingencies than insured, or when the magnitude of events exceed the insure capacities 
of the firm.  
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products, and substances used on their production. On the basis of these inputs, a 
risk ranking was performed, and the corresponding risk premium was estimated for 
the producers that wished to insure. 
The study acknowledges and separates the treatment of two risk types: those 
associated with inputs, waste and products of the production process, and those 
associated with the direct risk of nano-material. As a result, the authors show that 
the production process of nano-materials would imply lesser environmental risks 
than other types of manufactures. In conclusion, the experiment described, and 
carried out by Robichaud et al. (2005) suggested that the exposition to the 
considered nano-materials does not impose unknown or unusual risks in relation to 
those imposed by other manufactures142. 
As a first step towards the analysis of the relative risks involved, Robichaud et al. 
(2005) describe, and structure a scheme of the production process of five nano-
materials chosen on the basis of information availability, and its potentiality to 
reach an industrial level of massive scale in its production, as well as its diffusion. 
The chosen materials were single-walled carbon nanotubes, bucky balls, quantum 
dots composed of zinc selenide, alumoxane manoparticles y nano-titanium dioxide.  
From this scheme the authors found the realizations of the variables that they 
deemed important for risks analysis and that were, exclusively, those relevant from 
the perspective of insurers: the constitutive elements and their properties, and the 
parameters of the process (Robichaud et al., 2005). The objective of the study of 
said factors was to reach conclusions on the associated relative risk, understood as 
the exposition probability and the danger associated to the degree of emergence of 
new characteristics in nano-materials, considered as: toxicity, flammability, and 
persistence on the environment. This properties were, at first, identified 
qualitatively on the synthesis process, and then, combined to calculate a risk 
premium for the chemical manufacturing industry, by using an actuarial protocol 
(Robichaud et al., 2005).  
                                                 
142 The authors rescue the focus of insuring for the treatment of nano-materials risks. In this sense, investors 
and businessmen from the nano-manufacture world would benefit from lower costs, risk premiums, legal costs, 
loan rates, and from avoiding losses made because of consumer activists.  
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The exercise of adapting the collected information from the synthesis process to 
the risk analysis follows the scheme proposed by the authors (Robichaud et al., 
2005 p .8990) summarized as follows: 
Material and process identification. This phase implies the understanding of the 
synthesis processes, and the elements involved, and is comprised by two stages. 
On first stage, the authors revised the available information on the production 
methods to find the one suited for utilization on an industrial scale. On the other 
hand, once the method was chosen for each nano-material, they identified the 
characteristics of each process, of the inputs, products, and waste of the process. 
Characterization of the process. Each of the elements and processes of the 
previous phase were qualitatively ordered according to their associated relative 
risk. In the case of the materials, such an order emerged from an evaluation of the 
toxicity, water solubility, bioaccumulation, flammability, and expected emissions, 
according to each material on each step of its synthesis process. After this, 
additional information was collected and adapted to respect the requirements of the 
XL Insurance database program that allows for the calculation of scores of relative 
risks. 
Regarding the production processes, they were characterized to be included in the 
program in accordance with the elements involved, as well as factors such as 
temperature, and pressure. For each process, the involved substances were 
classified in terms of its role in the process, its physical transformation, given the 
temperatures and pressures corresponding to the process, and its emissions, to 
determine its incidence on risks. The role of the substances was instrumental to 
identify the exposition probability to each one. On its part, the physical state of the 
substance allowed for the estimation of its mobility and persistence degree, and to 
complete it on the database. Lastly, evaluations on the degree of emissions tended 
the magnitude of matter released to the environment in terms of kilograms per ton 
of product. Once the contribution of each substance to the risk, the program 
allowed for the classification of the synthesis processes chosen according to its 
conditions on the direction of potential dangers. 
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On the other hand, the methodology present on XL Insurance Database was used 
to assign a value on the risks relative to the production process scale for each of 
the five materials considered on the experiment. This database is widely used on 
the insurance industry, which allowed to rank not only the magnitude of risk143 of 
these five materials, but also to compare this results with the production processes 
of other manufactures not belonging to the world of nanotechnology from the optic 
of insurance. 
The actuarial protocol followed for the calculations allowed for the classification 
of each process on three relative risk rankings: incidental risk, normal operational 
risk, and latent contamination risk. Regarding the first, it is the one associated with 
the accidents that may occur under during the production process and that imply 
an accidental exposition. The second one is related to the emissions expected to 
occur during the production process, while the third embodies the long term 
contamination risks of present operations. 
As regards the classes of relative risks, three were established: the class of 
incidental probability, the class of risk quantity by danger, the class of risk by 
dangerous substance. This classes were incorporated on the actuarial calculations 
together with adjustment actuarial coefficients, giving birth to the final risk scores. 
From the perspective of insurance, what is relevant to calculate the final risk scores, 
are the constitutive substance that impose the greater risk (Robichaud et al., 2005), 
so the risk classes acquire their relative value in function of the value of the 
corresponding risk to the most dangerous substance. 
To analyse the results in the light of the use of the previous methodology, the 
authors compared the qualitative and insurance performance in terms of the risks 
of the nano-materials considered, with the results of other production processes of 
defunded materials: silicon, batteries, refined petroleum, and aspirin. This 
processes are heavily present on the day to day life and represent, for example, the 
                                                 
143 The dangers and risks of exposition associated to each process were determined from variables such as 
temperature, pressure, persistence, and mobility. The methodology consists on assigning a score of relative 
risk to each process. Then to establish a correspondence between this score and certain classes of relative risk. 




activity of the petrochemical complexes, and the pharmaceutical industry. The risk 
scores of this processes were obtained from the XL Insurance Database. 
On its original work (Robichaud et al., 2005), the qualitative results are presented 
on eleven tables that exhibit the name of the product considered (the five nano-
materials and the six manufactures for comparison) followed by all of its 
constitutive elements. As a second entry on the table, the five categories analysed 
for the risk evaluation are detailed, toxicity, water solubility, bioaccumulation, 
flammability, and emission impact. The first four are inherent to the components, 
while the last emerges from within the production process. On the intersection 
between the component and the risk category, the authors determine the qualitative 
result of the risk evaluation through a circle arrangement. A white circle represents 
the under risk category, do black circles mean high risk, and three black circles 
very high risk. In the case of impact on emissions, the evaluation is defined in terms 
of a range of values. 
The compared analysis between the nano-materials and the massive industrial 
products suggest that, as a group, the first have less constitutive elements than the 
second. Furthermore, they have less toxicity but higher projected emission levels. 
A possible explanation suggests that the lesser emission levels present on the 
traditional materials are owed to the fact that its production processes are so widely 
available that have been perfected to the point where the industry is able to 
recapture and recycle the dangerous elements used or produced during its 
production process. It also explains that they have a greater amount of constitutive 
elements, given that said recycling and recapture processes must involve more 
chemical than if they were absent. 
To summarize, the group of nano-materials seems to impose less risks than the 
production of refined petroleum or high density plastic. 
3.4 Public Perception 
In the light of what was said on the previous sections, it is fundamental to take into 
account the voices of the different actors (non technoscientists) with respect to the 
use of nanotechnology in general and its medical applications on particular. A 
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group of researchers from the University of Monash in Melbourne performed a 
study, using social sciences publications and newspapers as its source of 
information. The study intended to cast a light upon the nano perception other than 
the opinions of technoscientific experts (Seear et al., 2009).  This section 
reproduces some of the study’s results which are relevant for our research144. 
 There is a clear consensus on the fact that poorer individuals and developing 
countries have a greater probability of not having access to this technologies, this 
is why there is also a consensus on the importance of the user`s and the general 
community perception on risk control, and on the definition of new regulations.  
Regarding the issue of human enhancement, the literature debates upon the 
therapeutic, and diagnosis aspects, as well as those related to evolutionary design. 
It is a field characterized by widely divergent perspectives on the potential 
consequences of this, there is also a strong consensus on the necessity of a more 
open and rigorous debate. The authors inform that there is seldom agreement upon 
which policy and regulatory response is right, and even the areas where there is a 
built consensus exhibit a variety of opinions (Seear et al., 2009). 
With respect to the risk perception, polls show that, in general, there is a low level 
of knowledge about nano-medicine, yet the available opinions are positive. 
Nevertheless, it is widely agreed that social and economic consequences are closely 
related to issues regarding risk communication and risk perception across the 
general public. 
It is observed that a growing debate on how and why an international response 
might be necessary or preferred over a national focus regulation and a debate 
regarding if the voluntary focus of regulation are insufficient on its own (Seear et 
al., 2009). 
                                                 
144 In relation to the economic aspects, on the literature consulted by the authors, there are divergent 
perspectives on the size of the future market, although there is a large consensus on the great business 
opportunities that nano offers to certain groups (Morigi et al., 2012). Nevertheless, there is a critic literature 
that suggests that expectations on the nano-market may be exaggerated and the companies under the sector 
overvalued (Rogers, 2010). At the same time, there is a literature that examines the barriers and incentives to 




3.4.1  Users´ Voices 
In the last decades there has been a change of focus within the State in how they 
regulate technologies: moving from a vision where government experts had the 
lead, to one where multiple actors from the civil society interacts. It is important to 
acknowledge that this emphasis on social interactions does not subscribes to the 
neo-liberalist pro-market perspective. On the contrary, this thesis argues that it is 
necessary for the State to intervene on the market at the same time that it proposes 
to open new questions upon the institutional and political relations that allow to 
understand complex interdependencies among the nanotechnoscientific practice, 
the market, the State, and the civil society. 
Over the last years, both ethical and democratic considerations have gained in 
importance when it comes to the study of environmental risk. As Shrader-Frechette 
(1998) and León Olivé (2004) sustained, the role of the scientist must be to reflect 
in an ethical manner in order to discover the social impact that his evaluation on 
the prejudice to the environment and what course of action is best to follow will 
have. This is so, because the decision on environmental policy that are taken today 
on the basis of the acceptance or rejection of the hypothesis on environmental 
impact will have consequences on the interests of individuals today, and in the 
future. 
Shrader-Frechette understand that, if the scientific method points out that some 
hypothesis must be provisionally accepted, and some aren`t, then the scientific 
must, in addition, ask himself what impact would said acceptation of the hypothesis 
be. On the other hand, when evaluating these hypothesis, there is an equality 
dimension that must be accounted for as long as we are operating under the context 
of a democracy that invite the policy makers to revise their decisions to include the 
social welfare and to smooth the distribution of risk over time and space. 
León Olivé145 gave the principles that fundament and sustain ethically acceptable 
human relations are twofold. The first principle is to never treat people just as 
                                                 
145 León Olivé (2004) states that occidental democracy is subject to values and is functional to the real power. 
It is surprising the quantity of State secrets that first world occidental democracy has: the citizen cannot express 
his view; not even can he acknowledge what is the risk to which he is submitted under the real power. The 
author clearly contrasts the experts risk evaluation against the public perception of risk, summoning the 
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means (to achieve an objective), and the second, that people should always be 
allowed to act as rational, autonomous agents (Olivé, 2004:302). If democracy is 
to be understood as an association project under common values, then this 
definition is incompatible with any technocratic focus on risk whatsoever (Olivé, 
2004). 
3.5 Quantitative Models for the Regulation of Nanotechnology 
Given that risks are constituted together with the dynamic of nanotechnology, it is 
necessary to think on public policies and, in particular, to model and quantify these 
decisions. This section presents a model of the precautionary principle, allowing 
the government to make decisions on the basis of the quantification of the costs 
and benefits of a given policy. Then and there, an economic model analyses how 
to grant incentives to the nano industry in an efficient manner. 
3.5.1 A Quantification of the Precautionary Principle 
Despite the existence of a broad literature on the use of the precautionary principle 
within the European Union (Monaghan et al., 2012), it is still rather difficult to 
operationalize the concept as a quantitative instrument for governmental choice (de 
Sadeleer, 2012). This section formalizes this principle, following Scott Farrow 
(2004), to allow for the evaluation of investment projects as part of the decision-
making process. 
The model articulates risk evaluation techniques, the cot-benefit analysis of 
projects and the valuation of irreversible investments under uncertainty. Therefore, 
a model that quantifies the social value of precaution when the possibility of 
forwarding an R+D project is given. The proposal is to evaluate whether if 
performing a given project right now is optimal or if it is preferable to wait, thus 
transporting to the governmental practice what the literature on risks calls 
precautionary principle. 
                                                 
concept from Kristin Shrader-Frechette, that all risk is a perceived concept. If something is risky for humans 
and/or its habitat, then it must be perceived by some agent. There is not one only “correct” way to evaluate 
risk. Public participation on the identification and management of risks that affect humans or their environment 




 The challenge is to use a method that incorporated the uncertainty and 
irreversibility within the criteria of risk management that are used for the analysis 
of regulatory public policies. If the method is successful in this matter, then it 
should be superior to the cost-benefit standard methodology that simply proposes 
to carry out an action when net benefits are positive. Nevertheless, if the 
uncertainty and irreversibility of the project are accounted, this threshold is greater 
than zero.  
Following the proposal from (Farrow, 2004), the value of precaution is assimilated 
when facing of an investment project proposal, to a waiting option (Dixit and 
Pindyck, 1994). In particular, any project is associated with a socially irreversible 
cost (C), and most surely, social benefits (B), which are modelled through its 
present value net of irreversible costs. 
The irreversible social cost is a value determined by the specialist, while the social 
benefit is modelled as a geometric Brownian motion: 
 𝑑𝐵(𝑡) = 𝛼𝐵(𝑡)𝑑𝑡 + 𝜎𝐵(𝑡)𝑑𝑧 
(3.14) 
Formally, if the discount rate is 𝜌, the Bellman recursive equation corresponding 
to the waiting option (F) at time t is: 
 𝐹(𝐵(𝑡)) = Max ( 𝐵(𝑡) − 𝐶 ,   𝑒−𝜌𝑑𝑡 𝐸 (𝐹(𝐵(𝑡 + 𝑑𝑡))) ) 
(3.15) 
Where 𝐹(𝐵(𝑡)) is the quantification of the precautionary principle from the point 
of view of the government in charge of regulating the activity of interest. 
Next, the decision rule that allows for the decision on at what time it is optimal to 
invest is analysed. To achieve this, at time t, the values of the Project if it is 
executed today, ⌈𝐵(𝑡) − 𝐶⌉ is compared to the waiting value: 
  𝑒−𝜌𝑑𝑡 𝐸 (𝐹(𝐵(𝑡 + 𝑑𝑡))) . 
Mathematically, the resolution of this problem consist on its conversion into an 
optimal stopping problem, to find the critical value of the social benefit (𝐵∗) that 
separates the region where it is optimal to wait (𝐵 < 𝐵∗), from that where it is 
optimal to start the project immediately. So that the decision rule is of the form: 
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If 𝐵 < 𝐵∗  ⇒    𝐹𝐸(𝐵(𝑡)) =   𝑒
−𝜌𝑑𝑡 𝐸 ( 𝐹𝐸(𝐵(𝑡 + 𝑑𝑡))) 
If 𝐵 > 𝐵∗  ⇒    𝐹𝐷(𝐵(𝑡)) =  𝐵(𝑡) − 𝐶  
If 𝐵 = 𝐵∗  ⇒    𝐹𝐸(𝐵
∗) =  𝐹𝐷(𝐵






(B∗) (Continuity of the first derivative). 
At the same time, it is required that a monotonicity condition to be verified for 
 FD  and  FE and for 𝐵(𝑡 + 𝑑𝑡) given 𝐵(𝑡). So that within the region where it is 
optimal to wait, it is verified that: 
 𝐹𝐸(𝐵(𝑡)) =   𝑒
−𝜌𝑑𝑡 𝐸 ( 𝐹𝐸(𝐵(𝑡 + 𝑑𝑡))) 
Multiplying both members by  𝑒𝜌𝑑𝑡 , 
Subtracting  𝐹𝐸(𝐵(𝑡)) 
(𝑒𝜌𝑑𝑡 − 1)𝐹𝐸(𝐵(𝑡)) = 𝐸 ( 𝐹𝐸(𝐵(𝑡 + 𝑑𝑡)) −  𝐹𝐸(𝐵(𝑡))) 




𝐸 ( 𝐹𝐸(𝐵(𝑡 + 𝑑𝑡)) −  𝐹𝐸(𝐵(𝑡)))
Δ𝑡
 





On the other hand, as we know that B follows a geometric Brownian motion, we 
can write, using Ito’s lemma, the process  𝑑𝐹𝐸(𝐵) as: 






2𝐵2) d𝑡 +  𝐹′𝐸(𝐵)𝜎𝐵 𝑑𝑧 
The expectation is: 






















𝜎2𝐵2 𝐹′′𝐸(𝐵) +  𝛼𝐵𝐹
′
𝐸(𝐵) − 𝜌𝐹𝐸(𝐵) = 0 
(3.16) 
s.t.    𝐹𝐸(0) = 0, 𝐹𝐸(𝐵
∗) = 𝐵∗ − 𝐶 , 𝐹′𝐸(𝐵
∗) = 1 
A solution of the form: 𝐹𝐸(𝐵) = 𝐶 𝐵




𝜎2𝜈(𝜈 − 1) + 𝛼𝜈 − 𝜌 = 0 









































Summarizing, the general form of the solution is 𝐹𝐸(𝐵) = 𝐷1 𝐵
𝜈1 + 𝐷2 𝐵
𝜈2 . But 
the restriction 𝐹𝐸(0) = 0 imposes that the term with the negative exponent cannot 












The previous statement implies that the waiting option (if 𝐵 < 𝐵∗) is given by: 
𝐹𝐸(𝐵) = 𝐷1 𝐵
𝜈1 































) < 0 ⟹
𝜈1
(𝜈1 − 1)
↑⟹ 𝐵∗ ↑ 
 
The root 𝜈1and the critic benefit (B*) as a function of the volatility of the process. 
 
In the first place, the decision threshold proposed is more prudent than the 
traditional, where it is only required that the present value of future net benefits to 
be equal to the irreversible social cost of the project (B=C). Using the 
precautionary principle, the project is delayed until the benefits are greater than the 
costs, so as to contemplate the irreversible nature of costs, and the possibility that 
the net observed benefit observed today is optimistic (Farrow, 2004). 
 The government evaluates the net befits by analysing the expected social benefits, 
but also contemplating the risks for society that are attached to innovation. If at the 
moment of the evaluation, the expected benefit is not sufficiently greater than the 
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irreversible cost, the government prefers to maintain its precautionary option and 
not authorizing the project. 
The proposed procedure to reach a governmental decision is as follows. Firstly, the 
government is presented with a project that it needs to authorize and agrees with 
the private sector the following values: 
 The social irreversible cost that the Project will cause: 𝐶 
 The present values of the benefit net of future reversible costs at the starting 
moment: 𝐵(0) 
 The parameters of the process that this net benefit will follow B (  y 𝜎) are 
estimated. 
 Discount rate: 𝜌 
Then, the government may proceed to the calculation of the previously mentioned 
critical value B*: 






















 𝐶  
So the government’s decision rule is: If 𝐵(0) ≤ 𝐵∗ the waiting is in order, and the 
investment project should not be authorized. It should be noted that the present 




 𝐶 . This model contemplates the uncertainty included in the future benefit 
and is, therefore, more conservative than the traditional principle of comparing cost 
and expected benefit.  
3.5.2 Governmental Incentives Design 
In the context of public policies to foster innovations within medicine, the literature 
acknowledges two main categories of incentives: push y pull (Nemet, 2009). In 
this section, both proposals are evaluated by comparting its cost versus its social 
contribution (Hsu and Schwartz, 2008). 
A governmental push incentives program is that which contributes with a part of 
the initial developing cost. This type of financing can be awarded to people 
(scholarships or research prizes) or to businesses. On the other hand, the pull 
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program fosters research by increasing the income generated by the final product. 
The financing could consist on a buying compromise, or a patent extension. Hsu y 
Schwartz (2008) also consider an hybrid incentive plan that combine both. 
In the model, it is formalised the costs and benefits of a defined financing scheme: 
 𝑁𝑒𝑡 𝑝𝑟𝑒𝑠𝑒𝑛𝑡 𝑣𝑎𝑙𝑢𝑒 ( Govermment′s cost)
𝐸[𝑄(𝜏). 𝑞. 𝑇]
 (3.17) 
Where 𝑄 is the efficiency of the new product, 𝑞 are the supplied units per year, and 
𝑇 is the number of years of the subvention contract. The authors fail to contemplate 
any agency problems arising from the asymmetric information between the 
developer and the sponsor, neither they dwell on contracting issues. It is not 
considered that grant translate into an ownership transference of the innovation to 
the government, so that the public organism lacks the knowledge to possess, 
manage, and distribute pharmaceutical resources in an effective manner. 
On its part, Kremer (2002) concludes that the pull subvention programs are the 
most effective because they eliminate, to a great extent, agency problems between 
the sponsor and the developer. Within the pull alternatives, a patent extension 
policy is the most used to promote innovation in general. From the businesses point 
of view, the increased protection from patents, allows the company to maintain a 
monopolist market for a longer period of time146.  
Within the pull alternatives, governments must check for the quality of the final 
product. Consequently, if a company that has an assured sale of the product, 
decides to produce it with a poor quality, the government must monitor the 
development and establishes quality control guidelines. Given that the quality of 
the developed product is observed at time 𝜏, within the framework of the buying 
compromise, the contract establishes socially optimal units for buying. In this way, 
the quantity that the company sales to the government depends only on 𝑄 (𝜏).  
The distinctive characteristic of a buying compromise is that the government 
decides how and how much is the final product distributed. The company 
                                                 
146 Some activists and economists have sustained that the strengthening of the patent protection policy, or the 
extension of patent’s life for pharmaceutical products on underdeveloped countries increases business 
incentives for research on diseases that are specific of these countries (Kremer, 2002). 
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renounces to its right to obtain a monopolist rent in exchange for the buying 
compromise at a pre-established price. In other words, the government hires the 
company to supply a socially efficient quantity. Another alternative is the shared 
cost financing plan; it promotes innovation in the development of vaccines through 
the reduction of the research cost and the broadening of production. If the expense 
subvention scheme is used, the company opts to supply with the monopoly’s 
quantity that arises from the inverse demand function.  
Both the buying compromise and the shared cost financing scheme may be 
combined to create hybrid contracts, these contracts combine the positive attributes 
of both subvention types. The mechanism through which the shared cost financing 
is more effective in promoting R+D activities, yet ineffective to induce an efficient 
supply quantity to the market once the vaccine has been discovered. This clearly 
may be relieved if both subventions are combined within a hybrid contract. 
A business model widely used within the sector is the joint business of a small nano 
company (N) that is in possession of a patent, and a big pharmaceutical company 
(F) that has the capital and access to the market. This business model was analysed 
on the second chapter of this thesis (joint investment valuation). There, the 
variables of the model in question where detailed. This section formally analyses 
the situation under which the pharmaceutical company uses its market power to 
demand a high share on the venture’s income (thus forcing the nano company to 
abandon the project). Yet if the project is socially important for the government, a 
way to intervene is to promise a Pull incentive that consists on an extra payment to 
the nano company once the project is over. The additional value that the 
government offers to the nano company is such that eliminates the possible loss of 
it, while leaving intact the profit of the pharmaceutical company.  
Mathematically147, the problem requires that the following restrictions are satisfied 
for both companies to be part of the project. 
(N) β2[p max (u Yα, X) + (1 − p) max (d Y α, X)] ≥ KN 
(3.18) 
(F) β[p u Y(1 − α) + (1 − p) d Y (1 − α)] ≥ KF 
(3.19) 
                                                 
147 The used variables are the same that those use on chapter 2 to explain the business of conjunct production. 
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From the first restriction, corresponding to the nano company, it follows that the 
minimum value for the governmental promise must be X> 
𝐾𝑁
𝛽2
 (See graphic 4.6). 
It is important to point out that the incentive is paid at the end of the project, so it’s 
a counter-cyclical governmental policy. In this way, the government may increase 
the employment on the technological sector in times of recession without the need 
of cash148. This model can be used by governments to analyse incentives on the 
nanotechnology sector. The main characteristic of the proposal is that it does not 
require a disbursement at the beginning of the project. 
Chapter Conclusion 
This chapter started presenting risk as manufactured. It presented different 
approaches to the concept of risk, focusing on the characteristics of the so-called 
risk society. While this approach is relevant to this thesis, it is necessary to avoid 
its universalistic nature, incorporating nano micro complexity and its macro 
context. 
Subsequently, it examined the viewpoint of the industry, where uncertainty is taken 
as part of the process and concluded that the real options valuation methodology is 
the more efficient valuation approach, because it accounts for the uncertainty, 
flexibility, and irreversibility of investments, all relevant for the financial 
evaluation of nanomedicine projects. 
In addition, this chapter conceptualized nano risk as co-constituted both during the 
practice, as well as in its associated market. Moreover, these risks for the human 
being and for the environment were analysed with an emphasis on ethical questions 
that arose during the analysis. Accordingly, to exemplify the current risk evaluation 
process, this chapter analysed the risks associated to five nano-materials. It 
concluded that while this risk management procedure satisfies governmental 
regulation, it is not enough to contemplate social and environmental issues.  
                                                 
148 If the government is credible, it might even sell the option on the market. 
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On the last section, two mathematics models for the management of public policies 
were presented. The first one allowed to quantify the precautionary principle, so as 
to decide if a project should be started or not; and the second allowed for the 
effective distribution of innovation incentives. 
As a way to account for this complexity it is necessary to possess a wider 
perspective that contemplates the nano market as a process, and that its governance 
it is, also, part of the process. On the next chapter the problematic of a sustainable 
governance is analysed. 
4 Establishing a Sustainable Nanogovernance 
Introduction 
As analysed in chapter one, public perception of nanotechnology moves between 
two extremes: those who argue that nanotechnology is the salvation for humanity 
and those who assimilate it to apocalyptic nightmares (Mekel, 2006). While some 
groups produce narratives where the imagined future is a promise of small 
programmable machines capable of curing diseases or clean the planet from 
pollution, others assert a nightmare vision where these nanomachines achieve 
autonomy (Highfield, 2003).  
This sociotechnical network articulated its practice in interaction with its market. 
In recent years, nanotechnology future expectations have added economic value to 
investment projects, attracting new public and private investors. The nano-
industrial dynamics has developed from a mere discourse in the early millennium 
to an economic reality today. In this respect, the second chapter explained the 
process of companies´ creation and analysed how patents and nanoproducts 
become transactional goods in this market. Additionally, in order to understand its 
constitution, it is important to be able to account for the performative role of 
economic theory. The market is in a process of co-constitution, where collective 
hybrids of calculation perform transactions, thus strengthening the network149. The 
                                                 
149 In the case of the nanocarriers market it was described how they are objectified and singularized in order 
to become tradable.  
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distributed nature of these calculation agencies (humans and artefacts) indicates 
explicitly the importance of non-human agencies to understand the constitution 
process of the market. Moreover, it also elucidated that big pharmaceutical 
companies concentrate market power based on calculation power (fixing prices).  
From the investors point of view, it is important to evaluate the economic 
profitability of future investments. The traditional asset valuation methodologies 
typically used, cannot account for complex dynamics. Consequently, there is a 
need for technics that contemplate this multifaceted interaction and its social 
impacts uncertainty, and the irreversibility of its investments. To account for this 
complexity, on the third chapter of this thesis, it is argued that the methodology 
that best fits these needs is an eclectic articulation of real options and game theory. 
A company realizes the economic value of nanotechnology at the same time that it 
manages its associated risk in accordance with government´s regulation; leaving 
the remaining risk to hedge with an insurance company. Clearly, this risk 
management procedure does not contemplate social (or environmental) 
implications. This thesis argued that both, an involved society and an involved 
State, are required from the beginning of this process to ensure sustainability and 
responsibility. 
On the third chapter, it was analysed how these network of controversial relations 
co-constitutes new risks that become part of it, adding complexity and extending 
it. Each State could propose a different kind of regulation policies for the 
nanotechnology sector. For example, on the United States, the Converging 
Technologies for Improving Human Performance (CTIHP) program proposed a 
manipulation of the nanoworld for the benefit of the government, the market and 
the society. The idea is to allow companies regulate themselves (soft law) and, after 
some learning process, the State will intervene with a more explicit regulation 
(hard law) (Bowman and Hodge, 2006). Unlike the American program, the 
European Converging Technologies for the European knowledge society (CTEKS) 
created the idea of a knowledge society guided by the precautionary principle 
(Klinke et al., 2006). This network which was analysed and described in detail on 
these three chapters had a de facto governance, built on a day-to-day basis by 
uneven actors, in a constant conflict of interests (Rip, 2010). In this network, 
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nanomaterials are produced by multiple actor interactions, thus it is impossible to 
regulate it using a top-down approach. On the contrary, Rafols et al (2011) 
proposed a bottom-up regulation that takes into account both the distributed 
interactions on the system, and its de facto governance (Rip, 2010).  
Diverse disciplines and institutions interact inside the network establishing 
expectations, many times divergent, about future benefits. Each actor constitutes 
its expectations in a teleological manner by introjecting interests about how the 
technology must develop in the future. This is a flexible rhetoric instrument that 
attempts to provide legitimacy to the dominant position, avoiding public debate 
about objectives (and values) of future developments (Schummer, 2008). Over the 
last years, future expectations about nanotechnology have aggregated economic 
value to investment projects, attracting new investors, either public and private. 
Furthermore, a market´s forward-looking orientation invites to reflect about the 
new risks co-constituted. Accordingly, it is required a nanogovernance that 
contemplates this complex nanotechnology dynamics, incorporating a reflexive 
and deliberative citizens´ compromise that will ensure its sustainability (McGrail, 
2010). 
The dynamics of nanotechnology is a complex, conflictive, and uncertain process. 
Policymakers’ challenge is to align it to society´s necessities, hence, this requires 
a sustainable governance to reflect and deliberate about this processes, and to 
envision alternatives. To do it, the perspective of this thesis is individually 
reflexive, and socially deliberative, promoting a sustainable, socially responsible 
innovative process (Rip, 2014). In addition, it is of particular interest of this thesis, 
to analyse this process in the case of Argentina.  
To achieve this objective, this chapter divides itself on three sections. The first one 
analyses the conflictive process of constitution of the nanotechnology network, 
stressing how future expectations extend the network and the necessity of State´s 
intervention. The second section problematizes its sustainability, analysing the 
constitutive process of the sociotechnical network as a socially responsible one. 
The last section analyses inscriptions and translations of the nanotechnology 
process in Argentina, and, consequently, suggests guidelines about how this 
167 
 
sociotechnical network can converge to a sustainable and RRI responsible 
nanogovernance. 
4.1 Conflictive Constitution of the Sociotechnical Network 
Previous chapters presented the sociotechnical network as a conflictive constitutive 
process, which was analysed from three integrated perspectives: the 
nanotechnoscientific practice, its market, and its associated risks. This section 
stresses the performative role of future expectation on said process. The 
governmental agency is conceptualized as a collective hybrid of calculus in such a 
way that maintains the intuition of the State as an actor, while at the same time it 
takes into account its complexity and its dynamics of constitution (Passoth and 
Rowland, 2010). This network transforms itself in the light of a narrative of 
technoscientific regulation and of the translation of similar experiences. 
4.1.1 Future Expectations 
Economic theory has sustained since the 1970s of the past century, that the 
expectations about the future of innovation is crucial to understand how businesses 
adopts new technology (Rosenberg, 1976). It aggregated decisions, in permanent 
interaction with public policies, sustain future expectations and reproduce them. 
These expectations150 pressure the process of public national resource allocation 
(van Lente and Rip, 1998; van Lente, 1993).  
These uncertain future promises are functionally important to start a new market 
because they assign future value to the investments, transforming it. Scientists 
narratives aiming to mobilize resources towards their projects, meanwhile, 
governments define their financing policies based on their political priorities. Some 
visionaries researches anticipate the political agenda and strategically formulate 
                                                 
150 As was analysed on the first chapter of this thesis, nanotechnological expectations coordinate innovative 
actors, thus shaping the future of the technology while constituting sociotechnical networks. There has been 
over the last years a process of professionalization and commercialization of expectations. While general 
promises are convincing and serve a purpose on the political speech, pushing the industry to the future, its 
diffuse nature blocks its correct performance. Whenever only general promises are available, entrepreneurs 
are reluctant to invest on concrete developments, as future demand is not articulated. Therefore, we are in the 
presence of a complex and controversial dynamic where investigators, businesses, governments, and NGOs 
interact on a network of relations from positions that are in many times conflictive among each other.  
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promises that are contained on the agenda (Rip et al., 2010). These uncertain and 
general future promises receive the name of umbrella promises (Konrad, 2006). 
While in the beginning uncertain future promises clearly deliver a framework for 
the take-off of the dynamics, as it evolves, specific promises must appear in order 
to sustain the process.  These specific ones must answer concrete demands, they 
are expressed in concrete terms, and they have self-imposed success measures. 
These promises receive in the literature the name of promise-requirement cycle 
(van Lente, 1993). It is therefore established a dual dynamic151 of promises, where 
specific promises make reference to a concrete successful performance, of the 
general promise (Parandian et al., 2012). 
Nanotechnology market is an uncertain and complex constitutive process, so it is 
necessary to understand the sociotechnical network that unravels future 
expectations. Accordingly, governments (and lobby groups) can in conjunction 
tackle this matters, by building guidelines that will define public policies (Scoones 
et al., 2007). In particular, on the nanomedical field one could mention the 
fundamental role carried out by the Wellcome Trust, not only in the financing of 
projects, but also as an engine of the transference network of nanotechnology in 
the area of medicine (NanoKTN)152. 
The western hegemonic thought understands the relation between nature and 
society from the perspective of equilibrium (Worster, 1977; Worster, 1993). This 
idea is culturally rooted and was not confronted until well into the past century 
(Elton, 1930). On the political-economic field, under the neoclassical paradigm, 
policy-decision deal with the perspective of economic equilibrium. Therefore, 
when facing a crisis, actors search for the best public policy that returns the system 
to its lost equilibrium. A clear example is the reaction to the last international 
financial crisis, many governments promoted policies aiming a return to 
equilibrium. Hence, this perspective clearly reinforces the power of the dominant 
group and silences the voice of the affected people. This equilibrium is imposed by 
                                                 
151 This dynamic gives visibility to key controversies, for example if the success (or failure) of concrete projects 
are attributed correctly to certain vision of the future or it owes simply to project specific circumstances. In 
other words, whether the risk of failure is systemic inside the dynamic or is due to a specific problem of the 
project under review. 
152 The event Nano4Life (which started the 11th of February of 2009) gathered scientists, market 
representatives (both pharmaceuticals and spin offs), the government, and the general public. 
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the power and it is assumed to be the only valid path towards the future, blocking 
alternate paths (Scoones et al., 2007). 
This is critical in the case of emergent and underdeveloped countries. Developed 
countries export its policies, without reflecting about the local context of the 
recipient country. As was mentioned before, nanotechnology dynamics is a 
contextualized process, consequently, replicating models that were effective in 
developed societies can be disastrous to a developing economy (Cowen and 
Shenton, 1996). 
These processes, in different geographical and historical contexts, expose 
inevitable to multiple paths that include problems and its possible solutions in a 
process of co-constitution. Facing this complexity, there are two ways to answer it: 
a descriptive way, and a constructivist way (Ison et al., 1997). The first one 
declares that complex dynamics must be detailed in other to get a picture, then and 
there it will formalise (generally in a mathematical language) and, finally, the 
proposed model will offer solutions. On the contrary, this thesis has a constructivist 
proposal and involves a perspective that forces decision makers to involve itself 
building soft procedures that helps society. In order to answer to the complexity of 
this dynamics it is necessary to count with a constructivist perspective that includes 
political processes centred on the reflexive practice and on experimental learning 
(Scoones et al., 2007).  
Consequently, our proposal is a complex perspective that understands the 
constitution of the dynamics, in conjunction with an explicit normative stance, 
allowing for a governance that goes beyond the merely regulatory point of view. 
At the same time, the deliberative and reflexive proposal remarks different ways to 
work with politically controverted objectives that must be continuously 
reconsidered by groups of interest (Scoones et al., 2007). 
4.1.2 The State as an Agency of Distributed Calculus 
The concept of State has a long history and multiple meanings. With modernity, 
the State has been conceptualized as an element of the social order, nowadays, the 
conception of the State as an actor is currently the most accepted among 
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policymakers153 (Passoth and Rowland, 2010). Towards the end of the past century 
James Scott (1999) published a widely cited book where it offers an image of the 
State as a central agency, which creates and plans public policies aiming better 
quality of life. This vision of a centralized State was confronted at the beginning 
of the century, interpreting that it is a complex conglomerate of ideas and 
representations that includes bureaucratic organisms, the land, and the population 
(Carroll, 2006).  
The state can be understood simultaneously as an idea, a system, and a country as a 
complex of meanings, practices, and materialities. The state idea has become a 
powerful discursive formation, a cognitive structure, and assemblage of institutions; 
the state system has become a vast organizational apparatus that is practiced with 
varying degrees of coherence (and indeed incoherence) from the heads of executive 
agencies to the most mundane aspects of everyday life (e.g. the building police who 
insure the plumbing is up to code); and the state country is constituted through the 
materialities of land, built environment, and bodies/people, transformed by the co-
productive agencies of science and government, and rendered in the new forms of 
techno-territory, infrastructural jurisdiction, and bio-population… (Carroll, 2009 
p.592) 
 
Hence, instead of modelling State as a simple actor, it is important to problematize 
its complexity. This thesis offers an approach focused on the constitutive processes 
of institutions, defying the idea of the State as a monolithic actor. It is rather 
conceptualized as a constitutive process of a distributed network of agents154 (not 
necessarily coordinated) (Carroll, 2006; Latour, 2000; Passoth and Rowland, 
2010). Recognizing the historic process that constitutes States as a distributed 
agency, this thesis proposes, firstly, to conceptualize this agency as a collective 
hybrid of calculus. Attention is focused pragmatically on relations among actors as 
a way to understand the constitutive process. Using this approach has immediate 
implications. In the first place, no governmental entity is an actor per se, the action 
                                                 
153 The idea is born together with the neo-marxist theory between the 1960 and 1970 years, where it is proposed 
that the State is the group of institutions that serve class interest (Miliband, 1969; Offe and Vale, 1972). 
Nevertheless its existence is not a given aspect, rather it constitutes itself as the result of a certain history, it is 
not pre-existing (Abrams, 1988). 
154 Historically, thinking of the State as a network surges with Michael Foucault (1977) and is linked with his 
concept of power. The simplified approach sees the State as an articulate of human relations and the power is 
a network of forces that intertwines practices. Therefore States should not be analysed as defined instruments 
of power, rather they constitute themselves on the basis of interaction between existing forces (Deleuze, 1988). 
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of the State only acts in relation to collective hybrids that articulates both humans 
and non-humans agents155 (Carroll, 2006). 
Secondly, “…in speaking for states, states are enacted” (Passoth and Rowland, 
2010 p.829). A network of actors transforms themselves into a collective by 
successive translations that allow the network to become more extended and 
stronger. By translation we mean every negotiation, calculus or conflict that give 
way to a distributed agency (Callon and Latour, 1981). In the same way that on the 
first chapter, following Bruno Latour (1988), the figure of Pasteur was presented 
as a collective hybrid that represented the network he was part, here it is proposed 
to think the spokesmen of the State as the representative of a population. It is 
important to single out that when speaking as the State, the spokesmen has a 
simplified image of the interactions between the population, the land, the market, 
and the rest of the network. 
Thirdly, it is fundamental to incorporate the materiality of the distributed network 
that we call State, to the analysis. In facing the task of analysing the constitutive 
process of a sustainable nanogovernance, it is important to track the relations in the 
network among the distributed network, making visible the inscriptions and actions 
within itself. At the same time, it is necessary to explain by causal mechanisms the 
surge, transformation, and dissolution of hybrids within the network. 
4.1.2.1 Causal mechanisms  
The challenge that faces a democratic State in designing public policies requires 
understanding the experiences of other governments and realizes a critic evaluation 
that allows for collective construction adequate for its own problematic.  It is a 
matter where what is historical and what is geographic are crucial aspects; the 
social processes and world location determine the design. At the same time, public 
policies surge from a process that involves controversies rather than a mere 
aggregation of the independent decisions of citizens that maximize their utility. 
                                                 
155 In particular, the power that governmental actors use emerges from its own network. This was clearly 
exemplified on the second chapter as it was described how the power of pharmaceuticals in the nanomedicine 
market is not a priori, rather it explains on the basis of differences in the power to make calculations on the 
network (Passoth and Rowland, 2010).  
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There are currently two methodological paradigms on the social sciences that 
dispute with each other the search for causality. On the one hand there is the 
dominant tradition of quantitative analysis that postulates the use of statistic 
correlations as a way to find causes (MacIver, 1964) (MacIver, 1942). This 
methodology present grave issues for empirical research that treats macro 
phenomena like the Welfare State, the European integration, or regulation policies 
of new technologies. On the other hand there are the authors that postulate the 
necessity of causal mechanisms as the only valid form of scientific research 
(Hedström and Ylikoski, 2010). 
Analysing the relations of the sociotechnical network and starting a causal 
reconstruction process gives birth to a historical narrative. The network in question 
is a socio-natural hybrid very unlike the universal laws of physics. While these are 
supposed to be invariant in time and space, the nano sociotechnical network relies 
on the historical context and the cultural space to determine the explicative process 
(Mayntz, 2004). 
In this network, the institutions are decisive for the generation of aggregate macro 
effects driven by the actions of agents. The main challenge is to identify the 
structural and institutional characteristics that organize the actions of different 
actors so as to produce certain macro effect, desired by public policy. 
This analysis of causal mechanisms can be used to understand how decision are 
taken within the State. In the first place, the actions of the State are not based on a 
great number of individual decisions aggregated a posteriori, rather one collective 
action preceded by a deliberative process where controversies within the network 
find their expression. 
The technoscientific network is diverse and multiple in its development. The 
challenge that any State has, is to evaluate which model of governance is the most 
adequate to address its own problematic, forwarding an issues where the historical 
and geographic matters play an important role.156 Therefore the only way to 
                                                 
156 As was exposed on the previous section, working with aggregated variables built by political consensus 
invalidates the use of the statistic methodologies of correlation. The processes identified on a causal 
reconstruction of a particular case can be formulated as a chain of basic mechanisms if its causal structure can 
be found in other cases. Most of the macro phenomena cannot be explained by be the use of one model of 
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evaluate governance models is to find a new historical narrative that articulates the 
causal mechanisms that are present on the study cases and reconstruct a narrative 
for the network in question. This qualitative work must contemplate the historical 
and geographical processes overcoming what is merely descriptive. 
The challenge presents itself on different levels (national, regional, and global) that 
relate permanently to each other, constituting a unique historical process in 
concrete. To exemplify this, the work of Renate Mayntz (2007) is presented 
immediately. The author compares three sectors of the economy in the European 
context (pharmaceutic, tourism, and telecommunications) and identifies the causal 
mechanisms that link different characteristics of its multilevel governance (State, 
region, and global). 
In particular, the pharmaceutical and the telecom sectors have many characteristics 
derived from the technoscientific innovation associated to them. Renate Mayntz 
uses its theory about causal mechanisms to explain the internal relations between 
levels of governance and its narrative. Control is stressed as the objective of 
governance, the density of rules, the prevalence of public agents, and the 
predominance of the national level are closely intertwined in a causal chain. The 
objectives of governance differ between sectors centring on different parts of the 
production chain. Notoriously enough, in the telecom sector the objective is to 
maintain the quality of the service (meaning the territorial environment of 
communication), while in the case of the pharmaceutical industry the security of 
the products is the main concern. The control of negative externalities (of risks to 
the public health) is a more present concern in the management of pharmaceutical 
products (Mayntz, 2007). The objectives also differ by level (national, regional, 
global). On the three sectors, the legal regulation that controls the quality of 
products has the support of effective sanctions mainly on the national level. At the 
UE level, regulation serves mainly to help create the European unique market. On 
                                                 
mechanisms in particular; on the contrary, it implies a chain of different mechanisms that generate the result 
in conjunction. If our objective is to identify social mechanisms sufficiently specific so as to have explicative 
value on the particular observed results, while at the same time sufficiently general so as to apply to different 
empirical fields, it is necessary to explicit the range of the initial conditions that can generate different series 
of results through a process with a determined causal structure.  
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the international level, the expansion of the market beyond national and regional 
frontiers is the main goal (Mayntz, 2007). 
The presence of active private actors gives birth to a mixed regime of governance 
that works as a level specific system of negotiation. In the regional and 
international levels this negotiation is especially complex because the 
representatives of the industry have to meet not one but several governments whom 
many times follow divergent interests. The economic structure of the sectors are 
subject to historical change, this reflecting on the changes its governance. For 
example, the prevalence of public organisms in the present governance of telecoms 
is the result of a tradition that starts due to the ancient public condition of the 
service.157 
The main result is that, due to the consensus, the logic that a democratic State 
needs, in order to regulate technoscientific sectors, the use of quantitative 
methodologies based on the statistical correlations, are not appropriate. Rather it is 
necessary to count upon a historical narrative that connects social mechanisms for 
its correct use, the proposal of Renate Maynz is an example of this, in her already 
mentioned work on multilevel governance it is illustrated how three case studies 
can be useful to find the appropriate narrative by understanding the connections 
between the social mechanisms involved. 
4.1.3 Nanotechnology in Europe 
The European Technology Platform on NanoMedicine was launched in 2005 to 
promote the development of nanotechnology in Europe. Its foundational 
document158 is the expression of a vision where in the future nanotechnology will 
become a key enabler to achieve objectives on the medical attention sector and on 
general European health.159 
                                                 
157 At the same time in the pharmaceutical industry, the increasing power of manufacturers as a consequence 
of the dominant market positions of big corporations, together with the development of an ever-growing and 
increasingly expensive public health system, has motivated governments to reinforce the reach of their 
regulations on the matter. These observations show the importance of a historical perspective on the analysis 
of macro phenomena (Mayntz, 2007). 
158 Available at  ftp://ftp.cordis.europa.eu/pub/nanotechnology/docs/nanomedicine_visionpaper.pdf 
159 At the same time the document creates a sense of urgency to compete before the advancement of other 
world regions. Thus strict cooperation within the industry, universities, hospitals, regulatory organisms (and 
financers) and patients organizations is promoted (Frima et al., 2012). 
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Currently, concrete results are modest and they focus on the production of 
nanoparticules. The promises of the future benefits from nanotechnology are late 
to come, and public has started to suspect that maybe they will arrive to late or even 
never come. This situation has clearly transformed in the last years in an obstacle 
to the financing of the activities. While the general promise that nanocarriers will 
dramatically help to cure several diseases, in the last years there has been a surge 
in works that defy this hegemonic vision. It is postulated that the improvements in 
efficiency have yet to be proven, and that there hasn’t been enough investment to 
try new therapies that use nano-carriers, so notable improvements on efficiency 
will not be perceived (Ruenraroengsak et al., 2010). 
The reluctance of big pharmaceutic companies to invest on the development of 
nanocarriers has blocked its adoption on clinics, thus, they have not delivered to 
patients. New concepts and ideas that were innovative for research were not 
developed nor exploited in collaboration with the pharmaceutical industry. Some 
authors have pointed out that the cause of the delay investment is twofold. Firstly, 
specific promises not sufficiently proven in order to invest. Secondly, the big 
pharmaceutic companies are reluctant to take the risks of an innovative investment 
in nano-carriers such as they could continue with their traditional business, in what 
they are a monopoly (Parandian et al., 2012). 
The issue observed is that, starting from a set of promises that created general 
expectations about the future of nano-carriers, the absence of concrete results led 
the sector to a recessive state. Given this new recessive dynamic, the sociotechnical 
network started to focus on specific promises so as to promote an exit to the 
recessive dynamic. 
This interactions had their first inscription on the year 2009 through a European 
Union document titled (ETP Nanomedicine Secretariat): Joint European 
Commission/ETP nanomedicine expert report 2009: Roadmaps in nanomedicine 
towards 2020160.  While the document acknowledges the support given by the 
government and the general public remained intact, the development of nano-
                                                 




artifacts was limited acknowledging the necessity of more detailed and specific 
recommendations in order to achieve investments from the private sector.161 
Before the attractiveness of nanotechnoscience in terms of its potential to generate 
a scientific revolution based on the communication and manipulation of matter, 
both State policies and profit-seeking actions of private companies gain in 
importance. The European Programme Converging Technologies for the European 
knowledge society (CTEKS) stresses the importance of State’s technological 
policies in the creation of a knowledge based society with the ultimate objective of 
projecting the European Union to a leadership status in knowledge by 2010. 
The European Union program subjected its experts to its ten guide-principles that 
focus on building a European knowledge society, these guide-principles exposed 
in the document Group Mandate, which has great interest in governance. On the 
other hand, the document invited experts to make visible the benefits of their 
research so as to legitimate the project.162 At the same time, the creation of a 
technoscientific agenda that specifies political, social and economic goals to 
achieve in order to transform the European Union in a competitive group in the 
civil sector relative to the United States. With this, the scientific and technological 
objectives are subordinated to the creation of a society of knowledge. 
The document recognized the plurality of agendas in the programs Converging 
Technologies of the different member countries. This agendas can focus on a 
myriad of focuses including national defence, human capacity enhancement, 
Biosystems synthesis production, application to agriculture, environmental and 
food applications, natural languages processing, and artificial intelligence 
(Nordmann, 2004). In view of this diversity of national agendas, the European 
document concludes that human and social sciences become “capacitators” of the 
                                                 
161 Possibly the most important recommendation is the emergence of translational investigations, where the 
investigator works in direct relation with the clinic and the patient (te Kulve and Rip, 2013). 
162 The document also questioned itself in what was the role of the social and cognitive sciences on the program 
and what effects it had on education, this is also taken by the American document.  Yet unlike the American 
document, the European one urges experts to discover and handle ethical and social questions that emerge with 
the advancement of the research. It also stresses the need to benefit from innovation to attain social benefits 
rather than individual ones. An additional difference refers to the concern over ecological questions, evidenced 
under the principles of sustainability, precaution, anticipation, and risk management. 
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diverse technological systems as they provide guidance for the technoscientific 
agendas. 
In the European proposal, the civil society appears as a fundamental actor in the 
governance of technoscience because it should be taken into account as the 
Converging Technologies programs are carried out and its agenda is defined. It 
should be noted that technoscientific advancements are not an end within itself, but 
rather a medium to achieve diverse governance objectives stipulated by the 
agendas. 
4.2 Sustainable Nanogovernance and Responsible Innovation 
After analysing the conflictive constitution of the sociotechnical nano network and 
describing the European proposal, this work advances on the need for the 
constitution of a sustainable nanogovernance in a context of socially responsible 
innovation. It is thus important to explicit (and operationalize) the concepts of 
sustainability and responsible innovation within a European context, which will 
then be applied to the Argentinian case. 
4.2.1 Nanotechnological Governance 
Starting from a traditional perspective, Schummer (2007) presents three possible 
definitions of nanotechnology. The Real Definition focuses on the research fields 
are contained under it. It presents the nanotechnologies in plural, contemplating its 
multidisciplinary aspect163. The Nominal Definition considers the nanotechnology 
as “… the investigation and manipulation of material objects in the 1–100 
nanometre range so as to explore novel properties and develop new devices and 
functionalities that essentially depend on the 1–100 nanometre range” 
(Schummer, 2007 p.81)164. A third definition was introduced on 1986 by the 
                                                 
163 In other words, the nanotechnologies contain the latest advancements in other disciplines that incorporate 
nano dimensions, for example, genetic engineering, organic chemistry, electrical engineering, and microscopic 
research, among others. 
164 The problem with this definition is that it does not explicit the limits of an application field for 
nanotechnology that is different from any biological or engineering disciplines, because all materials in nature 
are formed by nano-metric structures. Therefore, this definition does not present ethical dilemmas as there is 
not a distinct line of research to what was previously developed. This traditional vision of governance is unfit 
to explain the dynamics of the nano-medical market nor its governance. 
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software engineer Eric Drexler, the Teleological Definition, which defines 
nanotechnology in terms of its future objectives and values, such as health, wealth, 
and security. This focus was inspired by science fiction and the ethical problems 
involved were exposed in a fictitious setting, yet it remains an interesting starting 
point to understand the role of future expectations on governance, as they 
coordinate and shape innovation, especially during process of technological 
transition. A nanogovernance of that expectations inscribed in its constitutive 
process is needed. 
Instead of describing the nanogovernance as something given, this work proposes 
to discover relations in the distributed network and its transformation process. It is 
in the interest of this thesis to explain the actions and discourses that are empirically 
observed by performing an analysis of the nanotechnoscientific. (Latour, 1983). 
This nanotechnoscientific practice and its market, presented in the earlier chapters 
of this work clearly have a performative character on its governance. 
The perspective extracted from Kornelia Konrad (Konrad, 2010)  proposes the 
concept of governance of and by expectations. It captures the different ways of 
coordinating and regulating expectations (governance of expectations) and the 
different ways under which expectations are coordinated and shape the 
technological dynamics and, thus, the government (governance by expectations). 
It is interest groups (much like the already mentioned Welcome Trust in England, 
or the Nanotechnological Foundation in Argentina) the ones that supply the 
structures where the expectations that perform the future vision, are created and 
contrasted. The diverse expectations are then objectivized and singularized, thus 
becoming tradable goods that actors use upon their interest165. It is expectations 
what drives innovation, give legitimacy to the assignment of State’s resources in 
R+D, and define the structure of social debate about this new technologies (Borup 
et al., 2006). Different persons (or groups) with different perspectives value this 
incipient nanomedical market in dissimilar ways166. Therefore, there are many 
                                                 
165 A clear example is the IBM video which shows atoms moving in order to produce images and movement; 
the video does not explain to the general public that what is being seen is the mere interpretation of an 
instrument. The expectation of being able to control an atom allows for the creation of a safe nano market.  
166 An example of this is what occurred in a London conference a few years ago. A lecturer was emphasizing 
the benefits of nano-carriers for the treatment of different diseases, the lecture was backed by solid data and 
arguments. At the end of the lecture a young man asks: “¿Is there a solution to eliminate after the therapy the 
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frameworks or contexts where the actors confront each other to negotiate the future 
of nano-medicine, these confrontations generate dynamic political processes 
present throughout society in its wholeness rather than only on formal government 
structures (Leach et al., 2007). It is important for a sustainable nanogovernance to 
critically analyse the social construction of the representation of nature in the 
scientific and political context (Forsyth, 2003). In this line, it is fundamental to 
break the separation between what is natural and what is human (social) (Latour, 
2004) and accept the complexity and the disequilibria of the problem (Scoones, 
1999). This focus allows for the understanding of the dynamics under study: 
expectations create the field and its government, then they are re-interpreted in an 
interactive network process. The dynamics of expectations must be in conjunction 
with the beginning of the discussion about possible futures and gradually become 
inscribed as that expectations are managed, thus showing greater 
institutionalization and long term stability within our society. 
4.2.2 Sustainable Nanogovernance 
A detailed analysis of what we understand by sustainable is due as this is one of 
the most widely used terms within political speech in the past years, not always 
with the same connotation. In the XVIII Century, the term sustainability was first 
mentioned by Hans Carl von Carlowitz in his Sylvicultura Oeconomica (Carlowitz, 
1713), where he lists norms for the long term management of woodlands.  
In the report Our Common Future a definition of the term is given:  
Sustainable development is development that meets the needs of the present 
without compromising the ability of future generations to meet their own needs 
(Brundtland, 1987 p.43). 
Many economists stress the necessity of a strong definition167 that contemplate the 
impossibility of substituting the necessary capital  and the life cycle analysis 
(Goodland and Daly, 1996). Clearly, these economists defy the paradigm of 
                                                 
gold nano-particles that are in my body right now?” The lecturer could not answer this question, the reference 
framework that she had built was completely changed. 
167 At the beginning of the 90’ of the past century, the concept gained recognition, especially during the Rio 
conference in 1992. Inside the economic discipline, the neoclassical concept was hegemonic and had a wide 
impact in the definition of public policy. This focus was supported by the theories of capital substitution 
(human and natural resources) to define a (weak) concept of sustainability where consume is smoothed and 
crises (always due to external factors) are corrected to maintain economic equilibrium. 
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neoclassical growth models by incorporating new complexities from the real 
economy. This positions within economics and public policies where recycled by 
the business community, where the sustainability term has been incorporated as a 
corporative objective (Elkington, 1998). This general vision of sustainable 
development grew evermore hegemonic both within businesses and inside the 
public policy decision process (see for example the Kyoto protocol168). 
Colloquially, sustainability implies the maintenance of the characteristics of a 
system in a general sense. This is a vital concept since many actors reach 
deliberation with it incorporated as true. Now, to achieve a sustainable governance 
of nano-medicine, an operative definition of sustainability is required. While the 
traditional definition takes into account the concepts of human needs (both future 
and present) and their limitations (technical, political, economic, and social), it 
does so in a static manner (Brundtland, 1987).  The nano-medicine has a complex, 
uncertain dynamic, therefore a static approach is insufficient; the valuation of the 
characteristics of the system, human needs and its limitation are a permanent co-
constitutive process. This dynamic is constituted from agents interacting with 
perspectives that could diverge169. 
The question remains, how should States respond to perturbations and, how to 
achieve a sustainable governance of innovative technologies? The public policies 
must account for the duration and precedence of the perturbation, to count with a 
procedure for systematic response. It is proposed to understand the sustainability 
of the network from four dimensions that interact to operationalize public 
responses. If the perturbation is internal and short in duration, there is a problem 
of stability, and the re-establishing of the lost equilibrium should be promoted. If 
the origin is external, on the contrary, there is a need for resilience to answer to the 
perturbation. If the perturbation is long term in nature and internal, the durability 
is in line, and if external, robustness (Scoones et al., 2007). A non-equilibrium 
                                                 
168 After several years since the evident failure of the proposed objectives and despite successive 
reformulations, neither governments, nor businesses abide the signed agreements (Berkhout, 2002). 
169 To understand it, in the previous chapters the nanotechnoscientific practice, the market, and its co-
constituted risks were introduced. To achieve this, the interactions between agents (human and material) were 
followed, its discourse frontiers, economic relations, and impact (spill over) were delimitated. It is therefore, 
necessary to incorporate the dynamic dimension of the sustainability process, to dare to a sustainable practice 
that is deliberatively and reflexively constituted on a day-to-day basis (Vogler and Jordan, 2003).   
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dynamic perspective is required together with a constructivist perspective 
(accounting for humans and materials as agents). 
The proposed focus is individually reflexive and socially deliberative, a 
problematic and conflictive governance of nano-medicine is proposed. Firstly, the 
shared problematic must be constructed by the different actors of the network: the 
government, the market, and fundamentally, the affected public (or the needed for 
medical solutions to come from nano research). After that, solutions are to be 
looked for in accordance with the shared problematic within a network with 
interests (that could be conflictive). Clearly this processes are closely intertwined: 
different people give birth to different conceptions of the world, this dissimilar 
proposed contexts of discussion negotiate to reach agreement within uncertain 
contexts where knowledge is incomplete (Hajer and Wagenaar, 2003; Leach et al., 
2007). Summarizing, the proposed perspective starts from a technical, political, 
and economic knowledge, and requires reflection, deliberation, and confrontation 
for a sustainable process. 
4.2.3 Socially Responsible Innovation  
The previous section presented a dynamic non-equilibrium perspective, 
complemented with a constructivist perspective (giving agent status to both 
humans and materials) in an integrated manner which allowed for a sustainable 
nanogovernance. This section will build on this, stressing the importance of 
socially responsible innovations.  
While the concept of responsible innovation has been analysed by the literature 
since almost a decade ago (Hellstrom, 2003), its appearance on a public policy 
linked discourse appeared first on May 2011170. The European model of socially 
responsible innovation is based upon the principle of inclusion, which requires the 
participation of all relevant actors since the first stages of any given project; a 
process of co-building is proposed to ensure co-accountability. Owen, Macnaghten 
y Stilgoe (2012) point out three of the main characteristics of the European 
                                                 
170 The opening conference on the workshop managed by the Directorate-General Research (Brussels) on May 
2011 in charge of Octavi Quintana, cited by Owen, Macnaghten y Stilgoe (2012). 
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discourse on the matter. Firstly, there is a clear emphasis on the concept of science 
for society, this meaning that the research and innovation must solve the concrete 
problems of society in the context of a deliberative democracy. The second 
characteristic of the discourse is its emphasis on science with society, stressing the 
necessity to give answers to social issues and co-build future development. Lastly, 
it refers to the explicit link between innovation and responsibility, claiming that 
each actor should embrace the latter (Owen et al., 2012).  
The concept of responsible innovation and research (RRI) emerges in the 
discourse of the European Community in 2011, in the framework of the Horizon 
2020 program171, which focused on the ability of Europe to face social issues. The 
challenge is on how to govern science and innovation172 accounting for future 
scenarios, motivating social actors to work together in an inclusive manner. It is 
desirable and sought to align the process and its results with the values, necessities, 
and expectations of the European society. The creation of a policy driven by the 
necessities of society and with the participation of all actors through an inclusive 
participative focus is proposed (Owen et al., 2012). 
The European commission details six principles under which innovation is deemed 
responsible. Firstly, it requires all social actors – researchers, businessmen, 
politics, and the civil society to be compromised with the process of research and 
innovation. Secondly, a compromise with gender equality is acquired. Thirdly, 
creative learning is promoted, Europe should not only increase its number of 
researchers, rather to train better future actors so that they count with the right tools 
and knowledge, necessary to take responsibility and participate in the process of 
research and innovation in an integrated manner. Next, the ethical principle is 
postulated as a way to achieve high quality results. The fifth principle proposes that 
innovative processes should be transparent and accessible to the whole population 
in general. Lastly and summarizing what was said before, it is proposed that 
innovation design should be made with and for society (Stilgoe et al., 2013). A 
                                                 
171 http://ec.europa.eu/programmes/horizon2020/en/ 
172 Historically, innovation has produced negative impacts (or externalities in a more economical language) on 
society, upon which the authorities have applied more controls and proposed tightening of regulatory norms. 
This retrospective vision aims at mitigating the impacts of innovation when this its already impacting society 
(Rip, 2014). Clearly, this has severe limitations when applied to nanotechnology, where both present and future 
impacts are unknown and there is no previous regulatory framework that contemplates the possible scenarios. 
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sustainable governance of nanotechnology requires a questioning, in a public and 
reiterative manner, about the purposes and motivation of the new nano-products 
proposed. Summing up, for an innovative process to be RRI responsible it must be 
reflexive, anticipatory, deliberative, and receptive173. 
The responsibility implies two dimensions: one moral, and one epistemic. The 
former justifies whether an action can be deemed responsible, the latter relates to 
the quality of scientific knowledge (framework, method and focus). Grunwald 
(2011) operationalizes the concept of responsibility by dividing it into three 
constitutive layers: Empirical, ethic, and epistemological. The empirical layer 
invites us to reflect upon who takes responsibility, forwarding the relation with 
governability of the field, the interested parties, the people affected, power matters 
and its influence. The ethical dimension analyses the criteria of what is deemed 
responsible: Responsible acting criteria, the solution of the moral conflicts of 
ethical reflection, the reconstruction of the ethical patterns of justification, and 
arguing. The epistemological dimension studies what is known about the 
respective field (opportunities, risks, etc.) and what can be said about the feasibility 
and quality of knowledge, uncertainty, possible future scenarios, and possible risks 
(Grunwald, 2011). 
For an innovation to be responsible, it must fulfil regulation, efficiently 
communicate its project and purpose, perform an anticipatory reflection of possible 
applications and its social impact, and, lastly, it has to articulate mechanisms to 
include the actors in the process. Summarizing, a sustainable governance of 
nanotechnological innovations is the ability of nations, organizations, and 
individuals to create their own desired future in a continued manner through the 
generation of a continuous process that accounts for resources, processes, relations 
with interest’s groups and its impacts. The generation of a virtuous cycle of socially 
responsible innovations implies the introduction of economic, social, and 
environmental criteria.  
                                                 
173 Anticipatory, because it requires to describe and analyse future impacts, be them economic, social, 
environmental, or other. Reflexive, because on must reflect on the ends, motivations and impacts, and frankly 
analyse about what is known and what is unknown (risks, and other). Deliberative, because it forces us to 
include different visions, purposes, motivations, and questionings, through a process of dialogue, debate, and 
compromise, to incorporate the perspective of all agents involved. Receptive, because it must be an inclusive 
and open learning process (Owen et al., 2013). 
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4.3 Nanotechnology Dynamic in Argentina 
In this section, the purpose is to enquire into whether the technical and scientific 
dynamic of nanotechnology in Argentina is sustainable and responsible. A 
discourse analysis of public agencies is carried out, as they turn visible conflicts 
into future expectations and develop a sociotechnical network in Argentina174. The 
trail of the applied mechanisms for public agencies to extend and strengthen the 
network was followed by analysing regulations and citizen participation. 
Afterwards, the way in which state encourages public - private partnerships to 
achieve to have impacts on national production network is analysed. However, this 
network cannot be wholly understood without incorporating citizen participation 
and its impacts. Closing the matter, guidelines to build sustainable and responsible 
nanotechnology in Argentina are proposed. 
4.3.1 Narratives, Expectations and Inscriptions  
In a local newspaper (La Nación) by the year 2004, Argentina’s Minister of 
Economy leading in that moment explained:  
nosotros acabamos de lanzar un programa para el desarrollo de las 
nanotecnologías. Tomando contacto con centros de excelencia, identifiqué a quien 
dirigió las tesis de cuatro argentinos que trabajan en nanotecnología en la que es 
probablemente la empresa más importante del mundo en la materia, Lucent. 
(Caligaris, 2004 p.1)  
Clearly the Minister was conscious of the significance of establishing articulation 
with this business, but the implementation of a monopolistic agreement with 
Lucent, was confronted; both from political opposition and from the practice, rose 
up voices contrasting the agreement. The network in Argentina at that time was 
split apart: on one side, a small group of physics starting to research on 
nanotechnology and, in the other side, government establishing international 
connection, intended to set up networks around Lucent (Andrini and Figueroa, 
2008). 
                                                 
174 In particular, the creation of Argentina Nanotechnology Foundation is a black -boxing process, where 
conflicts could be hidden under a new voice that claim to represent the network. By studying actors in the 
dynamics of nanomedicine in Argentina, conflicts and contradictions extending and strengthening the network 
will be specified. 
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Changing its initial vision, in the following year, the government created an 
organisation called Fundación Argentina de Nanotecnología (Nanotechnology 
Argentinean Foundation, FAN), with the objective of promoting the development 
of human resources and technicians in this area, driving future expectations on 
nanotechnology and producing improvement on industrial structural framework 
competitiveness175. It became the site where disputes between government and 
scientists took place. 
From the beginning, the government introduced umbrella future expectations on 
the network, in order to encourage research and align industry, prospecting an 
efficient transfer of research results to society. By the year 2004 the government 
organized the first national workshop on the issue, leading to a program for 
vacancy areas, to finance the first four nanotechnology networks focused in basic 
research176 (FAN, 2010). The Argentine-Brazilian Centre for Nanoscience and 
Nanotechnology was created in November of that year, pushing national policy 
towards internationalization. This beginning favoured during the period from 2004 
to 2005 a profound discussion in the scientific community about the future 
guidelines. By the year 2006, the network just included nanotechnology 
technicians and the government, leaving aside market and society. Expectations 
creating processes articulated by the hegemonic role of the government, 
encouraging researchers to apply for public funding. Next, in 2006, a troubled 
interaction gave place to an inscription within the socio technical network: 
government disclosed the basis of the pillar nanotechnology on the Bicentennial 
National Plan on Science, Technology and Innovation, which added the 
participation of Argentinean industrial structural framework (SCTIP, 2006). This 
                                                 
175 The decree which created the FAN was criticized by specific actors. Particularly, Argentina Physics 
Association questioned the transparency and fairness, and requested to have participation on future schedule 
of the NAF. In addition, political opposition in Congress Lilia Puig de Stubrin (Radical Party) claimed 
executive power to clarify the role of Lucent and the financing. Draft of resolution of the Chamber of Deputies 
(Argentina), available on http://www1.hcdn.gov.ar/dependencias/ccytecnologia/proy/2.844-D.-05.htm 
(accessed 19/10/2012). 
176 The networks created, according to the government document previously mentioned: 
1. Laboratory on Network for Design, Simulation and Manufacturing of Nano and Micro devices, prototypes 
and samples, 2. Self-organization of bio and nano-structures for information transmission on molecular 
structure in neurobiology and biological processes, 3. Nanoscience and Nanotechnology Argentine Network: 
nanostructured materials and nanosystems, 4. Nanoscience and Molecular, Supramolecular Nanotechnology 
and Interfaces Argentine Network. 
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inscription has allowed to strengthen the network, from a narrative of the 
controversies to extend it by adding the industrial framework.  
That year, 2006, the new Minister of Economy and Production created an advisory 
board for the FAN established conditions for allowing firms participation. The 
view of a government leading expectations was soon replaced by various actors 
taking part in the foundation (despite of government managing it by majority). The 
Advisory Board was composed as follows: Alberto Lamagna (National Atomic 
Energy Commission), as the chief, Dr. Ernesto Julio Calvo (Ministry of Science 
and Technology - University of Buenos Aires) as the secretary, Dr. Joaquín Valdez 
(National Industrial Technology Institute), Ricardo Sagarzazu (INVAP), Dr. 
Roberto Carlos Salvarezza (National Scientific and Technical Research Council), 
BA Alberto Ridner (CONAE) and Engineer Adolfo Cerioni (National Agricultural 
Technology Institute) (Premici, 2007). Although changes were produced, the 
members continued to be exclusively highly qualified technical and scientific 
professionals, so it would be necessary to include the civil society for an effective 
governance as was mentioned in previous sections. 
In that year, 2006, FAN’s treasurer (who then became the national minister of 
Science and Innovation for production) outlined the necessity of creating patents 
and FAN begun to be more receptive to the new market suggestions. For example, 
a novel procedure was adopted whereby firms could apply for funding projects all 
year round, allowing for immediate evaluation, which sets off the credit cycle. The 
market could foresight an initiative of corporative governance, contributing to the 
strengthening of  the sociotechnical network, despite of being mainly supported by 
public funds (Premici, 2007). 
As this set of promises lost strength in the absence of transference, the government 
called for a new kind of funding program, asking researchers to be explicit about 
which are the possible benefits in a clear reference to priorities detailed in the 
Argentina Strategic Areas Program177. In 2007, the government organized the first 
                                                 
177 It was asked to research groups applying for funding projects to be linked to related civil organizations, as 
to show the social aim of the project. In the same way, they were asked to have arranges with firms’ potential 
users of the results of the projects, in order to show also its orientation on production. Although this procedure 




congress of the sector, Nanomercosur 2007, and researchers were invited as well 
as the business and the general public. With its byword Science, enterprise and 
environment, the government intended to push a greater transfer from research 
groups to the entrepreneurs’ network. However, governance guidelines just 
reached a corporative level, leaving aside the decision process to civil society.  
By 2008, the Secretary of Science and Technology was upgraded to Ministry, 
hence, nanotechnology acquired fundamental importance as a technology 
platform178. Additionally, the already important focus on the medical applications 
of nanotechnology within the sectorial public policies was specially stressed by the 
government in 2009. The National Scientific Information Directorate and the 
National Studies Directorate of Ministry of Science, Technology and Production 
Innovation carried out a mapping of nanotechnology’s sociotechnical network. In 
2010, the FAN started the diffusion of a document named Who is who in 
Nanotechnology in Argentina. This text stressed some guidelines179 for a 
nanotechnology policy.  
These guidelines can be summarised in the following manner: 
La tendencia es a que no haya nanoproductos, sino los productos clásicos con importantes 
mejoras por la intervención de la Nanotecnología (FAN, 2010 p.13). 
In 2010, the public financing of nanotechnology was increased. An example was 
the call for funding called FS NANO 2010 by the Argentine Sectorial Fund 
(FONARSEC), in which public-private partnerships projects were reinforced180. 
Another example was the Technology on Nanotechnology Sectorial Funds 2010, 
which supported associative projects working on providing new technology 
platforms and promoting innovation on diverse production areas. The supporting 
consisted of non-refundable contributions, allowing for an execution period of up 
to four years, and requiring 20% of the total cost as a counterparty contribution 
                                                 
178 In the National Strategic Plan for Science, Technology and Innovation named "Bicentenario" (2006-2010) 
it is explicitly set nanotechnology as a priority, and the National Agency for Science and Technology supported 
more than 160 projects in the period 2000-2008. 
179 The Secretary set out a national positioning in applied research that focused on the final stages of life cycle 
of products that primarily would have social impacts and would encourage local network of productive sectors. 
She emphasized the aim of growing stronger the research groups in nanotechnology, by using appropriate 
facilities and highly qualified human resources. In particular, there was special interest in replacing traditional 
monodisciplinary treatment of degrees by interdisciplinary technical-scientific communities of practice (FAN, 
2010). 
180 Details and analysis of presentations are commented in this chapter. 
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(Secretaría de Planeamiento y Políticas en Ciencia Tecnología e Innovación 
Productiva, 2013). These calls represent an intervention of the Government on the 
sociotechnical network encouraging partnerships and innovation to extent and 
strengthen it. 
The FAN this year also pushed for the integration of nanotechnology research with 
industry. This was done by coordinating meetings and creating an incubator space, 
thus pursuing the aim of extending and strengthening the network with a heterodox 
market perspective (in which the State was both the source and moderator of the 
economy). A study carried on during 2011 related to the technology transfer 
between research groups and the business network, it concluded that there was a 
need of special professionals that articulate the transfer relationships. These 
professionals should have a fluent dialogue with researchers and at same time be 
able to handle commercial language. Due to a lack of professionals with this 
profile, the government supported a postgraduate course in technology 
management for managers training (or linkers) in local universities (Vila Seoane, 
2011; Vila Seoane and Rodríguez, 2012). 
In parallel, international linkages were established within the network. The 
Binational Argentine-Brazilian Nanoscience and Nanotechnology Centre was 
created with the objective of organizing events, enabling spaces of academic 
knowledge, promoting cooperation among groups in both countries181. Also the 
Argentine-European Union Science, Technology and Innovation Connection 
Office (ABEST) was created to motivate research groups, entrepreneurs and SMEs 
to participate in the EU 6th and 7th framework programs (in which nanotechnology 
was a priority)182. In addition there was an agreement for students exchange with 
the United States, and initiatives were signed up for cooperation with European 
universities (Aydogan-Duda, 2012). According to FAN (2010), the commercial 
performance of nanotechnology in Argentina was lower than in the rest of the 
world, so it was imperative to spread this technology to firms and it was 
implemented an heterogeneous incubation system for firms183. 
                                                 
181 For more information see the center web page http://cabnn.mincyt.gov.ar 
182 For more information see the web page http://www.abest.mincyt.gov.ar 
183 First, the format spin off was given in order to satisfy the demand of business projects that aimed to develop 
and commercialize nano products. Second, professionals who have ideas but no space nor management 
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Regarding medical applications, there was a survey in 2011 that concluded that 
human health was the nanotechnology application mostly identified by firms 
(FAN, 2012)184. The dynamics of the network were translated and signed up in a 
document written by the minister during 2012, and it was there emphasized that 
innovations should be applied to production and pursue social objectives. The text 
had performative pretensions on nanotechnology dynamics in Argentina. 
4.3.1.1 Key inscription in the network: the government explicit its 
productive and social objectives   
As mentioned on Chapter 1, inscriptions play a fundamental role in understanding 
the dynamics and relationships in the network. In particular, in this section it is 
analysed a document in which it is exposed public policy, and it became 
immediately the promoter of future expectations. 
In April 2012, the minister of Science, Technology and Productive innovation, 
Lino Barañao, detailed technical and scientific policy of the government in a 
conference in the Biology and Experimental Medicine Institute (Barañao, 2012). 
In that document, he gave an idea of the conflictive dynamic and translated the 
presidential policy of social inclusion within the network. It was also emphasized 
also that investment in science and technology is realized by the society, so the 
technical science should have as an objective the attention of social needs: 
Y nosotros creemos que la ciencia y la tecnología pueden contribuir efectivamente a 
crear trabajo de calidad, basado en la educación y en la investigación…Estamos 
convencidos de que avanzar hacia una economía basada en el conocimiento es la 
manera más democrática de llegar a una sociedad más justa (Barañao, 2012 p.340-
341). 
                                                 
capacity were looking for, and for them a training and monitoring program was given. Finally, having had 
conscious of the fuzzy frontiers between institutions, it was looked innovation under “open” paradigm  
(Chesbrough, 2003). 
184 Within private environ two corporations were marked and a university working on nanomedicine. Firstly, 
the Lab Gador, a company from private ownership which had links to foreign companies, universities and the 
government. The Lab worked on research and development of pharmaceutic products and was oriented 
towards the reduction of toxicity in delivering, using nanotechnology technics. Secondly, the company 
Eriochem, which had links to public financing organisms, was focused on manufacture of injectable products 
for use in oncology based on biodegradable polymers synthesized (at nanoscale). Finally, Austral University 
specialized in design and manufacture of nanobiosensors. From the public sphere several institutions were 
noted in this field. The National Atomic Energy Commission - Constituyentes Atomic Center (CNEA - CAC) 
had been working on design and manufacture of nanobiosensors. The National University of Quilmes 
(UNQUI) – Strategy design of targeting of drugs lab (LDTD) had its focus on nanomedical research based on 
approved drugs and on the design of nanosystems of delivery of drugs. The National University of Entre Ríos 
(UNER) – Faculty of Engineering developed nanomaterials for biomedical applications. 
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To reach that objective, the government focused on research-business and state-
business associations in a context of improvements on infrastructure and 
interdisciplinary dialogue on the network. Particularly, it is emphasized the need 
of supporting technology SMEs development in order to generate quality work. 
The minister invited to set aside the prejudice that assumes that scientists are just 
seeking the benefit of mankind and employers have no qualms to increase their 
own wealth whatsoever. The nanotechnology sociotechnical network in Argentina 
contains these actors and a leading role of the State is need in order to make them 
fulfil their social responsibility. 
Putting techno science at the service of social problems requires quality and 
innovation in laboratories with an interdisciplinary practice. The main obstacle to 
this is the mono-disciplinary character of advisory committees and most journals, 
driving the work within a single field. The evaluation of the interdisciplinary and 
transfer to society activities is difficult to do, this is a problem since the State seeks 
to encourage techno-scientific innovation and the articulation in the production 
activity of technology based firms. 
Nanotechnology is one of the three platforms that the government185 would connect 
to four priority sectors. Health, would make nanomedicine had a crucial role in 
planning public technological policies. The minister emphasized that the 
translational medicine186, and expected to strengthen laboratories and hospital 
practice articulation, by creating units of translational medicine187. This policy 
extended the network by including the users. 
                                                 
185 The government general expectation is that scientific system (universities and laboratories) receive funds 
to produce knowledge to transfer to firms that convert it in goods consumed by users. To sustain that promise 
it is developing concrete experiences on interaction between firms. An example, is the company SANOFI that 
counts with a drug for Chagas, bat it needs scientists to prove the efficiency of its compounds library. This 
experience is carrying on Rosario City with support from the company and the government.  
186 At international level, in 2008, the National Science Foundation organized the workshop “Re-Engineering 
Basic and Clinical Research to Catalyze Translational Nanoscience”. Based on this discussion and on literature 
review, the article “Translational nanomedicine: status assessment and opportunities” explores scientific, 
economics, and social aspects, linked nanomedical initiatives and its future perspectives (Murday et al., 2009). 
187 An example is Ballestrini hospital (La Matanza), where an engineering school have place, with the objective 
of developing drugs for testing in the hospital. 
191 
 
4.3.2 Collective Hybrids as Agents of Change 
The mentioned inscription expressed the new future expectation of the 
government, encouraging new associations that articulate public and private, and 
pursue the enhancement of the productive network with a social inclusive impact. 
These associations applied to several calls for funding as hybrid collectives 
performing as agents of change and building the network. In this section four 
argentine hybrid collectives are described and analysed. 
4.3.2.1 POTENCIAR 
Project POTENCIAR was a collective plan (hybrid) that articulated government, 
academic, enterprise and international actors. Doctors, chemists, physicists, 
biologists, and engineers (among others) participated in the project, exemplifying 
the interdisciplinary nature of nanomedicine, and constituting a small socio-
technical network within itself. The objective was developed and the project 
commercialized biomedical implants based on advanced technology, which were 
built with nanomaterials and nano-coatings. 
The socio-technical network was constituted around one material: the nano-coating 
with ultrananocrystalline diamond (UNCD). Having this material and the skills 
and networks from the rest of institutional participants, the project proposed to 
develop four products. First, the encapsulation of magnets that may be located in 
the outer wall of the eye to attract supermagnetic particles, and injected into the 
eye to paste the detached retina. Second, the optimization of prosthesis of hip and 
knee made by INVAP. Third, coating drain valves in treating glaucoma. Finally, 
using sheets from UNCD to coat implantable devices Bio-Electro-Mechanical-
Systems (bioMEMS) in the eye for drug delivery. The socio-technical network was 
compounded of seven institutional participants188.  
                                                 
188 First, the INTEC (Institute for technology development for chemical industry), which was joined to adviser 
ANL (Argonne National Laboratory de USA), spread out scientific and technological knowledge from the 
UNCD material in form of a thin film that had the international patent. Second, to develop bioMEMS devices, 
it had had the support of the INTEC/Bioengineering in the Faculty of Engineering, University of Entre Ríos 
(Argentina). The network also was compounded of prosthesis manufacturers, INVAP, a company dedicated 
to the design and construction of complex technological systems, 30 years long in Argentina. For the 
production of magnetic nanoparticles and coating of magnets, the network had the Atomic Center Bariloche 
(CAB), Río Negro, Argentina. For the manufacturing of electric cardiac pacemaker, the network had the 
support of the company FLECHA. By the way, University of Buenos Aires (UBA), thought the Pathology 
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The sociotechnical network proposed would acquire the legal figure of public 
consortium (University of Buenos Aires, University of Entre Ríos and CONICET) 
and private consortium (FLECHA, INVAP and the Austral University Hospital). 
This network had specific articulations between nodes. First, the design group of 
the BioMEMS/NEMS and biopackaging (INTEC/Bioengineering-University of 
Entre Ríos, UNER) was complemented with groups of characterization, 
manufacturing, in nanotechnology and synthesis of films  of UNCD. In fact, it was 
planned to install a plasma induced by microwaves MPCVD in the INTEC in 
conjunction with trainning of  its own staff by ANL. A second articulation was 
established between the enterprises INVAP and Flecha. In conjuntion these 
companies, would provide the design and manufacturing of prosthesis of hip and 
knee, and impantable devices, of electro cardiac pacemaker for applications 
respectively, and these should interact with INTEC on the nano encapsulation of 
the products. Also, INVAP would be responsible for evaluation of the tribological 
response of hip implants and the wear of the films of encapsulation. The third 
complementariety, was between the design and manufacturer group  of magnetic 
nano particles on charge on Atomic Center Bariloche (CAB) and the staff of the  
INTEC/Bioengineering (UNER) with the objective of coating magnets with 
UNCD. Finally  the articulation between the group of UBA and Autral Hospital for 
doing the preclinic and clinic phases respectively. 
The project translates the future dynamics necessary to inscript a text in stages that 
allow for the consolidation of the public financing. Planning had seven stages, each 
one with its own objectives, a proposed dynamic of work and cost189. A 
fundamental issue that would perform the dynamic was what the future market 
expected of the project. 
The project had a monopoly in the market since the patent was current. Once it 
expires the market would go in competence and all competitors would have access 
to the product without paying patent rights. The patent was expected for two 
projects of the group: the use of films of UNCD to encapsulate magnets that would 
                                                 
department developed the preclinical for biocompatibility and the evaluation of intracorporeal implants. 
Finally, for developing the clinical phase of the project it has been available Austral Hospital (HA).  
189 In the appendix stages of POTENCIAR are detailed. 
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allow to paste the detached retina and the use of films as drain valves in the 
treatment of glaucoma. Commercially, these products could be sold directly to the 
public or by acquiring the rights of use of the patent190. 
4.3.2.2 Nanotechnology and Dengue 
Nowadays the manufacturing of clothes in the world is low tech but of high 
volume, so application of nanotechnology to the sector is attractive. The use of 
nanotechnology has raised in the last years, allowing to have multifunctional 
textiles: antibacterial, UV protection, easy cleaning, water and stains repellent. In 
this moment the innovation process has the focus on areas where the new principles 
are combined with traditional processes in order to achieve multifunctional 
products conserving its properties (Patra and Gouda, 2013).  
Textile industry in Argentina has a definite production chain. First, the 
manufacturing process of fibres, in which nanotechnology provides properties as 
UV rays absorption, antibacterial properties, water repellent, among others. These 
composite fibres at nanoscale are produced by dispersing nano sized materials in a 
fibre matrix. Second, the process of yarn, in which carbon nanotubes are used to 
release fragrances easily or allow the  clothing change its colour upon request (Ngo 
and Van de Voorde, 2014). 
One of the applications with greater social impact that could have Argentina is the 
capacity of manufacturing clothing that allow be mosquitoes repellent in order to 
prevent dengue in the country. The sickness is caused by the flavivirus transmitted 
to humans by the bite of the mosquito Aedes aegypti, the main vector in Southern 
America. Infection with any of four different virus serotypes leads to flu symptoms 
that specifically immunizes the subject against serotype in question, but the 
immunity is only partially against other viruses. Moreover, a second infection with 
another serotype triggers more severe haemorrhagic disease, with high risk of death 
(Estrada-Franco and Craig, 1995). 
                                                 
190 Other products: Coating if prosthesis of hip and knee, use of films of UNCD for BioMEMS devices to 
implant in the eye that have no patent awarded. These projects could commercialize just as projects. 
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Since 1916191  there were no indigenous cases until 1997, the year the dengue was 
restored in Argentina. This remains a matter of concern for the health of the 
population due to the presence of the vector in high densities in several places, low 
levels of immunity in the human population, the presence of endemic virus in 
neighbouring countries and the widespread presence of poor living conditions , 
including lack of drinking water, in areas where it is more likely that the virus 
would be entered (Aviles et al., 1999). 
Citronella oil is well established in the industry as an excellent mosquito repellent 
for use on clothing or curtains. Recently, the use of nanotechnology allows a slower 
release of oils, thus prolonging the time during which the fragrance is effective. In 
particular, the insect repellent is a nanoemulsion encapsulated of citronella oil, 
which is prepared by high pressure homogenization creating stable droplets that 
increase oil retention and reduce the release rate. Thus, the time is prolonged 
protection against mosquitoes (Sakulku et al., 2009; Specos et al., 2010). 
In Argentina, through the Science, Technology and Productive Innovation 
Ministry, government supported different projects. Particularly, it raises interest 
the project Nanotechnology for functional Textiles, which pursue to develop 
clothing that could repel insects, directed towards the vector of dengue and had the 
support of National Diagnostic and research in endemic and epidemic Centre. The 
project consists of a public-private association made by the National Institute of 
Industrial Technology (INTI), the Institute for Research in Science and 
Technology of Materials (INTEMA), the company Guilford Argentina and the Pro 
Work Foundation. The project has received 3 million pesos in the period 2011-
2014 (Abraham et al., 2012; Tallone, 2015). 
Clearly this project presents itself as a socio-technical that responsibly innovates 
to solve a social problematic, while streamlining the textile market. 
                                                 
191 Historically, several cases of dengue were reported in Argentina in the early twentieth century. In 1916, an 
epidemic with 15,000 reported cases occurred in the province of Entre Rios, in eastern Argentina. None of 
these patients had bleeding symptoms. 
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4.3.2.3 The case of arsenic  
In several regions of Argentina drinking water has high levels of arsenic. The 
national government estimates that more than 3 million Argentines are exposed to 
concentrations above 0.05 milligrams per litter of drinking water192, which is a 
serious public health problem193 (Swiecky, 2006). The most affected provinces are 
Buenos Aires, Chaco, Córdoba, Formosa, Jujuy, La Pampa, La Rioja, Mendoza, 
Santa Fe, Santiago del Estero, San Luis, Salta, San Juan and Tucuman and 
treatment technologies currently used to purify water are primarily by filtration 
(reverse osmosis) (Auge et al., 2010). 
In particular Argentine Government define the sickness known as Regional 
Chronic Endemic hydroarsenicism (HACRE) like 
…la enfermedad producida por el consumo de arsénico a través del agua y los 
alimentos. Esta enfermedad se caracteriza por presentar lesiones en la piel y 
alteraciones sistémicas cancerosas y no cancerosas, luego de un período variable de 
exposición a concentraciones mayores de 10 ppb en agua de consumo diario. 
Estudios recientes han demostrado que la población infantil expuesta durante el 
período prenatal y posnatal puede tener menor desempeño neurológico que los 
niños no expuestos. (Swiecky, 2006) 
The residents of the 9 de Julio shanty town submitted in July 2010 an injunction 
against the water company, ABSA, by high levels of arsenic in the water supply. 
While in the first instance the Argentinian Justice forced the company to deliver 
cans of drinking water to the population, the company appealed the measure. On 
December 2, 2014 the Supreme Court of Argentina issued a ruling where the need 
for a solution of the problem arises and emphasized that  
… el acceso al agua potable incide directamente sobre la vida y la salud de las 
personas, razón por la cual debe ser tutelado por los jueces. (Corte Suprema de 
Justicia de Argentina, 2014 p.2) 
Nanotechnology offers new possibilities for purification of water in the affected 
areas, namely, a new nano-oxide methodology used to remove arsenic from 
drinking water by adsorption. By using the oxide nanoscale, the contact surface is 
increased, so hundredfold arsenic is captured. In particular studies suggest that a 
                                                 
192 0,05mg/L present a serious problem, since the limit accepted by the World Health Organization is 0.01 
mg/L 0.01 mg/L. 
193 Hay evidencia epidemiológica que indica que la ingestión de arsénico inorgánico de manera prolongada 
provoca hiperqueratosis palmo plantar, cuyo síntoma principal es la pigmentación de la piel y la aparición de 
callosidades en las palmas de las extremidades (Castro de Esparza, 2004). 
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dose of between 200 and 500 milligrams of nano-rust allows to effectively treat 
one liter of water (Rocco, 2011). Moreover, some studies compare the efficiency 
of different commercial products in absorbing arsenic (Bang et al., 2011).  
While these new methods of purification are very efficient at removing arsenic 
from water, there is a need for specific research around possible environmental 
risks and health risks from the use of nanoparticles, it is necessary to analyse 
whether the increased reactivity has no toxic effects in humans or the environment. 
4.3.2.4 Biocatalysts with nanotubes 
The chemical industry is one of the most important and most developed economic 
sector at global level. It is continuously introducing new technologies, allowing 
access to new market segments and products in analytical and synthetic 
applications. In particular, bio catalysis is booming, as applications of catalytic 
enzymes in the industry are rising rapidly194 (Schmid et al., 2002). 
An Argentine association of public organisms, which developed biocatalysts based 
on a biological nanotubes support is an example of how different actors and 
resources can articulate to achieve registration of a patent at a national and 
international level, being of great potential for industry. The association involves 
researchers from national universities, University of Tucumán, and University of 
Santiago del Estero. In this line, the project was forwarded by the joint efforts from 
university researchers and Leloir Institute Foundation researchers. The articulation 
was managed by Inis Biotech, the exclusive representative for commercialization 
and industrialization of inventions and developments outcomes of the Leloir 
Institute. Finally, Conicet was involved also in the work group as funder, 
supporting salaries and infrastructure. Thus the group had four pillars that were 
articulated, allowed to register a patent for the new product in 2012.  
                                                 
194 To improve the level of efficiency of the catalysts, hard research work in industry has been made directed 
to optimize the carrier materials structure. In this sense, nanomaterials provide the right balance between the 
efficiency of the biocatalysts (surface, mass transfer resistance) and the amount of enzyme consumed in the 
process. Plenty of highly stable and efficient catalysts systems have been developed in nanotechnology labs, 
which function like molecular machines to catalyze multiple reactions, making a rapid change in biocatalysts 
industry (Wang, 2006). Due to biocatalysts functioning is based on the activity of the enzyme, it has advantages 
over the chemical treatments, because they are environmental respectful, work more efficiently, and reduce 
risk to operators (Bayona, 2014).  
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By the year 2012 the group presented, in fact, the national patent of the product 
named LYSOZYME AMYLOID FIBERS, SOLID CARRIER, BIOCATALYST 
AND PROCESSES (P20120102400), being owned by the four organizations, and 
leaving evidence of the inventors. In January 2014 the same group registered the 
patent at international system as WO2014006560 (A2)195. 
Applications of this product are diverse: it allows the possibility of cleanly 
synthesize biodiesel, and oil modification. Ecological synthesis from vegetable oil 
allows to obtain fatty acids esters (biodiesel)196, which is useful for a society which 
needs clean energy generation mechanisms. The possibility of modifying the 
properties of lipids allows for more added value from oils and from cheaper fats, 
which is interesting for the food and pharmaceutical industries. Already there are 
enterprises interested in the patent, such as biocatalysts manufacturers, biofuels 
producers and oil processors (Bayona, 2014). Clearly, we have actors in the market 
that are related to each other (or can be) with the patent (or its owners) to start a 
process of co-constitution that allows to draw sustainable energy and to make food 
industry processes more efficient. 
Beyond the analysis of the hybrid collectives, the following section intends to face 
the challenge of proposing a sustainable nanotechnology governance in Argentina. 
As was mentioned earlier, the European Union has incorporated the concept of 
Responsible Research and Innovation (RRI) in the narrative of the regulatory 
documents and in the financing of nanotechnologies. There are some articles and 
reports that analyse the impact of RRI in the nanotechnology sociotechnical 
networks in OECD countries. However, there is a lack of attention on the 
application in the developing countries, particular Argentina. 
4.3.3 The Constitution of the Nano Network in Argentina  
In this section, the dynamic of nanotechnology in Argentina is studied under the 
perspective of RRI, and in the context of a sustainable nanotechnology governance. 
                                                 
195 To see details of the patent follow this link: 
http://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140109&DB=EPODOC&locale=
en_EP&CC=WO&NR=2014006560A2&KC=A2&ND=2 
196 Glycerol in the process is also obtained as a byproduct. 
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It was argued that the sociotechnical network in Argentina was neither responsible 
nor sustainable, in accordance with the perspective exposed in the previous section. 
In the following paragraphs, the aspects that sustain this argumentation are 
presented, and the six principles proposed are analysed.  
In first place, RRI requires to be in touch with a commitment with all social actors: 
researchers, entrepreneurs, responsible politicians, civil society in the process of 
research and innovation. As mentioned earlier (4.2.1.), in 2004 the Argentine 
government began the building process of the nanotechnology industry by an 
arrangement with the company Lucent, trying to give direction from an un-
consulted vision, imposed by the state. The call in 2010 to offer financing is a clear 
example in which the Argentine government intended to lead the evolution of the 
network, giving partial participation to the private actors and the researchers on the 
constitution of the practice. The minister in charge of the innovation policies 
explained that public funding should have production objectives, as well as social 
ones197 and asked the engagement of all parts. However, in this new narrative, just 
experts the private firms and relater governmental agencies were involved in the 
decision making process. The stakeholders of society are summoned on the 
discourse, yet they are marginalized from the decision process. 
Secondly the RRI asks a commitment with gender equality. Nanotechnology is a 
new interdisciplinary techno-scientific domain; with different profiles converging 
on it. Professionals in physics, engineering and chemistry have been by a long time 
mostly man in Argentine and in the world, while in biology or medicine it has been 
identifying a rise in women in the last years. This nanotechnology network at work 
presents new possibilities and problems to the woman’s role (Meng and Shapira, 
2011). In this early stage in Argentina, it is important to achieve a greater degree 
of gender diversity within the laboratories, the companies and in government 
organisms, in order to achieve a sustainable nanogovernance. The government 
                                                 
197 In the article “Nanotechnological approaches against Chagas disease” authors set the issue of the illness 
chagas in America, responsible dor over 50.000 deaths annually (chronic chagas cardiomyopathy) and they 
realized a critic revision on the few research works published in the last 20 years in this issue. This manifested 
the difficulties to the design of drugs are more effective. In particularly, the nano systems of administration of 
drugs (nanoDDS) are useful to selectively deliver the drug into a intracellularly level, but the preclinical 





should give the example on this matter. It is a problem for the responsible 
sustainability of the dynamic that the board of the FAN was composed of seven 
men and just two women. 
Thirdly, being responsible includes carrying on a continuously creative learning 
process. Argentina not only has to rise its number of researchers, it is also necessary 
to train future actors so that they have better knowledge and tools to fully 
participate and assume responsibility in innovative process. One of the challenges 
is to prepare the new managers of nanotechnology enterprises. In this respect, The 
Faculty of Economic Sciences, of the University of Buenos Aires, began in 2014 
the Master in Management of Technology based Enterprises with the objective of 
training professionals to be managers. This postgraduate programme has the 
support of private firms and public organisms for its funding. In the curricula, it is 
included a seminar on nanotechnology industry where it is presented a general 
vision and current art practice, and they set out the expected trends on diverse 
environments; national, regional and global. The second challenge is to achieve 
that schools and universities be set out a creative learning process that allows 
citizens to become better informed and have capability, and to understand the 
nanotechnology innovative processes. 
Fourth, regardless of the legal and regulatory aspects in Argentina, RRI responsible 
innovation requires ensuring social relevance and acceptability of the results 
arising from the sociotechnical network. A study conducted in 2011 concluded that 
the Argentine nano research groups see the importance of regulatory issues and 
there are concerns about the toxicity of the materials involved. Although 
researchers in laboratories take precautions, it is necessary to ensure that when the 
materials are in contact with the users, they are not harmful to health, in this 
particular, there is an obvious emphasis on the nanomedical area. The study has 
two positions: some believe that the precautionary principle can control risks, 
others emphasize the need for a new regulation that addresses innovation and 
require social inclusion (Vila Seoane, 2011). 
With regard to the assessment of nanotechnology risks in Argentina, they are  
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abordando los temas de riesgos e impactos potenciales de la nanotecnología, 
articulando esfuerzos con los organismos regulatorios y, particularmente, formando 
parte del Comité de Nanotecnologías del IRAM. Este Comité es el encargado de la 
revisión y las recomendaciones relacionadas a: “Hoja de Datos de Seguridad” y 
“Metodología para la Evaluación del Riesgo de Nanomateriales”, entre otros. FAN 
(2014) 
This risk analysis performed by the Argentine state is performed on the basis of the 
international regulations of the International Organization for Standardization 
(ISO)198, which have been studied and included in local regulation without the 
participation of society. The contribution of users is crucial for the process to be 
responsible, it is previously required to inform the population to give all the 
necessary knowledge on the regulatory review. A key aspect of nanotechnology 
risks is to protect workers who are exposed to them, but also allowing them to 
participate and opine. In Argentina, the Superintendence of Occupational Risks199 
created in 2014 the Nanotechnology Observatory and Workers' Health for the 
purpose of disseminating information on the prevention of occupational risks in 
production environments or in the context of the analysis of nanomaterials. On the 
website of the observatory200 it is provided information on nanomaterials and 
recommendations for safe work and analysis and discussion of qualitative methods 
of bands control, which are currently used in various countries in nanotechnology 
risk assessment. Seldom is meant from the title an intention to foster inclusive 
participation, in fact the project simply disseminates information to third parties 
without problematizing it and without analysing the relevance to Argentine 
workers.  
With regard to medical applications, the provision 1719/2011 of the National 
Administration of Drugs, Food and Medical Technology (ANMAT) of the 
Argentine government, created the Program to Support Innovation in Medicines 
and Health Products (ANMAT, 2011). In its preamble, it makes clear that the new 
                                                 
198 This international organization is developing standards for nanotechnology industry primarily through the 
work of the Technical Committee 229, formed in 2005. The same has 34 participants and 14 observer countries, 
in joint with linking organisms including officials of the Union European and it consists of six working groups 
that address the following areas: terminology and nomenclature, measurement and characterization, 
environmental health and safety, material specifications, consumer and social issues, and a group that works 
on sustainable development. 
199This organism was created by Law No. 24,557, and it depends on the Ministry of Social Security of the 
Ministry of Labor, Employment and Social Security of Argentina. Its purpose is to ensure the effective 




generations of drugs (among them, the nanomedical drugs 201) require new 
approaches. The main objective of the program is to have a platform developed to 
accompany the R&D projects that articulate the interest of public health202. 
Although the idea is in line RRI, the website has only one built from 2011 to 2014 
project, clearly scope is extremely limited and does not guarantee an innovative 
process responsible. 
Fifth, RRI proposes that innovative processes are transparent and accessible to the 
general population. As previously mentioned in this thesis, to be responsible, the 
results and problems of nano must be clear and understandable. The Argentine 
government, through the ANF carries out various initiatives in this direction, but 
they have proven insufficient to ensure a responsible process. 
For example, the Nanotechnology for Industry and Society initiative holds regular 
meetings to link scientists with academic and industrial sectors, allowing it to share 
the opportunities offered by nanotechnology to improve products and processes, to 
increase competitiveness and to expand penetration market. It encourages scientists 
to articulate with business chambers, professional associations and government 
agencies interested in promoting new technologies. A positive aspect consists on 
that it is being carried out in various parts of the country and allows for the 
dissemination nanotechnology and its applications. The problem is that, judging by 
the respective programs of activities, has a top-down approach to the subject, does 
not have effective mechanisms to include society in the discussion and in the 
proposal of innovation.  
Also, with the aim of publicizing the risks and impacts of nanotechnology, 
coordination efforts are made with regulatory agencies under the "Nano-
sustainable" program, promoting contact between government agencies, 
                                                 
201 In particular, procedures that articulate the participation of various actors are established, in the field to 
allow inquiries regarding technical-scientific or regulatory issues. At the end of October 2012 there was only 
one project that entered the Faculty of Pharmacy and Biochemistry, University of Buenos Aires led by 
Professor Dr. Alejandro Sosnik. The initial target population are HIV-infected children, so it is a project with 
high social impact and constitutes an innovation as it is the first aqueous solution EFV developed for oral 
administration to children. 
202 See project entered in the webpage of ANMAT: 
http://www.anmat.gov.ar/apoyo_innovacion/aprobados/NUEVA%20FORMULACION%20PEDIATRICA%
20DE%20EFAVIRENZ%20Se%20plantea%20el%20estudio%20en%20un%20voluntario%20en%20Julio%
20de%202011.asp (consultado 10 diciembre 2014). 
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researchers and industry. While the proposal is interesting on the surface, in fact, 
they only spread international work and mention the work of the National Institute 
of Standardization (IRAM). 
Another initiative was prompted FAN Nano U203 program. This was proposed to 
make sensible university students about the importance of nanotechnology, 
challenges and implications in the field of labour and production. On the one hand, 
introductory activities will be held in different technical courses at universities 
across the country. On the other hand, a course is taught online, creating a space 
for interaction between participants and experts. The reality is that it only has a 
virtual course, which although interesting, it is clearly insufficient and too general 
on nanotechnology. 
In line with the previous initiative, but with the aim to sensitize primary and 
secondary students, he boosted FAN nanotechnologists for a Day204 program. The 
same is planned to disseminate and publicize nanotechnology in secondary level 
educational institutions in Argentina. Specifically, a contest where students must 
enter the world of nanotechnology and develop a working form is made aware of 
and sensitive. These initiatives are very good but isolated, not articulated with the 
network, so they do not allow extending it by including students and teachers in 
the process. 
Finally, regarding the fifth principle, the State organized the First Conference on 
"Nanotechnology and Sustainability", organized by the ANF, under the auspices 
of leading companies in nanotechnology and national universities205, aimed to 
define an agenda linked the regulation of the sector which cover environmental 
aspects and human health (including the entire life cycle of products). It was 
pursued contribute to the development of regulatory standards and industry 
standards, while it sought to promote communication between government and 
industry researchers to strengthen the technical and scientific basis in order to 
develop new regulatory frameworks. For it is explicitly made reference to what has 
                                                 
203 http://www.fan.org.ar/nanou/ 
204 http://www.fan.org.ar/acciones/nanotecnologos-por-un-dia 




been done in this area both in Europe and in the United States. The presentations 
potential risks of nanotechnology on human health and the environment, and to 
propose some good practices in laboratories and in industry were analysed. Also in 
the round tables of the regulation the situation in Argentina was discussed and 
emphasized the importance of establishing a regulatory framework specific 
Argentine nanotechnology should be articulated with other international initiatives. 
Finally, as a way of unifying the first five principles, RRI requires that 
nanotechnology is developed with and for the Argentina society. While  the FAN 
incubated companies and makes direct actions to bring the industry to work for 
society, it does not give society participation in policy decisions, also it neither 
opens public debate, nor a critical analysis of ongoing developments, nor opinion 
of users is contemplated is performed206. This has drawn criticism from various 
sectors of society in Argentina. In response thereto and in order to involve the 
whole society in the governance process, the ANMAT created a public consultation 
process on the web207. But until October 2014 he was empty: no consultation 
projects entered, which clearly states that cash is not functioning. 
As discussed in this section is clear that in Argentina there is now a de facto 
governance, built on a day-to-day business, government, researchers and society 
with conflicting interests. It is the action of the Argentine state which sets the 
context of the political debate and control dynamics with a techno-scientific top-
down policy, as it has explained. Clearly not responsible for failing to fulfil the six 
RRI principles and is not sustainable.  
4.3.4 Proposals for a Sustainable Nanogovernance 
To propose a new nano sustainable governance for Argentina was crucial to 
understand the existing de facto governance, which was made explicit above. From 
the current sociotechnical network described, it is proposed to incorporate a 
                                                 
206 Moreover, while the government organizes events in various cities titled Nanotechnology for the industry 
and society (e.g. the event developed the August 22, 2014, entitled Nanotechnology for Industry and Society 
in Rosario), a detailed analysis reveals that the agenda are events where scientific experts spread mainly 
nanotechnology. 
207 It is a tool for both the general public and professionals and institutions that can review issues under the 
competence of the body (the tool is available at http://opinion_publica.anmat.gov.ar/, retrieved December 10, 
2014). In it, the user can consult the draft of interest and send your opinion to be analyzed. 
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bottom-up management to conceptualize society-material interaction208 . Clearly, 
what is intended to regulate co-constitutes its governance process. 
From the operational point of view, and for effective public policy, this thesis 
proposes to use quantitative tools developed in chapter three. The first allows, from 
the numbers of the public-private project in question, consider the uncertainty of 
the future benefit of an innovative project and that the State consider the 
advisability of carrying out or not. If you choose to carry it out, the second tool 
helps the Government to assess what is the most efficient way to do it. In general, 
and as developed in chapter three, what is proposed is to combine purchase 
contracts with commitment to cost-share funding to create hybrid contracts, in 
order to have the benefits that can give an initial sum to projects (Push) but also 
have an innovative project award for socially responsible way and achieved a 
solution to a public problem (Pull). Such tools allow state the main funder of the 
controversial article network and make efficient projects to extend and strengthen 
the socio-technical network, giving sustainability decisions. 
In addition, to improve the dynamics of the nanogovernance constitution, it is 
required to change certain practices of the Argentine State that expand, from the 
scientific vision for society. Four strategies are proposed: (a) to incorporate the use 
of multi-criteria evaluation systems, (b) to achieve transparency of future scenarios 
knowing what we must do today (Backcasting), (c) to perform sensitivity analysis 
of the scenarios analysed and, finally, (d) to make a clear and precise mapping 
report of the various possible reference frames.  
An interesting proposal that would promote citizen participation and that the State 
should intensify in the future is the creation of the ANMAT observatory by the 
disposition 907/2011 ANMAT(2011). It is an instrument that aims to articulate the 
government agency with the various health institutions and citizens. It seeks to 
identify social problems to guide the regulator through a participatory and inclusive 
                                                 
208 The political ecology analyzes the relations between the environment, politics and society, emphasizing 
inequality, hierarchical relationships and asymmetries of power in relationships. Some authors assume that 
capitalism is the root cause of environmental degradation (from the domination of nature) (Vogel, 1995). On 
the other hand, others politics contemplates in its many forms, incorporating civil resistance movements 
(Paulson et al., 2003), individual relations and local cultural experiences (Peet and Watts, 1996; Bryant and 




system. Clearly this observatory democratizes the process of making the 
ANMAT209 it actively involves the citizenry. To give voice to professionals, 
meetings are held210 with associations representing a particular medical specialty 
where industry demands are identified and cooperation activities are developed. 
In summary, currently the nano dynamic driven and regulated by the Argentine 
State is established from a top-down approach. While the State clearly has a 
nanotechnology policy that aims to support the production structure to social 
inclusion, no participation is given to different actors in the process, neither the 
possible future scenarios are anticipated nor there is place for a reflective-
deliberative process that allows for sustainability. To be socially responsible, 
anticipation, reflection, discussion and confrontation are required, between 
different views and interpretations, to give sustainability, so as to go beyond the 
hegemonic perspective on what the problems are and what is the way forward211. 
It is important to accept (and publicize) that knowledge of the dangers is 
incomplete without forcing the concept of actuarial (or engineering) risk, adopting 
strategies that respond adaptively to the system and do not try to stabilize it. 
Chapter Conclusion 
This chapter has argued that Argentina has not a sustainable nano-governance. 
While Argentina nanotech policy is geared towards productive innovation with 
social inclusion, it has a top-down government approach, excluding society from 
the decision process. There is a need for public policies that foster an anticipative, 
thoughtful, deliberative and responsive dynamic. Anticipation requires a detailed 
analysis of all future, economic and social or environmental impacts. Government 
funding should be accompanied by a multiple impact analysis of each of nanotech 
                                                 
209 The Observatory is structured in two levels. The first works directly with the actors, analyzing their vision 
and perspectives on every topic under discussion. Participatory diagnosis forums where citizens meet with 
officials to assess ANMAT action lines of the body are made. 
210 In the framework of the Observatory, the ANMAT and Argentina Association of Pharmacy and Industrial 
Biochemistry (SAFYBI) organized a specific seminar nanotechnology during the month of October 2012 
where specific nano applications for the pharmaceutical industry were analyzed. They gathered at the event as 
researchers, technical, commercial, regulatory and general public directors. In particular, between national 
speakers highlighted Dr. Alejandro Sosnik (who, as noted, has a bill introduced in the ANMAT about HIV 
drug for children), Dr. Dante Beltramo (CONICET) and Dr. Eder Romero (who heads a research group at the 
University of Quilmes on nanomedicine). 
211 Thus multiple potential targets (and values) are recognized from a politicized perspective of sustainability. 
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projects. For example, in the case referred to the development of mosquito repellent 
clothing it is essential to examine in advance how this innovation could change 
labour relations in the economy and what will be its environmental impact. 
Reflexivity requires an introspective analysis of the motivations and promotes 
honest discussions about what is known and what is not, on nanotechnology. It 
does not give rise to much debate. The government risk analysis is only based on 
international standards. This perspective can be effective in certain industrialized 
countries, but its application can be detrimental to Argentina society. More 
research is needed in the Argentine context in order to have a responsible public 
policy. 
The release requires the inclusion of the perspectives of the stakeholders through 
open dialogue forums. The top-down approach only considers the government 
vision of nanotechnology. In this thesis it has been argued that it is important to 
give greater participation to the Congress and universities. Public interaction 
between agents with opposing views will help find a sustainable management that 
is socially efficient. 
Receptivity encourages open and inclusive process of learning. In this sense, this 
thesis is the importance of developing databases updated with information on all 
kinds of nanotechnology projects (whether successful or not). This will allow 
researchers to learn from past experiences and propose best practices for the future. 
In addressing the problem of nano sustainable governance, it has been taken into 
account that it is a discipline that combines basic science and technology, as a 
hybrid of both, poses a challenging dynamic. It is argued, therefore, that the 
specific features of industrial dynamics presented in chapter two has strong 
implications for regulation because they limit and intervene to shape the 
technology used. The key issue is that nanomaterials are not in general consumer 
products are intermediate goods that are used by other industries, which 
complicates the issue. 
To achieve the goal of this chapter has presented the innovative dynamic nano 
described in the first three chapters as a socio-technical network in the process of 
incorporation. First, we analysed how nanotechnology actors coordinate 
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expectations innovating, shaping a complex and controversial dynamics, where 
researchers, companies, governments and NGOs interact in a network of 
relationships from positions often conflict with each other. Then the state role is 
problematized in the process of establishing the network and is interpreted as a 
distributed computing agency. Now, to understand how this dynamic is perceived 
by the community in various ways, various surveys that incorporate the voice of 
users were analysed. Then it has been critically analysed the North American and 
European models of regulation, arguing that only the precautionary principle is 
compatible with sustainable governance. It was argued that the nanomedicine 
market is a dynamic non-equilibrium system, in contrast to the orthodox approach 
hegemonic "market equilibrium", which allows a clear conclusion on the need for 
sustainable governance to account for the complexity of economic systems 
involved. 
From the above, it was analysed the Argentinian case. Initially it described the 
public policy of the national government, which has prioritized technology and 
productive innovation in its action plan. Also it is shown in the public discourse a 
move from the old funding for basic science towards financing technologies 
applied to social and economic impact. This has been enrolled in the speech of the 
Minister of Innovation in 2012. Then four recent experiences of collective hybrids 
acting as agents of change, public-private partnerships with clear objectives to 
innovate in the context nano we analysed and plans. They are seeking to solve 
specific social and sensitive issues for society Argentina. Then the dynamic nano 
critically analysed in Argentina since the proposal of responsible innovation. While 
the government promotes this initiative, various problems and issues to resolve for 






The term Nanotechnoscience denotes an investigation method in which scientific 
and technical practices converge, being an engineering way of making science. 
Researchers in this field work in a complex context between Quantum and 
Classical Theory, using eclectic principles for producing new materials. Even 
though Nanotechnoscience has disciplinary antecedents in Physics and Chemistry, 
it involves different laboratory practices. On the one hand, new lines of inquiry are 
being exponentially unfolded, following a divergent research dynamics, where new 
hypothesis are generated from established paradigms. On the other hand, new 
patterns of complementarity arise such as development processes, new ways of 
using existing infrastructure and the institutional cooperation among different 
types of actors. 
This interaction amongst researchers, materials and devices in laboratories leads to 
a nanotechnoscientific practice. Human actors have different basic training. Hence 
they tend to select different theories when for solving a similar problem. However, 
all of them agree in choosing the same measuring instruments and the same 
computers programs. These devices have become a common reference in the 
scientific community and they have acquired great relevance in the dynamic of the 
practice itself. Furthermore, due to the need of scientific group members of getting 
government funds, the narratives about the past of similar technologies and the 
future expectations, play a major role for understanding interactions. This 
nanotechnoscientific practice spreads leading to a sociotechnical network 
articulated with its own dynamics. This resulting market has become a coordination 
mechanism through which the agents maximize their interests by establishing 
economic calculations and solving their disagreements defining prices according 
to their economic power. 
This sociotechnoscientific network have promoted great expectations, and co-
creates emergent risks in its own dynamic. Confronting with this incredible 
potential and its uncertain risks, policymakers have an important role to play in 
regulating this process. Firstly, they have to promote that companies work together 
with States, the scientific community and society, from the very beginning of the 
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innovation process. Secondly, they have to do the job under specific legal context, 
proposing actions aiming to reach an efficient sustainable governance of the 
industry. Given this problematic context, this doctoral thesis has argued (see 
chapter four) that it is necessary to build a sustainable and a RRI responsible 
process that co-creates a nanotechnology dynamic with and for the society. In 
addition, this chapter has argued that the application of this perspective to the de 
facto governance that is operating in the Argentinean nanotechnological field, 
would contribute to the development of a network constituted with and for society.  
This nanotechnological dynamics could be traced in every sector of the economy, 
providing many solutions to social problems. One possible application would be to 
eradicate the global hunger, increasing the agricultural and farming productivity. 
Another contribution has been the use of nanoproducts in textiles, which has 
contributed to the development of new functionalities. Moreover, a variety of nano-
innovations has been developed to create new and more efficient energy generation 
sources while achieving a reduction of pollution. The use of nanomembranes 
allows increasing the leaching methods effectiveness. Regarding to the pollution 
of the cities, nanotechnology has also offered more efficient ways to monitor air 
pollution. Moreover, nanomedicine has been a particularly rich field wherein 
variety of artefacts and products with high impact on human health have been 
developed. This is an interdisciplinary sector which has united biology, material 
science and engineering. Its impact has been noticeable on several medical fields 
such as diagnosis, drugs management, and regenerative medicine. It has been 
particularly emphasized the importance of nanotechnology when facing 
Alzheimer´s disease and many problems related to diabetes.  
This successful spread over variety of sectors has been forged by a sociotechnic 
network capable of claiming public and private funds for its research and 
production. This has opened up a public debate about the role of public policies in 
estimating costs of nanotechoscientific projects and, more importantly, to assess 
their potentials risks and social impacts. This thesis has examined the constitution 
processes and the dynamics of the nanotechnoscientific network and developed 
original valuation tools of its investment projects. To understand the constitution 
process of this network and its effects on several social areas, this thesis employed 
210 
 
the ANT perspective articulated with the risk society approach. In this way, it 
combined an observation of human and non-human interaction on the micro level 
with a theoretical interest in the organization of society. This nanotechnoscientific 
narrative and its social impact were examined, in such a way that it critically 
expanded traditional actuarial, financial and engineering approaches. Additionally, 
these investments in this sector have sunk costs and uncertain future benefits, 
hence, efficient valuation tools are needed for public management.  
This thesis has shown that the nanotechnoscientific network is built every day by 
the interaction of agents with conflicting interests, which is why public policies are 
essential to promote a sustainable governance. Even though the complex nano-
dynamics emerged in post-industrialised countries, it has spread throughout 
emerging countries and it has acquired particular characteristics. This thesis 
scrutinised the Argentine context, where public institutions together with 
technological companies have configured a sociotechnical network which is 
rapidly expanding. Since 2006, the Argentinean government has been promoting 
the development of the nanotechnology market, encouraging public-private 
partnerships to produce a positive impact on different economic sectors. The State 
has promoted and funded several projects in key areas of scientific innovation 
which have promised to produce socially inclusive future benefits.  
This thesis demarcated and articulated the concepts of sustainable nanogovernance 
and RRI responsible (section 4.2), and demonstrated that the Argentinean 
nanotechnology network is regulated by a de facto governance (section 4.3). Even 
though State´s policies intervene the productive sector aiming at addressing social 
inclusion needs (for the society), the State has a top-down perspective on policy 
making that excludes society from the different stages of the decision-making 
process. In response to this finding, this thesis proposed the incorporation of a 
bottom-up public management approach that integrates the recognition of the 
centrality of the interactions between society and nature (materials) - allowing 
policy makers to work with society. On the one hand, this thesis contributes to 
unfold the complex layers and interactions that feature the nanotechnoscientific 
network by looking at the practice, the market, the associated risks, the State and 
the users, and the conflicting interests and expectations that are being mobilised in 
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its constitution. On the other hand, this thesis contributed to the theory of 
technological governance theory by integrating the socio-material perspective 
offered by ANT theory.  
This thesis argued (section 4.3.3) that Argentina only relies on a de facto 
governance. To overcome this situation, this thesis formulated five proposals 
(section 4.3.4) that would contribute to move towards a sustainable governance and 
a responsible RRI. Firstly, it argued that it is necessary that the State evaluates 
research and investment projects incorporating variety of criteria addressing the 
complexities and layers the nanotechnoscientific practice and its effects involves. 
Secondly, it argued that it is important to imagine socially desirable future 
scenarios and perform backward induction analysis in order to define what it is 
necessary to do today (known in the specialised literature as backcasting). Thirdly, 
it argued that technicians have to consider users´ perceptions, opinions and 
sensibility towards risks when defining their research and production processes and 
goals. This thesis also highlighted the need to produce clear reports and to map the 
different interpretative frameworks mobilised by different stakeholders. In addition 
to this, this thesis offered evaluative quantitative tools to assess nano investments 
and projects that could be used by policy makers and investors (see chapter three). 
This toolkit addresses conflicting interests and provides clues to make efficient 
decisions that would both expand and strengthen the network and contribute to 
social sustainability. 
In order to have a nanodynamics sustainable and socially RRI responsible, this 
thesis also demonstrated that policymaking needs to be transformed. It has to 
abandon its underpinning conception of technology for society in favour of a new 
perspective of research with and for society – in line with the European approach 
to scientific, technological and social risks. In so doing, this thesis has deployed a 
critical analysis of the current regulatory frameworks operating in the US and in 
continental Europe (see section 4.2.1). In post-industrial Western countries, the 
neoclassical theory has been the hegemonic paradigm to understand economic 
investments and decisions. In this perspective, decisions must be oriented towards 
the establishment of an equilibrium. Hence, innovations should be regulated by the 
system in such ways that the equilibrium would be restored. This operates as an 
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imposition from above (from those with power) denying alternative ways to 
integrate the complex nanotechnology dynamics. This reinforces the power of 
dominant groups and silences society. To unpack policy making in the US and 
continental Europe, this thesis has drawn upon new narratives and made visible 
controversies and conflicting interests.  
Nano regulatory frameworks have been exported by these economic zones and 
have been also borrowed by emergent countries such as Argentina. Both policy 
transfer and borrowing have neglected the complexities and interactions that 
configure the network in each country. As a critical response to these approaches, 
this thesis demonstrated that the nanodynamics is a historically and geographically 
situated process. Hence, policy making needs to recognise and address the 
particularities of regional, national and local scenarios. The traditional perspective 
on economic investments – that revolves around the notion of equilibrium and only 
offers actuarial assessment tools- was not only criticised in this thesis, but it has 
also been expanded including previously neglected social and environmental. 
There are different perspectives on how to deal with this complexity. A dominant 
approach has argued that the State needs to statically regulate the nano dynamics. 
The metaphor of taking a picture of the nano dynamics in order to regulate captures 
the core of this conception. This thesis, on the contrary, proposed a constructive 
path analysis, wherein all agents take part in a collaborative network, which 
encompass reflexive and deliberative political processes (see section 4.1). 
Stakeholder groups (such as the already mentioned Welcome Trust in England, or 
the Nanotechnology Foundation in Argentina) have configured embryonic 
networks forging and disputing expectations about technology while also 
performing and constituting themselves. Different expectations have been 
converted into tradable goods, which has prompted innovators to legitimate their 
claims for state funding in Research and Technology and shaped the public debate 
on new technologies. Variety of interpretative frameworks confront in diverse 
scenarios in a continuous attempt to expand the sociotechnical network, generating 
dynamic political processes that are present not only in the bureaucratic, 
administrative and political structures of the state but also in wider society. In this 
context, this thesis described the nanodynamics unmasking relations and 
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transformational processes within the network, departing from analysis centred on 
the role of experts and of regulatory frameworks.  
This thesis also argued that nanotechnology governance must be sustainable. In so 
doing, it critically explored the traditional approach on governance highlighting its 
static perspective. Moreover, even though the traditional definition of 
sustainability encompasses an interest on social impacts; it neglects the complex 
and uncertain constitution processes involved and the interactions between society 
and nature. It is argued that the traditional static approach should be overcome to 
achieve a dynamic sustainability. The static approach to economic decision making 
is still dominant both amongst companies and policy makers. This thesis, on the 
contrary, argued that only a governance that includes reflection, deliberation and 
confrontation of different points of view and interpretations could shape a 
sustainable nano dynamics.  
To have a sustainable governance, this thesis argued that policymakers have to deal 
with disturbances with in-depth knowledge of their characteristics and deploy 
different responses to diverse scenarios. This thesis identified four potential 
scenarios and featured the corresponding optimal responses. Firstly, to deal with 
an internal disturbance of short duration, policy makers have to re-establish the lost 
equilibrium. Secondly, to deal with an external disturbance of short duration, 
policy makers need to be resilient. Thirdly, to address an internal disturbance of 
long duration, policy makers need to deploy durable strategies. Finally, to tackle 
an external disturbance of long duration; the efficient answer should be robust.  
This analysis has forged the concept of sustainable dynamics, in line with the 
European perspective “innovation and responsible research” (RRI). This RRI 
approach emerged in 2011, strengthening The European Union’s ability to deal 
with the new social challenges that the nano sociotechnical network has brought 
about. This perspective has sought to align the innovation process and its expected 
benefits with the values, necessities and expectations of the European society. The 
European Union has demanded that the socioscientific network should be 
immersed in an anticipatory, reflexive, deliberative and receptive governance. 
Anticipation requires detailed studies of the economic, social and environmental 
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carried by nano investments, research and projects.  In other words, state funding 
also has to be accompanied by a sophisticated social impact analysis. Reflexivity 
demands introversion about the motivations of launching new products on the 
market as well as honest debates around the available public information. 
Deliberation involves taking seriously users’ points of view by engaging them in 
permanent dialogue. These public interactions between contradictories points of 
view will help to find new and more efficient ways to shape a sustainable and a 
responsible RRI management. Lastly, receptivity should be encouraged by creating 
open and inclusive learning situations focusing on the features, risks and challenges 
of the production of nanomaterials and products. This thesis highlighted the 
importance of developing updated databases containing information on every 
nanotechnological project. 
The definition of sustainable and RRI responsible governance has required the 
articulation of diverse theoretical and methodological perspectives. This has 
allowed to unpack the nano dynamics in Argentina. Firstly, this study offered a 
better understanding of the nanotechnoscientific practice drawing upon ANT. This 
approach has made visible not only the sociotechnical network that underpins it 
but also its constitution process that takes place in the laboratory and in wider 
society. This thesis favoured the use of the term Nanotechnoscience due to its 
ability to capture the convergence of scientific and technical aspects of the 
investigation, expressing an engineering approach to science. Scientists, objects 
and materials interact defining a practice in laboratories. They are also part of an 
eclectic framework, where narratives of the past and of the future perform network 
interactions. This study, in line with its first specific objective, examined how 
laboratory practice is constituted through interactions amongst humans and 
devices. 
Moreover, this thesis analysed nano-industrial dynamics as an extension of its 
scientific practice. It re-elaborated a market theory where interactions are co-
produced alongside the generation of new risks. In so doing, this analysis focused 
on the design of markets and the role of experimentation, conceptualizing agents 
as collectives’ hybrids with unequal economic power. Additionally, this thesis 
illustrates the application of this approach to the nano market through an 
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examination of the construction processes of nanocarriers market, tracing 
controversies amongst researchers who register patents, investors who seek for 
profitability, pharmaceuticals that try to impose its authority in the market, a State 
that tries to regulate them, doctors who obey protocols, and users who seek a cure 
of to an illness. This was carried out by scrutinising the transactions between hybrid 
agents (humans and artefacts), which interact in a constant process of co-creation. 
Moreover, this thesis depicted how agents’ computing power is built, and how it 
reflects its own ability to impose prices. In this sense –responding to its second 
specific objective- it looked at how the laboratory practice is constituted as a 
sociotechnical network and a market. 
The nano dynamics have co-constituted risks not only for human beings but also 
for the environment. Making visible these effects configured another contribution 
of this thesis, which critically studied the dominant approach to risk management. 
To unpack how the market works, it showed the associated risks of the production 
of five nanomaterials, demonstrating that experts need to engage with other bodies 
of knowledge if they want to assess the implementation and effects on the 
innovations.  In so doing, it examined risk measurements in the production of five 
nanomaterials. Consequently, this thesis recommended that risk management 
methodologies should be changed in order to tackle current challenges.  
This thesis also contributes to the field of knowledge production on Science, 
Technology and Society. As part of its explanatory framework, this analysis 
integrated not only actors’ incentives but also mathematical models. In this way, 
this study payed attention not only to the complex features of the sociotechnical 
network but also to the construction of algorithms that would contribute to perform 
and extend it. In order to understand how actors make decisions, this study 
examined traditional investment valuation methodologies and highlighted their 
limits in uncertain and strategic contexts. It proposed the use of the real option 
methodology instead.  In so doing, it offered four economic models that could be 
used by States to value incentives in the network. The first model formalised the 
valuation of combined investments, contemplating the development stages, and the 
uncertainty over raw material prices and life cycle. A second model allows 
valuating nanotechnological investment projects accounting for multiple sources 
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of uncertainty. The third model mathematically operationalized the precautionary 
principle. The last model includes the State intervention in the market. Subsidies 
can be granted at the beginning of the project (push), or can be promised if the 
project succeeds (pull). The elaboration of these models is linked to the fourth 
specific aim, which proposed elaborating evaluative tools of investment projects in 
the nanotechnological market of combined investments contemplating the required 
cooperation among the actors of the market, the market’s uncertainty and the state 
regulations and incentives. 
Although this thesis contributes to the understanding of the problematic of the 
governance process in Argentina, this research has not succeeded in answering all 
its guiding questions. Next, some of the remaining tasks will be identified and will 
serve as refined questions for future investigations. 
This thesis, in line with its first specific objetive, analysed different visions about 
nanotechnology, and described the constitution of a new discipline that works 
using an eclectic theoretical frame. In this perspective, the narratives of the past 
and future expectations perform the nanotechnoscientific practice as a search 
regime. Although it contributed to a better understanding of the nanotechnology 
practice, it is essential to broaden its scope by doing more intense qualitative 
research in laboratories in order to contrast these new findings with those of this 
thesis. This is crucial to interpret agents’ interactions and the meanings attach to 
them. At the beginning of this investigation, the nano research centres were few 
with similar characteristics. However, during the last few years, the number of 
actors has rapidly increased as well as the heterogeneity amongst them.  
With regard to the second specific aim, this thesis examined how the 
technoscientific practice has been extended through a construction process of a 
sociotechnical network and creating its own market. Departing from the nano-
dynamics transforming power, both the constitution of the nano conveyors market 
and the economic power asymmetries were explained. Moreover, this study 
described the process by which new companies were created and identified the 
valuation methodologies used to assess nano assets. In relation to this objetive, it 
would be relevant to carry out qualitative research to further explore the 
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constitution of spin-offs in order to deepen the available knowledge on how 
companies are constituted in this sector. This kind of approach would offer relevant 
information that could inform policy making. 
With regard to the third specific objective, although this thesis showed that the 
nano network simultaneously co-constitutes risks while performing itself, it would 
valuable to deepen the analysis of the insurance companies’ role, particularly in the 
Argentine context. These companies are the only ones that effectively moderate 
innovations, due to their awareness that risks involved in the production of a 
nanoproduct could potentially lead to their bankruptcy. 
The fourth specific aim of this research guided the elaboration of an evaluation 
model of nanotechnological investment projects encompassing the required 
cooperation among the actors, the uncertainty in the market and the State 
regulations. Though four quantitative tools were successfully developed for 
orienting the public decision making process, it would be very useful to also 
develop an open source software. In this sense, another line of work could be the 
creation and implementation of a digital dashboard that articulates these four tools 
in such ways that could be used by variety of users, such as policymakers, 
entrepreneurs, scientists and lay public.  
The fifth specific aim of this thesis unpacked the role of the regulatory framework 
in the configuration of a market, focusing in particular on the role of the State. Even 
though the European regulatory framework was analysed, the future exploration of 
other normative matrixes would allow its critical assessment. To do so, it would be 
relevant to carry out comparatives studies of different national public policies, 
especially in Latin-America to map alternatives solutions that could improve, 
challenge or redefine the proposed sustainable and RRI responsible agenda.  
The last specific objective of this study explored the nanotechnoscientific dynamic 
in Argentina and argued that it has a de facto governance. As a response to this 
scenario, it has been argued that a sustainable and RRI responsible governance 
should be promoted instead. Registers, translations and black boxes are analysed 
in the constitution process of the sociotechnical network in Argentina. Proposals 
of how this new network could be steered towards a nano sustainable governance 
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has also been made. However, the political scenario has recently changed. After 
the general elections held in November 2015, an opposition party coalition will be 
in office from December onwards. Despite ideological differences with the current 
political power in office, the elected government has announced that current 
Science and Technological policies would be continue. This changing scenario 
demands more research on the particularities that nano governance would assume 
under this new government. 
Recent literature on standardization processes of the nanotechnological sector 
offers new lines of inquiry (Malsch et al., 2015; Queipo et al., 2015; Zi y Blind, 
2015). Over the last few years, the European Community has focused on 
standardization processes as a key to successfully link research along with global 
market. Hence, it has launched the nanoSTAIR project. It has built a platform that 
contributes to convert scientific knowledge into industrial documents, name as 
Standardization, Innovation and Research (STAIR). Particularly, the purpose of 
the nanoSTAIR initiative has been the promotion of a sustainable process which 
helps to transfer academic knowledge into standards accepted at global level, 
which would contribute to increase the productivity of relevant European 
companies. This initiative has been welcomed by researchers and the market 
(López de Ipiña et al., 2015). This development should guide new research that 
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Etapas del proyecto POTENCIAR 
La primera etapa es el desarrollo de las obras de infraestructura. Esta etapa incluye 
los costos de acondicionamiento de las instalaciones en las que se desarrollan los 
productos. El sistema MPCVD se instala en el Instituto de Desarrollo Tecnológico 
para la Industria Química (INTEC), el mismo provee la capacidad de 
nanoencapsulado de dispositivos implantables en el cuerpo humano. Esta 
instalación requiere de un acondicionamiento de INTEC, así como también el 
acondicionamiento de diversas áreas de la UBA.  
La segunda etapa contempla la adquisición de equipamiento. Primeramente, la 
compra del sistema MPCVD permite la elaboración del material principal que está 
presente en cada producto, el UNCD. Asimismo, para el recubrimiento de prótesis 
de caderas se necesita equipamiento, adquisición de literatura y revisión 
bibliográfica, el diseño y fabricación de dispositivos y máquinas de ensayo, el 
desarrollo de herramientas de cálculo y modelado, la instalación de máquinas y la 
puesta en marcha de las mismas. Dado que las prótesis de caderas son adquiridas a 
través del INVAP y es en este lugar donde se realizan los estudios tribológicos del 
producto creado, se necesita la adquisición de equipamiento para el laboratorio que 
esté ubicado en el lugar.  
En la tercera etapa se propone lograr el diseño, fabricación y caracterización de 
microchip para liberación controlada de medicamentos. Para esto se utiliza las 
facilidades de laboratorio de micro-nanofabricación de ANL/INTEC. Allí se utiliza 
un Sputtering de magnetrón y CVD para hacer crecer un piezoléctrico que sirva 
para romper la membrana permitiendo la liberación del medicamento, así como 
para mejorar la biocompatibilidad del implante.  
En la cuarta etapa se realizan las pruebas de funcionamiento de las prótesis y en 
especial las pruebas tribológicas212 de las mismas. A través de estas pruebas se 
                                                 
212 La tribología es el estudio de la fricción, del desgaste y de la lubricación que tienen lugar durante el contacto 
entre superficies sólidas en movimiento. 
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estudia el comportamiento de recubrimientos de UNCD; esto forma parte del 
estudio de la tribología.  
En la quinta etapa se realizan los estudios en laboratorios con animales como con 
células. Asimismo, se incluyen las aprobaciones de las entidades regulatorias, el 
diseño y generación de documentos y protocolos, los gastos en movilidad desde 
los centros de complementariedades. En el uso de nanopartículas para el 
desprendimiento de retina se procede, en esta etapa, a un completo y detallado 
diseño de protocolo según las normativas de: International Conference on 
Harmonisation (ICH), Good Clinical Practice (GCP) y Administración Nacional 
de Medicamentos, Alimentos y Tecnología Médica (ANMAT). Se elabora el 
Manual de Investigador (este permite servir de guía y da a conocer cada uno de los 
procedimientos necesarios para la ejecución del proyecto), consentimiento 
informado (procedimiento médico formal, el cual tiene como objetivo el respeto 
hacia la libertad que tienen los pacientes como individuos), diseño de CRF, carpeta 
de investigador, carpeta regulatoria. Junto a todo esto se incluiye la presentación 
en el ANMAT y Provincia de Buenos Aires la aprobación de pruebas clínicas Fase 
I y el sometimiento de la aprobación del protocolo según IRB del centro (comité 
de ética). Con respecto a la microválvula para el tratamiento de glaucoma, en esta 
etapa se deberían diseñar los estudios preclínicos.  
Para esta etapa pre-clínica, es necesario conseguir nuevas fuentes de 
financiamiento, teniendo un dispositivo funcionando y validado exploratoriamente 
siguiendo las guías de la normativa vigente en los organismos regulatorios como 
la FDA (USA), los más estrictos. Llegado a este punto se puede interesar al capital 
privado y hacer eficiente la transferencia de acciones o licencia. 
Los directivos del proyecto, al momento de presentarse al pedido de financiamiento 
público inicial, ya habían realizado varias reuniones con interesados (un inversor 
de riesgo extranjero, un inversor ángel nacional, una empresa farmacéutica 
nacional, una empresa de dispositivo farmacéutico nacional). 
En el caso de dispositivos para la liberación de drogas los objetivos son los mismos 
en cuanto al tipo de dispositivo que se trate; en el caso de dispositivo de UNCD y 
silicio y el dispositivo de polímero se realizarán estudios in vivo, es decir estudios 
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en conejos en el laboratorio de la UBA para evaluar la eficacia de liberación de la 
droga, el efecto terapéutico y seguridad. En el recubrimiento de prótesis de caderas 
con UNCD se analiza la influencia de parámetros de fabricación en la 
reproducibilidad de resultados, el análisis de los parámetros de fabricación en la 
reproducibilidad de los resultados, la influencia de las tolerancias en los materiales, 
en las tolerancias dimensionales y otros parámetros de fabricación. 
En la sexta etapa se realizan los estudios clínicos fase I. En esta etapa se tiene en 
cuenta las condiciones legales de protección intelectual de los productos 
desarrollados, diseño de documentos y contratos de conocimientos, gastos en 
cirugías y extracción de implantes, actividades clínicas (internaciones), estudios 
clínicos complementarios y calificación del personal para el desarrollo de esta 
etapa. Como ya fue aclarado el lugar del desarrollo de esta etapa es el Hospital 
Austral. 
En el uso de nanopartículas para el desprendimiento de retina se pretende el 
desarrollo de la técnica quirúrgica. Para esto se realizan tareas de entrenamiento a 
grupos de profesionales, con la necesidad de capacitar a cirujanos con 
entrenamiento en la técnica, el reclutamiento de pacientes en los que se va a realizar 
la prueba, el seguimiento de los mismos, la elaboración de las estadísticas y el 
informe final. En la microválvula para el tratamiento de glaucoma se realizarían 
los estudios clínicos correspondientes. En relación a los dispositivos para el 
transporte de medicamentos se propone realizar estudios clínicos bajo las normas 
GCP, siguiendo los requisitos FDA y ANMAT. Asimismo, se llevan a cabo estudio 
de fase I en seres humanos para evaluar la eficacia y seguridad. El recubrimiento 
de prótesis de caderas con UNCD plantea la necesidad de probar el producto en 
personas para ver su eficacia. 
Es necesario tener en cuenta que esta fase puede subdividirse en tres sub-fases: la 
fase A en la cual la prueba se realiza en un pequeño grupo de gente en general 
totalmente sana, básicamente para obtener el grado de toxicidad y seguridad que 
posee el producto en seres humanos. En la fase B es administrado a un grupo mayor 
de personas a los cuales se los considera como aquellos que necesitan el producto 
para una posterior recuperación, esto se hace para ver el grado de eficacia y la 
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información adicional en cuanto a seguridad que posee el mismo. En la etapa C la 
administración es masiva, por el hecho de encontrar un grado de eficacia definitivo 
y las posibles reacciones adversas. Una vez que se ha completado la fase clínica y 
se puede llegar a considerar que el producto podrá llegar a ser aprobada, se 
presentará ante el organismo necesario para su posterior aprobación. 
Con esta subdivisión se realiza la aclaración de que tanto el uso de nanopartículas 
para el desprendimiento de retina como los dispositivos para la eliminación de 
medicamentos terminarán en la sub-etapa B, ya que los mismos no tienen la 
posibilidad de ser probados en forma masiva. Es decir que se patentan no como 
productos sino como proyectos, en cambio los otros dos productos si serán 
lanzados al mercado para ser comercializados. 
La última etapa es la de patentamiento. El mismo se realiza por persona, como 
podrá observarse el recubrimiento de prótesis de caderas con UNCD y los 
dispositivos para la eliminación de medicamentos aun no tienen patente. Mientras 
que el uso de nanopartículas para el desprendimiento de retina y la microválvula 
para el tratamiento de glaucoma tienen en vías sus patentes. A partir de esta etapa 
se podrá considerar la existencia de una octava etapa relacionada al post-
patentamiento. 
 
